Sie sind auf Seite 1von 348

Cumulartive Designated Products as of: 10/3/2007 total designated products: 1749

Generic Name Trade Name Designated Indication

Valortim Treatment of anthrax infection


(+/-)-7-[3-(4-acetyl-3-methoxy-2- Prevention of serious adverse events associated with
propylphenoxy)propoxy]-3,4-dihydro-8-propyl- vascular leak syndrome caused by Interleukin-2
2H-1-benzopyran-2-carboxylic acid therapy
(1R,2S) 6-bromo-alpha-[2-
(dimethylamino)ethyl]-2-methoxy-alpha-(1-
naphthyl)-beta-phenyl-3-quinolineethanol Treatment of pulmonary tuberculosis (active disease)
Treatment of chronic lymphocytic leukemia and
(1S)-1-(9-deazahypoxanthin-9-yl)-1,4- related leukemias to include prolymphocytic leukemia,
dideoxy-1,4-imino-D-ribitol-hydrochloride adult T-cell leukemia, and hairy cell leukemia

(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-
dideoxy-1,4-imino-D-ribitol-hydrochloride Treatment of acute lymphoblastic leukemia

(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-
dideoxy-1,4-imino-D-ribitol-hydrochloride Treatment of T-cell non-Hodgkin's lymphoma
(2Z)-2-cyano-3-3hydroxy-N-[4- Prevention of acute rejection following kidney, heart,
(trifluoromethly)phenyl]-2-hepten-6-ynamide FK778 and liver tranplantation
For use in the treatment of cystic fibrosis resulting fron
a nonsense (premature stopcodon) mutation in the
(3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]- cystic bibrosis transmembrane conductance
benzoic acid regulatory gene.
(3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]- Treatment of Muscular Dystrophy resulting from
benzoic acid) premature stop mutations in the dystrohin gene.

(3S)-3-(4-trifluoromethoxybenzyloxy)-6-nitro-
2H-3,4-dihydroimidazo[2,1-b]oxazine Treatment of tuberculosis.

(3S)-3-[(2S)-2-({N-[2-tert-
butyl)phenyl]carbamoyl}carbonylamino)
propanoylamino]-4-oxo-5-(2,3,5,6- Treatment of patients undergoing solid organ
tetrafluorophenoxy) pentanoci acid transplantation.
(4S)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-
tetrahydro-1-H-pyrano[3?,4?:6,7]-indolizino-
[1,2-b]-quinoline-11-carbaldehyde O-(tert-
butyl)-(E)-oxime Gimatecan Treatment malignant glioma
For use in combination with 5-fluorouracil for the
(6R,S)5,10-methylene-tetrahydrofolic acid CoFactor treatment of patients with pancreatic cancer
(9-[N-(3-morpholinopropyl)-sulfonyl]-5,6-
dihydro-5-oxo-11-H-indeno [1,2-c] Prevention of post-operative complications of aortic
isoquinoline methanesulfonic acid anuerysm surgical repair
(R)-2-methyl-6-nitro-2-{4-[4-(4-
trifluoromethoxyphenoxy)piperidin-1-
yl]phenoxymethyl}-2,3-dihydroimidazo[2,1-
b]oxazole Treatment of pulmonary tuberculosis.
(R)-N-[2-(6-chloro-5-methoxy-1H-indol-3- Treatment of circadian rhythm sleep disorders in blind
yl)propyl]acetamide people with no light perception
(R)-N-[2-(6-Chloro-methoxy-1H-indol- Treatment of neuroleptic-induced tardive dyskinesia in
3yl)propyl]acetamide schizophrenia patients

(UDU-stereoisomer of c-UJUun UNU-terminal


UkUnhibitor) Treatment of acute sensorineural hearing loss

[5,10,15,20-tetrakis(1,3-diethylimidazolium-2-
yl)porphyrinato] manganese(III)pentachloride Treatment of Amyotrophic Lateral Sclerosis
For use to improve the yield of progentor cells in the
apheresis product for subsequest stem cell
1,1'-[1,4-phenylenebis(methylene)-bis- transplantation following myelosuppressive or
1,4,8,11-tetraazacyclotetradecan myeloablative chemotherapy
1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-
[(methylamino)carbonyl]hydrazine Cloretazine Treatment of acute myelogenous leukemia

1,5-(Butylimino)-1,5 dideoxy,D-glucitol Treatment of Fabry's disease.

Treatment of somatostatin receptor positive


111Indium pentetreotide SomatoTher neuroendocrine tumors.

166Ho-DOTMP Treatment of multiple myeloma.

17 a-Hydroxyprogesterone caproate Gestiva Prevention of preterm birth in singleton pregnancies

17-alltlamino-17-demethoxygeldanamycin
(17-AGG) Treatment of multiple myeloma.

17-allylamino-17-demethoxygeldanamycin
(17-AGG) For the treatment of chronic myelogenous leukemia

1-Deoxygalactonojirimycin Treatment of Fabry Disease

1-dexynojirimycin hydrochloride Treatment of Pompe disease

2-(3,5-dichloro-phenyl)-benzoxazole-6-
carboxylic acid Treatment of familial amyloid polyneuropathy

2-(3-diethylaminopropyl)-8,8-dipropyl-2- Treatment of mulitple myeloma and associated bone


azaspiro [4,5] decan dimaleate Atiprimod resorption

2-(3-Diethylaminopropyl)-8,8-dipropyl-2-
azaspiro[4,5] decane dimaleate Atiprimod Treatment of carcinoid tumors

2',3',5'-tri-o-acetyluridine Treatment of mitochondrial disease

2-0-Butyryl-1-0-octyl-myo-inositol 3,4,5,6-
tetrakisphosphate Treatment of cystic fibrosis

2-0-desulfated heparin Aeropin Treatment of cystic fibrosis.

20-mer complementary to Akt mRNA Treatment of stomach cancer

20-mer oligonucleotide complementary to Akt


mRNA Treatment of pancreatic cancer

20-mer oligonucleotide complementary to Akt


mRNA Treatment of glioblastoma

20-mer oligonucleotide complementary to Akt


mRNA Treatment of renal cell carcinoma
20-mer oligonucleotide complementary to Akt
mRNA Treatment of ovarian cancer

2'-3'-dideoxyadenosine Treatment of aquired immunodeficiency syndrome.

24,25 dihydroxycholecalciferol Treatment of uremic osteodystrophy.

2-chloroethyl-3-sarcosinamide-1-nitrosourea Treatment for malignant gliomas

2-chloroethyl-3-sarcosinamide-1-nitrosourea Sarmustine Treatment for malignant glioma


As a host-protective agent in the treatment of acute
2'-deoxycytidine myelogenous leukemia.

2-methoxyestradiol PulmoLAR Treatment of pulmonary arterial hypertension

2-methoxyestradiol Panzem NCD Treatment of ovarian cancer

2-methoxyestradiol Panzem Treatment of multiforme glioblastoma

2-methoxyestradiol Panzem Treatment of multiple myeloma

2'-O-methyl-phosphorothiolate
oliogribonucleotide Treatment of Duchenne muscular dystrophy

3-(3,5-Dimethyl-1H-2ylmethylene)-1,3-
dihydro-indol-2-one Treatment of von Hippel-Lindau disease.

3-(3,5-dimethyl-1H-2ylmethylene)-1,3-dihydro-
indol-2-one Treatment of Kaposi's sarcoma.

3,4-diaminopyridine Treatment of Lambert-Eaton myasthenic syndrome.


Treatment of well-differentiated papillary, follicular or
combined papillary/follicular carcinomas of the thyroid
3,5,3'-triiodothyroacetate gland.

3'-azido-2',3'dideoxyuridine AZDU Treatment of acquired immunodeficiency syndrome.


Treatment of Chronic Functional Vomiting to include
4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl) functional vomiting and cyclic vomiting syndrome.

4-(3-Methanesulfonyl-phenyl)-1-
propylpiperidine HCl Treatment of Huntington disease.

4,5-dibromorhodamine 123 Theralux Irradiation Deviceof chronic myelogenous leukemia


Treatment
Treatment of chronic iron overload resulting from
conventional transfusional treatment of beta-
40SD02 thalassemia major and sickle cell anemia.
4-Amino-1-[5-O-[(2R, 4S)-2-oxido-4-(4-
pyridinyl)-1, 3, 2-dioxaphosphorinan-2-yl]-b-D-
arabinofuranosyl]-2(1H)-pyrimidinone Treatment of hepatocellular carcinoma.
Treatment chronic functional motor and sensory
4-Aminopyridine deficits from Guillain-Barre syndrome
Treatment of acute flares in pediatric patients with
4-aminosalicylic acid Paser Granules ileo-cecal Crohn's disease
Treatment of mild to moderate ulcerative colitis in
4-aminosalicylic acid Pamisyl (P-D), Rezipas
patients (Squibb)
intolerant to sulfasalazine.

4-cholest-en-3-one, oxime Treatment of amyotrophic lateral sclerosis


4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-
[dimethylamino)acetyl]-4-piperidinyl]phenyl]-
1H-imidazole-2-carboxamide
monohydrochloride Treatment of acute myeloid leukemia
4-trifluoromethyl-N-(3.3a.4.4a.5,5a,6,6a-
octahydro-1,3-dioxo-
4,6ethenocycloprop[f]isoindol-2(1H)-yl)-
benzamide Treatment of smallpox.
4-trifluoromethyl-N-(3.3a.4.4a.5,5a,6,6a-
octahydro-1,3-dioxo-
4,6ethenocycloprop[f]isoindol-2(1H)-yl)-
benzamide post exposure prophylaxis against smallpox

5(S)-(2'-hydroxy ethoxy)-20(S)-Camptothecin Treatment of osteosarcoma (bone cancer)

5,12-Naphthacenedione, 10-[[3-amino-2,3,6-
trideoxy-4-O-(phenylmethyl)-a-L-lyxo-
hexopyranosyl]oxy]-7,8,9,10-tetrahydro-
6,8,11-trihydroxy-8-(hydroxyacetyl)-1-
methoxy-, hydrochloride, (8S,10S)- (9CI) Treatment of malignant gliomas
5,5',5"-[Phosphinothioylidyne-tris(imino-2,1-
ethanediyl)]tris[5-
methylchelidoninium]trihydroide
hexahydrochloride Treatment of pancreatic cancer

5,6-dihydro-5-azacytidine Treatment of malignant mesothelioma.

5,7-dihydroxy-3-(4-hydroxyphenyl)-chromen-
4-one Prevention of acute radiation syndrome

506U78 Treatment of chronic lymphocytic leukemia.


For use in post-exposure prophylaxis for occupational
5a8, monoclonal antibody to CD4 exposure to human immunodeficiency virus.

5-aza-2'-deoxycytidine Treatment of acute leukemia.

5-hydroxymethyl-2-furfuraldehyde Treatment of sickle cell disease

5-iodo-2-pytimidinone-2'-deoxyribose Treatment of malginant glioma

5-methyl-1-phenyl-2-(1H)-pyridone(CAS
53179-13-8) Pirfenidone Treatment of idiopathic pulmonary fibrosis

6,8-bis-benzylsulfanyl-octanoic acid Treatment of pancreatic cancer


Treatment of histologically confirmed advanced or
6-hydroxymethylacylfulvene metastatic pancreatic cancer.

8 Cyclopentyl 1,3-dipropylxanthine Treatment of cystic fibrosis.


For use in conjunction with the UVAR photopheresis
8-methoxsalen Uvadex to treat diffuse systemic sclerosis.

For the prevention of acute rejection of cardiac


8-methoxsalen Uvadex allografts.

90Y-hPAMA4 PAN-Cide Treatment of pancreatic cancer


Prevention of retinal detachment due to proliferative
9-cis-retinoic acid vitreoretinopathy.

9-nitro-20-(S)-camptothecin Treatment of pancreatic cancer.

9-nitro-20-(S)-camptothecin Camvirex Treatment of pediatric HIV infection/AIDS

a-(3-aminophthalimido) glutaramide Actimid Treatment of multiple myeloma

A10 & AS2-1 Antineoplaston Treatment for patients with brain stem glioma

Abetimus Treatment of lupus nephritis.

ACA125 Treatment of epithelial ovarian cancer


Intravenous treatment of patients presenting with
Acetylcysteine Mucomyst/Mucomyst 10 IV
moderate to severe acetaminophen overdose.

For the intravenous treatment of moderate to severe


acetylcysteine Acetadote acetaminophen overdose

Acid sphingomyelinase Treatment of Niemann-Pick disease type B.

Aconiazide Treatment of tuberculosis.

Adalimumab Humira Treatment of pediatric Crohn's disease.

Adalimumab Humira Treatment of juvenile rheumatoid arthritis

Adeno-associated vector expressing the


human lipoprotein lipase protein Treatment of lipoprotein lipase deficiency
Adeno-associated viral vector containing the Intramuscular treatment of patients with moderate to
gene for human coagulation factor IX Coagulin-B severe hemophilia
Adeno-associated viral vector containing the Intrahepatic treatment of patients with moderate to
gene for human coagulation factor IX Coagulin-B severe hemophilia

Adeno-associated viral vector expressing


human acid alpha glucosidase gene Treatment for Pompe disease

adeno-associated viral vector expressing


human retinoschisin-1 gene Treatment of X-linked juvenile retinoschisis (XLRS).

Adeno-associated viral-based vector cystic


fibrosis gene therapy Treatment of cystic fibrosis.

For use in conjunction with BCNU in the treatment of


Adenosine brain tumors.

Adenoviral vector expressing Herpes simplex


virus thymidine kinase gene Treatment of malignant brain tumors

Adenovirus-based vector Factor VIII


complementary DNA to somatic cells MiniAdFVIII Treatment of hemophilia A.

adenovirus-mediated herpes simplex virus- Use with gancyclovir in the treatment of malignant
thymidine kinase gene glioma

Treatment of respiratory syncytial virus lower


Aerosolized pooled immune globulin respiratory tract disease.

a-Galactosidase A Plant-Produced Human a-Glactosidase


Treatment A
of Fabry's disease

Aglycosyl anti-CD3 monoclonal antibody Treatment of new-onset type I diabetes mellitus

AI-RSA Treatment of autoimmune uveitis.


Treatment of neurocysticercosis due to Taenia solium
as: 1) chemotherapy of parenchymal, subarachnoidal
and racemose (cysts in spinal fluid)
neurocysticercosis in symptomatic cases and 2)
prophylaxis of epilepsy and other sequelae in
Albendazole Albenza asymptomatic neurocys
Treatment of hydatid disease (cystic echinococcosis
due to E. granulosus larvae or alveolar
Albendazole Albenza echinococcosis due to E. multilocularis larvae).

Albuterol Prevention of paralysis due to spinal cord injury


Treatment of primary immunodeficiency disease
Aldesleukin Proleukin associated with T-cell defects.

Aldesleukin Proleukin Treatment of metastatic renal cell carcinoma.

Aldesleukin Proleukin Treatment of metastatic melanoma.

Aldesleukin Proleukin For the treatment non-Hodgkin's lymphoma.


alemtuzumab Campath Treatment of chronic lymphocytic leukemia.
Treatment of osteogenesis imperfecta in pediatric
alendronate Fosamax patients 4 years of age and older

Treatment of the bone manifestations of Gaucher


Alendronate disodium Fosamax disease

Alfentanil Management of postherpetic neuralgia

Alfentanil Treatment of painful HIV-associated neuropathy


Replacement therapy in patients with Type II and III
Alglucerase injection Ceredase Gaucher's disease.

For replacement therapy in patients with Gaucher's


Alglucerase injection Ceredase disease type I.
Topical treatment of cutaneous lesions in patients with
Alitretinoin Panretin AIDS-related Kaposi's sarcoma.

Alitretinoin Panretin Treatment of acute promyelocytic leukemia


Treatment of skin blistering and erosions associated
allantoin Alwextin with inherited epidermolysis bullosa

Allogeneic human retinal pigment epithelial Treatment of Hoehn and Yahr stage 3 and 4
cells on gelatin microcarriers Spheramine Parkinson's disease.
Allogeneic peripheral blood mononuclear cells
sensitized against patient alloantigens by
mixed lymphocyte culture CYTOIMPLANT Treatment of pancreatic cancer
Allogeneic retinal epithelial cells transfected
with plasmid vector expressing ciliary
neurotrophic growth factor Treatment of retinitis pigmentosa
Allogeneic T-cells cultured with anti-CD3 and
IL-2; transduced with retroviral vector
(SFCMM-3), expressing herpes simplex 1
virus-thymidine kinase (HSV-TK) and Immunotherapy for acceleration of T-cell
truncated low affinity nerve growth factor reconstitution in patients undergoing allogeneic
receptor; selected with anti-low affinity nerve hematopoietic stem cell transplantation
gro

Allopurinol riboside Treatment of cutaneous and visceral leishmaniasis.

Allopurinol riboside Treatment of Chagas' disease.


Management of patients with leukemia, lymphoma,
and solid tumor malignancies who are receiving
cancer therapy which causes elevations of serum and
urinary uric acid levels and who cannot tolerate oral
Allopurinol sodium Aloprim for Injection
therapy.
Ex-vivo preservation of cadaveric kidneys for
Allopurinol sodium transplantation

Alpha-1-acid glycoprotein Treatment of cocaine overdose

Alpha-1-acid glycoprotein Treatment of tricyclic antidepressant poisoning


As supplementation therapy for alpha-1-antitrypsin
Alpha-1-antitrypsin (recombinant DNA Origin) deficiency in the ZZ phenotype population.
Inhalation therapy for the the treatment of congential
Alpha1-Proteinase Inhibitor (Human) deficiency of alpha1-proteinase inhibitor.

Alpha1-Proteinase Inhibitor (Human) ARC-API Treatment of cystic fibrosis


For slowing the progression of emphysema in alpha1-
Alpha1-proteinase inhibitor (human) antitrypsin deficient patients.

For replacement therapy in the alpha-1-proteinase


Alpha1-proteinase inhibitor (human) Prolastin inhibitor congenital deficiency state.

Alpha-galactosidase A Fabrase Treatment of Fabry's disease.

Treatment of alpha-galactosidase A deficiency


Alpha-galactosidase A CC-galactosidase
(Fabry's disease).
Long-term enzyme replacement therapy for the
Alpha-galactosidase A Replagal treatment of Fabry disease.
Prevention and treatment of intrinsic acute renal
Alpha-melanocyte stimulating hormone failure due to ischemia.

Treatment of inherited mitochondrial respiratory chain


Alpha-tocopherol quinone diseases
Treatment of severe peripheral arterial occlusive
disease (critical limb ischemia) in patients where other
Alprostadil procedures, grafts or angioplasty, are not indicated.
Treatment of intraventricular hemmorage associated
alteplase Activase with intracerebral hemmorrhage

Altretamine Hexalen Treatment of advanced adenocarcinoma of the ovary.


Teatment of B-cell chronic lymphocytic leukemia (B-
Alvocidib CLL) or prolymphocytic leukemia arising from CLL.

ambrisentan Letairis Treatment of pulmonary arterial hypertension

AMG 531 Treatment of immune thrombocytopenic purpura.

Amifostine Ethyol Treatment of myelodysplastic syndromes.


For use as a chemoprotective agent for cisplatin in the
Amifostine Ethyol treatment
For use asofa metastatic melanoma.
chemoprotective agent for
cyclophosphamide in the treatment of advanced
Amifostine Ethyol ovarian carcinoma.
For use as a chemoprotective agent for cisplatin in the
Amifostine Ethyol treatment of advanced ovarian carcinoma.
Reduction of the incidence of moderate to severe
xerostomia in patients undergoing post-operative
Amifostine Ethyol radiation treatment for head and neck cancer.
For the reduction of the incidence and severity of
Amifostine Ethyol toxicities associated with cisplatin administration.
Treatment of bronchopulmonary Pseudomonas
Amikacin SLIT Amikacin aeruginosa infections in cystic fibrosis patients

Amiloride HCl solution for inhalation Treatment of cystic fibrosis.

For the topical treatment of traumatic hyphema of the


Aminocaproic acid Caprogel eye.

Aminolevlinic acid hydrochloride Levulan Treatment of esophageal dysplasia

Aminosalicylate sodium Treatment of Crohn's disease.

Aminosalicylic acid Paser Granules Treatment of tuberculosis infections

Aminosidine Paromomycin Treatment of visceral leishmaniasis

Aminosidine Paromomycin Treatment of visceral leishmaniasis (kala-azar).

Aminosidine Gabbromicina Treatment of tuberculosis.

Aminosidine Gabbromicina Treatment of Mycobacterium avium complex.

Amiodarone Amio-Aqueous Treatment of incessant ventricular tachycardia.


For the acute treatment and prophylaxis of life-
threatening ventricular tachycardia or ventricular
Amiodarone HCl Cordarone fibrillation.

Ammonium tetrathiomolybdate Coprexa Treatment of Wilson's disease.

amonafide L-malate Xanafide Treatment of acute myeloid leukemia.


Prevention of pulmonary fungal infections in patients
at risk for aspergillosis due to immunosuppressive
therapy including those receiving organ or stem cell
transplants, or teated with chemotherapy or radiation
Amphotericin B inhalation powder for hematologic malignancies

Amphotericin B lipid complex Abelcet Treatment of invasive protothecosis.

Amphotericin B lipid complex Abelcet Treatment of invasive sporotrichosis.


Amphotericin B lipid complex Abelcet Treatment of invasive coccidioidomycosis.

Amphotericin B lipid complex Abelcet Treatment of invasive zygomycosis.

Amphotericin B lipid complex Abelcet Treatment of invasive candidiasis.

Amphotericin B lipid complex Abelcet Treatment of invasive fungal infections.

Amsacrine Amsidyl Treatment of acute adult leukemia.

Amyl nitrite, sodium nitrite, sodium thiosulfate Cyanide AntidoteTreatment


Kit of cyanide poisoning

Treatment of thrombocytosis in chronic myelogenous


Anagrelide Agrylin leukemia.

Anagrelide Agrylin Treatment of essential thrombocythemia.

Anagrelide Agrylin Treatment of polycythemia vera.

Ananain, comosain Vianain For the enzymatic debridement of severe burns.

Anaritide acetate Auriculin Treatment of patients with acute renal failure.


Improvement of early renal allograft function following
Anaritide acetate Auriculin renal transplantation.
Treatment of patients having experienced a severe
traumatic brain injury (Glasgow Coma Scale 3 to 8) in
order to decrease early mortality and improve long-
To establish and maintain anticoagulation in heparin-
Anatibant term functional andundergoing
neurological outcome
intolerant patients cardiopulmonary
bypass.
Ancrod Viprinex

Angiotensin 1-7 MARstem Treatment of myelodysplastic syndrome


Treatment of neutropenia associated with autologous
Angiotensin 1-7 bone marrow transplantation.
For ex-vivo treatment to eliminate mature T cells from
Anti pan T lymphocyte monoclonal antibody Anti-t Lymphocyte Immunotoxin
potential Xmmly-h65-rta
bone marrow grafts.
For in-vivo treatment of bone marrow recipients to
Anti pan T lymphocyte monoclonal antibody Anti-t Lymphocyte Immunotoxin
prevent Xmmly-h65-rta
graft rejection and graft versus host disease.

antiangiogenic components extracted from


marine cartilage Neovastat (AE-941)
Treatment of renal cell carcinoma

anti-CD23 IgG1, kappa monoclonal antibody Treatment of chronic lymphocytic leukemia

Anti-CD40 mAb Treatment of chronic lymphocytic leukemia


Prevention of acute graft rejection of human organ
Anti-CD45 monoclonal antibodies transplants.

Anti-CEA Sheep-human chimeric monoclonal


antibody labeled w/iodine-131 (KAb201) Treatment of pancreatic cancer
Prevention of human cytomegalovirus infection in
Anti-cytomegalovirus monoclonal antibodies bone marrow and organ transplant patients.
Treatment of human cytomegalovirus infection in
Anti-cytomegalovirus monoclonal antibodies bone marrow and organ transplant patients.
Prevention of human cytomegalovirus infection in
Anti-cytomegalovirus monoclonal antibodies patients diagnosed with AIDS.
Treatment of human cytomegalovirus infection in
Anti-cytomegalovirus monoclonal antibodies patients diagnosed with AIDS.

Anti-cytotoxic T lymphocyte antigen 4 Treatment of stage IIb to stage IV metastatic


monoclonal antibody melanoma
Treatment of drug resistant generalized tonic-clonic
Antiepilepsirine epilepsy in children and adults.

Antihemophilic factor (human) Alphanate Treatment of von Willebrand's disease


For the control and prevention of hemorrhagic
episodes and for surgical prophylaxis in patients with
hemophilia A (congenital factor VIII deficiency or
Antihemophilic factor (recombinant) ReFacto classic hemophilia).
Prophylaxis and treatment of bleeding in individuals
with hemophilia A or for prophylaxis when surgery is
Antihemophilic factor (recombinant) Kogenate required in individuals with hemophilia A.

Antihemophilic factor/von Willebrand factor Treatment of patients with von Willebrand's disease
complex (human), dried, pasteurized Humate-P

For the treatment of immunologic corneal allograft


anti-interferon-gamma Fab from goats rejection

Antimelanoma Antibody XMMME-001-DTPA Diagnostic use in imaging systemic and nodal


111 Indium Antimelanoma Antibody
melanomaXMMME-001-DTPA
metastasis. 111 Indium

Treatment of stage III melanoma not amenable to


Antimelanoma Antibody XMMME-001-RTA Antimelanoma Antibody XMMME-001-RTA
surgical resection.

For use as an index of hepatic drug-metabolizing


Antipyrine Test capacity.
Antisense 20-mer oligonucleotide
complementary to R2 component of
ribonucleotide reductase mRNA Treatment of acute myeloid leukemia

antisense 20-mer phosphorothioate


oligonucleotide [complementary to the coding
region of R2 component of the human
ribonucleotide reductase mRNA] GTI-2040 Treatment for renal cell carcinoma

Treatment of homozygous familial


Antisense inhibitor of apoB-100 hypercholesterolemia
Anti-tap-72 immunotoxin Xomazyme-791 Treatment of metastatic colorectal adenocarcinoma.

Anti-tenascin 81C6 monoclonal antibody


labeled w/ I 131 Treatment of primary malignant brain tumors
For the treatment of patients with hereditary
antithrombin III deficiency in connection with surgical
or obstetrical procedures or when they suffer from
Antithrombin III (human) ATnativ thromboembolism.
For replacement therapy in congenital deficiency of
AT-III for prevention and treatment of thrombosis and
Antithrombin III (human) Thrombate III pulmonary emboli.
For prophylaxis and treatment of thromboembolic
Antithrombin III (human) concentrate IV Kybernin P episodes in patients with genetic AT-III deficiency.
Preventing or arresting episodes of thrombosis in
patients with congenital AT-III deficiency and/or to
prevent the occurrence of thrombosis in patients with
AT-III deficiency who have undergone trauma or who
Antithrombin III human Antithrombin III human
are about to undergo surgery or parturition.

Anti-thymocyte Globulin (Rabbitt) Thymoglobulin Treatment of myelodysplastic syndrome (MDS)


Treatment of allograft rejection, including solid organ
(kidney, liver, heart, lung, and pancreas) and bone
Anti-thymocyte serum Nashville Rabbit marrow
Anti-thymocyte Serum
transplantation.

Antivenin crotaline (pit-viper) equine immune


F(ab)2) Antivipmyn Treatment of envenomation by Crotaline snakes

Antivenin, crotalidae polyvalent immune Fab Treatment of envenomations inflicted by North


(ovine) CroFab American crotalid snakes.
Treatment of envenomation by poisonous snakes
Antivenom (crotalidae) purified (avian) belonging to the Crotalidae family.
Treatment of acute graft-versus-host disease in
AP1903 patients undergoing bone marrow transplantation.

APL 400-020 V-Beta DNA vaccine Treatment of cutaneous T cell lymphoma.


For use as rescue treatment for early morning motor
Apomorphine dysfunction in late-stage Parkinson's disease.
Treatment of the on-off fluctuations associated with
Apomorphine late-stage Parkinson's disease.

Treatment of the on-off fluctuations associated with


Apomorphine HCl Apokyn late-stage Parkinson's disease.
For the treatment of patients in a vegetative state or
minimally conscious state for up to 12 months
following a severe traumatic brain injury (traumatic or
Apomorphine hydrochloride spontaneous)

For prophylactic use to reduce perioperative blood


loss and the homologous blood transfusion
requirement in patients undergoing cardiopulmonary
bypass surgery in the course of repeat coronary artery
bypass graft surgery, and in selected cases of primary
Aprotinin Trasylol c
Diagnosis and localization of primary, residual,
Arcitumomab 99m Tc-labeled CEA-Scan
recurrent and metastatic medullary thyroid carcinoma.

Arginine butyrate Treatment of sickle cell disease and beta thalassemia.


Treatment of beta-hemoglobinopathies and beta-
Arginine butyrate thalassemia.

arimoclomol Treatment of amyotrophic lateral sclerosis

Aripiprazole Abilify Treatment of Tourette's syndrome


Treatment of acute myelocytic leukemia subtypes M0,
arsenic Trisenox M1, M2, M4, M5, M6 and M7

Arsenic trioxide Trisenox Treatment of malignant glioma

arsenic trioxide Trisenox Treatment of chronic myeloid leukemia

Arsenic trioxide Trisenox Treatment of acute promyelocytic leukemia.

Arsenic trioxide Trisenox Treatment of multiple myeloma.

arsenic trioxide Trisenox Treatment of liver cancer

Arsenic trioxide Trisenox Treatment of chronic lymphocytic leukemia

arsenic trioxide Trisenox Treatment of myelodysplastic syndrome.


For the treatment of infections due to Plasmodium
artemether/lumefantrine Coartem falciparum or mixed infections including P. falciparum.

Artesunate Immediate treatment of malaria

Artesunate Treatment of malaria.

As-101 Treatment of acquired immunodeficiency syndrome.

Ascorbic acid Ascor L 500 Treatment of scurvy

Atomoxetine hydrochloride STRATTERA Treatment of Tourette's Syndrome


Prevention of Pneumocystis carinii pneumonia (PCP)
in high-risk, HIV-infected patients defined by a history
of one or more episodes of PCP and/or a peripheral
CD4+ (T4 helper/inducer) lymphocyte count less than
Atovaquone Mepron or equal to 200/mm3.

Treatment of AIDS associated Pneumocystis Carinii


Atovaquone Mepron Pneumonia.
Primary prophylaxis of HIV-infected persons at high
Atovaquone Mepron risk for developing Toxoplasma gondii encephalitis.

Treatment and suppression of Toxoplasma gondii


Atovaquone Mepron encephalitis.

Attenuated autologous cancer cells and


granulocyte macrophage colony stimulating
factor in combination with activated Treatment of primary central nervous system
autologous blood derived T-cells malignancies

augmerosen Genasense Treatment of acute myelocytic leukemia

augmerosen Genasense Treatment of multiple myeloma

augmerosen Genasense Treatment of chronic lymphocytic leukemia

autologous antigen presenting cells pulsed


with autologous tumor Ig idiotype Mylovenge Treatment of multiple myeloma
Autologous cultured endothelial cells on a Treatment of Fuch's dystrophy, pseudophakic bullous
donor human corneal disk keratopathy, and bullous keratopathy
Autologous dendritic cells pulsed with
autologous antigens from primay malignant
brain tumor cells DCVax-Brain Treatment
For adjuvantof therapy
primary in
brain malignant
melanoma cancerwith
patients
surgically resectable lymph node metastasis (Stage III
Autologous DNP-conjugated tumor vaccine M-Vax and limited Stage IV disease).
Therapy to improve the motor and sensory
neurological outcome in acute cases of spinal cord
Autologous
Autologous incubated macrophage injury
or allogeneic limbal epithelial stem
cells expanded ex vivo on human amniotic Treatment of ocular surface diseases that are
membrane characterized by total limbal stem cell deficiency

autologous tumor-derived gp96 heat shock


protein-peptide complex Oncophage Treatment of renal cell carcinoma

autologous tumor-derived gp96 heat shock


protein-peptide complex Oncophage Treatment of metastatic melanoma

Autolymphocyte therapy Treatment of renal cell carcinoma.

axitinib For treatment of pancreatic cancer.

azacitidine Vidaza Treatament of myelodysplastic syndromes

Treatment of oral manifestations of graft-versus-host


Azathioprine Imuran disease.
Inhalation therapy for control of gram-negative
bacteria in the respiratory tract of patients with cystic
aztreonam fibrosis

Treatment of stage IIb through IV metastatic


Bacillus Calmette-Guerin vaccine melanoma
Treatment of antibiotic-associated
pseudomembranous enterocolitis caused by toxins A
Bacitracin Altracin and B elaborated by Clostridium difficile.
Treatment of intractable spasticity caused by spinal
cord injury, multiple sclerosis, and other spinal
diseases (including spinal ischemia, spinal tumor,
transverse myelitis, cervical spondylosis, and
Baclofen Lioresal Intrathecal
degenerative myelopathy).
Treatment of intractable spasticity due to multiple
Baclofen sclerosis or spinal cord injury.

Baclofen Lioresal Intrathecal


Treatment of spasticity associated with cerebral palsy.

baclofen Treatment of dystonia

Balsalazide disodium Colazal Treatment of pediatric patients with ulcerative colitis

Prophylaxis of solid organ rejection.


Basiliximab Simulect

Prevention of gastrointestinal graft-versus-host


beclomethasone 17,21-dipropionate Bec disease
For oral administration in the treatment of intestinal
Beclomethasone dipropionate graft-versus-host disease.

Bendamustine hydrochloride Treanda Treatment of chronic lymphocytic leukemia


For adjunctive therapy in the prevention and treatment
of hyperammonemia in patients with urea cycle
enzymopathy due to carbamylphosphate synthetase,
ornithine, transcarbamylase, or argininosuccinate
Benzoate and phenylacetate Ucephan synthetase deficiency.

Treatment of acute hyperammonemia and associated


encephalopathy in patients with deficiencies in
benzoate/phenylacetate Ammonul enzymes of the urea
For the prevention of cycle.
visible light induced skin
Benzophenone-3, octylmethoxycinnamate, photosensitivity as a result of porfimer sodium
avobenzone, titanium dioxide, zinc oxide Total Block VL SPF 75
photodynamic therapy
Prophylactic treatment of oral mucositis resulting from
Benzydamine hydrochloride Tantum radiation therapy for head and neck cancer.
Assessing the risk of administrating penicillin when it
is the preferred drug of choice in adult patients who
Benzylpenicillin, benzylpenicilloic, have previously received penicillin and have a history
benzylpenilloic acid Pre-Pen/MDM of clinical sensitivity.
Treatment of full-term newborn infants with respiratory
failure caused by meconium aspiration syndrome,
persistent pulmonary hypertension of the newborn, or
Beractant Survanta Intratracheal Suspension
pneumonia and sepsis.

Beractant Survanta intratracheal suspension


Prevention of neonatal respiratory distress syndrome.

Beractant Survanta intratracheal suspension


Treatment
Treatment of
of neonatal
pulmonaryrespiratory distress syndrome.
arterial hypertension
associated with any New York Heart Association
Beraprost classification (Class I, II, III, or IV).

Beta alethine Betathine Treatment of metastatic melanoma.


Beta alethine Betathine Treatment of multiple myeloma.

Betaine Cystadane Treatment of homocystinuria.

Prevention of recurrence of primary ventricular


Bethanidine sulfate fibrillation.

Bethanidine sulfate Treatment of primary ventricular fibrillation.

Betulinic acid Topical treatment of metastatic melanoma

Bevacizamub Avastin Treatment of malignant glioma

Bevacizumab Avastin Therapeutic treatment of patients with ovarian cancer

Bevacizumab Avastin Treatment of pancreatic cancer

Bevacizumab Avastin Treatment of renal cell carcinoma


Treatment of cutaneous manifestations of cutaneous
T-cell lymphoma in patients who are refractory to at
Bexarotene Targretin least one prior systemic therapy.

bifidobacterium longum infantis 35624 Treatment of pediatric Crohn's disease

Bindarit Treatment of lupus nephritis.


Bioartificial liver system utilizing xenogenic Treatment of patients with acute liver failure
hepatocytes in a hollow fiber bioreactor presenting with encephalopathy deteriorating beyond
cartridge (BAL) Parson's grade 2
Use in the management of patients undergoing
continuous renal replacement therapy with
biocarbonate infusate Normocarb HF hemofiltration
For use as a graft for restoring a cornea-like epithelial
phenotype to
substitute for the normal corneal epithelium that is lost
in patients due to total limbal stem cell deficiency
Bio-engineered oral mucosal tissue

Bis(4-fluorophenyl)phenylacetamide Treatment of sickle cell disease.


Bispecific molucule with two linked murine
single-chain Fv regions directed against CD3 Treatment of indolent B-cell lymphoma, excluding CLL
& CD19 and NHL with CNS involvement
For use as an anticoagulant in patients with or at risk
of heparin-induced thrombocytopenia/heparin-induced
bivalirudin Angiomax thrombocytopenia thrombosis syndrome

Bleomycin Blenoxane Treatment of pancreatic cancer.


Bleomycin sulfate Blenoxane Treatment of malignant pleural effusion.

BMY-45622 Treatment of ovarian cancer.

Bortezomib Velcade Treatment of multiple myeloma

Bosentan Tracleer Treatment of pulmonary arterial hypertension.


Treatment of dynamic muscle contractures in pediatric
Botulinum toxin type A Dysport cerebral palsy patients.

Botulinum toxin type A Dysport Treatment of spasmodic torticollis (cervical dystonia).

Botulinum toxin type A Dysport Treatment of essential blepharospasm.


Treatment of dynamic muscle contracture in pediatric
Botulinum toxin type A Botox cerebral palsy patients.
Treatment of synkinetic closure of the eyelid
associated with VII cranial nerve aberrant
Botulinum toxin type A regeneration.

Botulinum toxin type A Botox Treatment of cervical dystonia.


Treatment of strabismus associated with dystonia in
Botulinum toxin type A Botox adults (patients 12 years of age and above).
Treatment of blepharospasm associated with dystonia
Botulinum toxin type A Botox in adults (patients 12 years of age and above).

Botulinum toxin type B Myobloc Treatment of cervical dystonia.

Botulinum toxin type F Treatment of spasmodic torticollis (cervical dystonia).

Botulinum toxin type F Treatment of essential blepharospasm.

Botulism immune globulin BabyBIG Treatment of infant botulism.

Bovine colostrum Treatment of AIDS-related diarrhea.


Treatment and symptomatic relief of Cryptosporidium
Bovine immunoglobulin concentrate, parvum infection of the gastrointestinal tract in
Cryptosporidium parvum Sporidin-G Treatment of cryptosporidiosis
immunocompromised patients. caused by the
presence of Cryptosporidium parvum in the
gastrointestinal tract of patients who are
immunodeficient/immunocompromised or
Bovine whey protein concentrate Immuno-C immunocompetent.

Branched chain amino acids Treatment of amyotrophic lateral sclerosis.

Brimonidine Alphagan Treatment of anterior ischemic optic neuropathy.


Brivaracetam Treatment of symtomatic myoclonus
Treatment of mild to moderate keratoconjunctivitis
Bromhexine Bisolvon sicca in patients with Sjogren's syndrome.

Radiation sensitizer in the treatment of primary brain


Broxuridine Broxine/Neomarktumors.
For use in combination with paclitaxel in the treatment
bryostatin-1 of esophageal cancer
For use as a diluent in the intrathecal administration of
methotrexate and cytarabine for the prevention or
Buffered intrathecal electrolyte/dextrose treatment meningeal leukemia and lymphocytic
injection Elliotts B Solutionlymphoma.

For the treatment of pruritus in patients with Alagille


Buffered Ursodeoxycholic Acid Ursocarb Syndrome

Buprenorphine hydrochloride Subutex Treatment of opiate addiction in opiate users.

Buprenorphine in combination with naloxone Suboxone Treatment of opiate addiction in opiate users.

As preparative therapy in the treatment of


Busulfan Busulfex malignancies with bone marrow transplantation.
For use as preparative therapy for malignancies
Busulfan Spartaject treated with bone marrow transplantation.

Busulfan Spartajet-Busulfan
Intrathecal therapy for neoplastic meningitis
Preparative therapy for pediatric patients undergoing
busulfan Partaject bone marrow transplantation

Busulfan Spartaject Treatment of primary


For use in children asbrain malignancies.
a modulator of chemotherapy
for the treatment of pediatric patients with
Buthionine sulfoxamine neuroblastoma
Use as a modulator of chemotherapy for the treatment
of pediatric patients with primary malignant brain
Buthionine sulfoxamine tumors

Butyrylcholinesterase Treatment of post-surgical apnea.


For the reduction and clearance of toxic blood levels
Butyrylcholinesterase of cocaine encountered during a drug overdose.

BW 12C Treatment of sickle cell disease.

C1 esterase inhibitor (human) Treatment of angioedema


Treatment and prevention of angioedema caused by
C1 esterase inhibitor (human) C1-esterase inhibitor deficiency.
Prevention and/or treatment of acute attacks of
C1-esterase-inhibitor, human, pasteurized Berinert P hereditary
Preventionangioedema.
of acute attacks of angioedema, including
short-term prophylaxis for patients requiring dental or
C1-inhibitor C1-inhibitor (human)
othervapor heated,
surgical Immuno
procedures.
C1-inhibitor C1-inhibitor (human) vaporofheated,
Treatment Immuno
acute attacks of angioedema.

cAC10-vcMMAE (4) Treatment of Hodgkin's lymphoma.

Caffeine Cafcit Treatment of apnea of prematurity.

Treatment of symptomatic Paget's disease (osteitis


Calcitonin salmon nasal spray Miacalcin Nasal Spray
deformans).

Treatment of symptomatic Paget's disease (osteitis


Calcitonin-human for injection Cibacalcin deformans).

Treatment of hyperphosphatemia in end stage renal


Calcium acetate Phos-Lo failure.

Treatment of hyperphosphatemia in end stage renal


Calcium acetate disease.
Treatment of hyperphosphatemia in patients with end
Calcium carbonate R & D calcium carbonate/600
stage renal disease.

For use as a wash for hydrofluoric acid spills on


Calcium gluconate Calgonate human skin.
For use in the emergency topical treatment of
Calcium gluconate gel H-F Gel hydrogen fluoride (hydrofluoric acid) burns.
Emergency topical treatment of hydrogen fluoride
Calcium gluconate gel 2.5% (hydrofluoric acid) burns.

Calfactant Infasurf Acute respiratory distress syndrome (ARDS)

Capsaicin Treatment of postherpetic neuralgia.


Treatment of intermetatarsal neuroma (Morton's
Neuroma) that does not respond to conservative
treatment and requires either neurectomy or
Capsaicin neurolysis

capsaicin Treatment of erythromelalgia

Capsaicin Treatment of painful HIV-associated neuropathy

Treatment of N-acetylglutamate synthetase


Carbamylglutamic acid deficiency.
Treatment of persons with AIDS and in patients with
symptomatic HIV infection and a CD4 count less than
Carbovir 200/mm3.

Carmustine Treatment of intracranial malignancies.

Treatment of oral drug overdosage to speed lower


Cascara sagrada fluid extract bowel evacuation.

Catumaxomab Removab Treatment of ovarian cancer


CD4 human truncated 369 AA polypeptide Soluble T4 Treatment of acquired immunodeficiency syndrome.
Treatment of graft versus host disease and/or
rejection in patients who have received bone marrow
CD5-T lymphocyte immunotoxin Xomazyme-H65 transplants.

CDP571 Treatment of Crohn's disease.

Ceftriaxone sodium Rocephin Treatment of amyotrophic lateral sclerosis


For use in patients receiving high dose chemotherapy
who are unable to generate an acceptable dose of
peripheral blood stem cells and who have a sufficient
Cells produced using the AastromReplicelle bone marrow aspirate without morphological evidence
System and SC-I Therapy Kit of tumor

Cenersen sodium Treatment of acute myeloid leukemia

Treatment of scorpion envenomations requiring


Centruroides immune F(ab)2 Alacramyn medical attention.

Ceramide trihexosidase/alpha-galactosidase
A Fabrazyme Treatment of Fabry's disease.

Prophylactic treatment of patients exposed to


cethromycin inhalation anthrax.

Cetiedil citrate injection Treatment of sickle cell disease crisis.

cetuximab Erbitux Treatment of pancreatic cancer

Treatment of squamous cell cancer of the head and


neck in patients who express epidermal growth factor
Cetuximab Erbitux receptor.

Chenodeoxycholic acid Chenofalk Treatment of cerebrotendinous xanthomatosis

chenodeoxycholic acid Treatment of cerebrotendinous xanthomatosis


For patients with radiolucent stones in well opacifying
gallbladders, in whom elective surgery would be
undertaken except for the presence of increased
Chenodiol Chenix surgical risk due to systemic disease or age.

Chimeric (human-murine) G250 IgG


monoclonal antibody Treatment of renal cell carcinoma.

chimeric (murine-human) IgG1 mAb against


IL-6 Treatment of multiple myeloma

Chimeric (murine-human) IgG1k monoclonal


antibody against interleukin-6 Treatment of Castleman's disease

For treatment of shiga-toxin producing bacterial


Chimeric monoclonal antibodies infection.
Chimeric monoclonal antibody to mesothelin Treatment of pancreatic cancer

Chimeric M-T412 (human-murine) IgG


monoclonal anti-CD4 Treatment of multiple sclerosis.
Chimeric, humanized monoclonal antibody to Prophylaxis of Staphylococcus epidermidis sepsis in
staphylococcus low birth weight (1500 grams or less) infants.
For use in the amelioration of oral mucositis
associated with cytoreductive therapy used in
conditioning patients for bone marrow transplantation
Chlorhexidine gluconate mouthrinse Peridex therapy.
cholic acid (3 alpha, 7 alpha, 12 alpha Treatment of inborn errors of cholesterol and bile acid
trihydroxy 5-beta cholanolic acid) Falkochol synthesis and metabolism
Treatment of choline deficiency, specifically the
choline deficiency, hepatic steatosis, and cholestasis,
Choline chloride Intrachol associated with long-term parenteral nutrition.
Prevention and/or treatment of choline deficiency in
Choline chloride IntraChol patients on long-term parenteral nutrition

For use in correcting vesicoureteral reflux in the


Chondrocyte-alginate gel suspension pediatric population.

Chondroitinase Treatment of patients undergoing vitrectomy.

cilengitide Treatment of malignant glioma

Ciliary neurotrophic factor Treatment of amyotrophic lateral sclerosis.


Treatment of motor neuron disease (including
amyotrophic lateral sclerosis, progressive muscular
Ciliary neurotrophic factor, recombinant atrophy, progressive bulbar palsy, and primary lateral
human sclerosis).

Ciliary neurotrophic factor, recombinant


human Treatment of spinal muscular atrophies.

Treatment of hypercalcemia in patients with


cinacalcet Sensipar parathyroid carcinoma

cis-Amminedichloro(2-
methylpyridine)platinum(II) Treatment of small cell lung cancer.

Treatment of osteogenic sarcoma metastatic to the


Cisplatin in liposomal formulation SLIT Cisplatin forlung
inhalation

Cisplatin/epinephrine IntraDose Treatment of metastatic malignant melanoma.

Treatment of squamous cell carcinoma of the head


Cisplatin/epinephrine IntraDose and neck.
Citric acid, glucono-delta-lactone and Treatment of renal and bladder calculi of the apatite
magnesium carbonate Renacidin Irrigation
or struvite variety.

Treatment of postherpetic neuralgia of the trigeminal


Civamide Zucapsaicin nerve
Cladribine Leustatin Treatment of acute myeloid leukemia.

Cladribine Leustatin Injection


Treatment of hairy cell leukemia.

Cladribine Leustatin Injection


Treatment of chronic lymphocytic leukemia.

Treatment of the chronic progressive form of multiple


Cladribine Mylinax sclerosis.

Cladribine Leustatin Injection


Treatment of non-Hodgkin's lymphoma.

Treatment of cerebral vasospasm following


Clazosentan Erajet subarachnoid hemorrhage

Prevention of Pneumocystis carinii pneumonia in


Clindamycin Cleocin AIDS patients.
Treatment of Pneumocystis carinii pneumonia
Clindamycin Cleocin associated with AIDS patients.

Clindamycin hydrochloride Treatment of sarcoidosis

clofarabine Clofarex Treatment of acute myelogenous leukemia

clofarabine Clolar Treatment of acute lymphoblastic leukemia


Treatment of lepromatous leprosy, including dapsone-
resistant lepromatous leprosy and lepromatous
Clofazimine Lamprene leprosy complicated by erythema nodosum leprosum.

Clonazepam Klonopin Treatment of hyperekplexia (startle disease).


For continous epidural administration as adjunctive
therapy with intraspinal opiates for the treatment of
pain in cancer patients tolerant to, or unresponsive to,
Clonidine Duraclon intraspinal opiates.
Treatment of advanced (involutional or residual stage)
Clostridial collagenase Dupuytren's disease.

Clotrimazole Topical treatment of children and adults with pouchitis

Clotrimazole Treatment of Huntington's disease

Clotrimazole Treatment of sickle cell disease.

c-myb antisense oligodeoxynucleotide Treatment of chronic myelogenous leukemia


Replacement treatment and prophylaxis of the
Coagulation factor IX Mononine hemorrhagic complications of hemophilia B.
For use as replacement therapy in patients with
hemophilia B for the prevention and control of
bleeding episodes, and during surgery to correct
Coagulation Factor IX (human) AlphaNine defective hemostasis.

Coagulation Factor IX (recombinant) BeneFix Treatment of hemophilia B.


Prevention of bleeding episodes in patients with
Coagulation factor VIIa (recombinant) NovoSeven acquired inhibitors to Factor VIII or Factor IX

Prevention of bleeding episodes in Glanzmann's


Coagulation factor VIIa (recombinant) NovoSeven thrombasthenia
Prevention of bleeding episodes in patients with
congenital Factor VII
deficiency
Coagulation factor VIIa (recombinant) NovoSeven
Treatment of bleeding episodes in patients with
Coagulation Factor VIIa (Recombinant) NovoSeven acquired inhibitors to Factor VIII or Factor IX

Prevention of bleeding episodes in patients with


Coagulation factor VIIa (recombinant) NovoSeven hemophilia A or B, with or without inhibitors

Treatment of bleeding episodes in Glanzmann's


Coagulation factor VIIa (Recombinant) NovoSeven thrombasthenia
Treatment of bleeding episodes in patients with
Coagulation factor VIIa (recombinant) NovoSeven congenital factor VII deficiency
Treatment of bleeding in patients experiencing
Coagulation Factor VIIa (Recombinant) NovoSeven intracranial hemorrhage.
Treatment of bleeding episodes in hemophilia A or B
Coagulation factor VIIa (recombinant) NovoSeven patients with inhibitors to Factor VIII or Factor IX.

cobiprostone Treatment of cystic fibrosis

Coenzyme Q10 Treatment of Huntington's disease

colchicine Treatment of familial Mediterranean fever

colchicine For the treatment of Behcet's Syndrome.


For arresting the progression of neurologic disability
Colchicine caused by chronic progressive multiple sclerosis.
Treatment of established hyaline membrane disease
Colfosceril palmitate, cetyl alcohol, tyloxapol Exosurf Neonatalat
for
all Intratracheal Suspension
gestational ages.
Prevention of hyaline membrane disease, also known
as respiratory distress syndrome, in infants born at 32
Colfosceril palmitate, cetyl alcohol, tyloxapol Exosurf Neonatalweeks
for Intratracheal Suspension
gestation or less.

Colfosceril palmitate, cetyl alcohol, tyloxapol Exosurf Treatment of adult respiratory distress syndrome.

Collagenase (lyophilized) for injection Plaquase Treatment of Peyronie's disease.

Combretastatin A4 phosphate Treatment of ovarian cancer


Treatment of anaplastic thyroid cancer, medullary
thyroid cancer, and stage IV papillary or follicular
Combretastatin A4 Phosphate thyroid cancer
conjugate of human transferrin and a mutant Treatment of malignant tumors of the central nervous
diphtheria toxin (CRM 107) TransMID system

Treatment of steatorrhea in patients with short bowel


conjugated bile acids COBARTin syndrome
Intrathecal treatment of neuropathic pain associated
Contulakin-G with spinal cord injury

Cordycepin Treatment of TdT-positivepituitary


acute lymphocytic
For use in differentiating and ectopic leukemia
production of ACTH in patients with ACTH-dependent
Corticorelin ovine triflutate Acthrel Cushings syndrome.

Corticotropin-releasing factor, human Xerecept Treatment of peritumoral brain edema.

Coumarin Onkolox Treatment of renal cell carcinoma.

Treatment of stage II (T4), stage III, and stage IV


Coxsackievirus A21 Cavatak melanoma

Creatine Creapure Treatment of Huntington's disease

creatine Creapure Treatment of amyotrophic lateral sclerosis

Cromolyn sodium Gastrocrom Treatment of mastocytosis.

Cromolyn sodium 4% ophthalmic solution Opticrom 4% ophthalmic


Treatmentsolution
of vernal keratoconjunctivitis.
Cryptosporidium hyperimmune bovine Treatment of diarrhea in AIDS patients caused by
colostrum IgG concentrate infection with for
Cryptosporidium parvum.
As a therapy primary immune deficiency resulting
cultured, partially T-Cell depleted, allogenic from athymia associated with complete DiGeorge
thymic tissue for transplantation Syndrome
Treatment of neonates and infants undergoing
cardiopulmonary bypass during surgical repair of
CY-1503 Cylexin congenital heart lesions.
Treatment of post-ischemic pulmonary reperfusion
edema following surgical treatment for chronic
CY-1503 Cylexin thromboembolic pulmonary hypertension.
Treatment of chronic active hepatitis B infection in
CY-1899 HLA-A2 positive patients.
Cyclo {{(E,Z)-(2S,3R,4R)-3-hydroxy-4-methyl-
2-(methylamino)nona-6,8-dienoyl}-L-2-
aminobytyrl-N-methyl-glycyl-N-methyl-L-
leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-
alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N- Treatment and chronic control of non-infectious
methyl-L-valyl} posterior, intermediate and pan-uveitis

Prophylaxis of organ rejection in patients receiving


cyclosporin allogeneic lung transplant

Treatment of amyotrophic lateral sclerosis and its


Cyclosporin A Cyclosporin variants
Treatment of acute rejection in patients requiring
cyclosporine Pluminiq allogenic lung transplants.
Treatment of patients at high risk of graft rejection
Cyclosporine 2% ophthalmic ointment following penetrating keratoplasty.
For use in corneal melting syndromes of known or
presumed immunologic etiopathogenesis, including
Cyclosporine 2% ophthalmic ointment Mooren's ulcer.

cyclosporine A Treatment of vernal keratoconjunctivitis

For the prevention of acute rejection in cornea


Cyclosporine A implant transplant patients

Cyclosporine in combination with omega-3


polyunsaturated fatty acids Prevention of solid organ graft rejection.
Treatment of severe keratoconjunctivitis sicca
Cyclosporine ophthalmic Optimmune associated with Sjogren's syndrome.

Cyproterone acetate Androcur Treatment of severe hirsutism.

Cysteamine Treatment of nephropathic cystinosis.

Cysteamine Cystagon Treatment of nephropathic cystinosis.


Treatment of corneal cystine crystal accumulation in
Cysteamine hydrochloride cystinosis patients.

Cystic fibrosis gene therapy Treatment of cystic fibrosis.

Cystic fibrosis Tr gene therapy (recombinant


adenovirus) AdGVCFTR.10 Treatment of cystictransmembrane
For cystic fibrosis fibrosis. conductance
Cystic fibrosis transmembrane conductance regulator protein replacement therapy in cystic fibrosis
regulator patients.

Cystic fibrosis transmembrane conductance


regulator gene Treatment of cystic fibrosis.

Cytarabine liposomal DepoCyt Treatment of neoplastic meningitis.

cytarabine liposome DepoCyt Treatment of gliomas


For use in prevention of clinically significant CMV
viremia, CMV disease and associated complications
Cytomegalovirus DNA Vaccine in at-risk hematopoietic cell transplant and solid organ
w/Copolymer/Benzalkonium Chloride transplant populations
Prevention of clinically significant cytomegalovirus
(CMV) viremia, CMV disease and asociated
Cytomegalovirus DNA vaccine with plasmids complications in at-risk hematopoietic cell transplant
expressing pp65 and gB genes and solid transplant populations

Prevention or attenuation of primary cytomegalovirus


disease in immunosuppressed recipients of organ
Cytomegalovirus immune globulin (human) CytoGam transplants.
For use in conjunction with ganciclovir sodium for the
Cytomegalovirus immune globulin intravenous treatment of cytomegalovirus pneumonia in bone
(human) marrow transplant patients.
Daclizumab Zenapax Prevention of acute renal allograft rejection.

Dantrolene sodium Dantrium Treatment


Prophylaxisofofthe neuroleptic malignant
toxoplasmosis syndrome.
in severely
immunocompromised patients with CD4 counts below
Dapsone 100.
For the combination treatment of Pneumocystis carinii
Dapsone USP Dapsone pneumonia in conjunction with trimethoprim.

Dapsone USP Dapsone Prophylaxis for Pneumocystis carinii pneumonia.

Treatment of Philadelphia-positive acute


Dasatinib Sprycel lymphoblastic leukemia

Dasatinib Sprycel Treatment of chronic myelogenous leukemia


Treatment of patients with advanced HIV-associated
Daunorubicin citrate liposome injection DaunoXome Kaposi's sarcoma.

DEAE-rebeccamycin Treatment of bile duct tumors

Debridement of acute, deep dermal burns in


debrase Debridase hospitalized patients

Decitabine Dacogen Treatment of acute myeloid leukemia

decitabine Treatment of sickle cell anemia

Decitabine Treatment of chronic myelogenous leukemia.

Decitabine Dacogen Treatment of myelodysplastic syndromes.


Treatment of chronic iron overload in patients with
Deferasirox Exjade transfusion-dependent anemias
Treatment of iron overload in patients with
hematologic disorders requiring chronic transfusion
deferiprone Ferriprox therapy

deferoxamine-starch conjugate Treatment of acute iron poisoning.

defibrotide For the prevention of hepatic veno-occlusive disease.

Defibrotide For the treatment of hepatic veno-occlusive disease


Defibrotide Treatment of thrombotic thrombocytopenic purpura.
Treatment of systemic lupus erythematosus (SLE)
and the reduction in the use of steroids in steroid-
Dehydroepiandrosterone dependent SLE patients.

Replacement therapy in individuals with adrenal


Dehydroepiandrosterone (DHEA) Fidelin insufficiency

Dehydroepiandrosterone sulfate sodium Treatment of serious burns requiring hospitalization.


To accelerate the re-epithelialization of donor sites in
those hospitalized burn patients who must undergo
Dehydroepiandrosterone sulfate sodium autologous skin grafting.

Treatment of patients with Cutaneous T-cell


Denileukin diftitox Ontak Lymphoma.

Deslorelin Somagard

Desmoglein 3 synthetic peptide (PI-0824) Treatment of pemphigus vulgaris

Treatment of mild hemophilia A and von Willebrand's


Desmopressin acetate disease.
For use in posterior segment drug delivery system in
Dexamethasone Posurdex the treatment of idiopathic intermediate uveitis.
For the attenuation or amelioration of the long-term
neurological sequelae associated with moderate and
dexanabinol severe traumatic brain injury

Treatment of anthracycline extravasation during


dexrazoxane Totect chemotherapy

For the prevention of cardiomyopathy associated with


Dexrazoxane Zinecard doxorubicin administration.

dextran 1 Treatment of cystic fibrosis


Treatment of recurrent corneal erosion unresponsive
Dextran 70 Dehydrex to conventional therapy.

Dextran and deferoxamine Bio-Rescue Treatment of acute iron poisoning.

For use as an adjunct to the treatment of cystic


Dextran sulfate (inhaled, aerosolized) Uendex fibrosis.

Dextran sulfate sodium Treatment of aquired immunodeficiency syndrome.

DHA-paclitaxel Taxoprexin Treatment of pancreatic cancer

Treatment of adenocarcinoma of the stomach or lower


DHA-paclitaxel Taxoprexin esophagus

DHA-paclitaxel Taxoprexin Treatment of metastatic malignant melanoma


For use as a nutritional supplement for the treatment
Dianeal peritoneal dialysis solution with 1.1% of malnourishment in patients undergoing continuous
amino acids Nutrineal (Peritoneal Dialysis
ambulatory Solution
peritoneal with 1.1% Amino Acid
dialysis.
For the management of selected, refractory, patients
with epilepsy, on stable regimens of antiepileptic
drugs (AEDs), who require intermittent use of
Diazepam viscous solution for rectal diazepam to control bouts of increased seizure
administration activity.
Treatment of primary brain malignancies (grade III
Diaziquone and IV astrocytomas).

Dideoxyinosine Treatment of acquired immunodeficiency syndrome.

Diethyldithiocarbamate Imuthiol Treatment of AIDS.


For treatment of patients with known or suspected
internal contamination with plutonium, americium or
diethylenetriaminepentaacetate (DPTA) curium to increase the rates of elimination.
Treatment of patients with known or suspected
internal contamination with plutonium, americium, or
Diethylenetriaminepentaacetic acid (DTPA) curium to increase the rates of elimination.

Diethylnorspermine (DENSPM) Treatment for hepatocellular carcinoma

diferuloylmethane Treatment of cystic fibrosis

Digitoxin Treatment of cystic fibrosis

digitoxin Treatment of soft tissue sarcomas

digitoxin Treatment of ovarian cancer


Treatment of potentially life threatening digitalis
intoxication in patients who are refractory to
Digoxin immune FAB (Ovine) Digibind management by conventional therapy.
Treatment of life-threatening acute cardiac glycoside
intoxication manifested by conduction disorders,
ectopic ventricular activity and (in some cases)
Digoxin immune fab(ovine) Digidote hyperkalemia.
Treatment of uncomplicated malaria caused by
"Plasmodium falciparum," Plasmodium vivax,"
dihydroartemisinin and piperaquine Eurartesim Plasmodium malariae," or "Plasmodium ovale."
Treatment of weight loss in AIDS patients with HIV-
Dihydrotestosterone Androgel -DHT associated wasting.
Treatment of increased intracranial pressure in
patients with severe, closed-head injury, also known
as traumatic brain coma, for whom no other effective
Dimethyl sulfoxide treatment is available.

Treatment of cutaneous manifestations of


Dimethyl sulfoxide scleroderma.

Treatment of palmar-plantar erythrodysethesia


Dimethylsulfoxide syndrome.
Topical treatment for the prevention of soft tissue
Dimethylsulfoxide injury following extravastion of cytotoxic drugs.
Dipalmitoylphosphatidylcholine Prevention and treatment of neonatal respiratory
/phosphatidylglycerol ALEC distress syndrome.
Treatment of chronic severe forms of alopecia areata
diphenylcyclopenone (Alopecia Totalis [AT]/Alopecia Universalis [AU])
Treatment of pulmonary and hepatic metastases in
Disaccharide tripeptide glycerol dipalmitoyl Immther patients with colorectal adenocarcinoma.

Disodium clodronate Treatment of hypercalcemia of malignancy.

Treatment of increased bone resorption due to


Disodium clodronate tetrahydrate Bonefos malignancy.
Treatment of hepatic intoxication by Amanita
Disodium silibinin dihemisuccinate Legalon phalloides (mushroom poisoning).
Therapeutic management of patients with lung
DMP 777 disease attributable to cystic fibrosis.

DNA plasmid vector expressing human IL-12


gene Treatment of ovarian cancer.
DNA-lipid complex (DMRIE/DOPE)/plasmid
vector (VCL-1102, Vical) expressing human
interleukin-2 Leuvectin Treatment of renal cell carcinoma.

DNP-Modified autologous tumor vaccine O-Vax Adjuvant therapy for the treatment of ovarian cancer

docosahexanoic acid-paclitaxel Taxoprexin Treatment of hormone-refractory prostate cancer.


Treatment of bronchopulmonary infection in patients
with cystic fibrosis who are colonized with
Doripenem Pseudomonas aeruginosa or Burkholderia cepacia.

To reduce mucous viscosity and enable the clearance


Dornase alfa Pulmozyme of airway secretions in patients with cystic fibrosis.

Dovitinib Treatment of multiple myeloma

Doxorubicin HCL liposome injection Doxil Treatment of multiple myeloma

Doxorubicin HCl with pluronic L-61 and


pluronic F-127 Treatment of esophageal carcinoma

Doxorubicin liposome Doxil Treatment of ovarian cancer.

doxorubicin PIHCA nanoparticles Doxorubicin Transdrug


Treatment of hepatocellular carcinoma

D-peptide of the sequence AKRHHGYKRKFH


- NH2 PulmaDex Treatment of cystic of
For the stimulation fibrosis
appetite and prevention of
weight loss in patients with a confirmed diagnosis of
Dronabinol Marinol AIDS.
Treatment of neurogenic symptomatic orthostatic
hypotension in patients with primary autonomic failure,
dopamine-beta-hydroxylase deficiency, and
Droxidopa nondiabetic autonomic neuropathy.

Duramycin Treatment of cystic fibrosis.


Treatment of hereditary motor and sensory
Dynamine neuropathy type I (Charcot-Marie-Tooth disease).

Dynamine Treatment of Lambert Eaton myasthenic syndrome.

eculizumab Idiopathic membranous glomerular nephropathy

eculizumab Soliris Treatment of paroxysmal nocturnal hemoglobinuria


Treatment of somatostatin receptor-positive
Edotreotide OctreoTher neuroendocrine gastroenteropancreatic tumors
Adjunct to whole brain radiation therapy for the
treatment of brain metastases in patients with breast
Efaproxiral cancer

Eflornithine Treatment of anaplastic glioma

Treatment of Pneumocystis carinii pneumonia in AIDS


Eflornithine HCl Ornidyl patients.
Treatment of Trypanosoma brucei gambiense
Eflornithine HCl Ornidyl infection (sleeping sickness).

Elcatonin Intrathecal treatment of intractable pain.

Enadoline hydrochloride Treatment of severe head injury.


Treatment of type I diabetic patients who are already
Encapsulated porcine islet preparation BetaRx on immunosuppression.

Eniluracil Treatment of hepatocellular carcinoma


For use in organ transplant patients to diminish the
Enisoprost nephrotoxicity induced by cyclosporine.
For use with cyclosporine in organ transplant
Enisoprost recipients to reduce acute transplant rejection.

Enteric-coated cysteamine Treatment of cystinosis

Enzastaurin Treatment of glioblastoma


For acceleration of cornealmultiforme
epithelial regeneration and
the healing of stromal tissue in the condition of non-
Epidermal growth factor (human) healing corneal defects.
For promotion of cutaneous wound healing in extreme
Epidermal growth factor (human) burn treatment protocols.

Epirubicin Ellence Treatment of breast cancer.


Treatment of anemia associated with HIV infection or
Epoetin alfa Epogen HIV treatment.

Treatment of anemia associated with end stage renal


Epoetin alfa Epogen disease.

Epoetin alfa Treatment of myelodysplastic syndrome.

Treatment of anemia associated with end stage renal


Epoetin alpha Procrit disease.

Epoetin alpha Procrit Treatment of anemia of prematurity in preterm infants.


Treatment of HIV associated anemia related to HIV
Epoetin alpha Procrit infection or HIV treatment.

Treatment of anemia associated with end stage renal


Epoetin beta Marogen disease.

Treatment of secondary pulmonary hypertension due


Epoprostenol Flolan to intrinsic precapillary pulmonary vascular disease.

Epoprostenol Flolan Treatment of primary pulmonary hypertension.


Replacement of heparin in patients requiring
hemodialysis and who are at increased risk of
Epoprostenol Flolan hemorrhage.
Replacement of heparin in patients requiring
hemodialysis and who are at increased risk of
Epoprostenol Cycloprostin hemorrhage.

epratuzumab LymphoCIDE Treatment of non-Hodgkin's lymphoma.

Eprodisate Fibrillex Treatment of secondary amyloidosis


Prevention and treatment of EBV-post transplant
Epstein Barr Virus specific cytotoxic T lymphoproliferative disease after hematopoietic stem
lymphocytes cell transplant or solid organ transplant.

Erlotinib Hydrochloride Tarceva Treatment of malignant gliomas

Erwinia L-asparaginase Erwinase Treatment of acute lymphocytic leukemia.


For use as an alternative to E. coli asparaginase in
those situations where repeat courses of
asparaginase therapy for acute lymphoblastic
leukemia are required or where allergic reactions
Erwinia L-asparaginase force the discontinuance of the E. coli preparation.

Treatment of anemia associated with end stage renal


Erythropoietin (human, recombinant) disease.

Treatment of anemia associated with end stage renal


Erythropoietin (recombinant human) disease.
Estrogen replacement therapy in females with Turner
Estradiol Gel EstroGel Reduction in signs and symptoms of moderately to
syndrome
severely active polyarticular-course juvenile
rheumatoid arthritis in patients who have had an
inadequate response to one or more disease-
modifying anti-rheumatic drugs.
Etanercept Enbrel

Ethanol gel Treatment of congenital lymphatic malformations

Ethanol gel Treatment of congenital venous malformations


Treatment of patients with esophageal varices that
Ethanolamine oleate Ethamolin have recently bled, to prevent rebleeding.

Ethinyl Estradiol, USP Treatment of Turner's syndrome.


Use as a chemoprotective agent for cisplatin and
Ethiofos cyclophosphamide in the treatment of ovarian cancer.

Ethyl eicosapentaenoate Treatment of Huntington's disease.


Prevention of degenerative metabolic bone disease
occurring in patients who require long term (6 months
Etidronate disodium Didronel IV infusion
or greater) total parenteral nutrition.
Treatment of degenerative metabolic bone disease
occurring in patients who require long term (6 months
Etidronate disodium Didronel IV Infusion
or greater) of
Treatment total parenteral nutrition.
hypercalcemia of malignancy
inadequately managed by dietary modification and/or
Etidronate disodium Didronel oral hydration.

Etiocholanedione Treatment of Prader-Willi syndrome.

Etiocholanedione Treatment of aplastic anemia.

Ex vivo cultured adult human mesenchymal


stem cells Prochymal Treatment
Treatment of
of acute graftbreast
advanced versuscancer
host disease
in
postmenopausal women whose disease has
Exemestane Aromasin progressed following tamoxifen therapy.
For the suppression and control of colonic
adenomatous polyps in the inherited disease
Exisulind adenomatous polyposis coli.

Factor XIII [A2] homodimer, recombinant DNA


origin Treatment of congenital FXIII deficiency
Factor XIII [A2} homodimer, recombinant DNA For the prophylaxis of bleeding associated with
origin congential FXIII deficiency

factor XIII concentrate (human), pasteurized Fibrogammin P Treatment of congenital factor XIII deficiency.

Factor XIII, recombinant Treatment of congenital factor XIII deficiency.

Fampridine Neurelan Treatment of chronic, incomplete spinal cord injury.


Fampridine Neurelan Relief of symptoms of multiple sclerosis.

Felbamate Felbatol Treatment of Lennox-Gastaut syndrome.

Fenobam hydrochloride Treatment of fragile X syndrome

fenretinide Treatment of Ewing's sarcoma family of tumors.

Fenretinide Treatment of neuroblastoma


Treatment of patients with known or suspected
internal contamination with radioactive or non-
ferric hexacyanoferrate (II) "Prussian Blue" radioactive cesium or thallium

FIAU Adjunctive treatment of chronic active hepatitis B.


For the control of bleeding and prophylactic treatment
Fibrinogen (human) of patients deficient in fibrinogen.
Treatment of non-healing corneal ulcers or epithelial
defects which have been unresponsive to
conventional therapy and the underlying cause has
Fibronectin (human plasma derived) been eliminated.
Treatment of non-healing corneal ulcers or epithelial
defects which are unresponsive to conventional
therapy and for which any infectious cause of the
Fibronectin (plasma derived) defect has been eliminated.

Treatment of patients with severe chronic neutropenia


Filgrastim Neupogen (absolute neutrophil count less than 500/mm3).

Filgrastim Neupogen Treatment of myelodysplastic syndrome.

Treatment of neutropenia associated with bone


Filgrastim Neupogen marrow transplants.
Reduction in the duration of neutropenia, fever,
antibiotic use, and hospitalization, following induction
and consolidation treatment for acute myeloid
Filgrastim Neupogen leukemia.
Treatment of patients with AIDS who, in addition, are
afflicted with cytomegalovirus retinitis and are being
Filgrastim Neupogen treated with ganciclovir.
For use in the mobilization of peripheral blood
progenitor cells for collection in patients who will
receive myeloablative or myelosuppressive
Filgrastim Neupogen chemotherapy.

Floxuridine, FUDR Intraperitoneal treatment of gastric cancer.


Treatment of chronic lymphocytic leukemia (CLL),
Fludarabine phosphate Fludara including refractory CLL.
Treatment and management of patients with non-
Fludarabine phosphate Fludara Hodgkins lymphoma.
Treatment of hyperbilirubinemia in newborn infants
Flumecinol Zixoryn unresponsive to phototherapy.

Flunarizine Sibelium Treatment of alternating hemiplegia.


Treatment uveitis involving the posterior segment of
Fluocinolone Retisert the eye.
For use in combination with leucovorin for therapy of
Fluorouracil Adrucil metastatic adenocarcinoma
For use in combination of the colon
with interferon and rectum.
alpha-2a,
recombinant, for the treatment of esophageal
Fluorouracil carcinoma.
For use in combination with interferon alpha-2a,
recombinant, for the treatment of advanced colorectal
Fluorouracil carcinoma.

Fluorouracil Treatment of glioblastoma multiforme.

Treatment of body dysmorphic disorder in children


Fluoxetine Prozac and adolescents

Fluoxetine Prozac Treatment of autism.

For the initiation and re-initiation of spermatogenesis


in adult males with reproductive failure due to
hypothalamic or pituitary dysfunction,
hypogonadotropic hypogonadism. AMENDED
indication 6/27/00: For the induction of
Follitropin alfa, recombinant Gonal-F spermatogenesis in men with pr

Fomepizole Antizole Treatment of methanol or ethylene glycol poisoning.

Fomepizole Antizole Treatment of methanol or ethylene glycol poisoning.

For the acute treatment of patients with status


Fosphenytoin Cerebyx epilepticus of the grand mal type.
Treatment of painful vaso-occlusive episodes
Fructose-1,6-diphosphate Cordox associated with sickle cell disease.
Fusion protein consisting of human
immunoglobim G1 constant region Fc region
fused to the human receptor binding domain Treatment of X-linked hypohidrotic ectodermal
of ectodysplasin-A1 dysplasia

G17DT Immunogen Treatment of gastric cancer

G17DT Immunogen Treatment of adenocarcinoma of the pancreas

Gabapentin Neurontin Treatment of amyotrophic lateral sclerosis.

Gallium nitrate injection Ganite Treatment of hypercalcemia of malignancy.


Treatment of narcolepsy and the auxiliary symptoms
of cataplexy, sleep paralysis, hypnagogic
Gamma hydroxybutyrate hallucinations and automatic
Treatment of narcolepsy and behavior.
the auxiliary symptoms
of cataplexy, sleep paralysis, hypnagogic
Gamma-hydroxybutyric acid hallucinations, and automatic behavior.

Gammalinolenic acid Treatment of juvenile rheumatoid arthritis.


Ganaxolone Treatment of infantile spasms.

Treatment of acute herpetic keratitis (dendritic and


Ganciclovir Virgan geographic ulcers)

Ganciclovir intravitreal implant Vitrasert Implant Treatment of cytomegalovirus retinitis.


Treatment of cytomegalovirus retinitis in
Ganciclovir sodium Cytovene immunocompromised patients
Treatment of severe human with AIDS.
cytomegalovirus
infections in specific immunosuppressed patient
Gancyclovir populations.

Gangliosides as sodium salts Cronassial Treatment of retinitis pigmentosa.

Gavilimomab Acute graft-versus-host disease (aGVHD)

Gemtuzumab zogamicin Mylotarg Treatment of CD33-positive acute myeloid leukemia.


Gene plasmid hVEGF165 driven by human
cytomegalovirus, and [2,3-
bis(oleoyl)propyl]trimethyl ammonium and Prevention of complications due to neointimal
dioleoyl phosphatidyl ethanolamine Trinam hyperplasia disease in certain vascular anastomoses.

genetically engineered herpes simplex virus


(G207) Tretament of malignant glioma

Geneticin Treatment of amoebiasis.


Gentamicin impregnated PMMA beads on Treatment of chronic osteomyelitis of post-traumatic,
surgical wire Septopal postoperative, or hematogenous origin.
Treatment of disseminated Mycobacterium avium-
Gentamicin liposome injection Maitec intracellulare infection.

Glatiramer acetate Copaxone Treatment of multiple sclerosis.

Glatiramer acetate for injection Copaxone Treatment of primary-progressive multiple sclerosis

glucarpidase Voraxaze Treatment of patients at risk of methotrexate toxicity


For use with human growth hormone in the treatment
of short bowel syndrome (nutrient malabsorption from
the gastrointestinal tract resulting from an inadequate
Glutamine NutreStore absorptive
To decreasesurface).
intracranial hypertension and/or alleviate
cerebral edema in patients who may benefit from
Glyceol osmotherapy.

Glyceryl tri (4-phenylbutyrate) Treatment of spinal muscular atrophy

Glyceryl trioleate and glyceryl trierucate Treatment of adrenoleukodystrophy.


Treatment of pathologic (chronic moderate to severe)
Glycopyrrolate drooling in pediatric patients
Golimumab Treatment of chronic sarcoidosis
For induction of ovulation in women with hypothalamic
amenorrhea due to a deficiency or absence in the
quantity or pulse pattern of endogenous GnRH
Gonadorelin acetate Lutrepulse secretion.

Gossypol Treatment of cancer of the adrenal cortex.

Gp100 adenoviral gene therapy Treatment of metastatic melanoma.


Granulocyte macrophage-colony stimulating Treatment of severe thermal injuries in patients with
factor Leucomax greater than 40% full or partial thickness burns.
Granulocyte macrophage-colony stimulating Treatment of chronic lymphocytic leukemia to
factor Leucomax increase granulocyte count.

Granulocyte macrophage-colony stimulating


factor Leucomax Treatment of myelodysplastic syndrome.

Granulocyte macrophage-colony stimulating Treatment of neutropenia associated with bone


factor Leucomax marrow transplants.

Granulocyte macrophage-colony stimulating


factor Leucomax Treatment of neutropenia due to hairy cell leukemia.
Treatment of neonates for disseminated group B
Group B streptococcus immune globulin streptococcal infection.
For the long-term treatment of children who have
growth failure due to a lack of adequate endogenous
Growth hormone releasing factor growth hormone secretion.
Treatment of moderate to severe reflex sympathetic
Guanethidine monosulfate Ismelin dystrophy and causalgia.

Guanfacine Tenex Treatment of fragile X syndrome.

Gusperimus Spanidin Treatment of acute renal graft rejection episodes.

h5G1.1-mAb Treatment of dermatomyositis

Treatment of mild to moderate acute malaria caused


Halofantrine Halfan by susceptible strains of P. falciparum and P. vivax.

Halofuginone Stenorol Treatment of systemic sclerosis.

heat killed Mycobacterium w


immunomodulator CADI Mw Active tuberculosis
heat killed mycobacterium w Adjuvant to multi-drug therapy in the management of
immunomodulator CADI Mw multibacillary leprosy

Heme arginate Normosang Treatment of symptomatic stage of acute porphyria.

Heme arginate Normosang Treatment of myelodysplastic syndromes.


Amelioration of recurrent attacks of acute intermittent
porphyria (AIP) temporarily related to the menstrual
cycle in susceptible women and similar symptoms
which occur in other patients with AIP, porphyria
Hemin Panhematin variegata and hereditary coproporphyria.

Hemin and zinc mesoporphyrin Hemex Treatment of acute porphyric syndromes.

Heparin Treatment of cystic fibrosis

Heparin sodium Treatment of cystic fibrosis


Prevention and treatment of necrotizing enterocolitis
Heparin-binding epidermal growth factor-like (NEC) in preterm infants with birth weight less than
growth factor 1,500 grams
Hepatitis B immune globulin intravenous Prophylaxis against hepatitis B virus reinfection in
(human) Nabi-HB liver transplant patients.

Prophylaxis of hepatitis C infection in liver transplant


Hepatitis C virus immune globulin (human) recipients.
For the prevention of hepatitis B virus (HBV)
reinfection in patients who have received a liver
HepeX-B transplantation

Herpes simplex virus gene Treatment of primary and metastatic brain tumors.
For use as an adjunct to cytokine therapy in the
Histamine Maxamine treatment of malignant melanoma.
Adjunct to cytokine therapy in the treatment of acute
Histamine Ceplene myeloid leukemia.

Histrelin Supprelin LA Treatment of central precocious puberty


Treatment of acute intermittent porphyria, hereditary
Histrelin coproporphyria, and variegate porphyria.

Histrelin acetate Supprelin Injection


Treatment of central precocious puberty.

HIV neutralizing antibodies Immupath Treatment of acquired immunodeficiency syndrome.


HLA-B7/Beta2M DNA Lipid (DMRIE/DOPE) Treatment of invasive and metastatic melanoma
Complex Allovectin-7 (Stages II, III, and IV).

homoharringtonine Treatment for chronic myelogenous leukemia

HPA-23 Treatment of acquired immunodeficiency syndrome.

Treatment of recurrent respiratory papillomatosis


Hsp E7 (RRP)

For use in the treatment of 1D10+ B cell non-


Hu1D10, humanized monoclonal antibody Remitogen Hodgkin's lymphoma

Human acid precursor alpha-glucosidase,


recombinant Treatment of glycogen storage disease type II.
Treatment of patients with invasive (malignant) brain
Human alpha 2,6 sialyltransferase adenoviral and central nervous system tumors lacking alpha 2,6
gene therapy sialyltransferase.

Human anti-CD30 monoclonal antibody Treatment of Hodgkin's disease

human anti-CD4 monoclonal antibody HuMax-CD4 Treatment of mycosis fungoides

Human anti-integrin receptor av monoclonal


antibody Treatment of patients with angiosarcoma
human anti-integrin receptor avb3/avb5 Treatment of patients with high-risk stage II, stage III,
monoclonal antibody and stage IV malignant melanoma

human anti-transforming growth factor beta 1


monoclonal antibody Treatment of systemic sclerosis

human anti-transforming growth factor-B1,2,3 Treatment


Prevention ofof idiopathic
congenitalpulmonary fibrosis(CMV)
cytomegalovirus
infection following primary CMV infection in pregnant
Human cytomegalovirus immunoglobulin women
Treatment of gastrointestinal disturbances (to include
constipation, diarrhea, and abdominal pain)
associated with regression-onset autism in pediatric
human gammaglobulin patients.

human gammaglobulin Treatment of idiopathic inflammatory myopathies

human gammaglobulin Treatment for juvenile rheumatoid arthritis


Human IgM monoclonal antibody (C-58) To Prophylaxis of cytomegalovirus infections in bone
CMV Centovir marrow transplant patients.
Human IgM monoclonal antibody (C-58) To Treatment of cytomegalovirus infections in allogenic
CMV Centovir bone marrow transplant patients.

Human immune globulin Xepol Treatment of post-polio syndrome

Human immunodeficiency virus immune


globulin Treatment of AIDS.
Human immunodeficiency virus immune Treatment of HIV-infected pregnant women and
globulin infants of HIV-infected mothers.

Human immunodeficiency virus immune


globulin Hivig Treatment of HIV-infected pediatric patients.

Human immunoglobin anti-CD30 monoclonal


antibody Treatment of CD30+ T-cell lymphoma

Human immunoglobulin (IgG1k)antiCTLA-4 Treatment of high risk Stage II, Stage III, and Stage IV
monoclonal antibody melanoma
For neoadjuvant therapy in pts. w/squamous cell
human leukocyte-derived cytokine mixture carcinoma of the head and neck
Human monoclonal antibody against platelet- To slow the progression of IgA nephropathy and delay
derived growth factor D kidney failure in patients affected by the disease.
Human monoclonal antibody directed against Treatment of hospital acquired pneumonia caused by
serotype 011 Pseudomonas aeruginosa Aerumab 11 serotype 011 positive Pseudomonas aeruginosa
Human monoclonal antibody targeting CC-
chemokine ligand 2 Treatment of pancreatic cancer
Treatment of von Willebrand disease except for
surgical and/or invasive procedures in patients with
Human plasma coagulation Factor VIII and von Willebrand disease in whom desmopressin is
human plasma von Willebrand Factor Wilate either ineffective or contraindicated

Human telomerase reverse transcriptase


peptide vaccine Treatment of pancreatic cancer

Human T-lymphotropic virus type III Gp160


antigens Vaxsyn HIV-1 Treatment of AIDS.

Human umbilical tissue-derived cells Treatment of retinitis pigmentosa

Humanized anti-CD3 monoclonal antibody Treatment of recent-onset Type I diabetes

humanized anti-human CD16 monoclonal Treatment of adult idiopathic thrombocytopenic


antibody purpura
For the induction of donor-specific immunologic
unresponsiveness resulting in prophylaxis of organ
rejection without the need for chronic
immunosuppressive therapy, in patients receiving
Humanized anti-human CD2 MAb MEDI-507 allogeneic renal transplants.
Prevention of acute graft-vs-host disease following
Humanized anti-tac Zenapax bone marrow transplantation.

Humanized MAb (IDEC-131) to CD40L Treatment of systemic lupus erythematosus.


To prevent the development of or to decrease the
incidence and severity of hemolytic uremic syndrome
humanized monoclonal antibody against and associated sequelae of Shiga-like toxin-
Shiga-like toxin II producing E. coli.

Humanized monoclonal antibody to the high


affinity folate alpha receptor Treatment of ovarian cancer
Treatment of emphysema in patients due to alpha-1
hyaluronic acid antitrypsin deficiency
Treatment of severe intrapartum hypertension
(diastolic blood pressure greater than or equal to 110
or systolic blood pressure greater than or equal to
160) associated with severe preeclampsia/eclampsia
Hydralazine of pregnancy

Hydroxocobalamin Cyanokit Treatment of acute cyanide poisoning

Hydroxocobalamin Treatment of acute cyanide poisoning

Hydroxycobalamin/sodium thiosulfate Treatment of severe acute cyanide poisoning.

hydroxyurea Treatment of pediatric patients with sickle cell anemia.

Treatment of patients with sickle cell anemia as


Hydroxyurea Droxia shown by the presence of hemoglobin S.
Hypericin Treatment of glioblastoma multiforme.

Hypericin Treatment of cutaneous T-cell lymphoma.

I(131)-TM-601 (chlorotoxin) treatment of malignant glioma

Iboctadekin Treatment of renal cell carcinoma

ibritumomab tiuxetan Zevalin Treatment of B-cell non-Hodgkin's lymphoma.

Ibuprofen i.v. solution Salprofen Prevention of patent ductus arteriosus.

Ibuprofen lysine NeoProfen Treatment of patent ductus arteriosus.

Icatibant Treatment of angioedema

Treatment of burn patients hospitalized with burn-


Icatibant acetate induced edema

Icodextrin 7.5% with Electrolytes Peritoneal Treatment of those patients having end stage renal
Dialysis Solution Extraneal (with 7.5% Icodextrin)
disease Peritoneal
and requiring Dialysis
peritoneal dialysisSolutio
treatment.

Idarubicin Idamycin Treatment of chronic myelogenous leukemia.

Idarubicin Idamycin Treatment of myelodysplastic syndromes.


Treatment of acute myelogenous leukemia, also
Idarubicin HCl for injection Idamycin referred to as acute nonlymphocytic leukemia.

Treatment of acute lymphoblastic leukemia in


Idarubicin HCl for injection Idamycin pediatric patients.

idebenone Treatment of Leber's hereditary optic neuropathy.

idebenone Treatment of Duchenne muscular dystrophy

Treatment of cardiomyopathy associated with


Idebenone Friedreich's ataxia

Idoxuridine Treatment of nonparenchymatous sarcomas.


Long term enzyme replacement therapy for patients
idursulfase Elaprase with mucopolysaccharidosis II (Hunter Syndrome)

Ifosfamide Ifex Treatment of testicular cancer.

Ifosfamide Ifex Treatment of bone sarcomas

Ifosfamide Ifex Treatment of soft tissue sarcomas.

IL13-PE38QQR Treatment of malignant glioma

IL-4 Pseudomonas Toxin Fusion Protein (IL-


4(38-37)-PE38KDEL) Treatment of astrocytic glioma.

Iloprost inhalation solution Ventavis Treatment of pulmonary arterial hypertension

Treatment of Raynaud's phenomenon secondary to


Iloprost solution for infusion systemic sclerosis.

Iloprost solution for infusion Treatment of heparin-associated thrombocytopenia.

Imatinib Gleevec Treatment of chronic myelogenous leukemia

Treatment of systemic mastocytosis without the


Imatinib mesylate Gleevec D816V c-kit mutation
Treatment of myeloproliferative
disorders/myelodysplastic syndromes associated with
Imatinib mesylate Gleevec platelet-derived growth factor gene re-arrangements

Treatment of idiopathic hypereosinophilic syndrome


Imatinib mesylate Gleevec including acute and chronic eosinophilic leukemia

Treatment of Philadelphia-positive acute


imatinib mesylate Gleevec lymphoblastic leukemia

imatinib mesylate Gleevec Treatment of dermatofibrosarcoma protuberans

imatinib mesylate Gleevec Treatment of gastrointestinal stromal tumors


Detecting early necrosis as an indication of rejection
Imciromab pentetate Myoscint of orthotopic cardiac transplants.

imexon Amplimexon Treatment of ovarian cancer.

Imexon Treatment of multiple myeloma.


Imexon Treatment of pancreatic adenocarcinoma

Imexon Treatment of metastatic malignant melanoma


Replacement therapy in patients with types I, II, and III
Imiglucerase Cerezyme Gaucher's disease.

Immortalized human liver cells found in the Treatment of fulminant hepatic failure (acute liver
extracorporeal liver assist device ELAD failure)

Treatment of chronic inflammatory demyelinating


Immune Globulin (Human) Gamunex polyneuropathy

Immune Globulin (Human) containing high


titers of West Nile virus antibodies Omr-IgG-am (tm)Treatment
5% (WNV)of the West Nile virus infection

Immune Globulin Intravenous (human) Carimune NF Treatment for Guillain Barre Syndrome

Immune globulin intravenous (human) Gammagard Liquid


Treatment of multifocal motor neuropathy

Immune globulin intravenous (human) Immune GlobulinTreatment


Intravenous (human)
of patients withImmuno, Iveegam
acute myocarditis.

Immune globulin intravenous (human) Iveegam, Immuno


Treatment of polymyositis/dermatomyositis.

Immune globulin intravenous (human) Iveegam, Immuno


Treatment of juvenile rheumatoid arthritis.

Infection prophylaxis in pediatric patients affected with


Immune globulin intravenous, human Gamimune N the human immunodeficiency virus.
Treatment of patients with primary immune deficiency
(PID) that are intolerant to immune globulin
intravenous (IGIV) due to severe adverse events or
Immune Globulin Subcutaneous (Human) Vivaglobin P (proposed)
poor venous access

Treatment of homozygous familial


Implitapide hypercholesterolemia
For skin testing of victims of fire ant stings to confirm
fire ant sensitivity and if positive, for use as
immunotherapy for the prevention of IgE-mediated
Imported fire ant venom, allergenic extract anaphylactic reactions.

Inalimarev and falimarev Treatment of adenocarcinoma of the pancreas

Indium In 111 murine monoclonal antibody


FAB to myosin Myoscint To aid in the diagnosis of myocarditis.
Detection of suspected and previously unidentified
Indium In-111 altumomab pentetate Hybri-ceaker tumor foci of recurrent colorectal carcinoma.

Indium-111 pentetreotide NeuroendoMedixTreatment of neuroendocrine tumors

infliximab Remicade Treatment of juvenile rheumatoid arthritis


infliximab Remicade Treatment of giant cell arteritis

Treatment of pediatric (0 to 16 years of age)


Infliximab REMICADE ulcerative colitis

Treatment of pediatric (0 to 16 years of age) Crohn's


Infliximab REMICADE Disease

Infliximab Remicade Treatment of chronic sarcoidosis

Treatment of moderately to severely active Crohn's


disease for the reduction of the signs and symptoms,
in patients who have an inadequate response to
conventional therapy; and treatment of patients with
Infliximab Remicade fistulizing Crohn's disease for the reduction in th

INGN 201 ADVEXIN Treatment of head andof


Reduction (prevention) neck cancer bacteremia
nosocomial
caused by staphylococci in very low birth weight
INH-A00021 Veronate infants.

inolimomab Leukotac Treatment of graft versus host disease

Inosine pranobex Isoprinosine Treatment of subacute sclerosing panencephalitis.

Interferon alfa-2a Roferon A Treatment of chronic myelogenous leukemia.

Interferon alfa-2a (recombinant) Roferon-A Treatment of renal cell carcinoma.


For the treatment of metastatic malignant melanoma
Interferon alfa-2a (recombinant) Roferon-A in combination with Teceleukin.
For the concomitant administration with Teceleukin for
Interferon alfa-2a (recombinant) Roferon-A the treatment of metastatic renal cell carcinoma.

Interferon alfa-2a (recombinant) Roferon-A Treatment of AIDS related Kaposi's sarcoma.


For the concomitant administration with fluorouracil for
Interferon alfa-2a (recombinant) Roferon-A the treatment of advanced colorectal cancer.
For use in combination with fluorouracil for the
Interferon alfa-2a (recombinant) Roferon-A treatment of esophageal carcinoma.

Interferon alfa-2b (recombinant) Intron A Treatment of AIDS-related Kaposi's sarcoma.

Interferon alfa-2b (recombinant) Intron A Treatment of acute hepatitis B.

Interferon alfa-2b (recombinant) Intron A Treatment of primary malignant brain tumors.

Interferon alfa-2b (recombinant) Intron A Treatment of carcinoma in situ of the urinary bladder.
Interferon alfa-2b (recombinant) Intron A Treatment of invasive carcinoma of the cervix.

Interferon alfa-2b (recombinant) Intron A Treatment of ovarian carcinoma.

Interferon alfa-2b (recombinant) Intron A Treatment of chronic myelogenous leukemia.

Interferon alfa-2b (recombinant) Intron A Treatment of metastatic renal cell carcinoma.

Interferon alfa-2b (recombinant) Intron A Treatment of laryngeal (respiratory) papillomatosis.

Interferon alfa-2b (recombinant) Intron A Treatment


Treatment of
of chronic delta hepatitis. in patients with
human papillomavirus
severe resistant/recurrent respiratory (laryngeal)
Interferon alfa-nl Wellferon papillomatosis.

Interferon alfa-nl Wellferon Treatment of AIDS related Kaposi's sarcoma.

For the systemic treatment of metastatic renal cell


Interferon beta (recombinant) R-IFN-beta carcinoma.
For the intralesional and/or systemic treatment of
Interferon beta (recombinant) r-HuIFN-beta AIDS-related Kaposi's sarcoma.

For the systemic treatment of cutaneous T-cell


Interferon beta (recombinant) r-HuIFN-beta lymphoma.

Interferon beta, recombinant human Betaseron Treatment of acquired immunodeficiency syndrome.

Treatment of patients with secondary progressive


Interferon beta-1a Rebif multiple sclerosis.

Interferon beta-1a Avonex Treatment of multiple sclerosis.

Interferon beta-1a (recombinant human) Treatment of acute non-A, non-B hepatitis.

For the systemic treatment of cutaneous malignant


Interferon beta-1a (recombinant) r-HuIFN-beta melanoma.
Treatment of symptomatic patients with AIDS
including all patients with CD4 T-cell counts less than
Interferon beta-1a (recombinant) Rebif 200 cells per mm3.

Interferon beta-1b Betaseron Treatment of multiple sclerosis.

Interferon gamma 1-b Actimmune Treatment of chronic granulomatous disease.


Delaying time to disease progression in patients with
Interferon gamma-1b Actimmune severe, malignant osteopetrosis.

Interferon gamma-1b Actimmune Treatment of renal cell carcinoma.


Interferon-alfa-1b Treatment of multiple myeloma

Interleukin-1 alpha, human recombinant For hematopoietic potentiation in aplastic anemia.


For the promotion of early engraftment in bone
Interleukin-1 alpha, human recombinant marrow transplantation.

Interleukin-1 receptor antagonist, human


recombinant Antril Treatment of juvenile rheumatoid arthritis.
Interleukin-1 receptor antagonist, human Prevention and treatment of graft versus host disease
recombinant Antril in transplant recipients.
Treatment of Still's disease including juvenile
Interleukin-1 Trap rheumatoid arthritis and adult-onset Still's disease

Interleukin-1Trap Treatment of CIAS1-Associated Periodic Syndromes


In combination with interferon alfa-2a for the treatment
Interleukin-2 Teceleukin of metastatic malignant melanoma.

Interleukin-2 Teleleukin Treatment of metastatic malignant melanoma.

Interleukin-2 Teceleukin Treatment of metastatic renal cell carcinoma.


In combination with interferon alfa-2a for the treatment
Interleukin-2 Teceleukin of metastatic renal cell carcinoma.
Promotion of erythropoiesis in Diamond-Blackfan
Interleukin-3 human (recombinant) anemia (congenital pure red cell aplasia).
For sequential administration with sargramostim to
accelerate neutrophil and platelet recovery in patients
undergoing autologous bone marrow transplantation
for the treatment of Hodgkin's disease or non-
Interleukin-3, human, recombinant Hodgkin's lymphoma.
Prevention of dental caries due to radiation-induced
Intraoral fluoride releasing system IFRS xerostomia in patients with head and neck cancer

Intravenous immune globulin VitiGam Treatment of Stage IIB to IV malignant melanoma

Iobenguane I 123 For the diagnosis of pheochromocytoma.

Iobenguane I 123 For the diagnosis of neuroblastomas.

iobenguane I 131 Treatment of neuroendocrine tumors

Iobenguane I 131 Ultratrace Treatment of neuroendocrine tumors

For use as a diagnostic adjunct in patients with


Iobenguane Sulfate I 131 pheochromocytoma.
For scintigraphic detection, localization and staging of
Iobenguane Sulfate I-123 OmaClear neuroblastoma.

For the detection, localization, and staging of


iobenguane sulfate I-123 OmaClear pheochromocytomas.
Iodine 131 6B-iodomethyl-19-norcholesterol For use in adrenal cortical imaging.

Iodine I 123 murine monoclonal antibody to Detection of alpha-fetoprotein producing germ cell
alpha-fetoprotein tumors.

Iodine I 123 murine monoclonal antibody to Detection of hepatocellular carcinoma and


alpha-fetoprotein hepatoblastoma.
Iodine I 123 murine monoclonal antibody to Detection of hCG producing tumors such as germ cell
hCG and trophoblastic cell tumors.

Iodine I 131 bis(indium-


diethylenetriaminepentaacetic
acid)tyrosyllysine/hMN-14 x m734 F(ab')2
bispecific monoclonal antibody Pentacea Treatment of small-cell lung cancer.

Iodine I 131 Lym-1 Monoclonal Antibody Treatment of B-cell lymphoma.

Iodine I 131 murine monoclonal antibody


IgG2a to B cell Immurait, Ll-2-I-131
Treatment of B-cell leukemia and B-cell lymphoma.

Iodine I 131 murine monoclonal antibody to Treatment of alpha-fetoprotein producing germ cell
alpha-fetoprotein tumors.

Iodine I 131 murine monoclonal antibody to Treatment of hepatocellular carcinoma and


alpha-fetoprotein hepatoblastoma.
Iodine I 131 murine monoclonal antibody to Treatment of hCG producing tumors such as germ cell
hCG and trophoblastic cell tumors.

Iodine I-131 radiolabeled chimeric MAb tumor Treatment of glioblastoma multiforme and anaplastic
necrosis treatment (TNT-1B) 131IchTNT-1 astrocytoma.

irofulven Treatment of renal cell carcinoma.

irofulven Treatment of ovarian cancer.


Treatment of patients with known or suspected
internal contamination with radioactive or non-
iron(III)-hexacyanoferrate(II) Radiogardase radioactive cesium or thallium

Isobutyramide Treatment of sickle cell disease and beta thalassemia.


Treatment of beta-hemoglobinopathies and beta-
Isobutyramide Isobutyramide oral solution syndromes.
thalassemia

Isofagomine tartrate Treatment of Gaucher disease

Japanese encephalitis vaccine (live,


attenuated) Prevention
For use withofcyclosporine
Japanese encephalitis.
A to diminish the
nephrotoxicity induced by cyclosporine in organ
Ketoconazole Nizoral transplantation.

L-2-oxothiazolidine-4-carboxylic acid Procysteine Treatment of adult respiratory distress syndrome.


L-2-oxothiazolidine-4-carboxylic acid Procysteine Treatment of amyotrophic lateral sclerosis.

L-5-hydroxytryptophan Treatment of tetrahydrobiopterin deficiency.


Treatment of severe aphthous stomatitis in severely,
Lactic acid Aphthaid terminally immunocompromised patients.

lactic acid bacteria (Lactobacilli,


Bifidobacteria, and Steptococci) Treatment of active chronic pouchitis

lactic acid bacteria (Lactobacilli, Prevention of disease relapse in patients with chronic
Bifidobacteria, and Streptococcus species) pouchitis
Treatment of AIDS-associated diarrhea unresponsive
Lactobin Lactobin to initial antidiarrheal therapy.

L-aminocarnityl-succinyl-leucyl-argininal- Treatment of Duchenne and Becker muscular


diethylacetal dystrophy

Lamotrigine Lamictal Treatment of Lennox-Gastaut syndrome.

Lanreotide Somatuline Depot


Treatment for acromegly

laronidase Aldurazyme Treatment of patients with mucopolysaccharidosis-I.

Latrodectus immune F(ab)2 Aracmyn Treatment of black widow spider envenomations

Treatment of intractable spasticity in children with


L-Baclofen Neuralgon cerebral palsy.
Treatment of intractable spasticity associated with
L-baclofen Neuralgon spinal cord injury or multiple sclerosis.

L-Baclofen Treatment of trigeminal neuralgia.

L-baclofen Treatment of trigeminal neuralgia.

L-cycloserine Treatment of Gaucher's disease.


For the prevention and lessening of photosensitivity in
L-cysteine erythropoietic protoporphyria.
Prevention of acute and chronic rejection in patients
Leflunomide who have received solid organ transplants.

lenalidomide Revlimid Treatment of myelodysplastic syndromes

lenalidomide Revlimid Treatment of chronic lymphocytic leukemia.

lenalidomide Revlimid Treatment for multiple myeloma


Lentiviral vector encoded with a human beta- Treatment of beta-thalassemia major and beta-
globin gene plasmid Thalagen thalassemia intermedia

Treatment of heparin-associated thrombocytopenia


Lepirudin Refluden type II.

Lestaurtinib Treatment of acute myeloid leukemia


For use in combination with 5-fluorouracil for the
Leucovorin Leucovorin calcium
treatment of metastatic colorectal cancer.
For rescue use after high dose methotrexate therapy
Leucovorin Leucovorin calcium
in the treatment of osteosarcoma.
For use in combination with 5-fluorouracil for the
Leucovorin calcium Wellcovorin treatment of metastatic colorectal cancer.
Neoadjuvant therapy in patients with Squamous Cell
leukocyte interlukin Multikine Carcinoma of the Head and Neck

For use as an adjunct to microsurgical peripheral


Leupeptin nerve repair.

Leuprolide acetate Lupron Injection Treatment of central precocious puberty.

Levocabastine HCl ophthalmic suspension


0.05% Treatment of vernal keratoconjunctivitis.
Treatment of manifestations of carnitine deficiency in
patients with end stage renal disease who require
Levocarnitine Carnitor dialysis.
Treatment of manifestations of carnitine deficiency in
patients with end stage renal disease who require
Levocarnitine Carnitor dialysis.
For the treatment of secondary carnitine deficiency in
Levocarnitine Carnitor valproic acid toxicity.
For the prevention of secondary carnitine deficiency in
Levocarnitine Carnitor valproic acid toxicity.

Treatment of zidovudine-induced mitochondrial


Levocarnitine Carnitor myopathy.

Levocarnitine Carnitor Treatment of pediatric cardiomyopathy.

Treatment of primary and secondary carnitine


Levocarnitine Carnitor deficiency of genetic origin.

Levocarnitine Carnitor Treatment of genetic carnitine deficiency.

Levodopa and carbidopa Duodopa Treatment of late stage Parkinson's disease.

Treatment of heroin addicts suitable for maintenance


Levomethadyl acetate hydrochloride Orlaam on opiate agonists.

L-glutamine Treatment of sickle cell disease

L-glutamyl-L-tryptophan Treatment of AIDS-related Kaposi's sarcoma.


liarozole The treatment of congenital ichthyosis
For relief of allodynia (painful hypersensitivity), and
Lidocaine patch 5% Lidoderm Patch chronic pain in postherpetic neuralgia.

Lintuzumab Treatment of myelodysplastic syndrome.

lintuzumab Treatment of acute myeloid leukemia.

lintuzumab Zamyl Treatment of acute myelogenous leukemia

Liothyronine sodium injection Triostat Treatment of myxedema coma/precoma.

Lipid/DNA human cystic fibrosis gene Treatment of cystic fibrosis.

Liposomal amphotericin B AmBisome Treatment of histoplasmosis.

Liposomal amphotericin B AmBisome Treatment of visceral leishmaniasis.

Liposomal amphotericin B AmBisome Treatment of cryptococcal meningitis.

Liposomal annamycin Treatment of acute myeloid leukemia

Liposomal annamycin Treatment of acute lymphoblastic leukemia

Liposomal ciprofloxacin For the management of bronchiectasis

Liposomal ciprofloxacin for inhalation Management of cystic fibrosis

Liposomal cisplatin LipOva-Pt Treatment of ovarian cancer

For aerosolized administration in the prevention and


treatment of lung allograft rejection
and pulmonary rejection events associated with bone
Liposomal cyclosporin A Cyclospire marrow transplantation.

Liposomal doxorubicin hydrochloride Sarcodoxome Treatment of soft tissue sarcomas


Liposomal N-Acetylglucosminyl-N-
Acetylmuramly-L-Ala-D-isoGln-L-Ala
-gylcerolidpalmitoyl ImmTher Treatment of osteosarcoma.
Liposomal N-Acetylglucosminyl-N-
Acetylmuramly-L-Ala-D-isoGln-L-Ala
-gylcerolidpalmitoyl ImmTher Treatment of Ewing's sarcoma.
Liposomal nystatin Nyotran Treatment of invasive fungal infections.

liposomal p-ethoxy growth receptor bound


protein-2 antisense product Treatment of chronic myelogenous leukemia

Liposomal prostaglandin E1 injection Treatment of acute respiratory distress syndrome.

Liposomal-cis-bis-neodecanoato-trans-R,R-
1,2-diaminocyclohexane-Pt (II) Aroplatin Treatment of malignant mesothelioma.

Liposome encapsulated recombinant


interleukin-2 Treatment of brain and CNS tumors.

Liposome encapsulated recombinant


interleukin-2 Treatment of cancers of the kidney and renal pelvis.
Treatment of patients undergoing induction therapy
Lisofylline for acute myeloid leukemia.
For use in combination chemotherapy with the
approved agent 5-fluorouracil in the palliative
treatment of metastatic adenocarcinoma of the colon
L-leucovorin Isovorin and rectum.
For use in conjunction with high-dose methotrexate in
L-leucovorin Isovorin the treatment of osteosarcoma.

Lodoxamide tromethamine Alomide Ophthalmic Solution


Treatment of vernal keratoconjunctivitis.

Loxoribine Treatment of common variable immunodeficiency.

Treatment of spasticity associated with familial spastic


L-threonine paraparesis.

L-threonine Threostat Treatment of amyotrophic lateral sclerosis.

Treatment of neuropathic pain associated with spinal


L-threonyl-L-prolyl-L-prolyl-L-threonine cord injury

L-tyrosine-L-serine-L-leucine CMS-024 Treatment of hepatocellular carcinoma.

Prevention of bronchopulmonary dysplasia in


Lucinactant Surfaxin premature infants

Treatment of bronchopulmonary dysplasia in


Lucinactant Surfaxin premature infants.

Treatment of meconium aspiration syndrome in


Lucinactant Surfaxin newborn infants

Treatment of acute respiratory distress syndrome in


Lucinactant Surfaxin adults.

Treatment of respiratory distress syndrome in


Lucinactant Surfaxin premature infants.
Treatment of pain and fever secondary to sickle cell
Lysine acetylsalicylate injectable disease crisis.
For use as an adjunctive topical antimicrobial agent to
control bacterial infection when used under moist
dressings over meshed autografts on excised burn
Mafenide acetate solution Sulfamylon solution
wounds.

Mafosfamide Treatment of neoplastic meningitis

Mammalian target of rapamcyin (mTOR)


inhibitor Treatment of soft tissue sarcoma
For use to facilitate clearance of mucus in patients
with bronchiectasis and in patients with cystic fibrosis
Mannitol Bronchitol at risk for bronchiectasis

Treatment of high-risk Stage II, Stage III, and Stage IV


mannopentaose phosphate sulfate melanoma
Prevention of cytomegalovirus viremia and disease in
maribavir the populations at risk.

Marijuana Treatment of HIV-associated wasting syndrome.

Matrix metalloproteinase inhibitor Galardin Treatment of corneal ulcers.

MaxAdFVIII Treatment of Hemophilia A

Mazindol Sanorex Treatment of Duchenne muscular dystrophy.

Mecamylamine Inversine Treatment of Tourette's syndrome.

Mecasermin Myotrophin Treatment of amyotrophic lateral sclerosis.

Mecasermin Increlex Treatment of growth hormone insensitivity syndrome.

Treatment of growth hormone insensitivity syndrome


mecasermin rinfabate iPLEX (GHIS)

meclorethamine or nitrogen mustard Treatment of mycosis fungoides.

MEDI-522 Vitaxin For the treatment of metastatic melanoma

Medroxyprogesterone acetate Hematrol Treatment of immune thrombocytopenic purpura.

Prevention of chloroquine-resistant Falciparum


Mefloquine HCl Mephaquin malaria.
Mefloquine HCl Mephaquin Treatment of chloroquine-resistant Falciparummalaria.
Prophylaxis of Plasmodium falciparum malaria which
Mefloquine HCl Lariam is resistant to other available drugs.
Treatment of acute malaria due to Plasmodium
Mefloquine HCl Lariam falciparum and Plasmodium vivax.
Treatment of patients with anorexia, cachexia, or
significant weight loss (=/>10% of baseline body
Megestrol acetate Megace weight) and confirmed diagnosis of AIDS.

Treatment of stage IIIb through IV metastatic


Melanoma autologous dendritic cell vaccine melanoma

Melanoma cell vaccine Canvaxin Treatment of invasive melanoma.


Treatment of HLA-A2+ patients with stage IIB, IIC, III,
Melanoma peptide vaccine and IV malignant melanoma

Melanoma vaccine Melacine Treatment of stage III - IV melanoma.


Treatment of non-24-hour sleep-wake disorder in
Melatonin Circadin blind individuals without light perception
Treatment of circadian rhythm sleep disorders in blind
Melatonin people with no light perception.

meloxicam Mobic Treatment of juvenile rheumatoid arthritis


For use in hyperthermic regional limb perfusion to
Melphalan Alkeran for Injection
treat metastatic melanoma of the extremity.
Treatment of patients with multiple myeloma for whom
Melphalan Alkeran For Injection
oral therapy is inappropriate.

mepivacaine Treatment of postherpetic neuralgia

Mepivacaine Treatment of painful HIV-associated neuropathy

For first-line treatment in patients with


mepolizumab hypereosinophilic syndrome
Management of acute pulmonary exacerbations, in
cystic fibrosis patients, due to respiratory tract
Meropenem Merrem IV infection with susceptible organisms.
Inhibition of the urotoxic effects induced by
oxazaphosphorine compounds such as
Mesna cyclophosphamide.
For use as a prophylactic agent in reducing the
Mesna Mesnex incidence of ifosfamide-induced hemorrhagic cystitis.

Methionine/L-methionine Treatment of AIDS myelopathy.

Methotrexate Rheumatrex Treatment of juvenile rheumatoid arthritis.

Methotrexate sodium Methotrexate Treatment of osteogenic sarcoma.

Methotrexate with laurocapram Methotrexate/azone


Topical treatment of mycosis fungoides.
For use in conjunction with the UVAR photopheresis
Methoxsalen Uvadex system to treat graft versus host disease.

Treatment of metabolic disorders secondary to


metreleptin lipodystrophy
Treatment of leptin deficiency secondary to
generalized
metreleptin lipodystrophy and partial familial lipodystrophy

Metronidazole Metrogel Treatment of perioral dermatitis.


Treatment of grade III and IV, anaerobically infected,
Metronidazole (topical) Flagyl decubitus ulcers.

Metronidazole (topical) Metrogel Treatment of acne rosacea.

Mibefradil Treatment of ovarian cancer


Intraoperative aid in the identification and localization
Microbubble contrast agent Filmix Neurosonographic Contrast
of intracranial Agent
tumors.
Treatment of non-life threatening, mild to severe
Microvesiculated modified glycosylated tissue bleeding episodes due to cutaneous injuries or dental
factor procedures in hemophiliac patients
Treatment of bouts of increased seizure activity in
selected refractory patients with epilepsy who are on
stable regimens of anti-epileptic drugs and who
Midazolam HCl require intermittent use of midazolam

Treatment of patients with symptomatic orthostatic


Midodrine HCl Amatine hypotension.

mifamuritide Junovan Treatment of osteosarcoma


Treatment of Cushing's syndrome secondary to
Mifepristone ectopic ACTH secretion
Treatment of the clinical manifestations of
mifepristone Corlux endogenous Cushing's symdrome.

miglustat Zavesca Treatment of Gaucher disease.

miltefosine Impavido Treatment of leishmaniasis.

Minocycline HCl Minocin Intravenous


Treatment of chronic malignant pleural effusion.

Minocycline hydrochloride Treatment of sarcoidosis


Treatment of intrauterine fetal death not accompanied
by complete expulsion of the products of conception
misoprostol GyMiso in the second
Treatment and third
of diffuse trimesters oflymphoma,
non-Hodgkin's pregnancy.
including AIDS-related diffuse non-Hodgkin's
Mitoguazone apep lymphoma.

Treatment of invasive carcinoma of the uterine cervix


Mitolactol
As adjuvant therapy in the treatment of primary brain
Mitolactol tumors.
Treatment of refractory glaucoma as an adjunct to ab
Mitomycin-C externo glaucoma surgery.

Mitoxantrone Novantrone Treatment of hormone refractory prostate cancer.

Treatment of secondary-progressive multiple


Mitoxantrone Novantrone sclerosis.

Mitoxantrone Novantrone Treatment of progressive-relapsing multiple sclerosis.


Treatment of acute myelogenous leukemia, also
Mitoxantrone HCl Novantrone referred to as acute nonlymphocytic leukemia.

MN14 monoclonal antibody to


carcinoembryonic antigen Cea-Cide Treatment of small cell lung cancer

MN14 monoclonal antibody to


carcinoembryonic antigen Cea-Cide Treatment of pancreatic cancer.

Treatment of excessive daytime sleepiness in


Modafinil Provigil narcolepsy.
Treatment of AIDS patients with neutropenia due to
Molgramostim Leucomax the disease, AZTor ganciclovir.

Molgramostim Leucomax Treatment of aplastic anemia.

monarsen Treatment of Myasthenia Gravis

Monoclonal Ab(murine) anti-idiotype


melanoma-associated antigen Melimmune Treatment of invasive cutaneous melanoma.

Monoclonal antibodies (murine or human) to


B-cell lymphoma Treatment of B-cell lymphoma.

Monoclonal antibody 17-1a Panorex Treatment of pancreatic cancer.

Monoclonal antibody for immunization against


lupus nephritis Treatment of lupus nephritis.

Monoclonal antibody to cytomegalovirus Treatment of cytomegalovirus retinitis in patients with


(human) AIDS.
Monoclonal antibody to cytomegalovirus Prophylaxis of cytomegalovirus disease in patients
(human) undergoing
Prophylaxis solid organ transplantation.
of hepatitis B reinfection in patients
Monoclonal antibody to hepatitis B virus undergoing liver transplantation secondary to end-
(human) stage chronic hepatitis B infection.

Monoclonal antibody-B43.13 Ovarex MAb-B43.13


Treatment of epithelial ovarian cancer.
Monoclonal antiendotoxin antibody XMMEn- Treatment of patients with gram-negative sepsis
0e5 which has progressed to shock.

Monolaurin Glylorin Treatment of congenital primary ichthyosis.


For dissolution of cholesterol gallstones retained in
Monooctanoin Moctanin the common bile duct.
For use in microinfusion devices for intraspinal
Morphine sulfate concentrate (preservative administration in the treatment of intractable chronic
free) Infumorph pain.
For use in conjunction with whole brain radiation for
the treatment of brain metastases arising from solid
motexafin gadolinium Xcytrin tumors

MTC-DOX for Injection Treatment of hepatocellular carcinoma


Treatment of pulmonary infections due to
Mucoid exopolysaccharide Pseudomonas Pseudomonas aeruginosa in patients with cystic
hyperimmune globulin MEP IGIV fibrosis.
Prevention of pulmonary infections due to
Mucoid exopolysaccharide Pseudomonas Pseudomonas aeruginosa in patients with cystic
hyperimmune globulin MEP IGIV fibrosis.
Treatment of patients with functional
gastroenteropancreatic (GEP) neuroendocrine tumors
(specifically, carcinoid, insulinoma, gastrinoma,
Multi-ligand somatostatin analogue somastatinoma, GRFoma, VIPoma and glucagonoma.
For establishment and maintenance of total parenteral
Multi-vitamin infusion (neonatal formula) nutrition in very low birth weight infants.
Prevention of vitamin deficiency and thromboembolic
complications
in people receiving home parenteral nutrition and
warfarin-type anticoagulant therapy
multi-vitiam infusion without vitamin K M.V.I.-12
Murine MAb (Lym-1) and Iodine 131-I
radiolabeled murine MAb (Lym-1) to human
B-cell lymphoma Oncolym Treatment of B-cell non-Hodgkin's lymphoma.

Murine MAb to polymorphic epithelial mucin,


human milk fat globule 1 Theragyn Adjuvant treatment of ovarian cancer.

Mx-dnG1 or Rexin-G retroviral vector REXIN-G Treatment of pancreatic cancer


For use in the diagnosis of invasive Mycobacterium
Mycobacterium avium sensitin RS-10 avium disease in immunocompetent individuals.

Mycophenolate mofetil Cellcept Treatment of myasthenia gravis

Mycophenolate mofetil CellCept Treatment of pemphigus vulgaris

Myelin Treatment
Prevention ofof multiple sclerosis.
retinopathy of prematurity in preterm
infants at risk for developing retinopathy of
myo-inositol prematurity

myristoylated recombinant SCR1-3 of human Prevention of delayed graft function in solid organ
complement reseptor type I APT070 transplant
N-((methyl-diazacyclohexyl-
methylbenzamide)-asaphenyl- Treatment of malignant gastrointestinal stromal
aminothiopyrrole) mesylate tumors.
N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-
[(4-pyridinylmethyl)amino]-3-
pyridinecarboxamide, phosphate (1:2) Treatment of gastrointestinal stromal tumors
N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-
dihydro-4-oxoquinoline-3-carboxamide Treatment of patients with cystic fibrosis.
N-(2-amino-phenyl)-4-[(4-pyridin-3-yl-
pyrimidin-2-ylamino)-methyl] benzamide
dihydrobromide Treatment of Hodgkin's lymphoma

N-(methyl-diazacyclohexyl-methylbenzamide)-
azaphenyl-aminothiopyrrole) mesylate Treatment of multiple myeloma.

N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-
methoxybenzenesulfonamide Treatment of neuroblastoma
N-[3-(4',5'-bipyrimidin-2-ylamino)-4-
methylphenyl]-4-{[(3S)-3-
(dimethylamino)pyrrolidin-1-yl]methyl}-3- Treatment of Philadelphia chromosome-positive
(trifluoromethyl)benzamide chronic myelogenous leukemia.

N-[4-(3-amino1H-indazol-4-yl)phenyl]-N1-(2-
fluoro-5-methylphenyl)urea Treatment of hepatocellular carcinoma

N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-
c]quinolin-1-yl)butyl]methanesulfonamide Treatment of stages IIB-IV melanoma

N-[4-(4-amino-2-ethyl-lH-imidazo[4,5-
c]quinolin-1-yl)butyl]methanesulfonamide Treatment of cutaneous T-cell lymphoma
N-[4-bromo-2-(1H-1,2,3,4-tetrazol-5-
yl)phenyl]-N'-[3,5-
bis(trifluoromethyl)phenyl]urea Treatment of sickle cell disease

N-acetylcysteinate Lysine Nacystelyn Dry Powder Inhaler


For the management of cystic fibrosis

N-acetylcysteine Treatment of acute liver failure


N-acetylgalactosamine-4-sulfatase, Treatment of mucopolysaccharidosis Type VI
recombinant human Naglazyme (Maroteaux-Lamy syndrome).

N-acetyl-glucosamine thiazoline Treatment of adult Tay-Sachs disease


To lower the defibrillation energy requirement
sufficiently to allow automatic implantable cardioverter
defibrillator therapy in those patients who could
N-acetylprocainamide Napa otherwise
Preventionnot use the device. ventricular arrhythmias
of life-threatening
in patients with documented procainamide-induced
N-acetyl-procainamide lupus.
N-acetyl-sarcosyl-glycyl-L-valyl-D-
alloisoleucyl-L-threonyl-L-norvalyl-L-isoleucyl-
L-arginyl_L-prolylethylaminde acetate Treatment of soft tissue sarcoma

Nafarelin acetate Synarel Nasal Solution


Treatment of central precocious puberty.
For blockade of the pharmacological effects of
exogenously administered opioids as an adjunct to
the maintenance of the opioid-free state in detoxified
Naltrexone HCl Trexan formerly opioid-dependent individuals.

Natural human lymphoblastoid interferon-


alpha Treatment of polycythemia vera

Natural human lymphoblastoid interferon-


alpha Treatment of Behcet's disease.
Natural human lymphoblastoid interferon- Treatment of papillomavirus warts in the oral cavity of
alpha HIV positive patients.

NDROGE Treatment of postanoxic intention myoclonus.


Treatment of patients with gram-negative bacteremia
Nebacumab Centoxin which has progressed to endotoxin shock.

Treatment of acute lymphoblastic leukemia and


nelarabine Arranon lymphoblastic lymphoma

Treatment of motor neuron disease/amyotrophic


Neurotrophin-1 lateral sclerosis.
Diagnostic measure of the capacity of the pituitary
NG-29 Somatrel gland to release growth hormone.

Nifedipine Treatment of interstitial cystitis.

Nikkomycin Z Treatment of coccidioidomycosis

nilotinib Tasigna Treatment of gastrointestinal stromal tumors.

Nilotinib Treatment of chronic myelogenous leukemia

Nimotuzumab Treatment of glioma

niprisan Hemoxin Treatment of sickle cell disease

nitazoxanide Cryptaz Treatment for intestinal amebiasis

nitazoxanide Alinia Treatment of intestinal giardiasis

Nitazoxanide Alinia Treatment of cryptosporidiosis.

Nitisinone Orfadin Treatment of alkaptonuria

Nitisinone Orfadin Treatment of tyrosinemia type 1.

Nitric oxide Diagnosis of sarcoidosis

To reduce the risk of chronic lung disease in


Nitric oxide INOmax premature neonates
Treatment of persistent pulmonary hypertension in the
Nitric oxide INOmax newborn.

Treatment of acute respiratory distress syndrome in


Nitric oxide adults.
Treatment and prevention of cerebral vasospasm
Nitroprusside following
Treatmentsubarachnoid hemorrhage.
of follicular, medullary and anaplastic
N-Methyl-2-[3-[((E)-2-pyridin-2-yl-vinyl)-1H- thyroid carcinoma and metastatic or locally advanced
indazol-6-ylsulfanyl]benzamide Axitinib papillary thyroid cancer.

Novel Acting Thrombolytic (NAT) Treatment of peripheral arterial occlusion (PAO)

Nucleic acid aptamer binding to tumor cell


nucleolin Treatment of pancreatic cancer

Nucleic acid aptamer binding to tumor cell


nucleon Treatment of renal cell carcinoma
Enzyme replacement therapy in patients with all
NZ-1002 subtypes of Mucopolysaccharidosis I.

Obatoclax mesylate Treatment of chronic lymphocytic leukemia

Obatoclax mesylate Treatment of myelodysplastic syndrome

Obatoclax mesylate Treatment of myelofibrosis

Treatment of advanced malignant melanoma (Stages


oblimersen Genasense II,III, IV).
Treatment of severe diarrhea and flushing associated
Octreotide Sandostatin LARwith malignant carcinoid tumors.

Octreotide Sandostatin LARTreatment of acromegaly.

Treatment of diarrhea associated with vasoactive


Octreotide Sandostatin LARintestinal peptide tumors (VIPoma).

Ofloxacin Ocuflox Ophthalmic Solution


Treatment of bacterial corneal ulcers.

oglufanide disodium Treatment of ovarian cancer

OM 401 Drepanol Prophylactic treatment of sickle cell disease.

Omacetaxine mepesuccinate Treatment of chronic myelogenous leukemia


Omega-3 (n-3) polyunsaturated fatty acid with
all double bonds in the cis configuration Prevention of organ graft rejection.

Omega-3 (n-3) polyunsaturated fatty acids Omacor Treatment of IgA nephropathy.

Oncorad Ov103 Treatment of ovarian cancer.

Prevention of severe chemotherapy-induced


Oprelvekin Neumega thrombocytopenia.

oral unfractionated heparin Treatment of sickle cell disease


Treatment of familial amyotrophic lateral sclerosis
associated with a mutation of the gene (on
chromosome 21q) for copper, zinc superoxide
Orgotein for injection dismutase.

ortezomib Velcade Treatment of multiple myeloma

Oxaliplatin Treatment of ovarian cancer.

Oxalobacter formigenes Treatment of primary hyperoxaluria

Treatment of short stature associated with Turner's


Oxandrolone Oxandrin syndrome.

Treatment of constitutional delay of growth and


Oxandrolone puberty.
Treatment of patients with Duchenne's muscular
Oxandrolone Oxandrin dystrophy and Becker's muscular dystrophy.
Adjunctive therapy for AIDS patients suffering from
Oxandrolone Oxandrin HIV-wasting syndrome.
Treatment of moderate/severe acute alcoholic
hepatitis in the presence of moderate protein calorie
Oxandrolone Hepandrin malnutrition.

oxybate Xyrem Treatment of narcolepsy

oxybate Xyrem Treatment of narcolepsy.

For relief of severe intractable pain in narcotic-tolerant


Oxymorphone Numorphan H.P.patients.

Treatment of hyperuricemia in patients intolerant to


Oxypurinol allopurinol.

p1-(uridine 5'-)-p4-(2'-deoxycytidine 5'-)


tetraphosphate, tetrasodium salt For the treatment of cystic fibrosis

P1, P4-Di(uridine 5'-tetraphosphate),


tetrasodium salt Treatment of cystic fibrosis.
PA mAb Abthrax Treatment of anthrax

Paclitaxel Taxol Treatment of AIDS-related Kaposi's sarcoma.

Paclitaxel Paxene Treatment of AIDS-related Kaposi's sarcoma.

Paclitaxel (TOCOSOL) Treatment of non-superficial urothelial cancer

Treatment of human African trypanosomiasis


Pafuramidine maleate (sleeping sickness)

Pafuramidine maleate Treatment of malaria

pafuramidine maleate Treatment of pneumocystis jiroveci pneuomina.

Treatment of steatorrhea associated with chronic


pancrelipase VIOKASE pancreatitis.

panobinostat Faridak Treatment of cutaneous T-cell lymphoma

Papain, trypsin, and chymotrypsin Wobe-Mugos Treatment of multiple myeloma.

Treatment of sexual dysfunction in spinal cord injury


Papaverine topical gel patients.

parathyroid hormone Treatment of hypoparathyroidism.


Parvovirus B19 (recombinant VP1 and VP2; Prevention of transient aplastic crisis in patients with
S.frugiperda cells) vaccine MEDI-491 sickle cell anemia.
Treatment of patulous eustachian tube.

Patul-end

Patupilone Treatment of ovarian cancer.


For enzyme replacement therapy for ADA deficiency
Pegademase bovine Adagen in patients with severe combined immunodeficiency.

Pegaspargase Oncaspar Treatment of acute lymphocytic leukemia.


For use as chronic enzyme replacement therapy in
patients with Gaucher's disease who are deficient in
PEG-glucocerebrosidase Lysodase glucocerebrosidase.

Peginterferon alfa-2a PEGASYS Treatment of chronic myelogenous leukemia.


Peginterferon alfa-2a PEGASYS Treatment of renal cell carcinoma.
Treatment of primary immunodeficiencies associated
PEG-interleukin-2 with T-cell defects.

Pegvisomant Somavert Treatment of acromegaly.

Pegylated arginine deiminase Melanocid Treatment of invasive malignant melanoma.

Pegylated arginine deiminase


Pegylated recombinant human
Hepacid Treatment of hepatocellular carcinoma.
For reducing the period of thrombocytopenia in
megakaryocyte growth and development patients undergoing hematopoietic stem cell
factor MEGAGEN transplantation.

Peldesine Treatment of cutaneous T-cell lymphoma.

pemetrexed disodium Alimta Treatment of malignant pleural mesothelioma


Prevention of Pneumocystis carinii pneumonia in
Pentamidine isethionate Nebupent patients at high risk of developing this disease.

Pentamidine isethionate Pentam 300 Treatment of Pneumocystis carinii pneumonia.

Pentamidine isethionate Treatment of Pneumocystis carinii pneumonia.


Prevention of Pneumocystis carinii pneumonia in
Pentamidine isethionate (inhalation) Pneumopent patients at highinrisk
As an adjunct of developing
leukapheresis this disease.
to improve the
harvesting and increase the yield of leukocytes by
Pentastarch Pentaspan centrifugal means.
Treatment of patients with known or suspected
internal contamination with plutonium, americium, or
pentetate trisodium diethylenetriaminepentaacetate
curium.

Pentosan polysulfate sodium Elmiron Treatment of interstitial cystitis.

Treatment of patients with chronic lymphocytic


Pentostatin Nipent leukemia.

Pentostatin Nipent Treatment of peripheral T-cell lymphomas.

Pentostatin Nipent Treatment of cutaneous T-cell lymphoma.

Pentostatin for injection Nipent Treatment of hairy cell leukemia.

Peptide 144 TGF beta-1 inhibitor Treatment of systemic sclerosis

Peptide 144 TGF beta-1-inhibitor Treatment of localized scleroderma


Peptidomimetic analog of hexarelin Diagnosis of growth hormone deficiency

Treatment of acute respiratory distress disease


Perflubron LiquiVent (ARDS) in adults
For use in the ex-vivo treatment of autologous bone
marrow and subsequent reinfusion in patients with
acute myelogenous leukemia, also referred to as
Perfosfamide Pergamid acute nonlymphocytic leukemia.

Pergolide Permax Treatment of Tourette's syndrome.


For use as an adjunct to surgery, radiation therapy
and chemotherapy for the treatment of patients with
Phenylacetate primary or recurrent malignant glioma.

Phenylalanine ammonia-lyase Phenylase Treatment of hyperphenylalaninemia.

Phenylbutyrate Treatment of acute promyelocytic leukemia.

Treatment of ileal pouch anal anastomosis related


phenylephrine fecal incontinence

Phosphocysteamine Treatment of cystinosis.

Treatment of xerostomia induced by radiation therapy


Pilocarpine Salagen for head and neck cancer.

Treatment of xerostomia and keratoconjunctivitis


Pilocarpine HCl Salagen sicca in Sjogren's syndrome patients.

Piracetam Nootropil Treatment of myoclonus.


Treatment of infections caused by Pneumocystis
carinii, Toxoplasma gondii, and Mycobacterium
Piritrexim isethionate avium-intracellulare.

Plasmid DNA vector expressing cystic fibrosis


transmembrane gene Treatment of cystic fibrosis

Plevitrexed Plevitrexed Treatment of ovarian cancer

Plevitrexed Plevitrexed Treatment of gastric (stomach) cancer

Plitidepsin Aplidin Treatment of acute lymphoblastic leukemia

Plitidepsin Aplidin Treatment of multiple myeloma

polifeprosan 20 with carmustine Gliadel Treatment of malignant glioma


polifeprosan 20 with carmustine Gliadel Treatment of malignant glioma.
Treatment of vasospasm in subarachnoid
hemorrhage patients following surgical repair of a
Poloxamer 188 ruptured cerebral aneurysm.

Poloxamer 188 Flocor Treatment of sickle cell crisis.

Poloxamer 188 Florcor Treatment of severe burns requiring hospitalization.

Poloxamer 331 Protox Initial therapy of toxoplasmosis in patients with AIDS.

Poly I: poly C12U Ampligen Treatment of renal cell carcinoma.

Treatment of invasive metastatic melanoma (stage


Poly I: poly C12U Ampligen IIb, III, IV).

Poly I: poly C12U Ampligen Treatment of chronic fatigue syndrome.

Poly I: poly C12U Ampligen Treatment of AIDS.


To control the clinical consequences of hyperuricemia
in patients with severe gout in whom conventional
Polyethylene glycol (PEG)-uricase therapy is contraindicated or has been ineffective.
Treatment of hyperuricemia in patients with gout
refractory to conventional therapy or in whom
Polyethylene glycol-modified uricase conventional therapy is contraindicated
Prophylaxis of hyperuricemia in cancer patients prone
to develop tumor lysis syndrome during
Polyethylene glycol-modified uricase Zurase chemotherapy.
Treatment of tumor lysis syndrome in cancer patients
Polyethylene glycol-modified uricase Zurase undergoing chemotherapy.

Poly-ICLC Hiltonol Treatment of primary brain tumors.


Treatment of flavivirus infections including those due
to West Nile, Japanese encephalitis, dengue, St.
Louis encephalitis, yellow fever, Murray valley, and
polyinosinic-polycytidilic acid Poly-ICLC Banzai viruses

polyinosinic-polycytidilic acid Poly-ICLC As an adjuvant to smallpox vaccination

polyinosinic-polycytidilic acid (Poly-ICLC) Hiltonol Treatment for orthopox virus infections

Polymeric oxygen Treatment of sickle cell anemia.

Polyvalent, shed-antigen melanoma vaccine Treatment of stage IIb to and stage IV melanoma
Porcine fetal neural dopaminergic cells and/or
precursors aseptically prepared and coated
with anti-MHC-1 Ab for intracerebral Treatment of Hoehn and Yahr stage 4 and 5
implantation NeuroCell-PD Parkinson's disease.
Porcine fetal neural dopaminergic cells and/or
precursors aseptically prepared for Treatment of Hoehn and Yahr stage 4 and 5
intracerebral implantation. NeuroCell-PD Parkinson's disease.
Porcine fetal neural gabaergic cells and/or
precursors aseptically prepared and coated
with anti-MHC-1 Ab for intracerebral
implantation NeuroCell-HD Treatment of Huntington's disease.
Porcine fetal neural gabaergic cells and/or
precursors aseptically prepared for
intracerebral implantation for Huntington's
disease. NeuroCell-HD Treatment of Huntington's disease.
Porcine Sertoli cells aseptically prepared for
intracerebral co-implantation with fetal neural Treatment of Hoehn and Yahr stage four and five
tissue N-Graft Parkinson's disease.
For the ablation of High-Grade Dysplasia in Barrett's
Esophagus in patients who are not considered to be
porfimer Photofrin candidates for esophagectomy

Porfimer sodium Photofrin Treatment of cholangiocarcinoma

For the photodynamic therapy of patients with primary


or recurrent obstructing (either partially or completely)
Porfimer sodium Photofrin esophageal carcinoma.
For the photodynamic therapy of patients with
transitional cell carcinoma in situ of the urinary
Porfimer sodium Photofrin bladder.

Porfiromycin Promycin Treatment of cervical cancer.

Porfiromycin Promycin Treatment of head and neck cancer.

Posaconazole Posoril Treatment of zygomycosis


For avoidance of the complication of calcium stone
Potassium citrate Urocit-K formation in patients with uric lithiasis.

Prevention of calcium renal stones in patients with


Potassium citrate Urocit-K hypocitraturia.

Potassium citrate Urocit-K Prevention of uric acid nephrolithiasis.


For the dissolution and control of uric acid and
Potassium citrate and citric acid cysteine calculi in the urinary tract.
For use as a thyroid blocking agent in pediatric
Potassium Iodide Oral Solution ThyroShield patients exposed to radiactive iodine

potassium sodium aluminosilicate For treatment of poisoning by or exposure to cesium.

Treatment of myelodysplastic syndromes (MDS)


PR1 Vaccine requiring therapy.

PR1 Vaccine Treatment of acute myelogenous leukemia

PR1 Vaccine Treatment of chronic myelogenous leukemia.


For the emergency rescue treatment of status
Pr-122 (redox-phenytoin) epilepticus, grand mal type.
Treatment of herpes simplex encephalitis in
PR-225 (redox-acyclovir) individuals afflicted with AIDS.

PR-239 (redox penicillin G) Treatment of AIDS associated neurosyphilis.


For the emergency rescue treatment of status
Pr-320 (molecusol-carbamazepine) epilepticus, grand mal type.

Pralatrexate Treatment of T-cell lymphoma


For the management of cognitive dysfunction and
enhancement of antidepressant activity associated
Pramiracetam Sulfate with electroconvulsive therapy.

Praziquantel Treatment of neurocysticercosis.

Prednimustine Sterecyt Treatment of malignant non-Hodgkin's lymphomas.


For use in combination with clindamycin hydrochloride
in the treatment of Pneumocystis carinii pneumonia
Primaquine phosphate associated with AIDS.

Procarbazine HCl Matulane Treatment of malignant


Establishment glioma of pregnancy in
and maintenance
women undergoing in vitro fertilization or embryo
Progesterone transfer procedures.

Propamidine isethionate 0.1% ophthalmic


solution Brolene Treatment of acanthamoeba keratitis.

Treatment of Fontaine Stage IV chronic critical limb


Prostaglandin E1 enol ester (AS-013) Circulase ischemia.
Treatment of ischemic ulceration of the lower limbs
Prostaglandin E1 in lipid emulsion Lipo-PGE1 due to peripheral arterial disease.

Protaxel Treatment of ovarian cancer


For replacement therapy in congenital protein C
deficiency for the prevention and treatment of
thrombosis, pulmonary emboli, and purpura
Protein C concentrate Ceprotin fulminans.
For use in the prevention and treatment of purpura
Protein C concentrate Protein C Concentrate (human)
fulminans Vapor Heated, Immuno
in meningococcemia.
For replacement therapy in patients with congenital or
acquired protein C deficiency for the prevention and
treatment of warfarin-induced skin necrosis during
Protein C concentrate Protein C Concentrate (human) Vapor Heated, Immuno
oral anticoagulation.
Prevention of infant respiratory distress syndrome
Protirelin associated with prematurity.

Protirelin injection Treatment of amyothrophic lateral sclerosis.

Prevention and treatment of infant respiratory distress


Pulmonary surfactant replacement syndrome.
For the treatment and prevention of respiratory
Pulmonary surfactant replacement, porcine Curosurf distress syndrome in premature infants.
Treatment of immune thrombocytopenia purpura
Purified extract of Pseudomonas aeruginosa ImmuDyn where it is required to increase platelet counts.

Purified type II collagen Colloral Treatment of juvenile rheumatoid arthritis.


Pyruvate Treatment of interstitial lung disease.
For prevention of recurrence of pneumothorax in
Quinacrine hydrochloride patients at high risk of recurrence.

quinine Sulfate Treatment of malaria

R-(-)-gossypol Treatment of chronic lymphocytic leukemia.

rAAV2-CB-hRPE65 Treatment of type II Leber's Congential Amaurosis


Induction treatment to prevent rejection and to
minimize maintenance immunosupression in pediatric
Rabbit anti-human thymocyte globulin (rATG) Thymoglobulin liver transplant recipients

Reduction of the risk of breast cancer in


Raloxifene Evista postmenopausal women

Ranprinase Onconase Treatment for malignant mesothelioma

Rapamycin Treatment of tuberous sclerosis complex

Rapamycin (mTOR) inhibitor Treatment of bone sarcoma

Treatment of malignancy-associated or
rasburicase Elitek chemotherapy-induced hyperuricemia.

recombinant adeno-associated virus alpha 1-


antitrypsin vector rAAV-AAT Treatment of alpha1-antitrypsin deficiency

Recombinant anti-CD40 monoclonal antibody Treatment of chronic lymphocytic leukemia

Recombinant anti-CD-40 monoclonal antibody Treatment of multiple myeloma

Recombinant bactericidal/permeability-
increasing protein Neuprex Treatment of severe meningococcal disease.

recombinant chimeric monoclonal antibody to


anthrax Anthim Treatment of exposure to B. anthracis spores

Recombinant coagulation factor VIIa Novoseven Treatment of diffuse alveolar hemorrhage

Recombinant deriative of C3 transferase Cethrin Treatment


Prevention of
of acute spinal cord injury
post-transplantation lymphoproliferative
Recombinant Epstein-Barr virus gp350 disorders in pediatric recipients of solid-organ
glycoprotein vaccine transplantation
recombinant fusion protein with a truncated Treatment of Ep-CAM-positive squamous cell
form of the cytotoxic protein Pseudomonas carcinoma of the head and neck
exotoxin Proxinium
Recombinant glycine2-human glucagon-like
peptide-2 Treatment of short bowel syndrome.

Recombinant human acid alpha-glucosidase Myozyme Treatment of glycogen storage disease type II.

Recombinant human alpha 1-antitrypsin Prevention of bronchopulmonary dysplasia

recombinant human alpha 1-antitrypsin (rAAT) Treatment of cystic fibrosis

recombinant human alpha-1 antitrypsin Treatment of cystic fibrosis.


To delay progression of chronic obstructive pulmonary
disease resulting from AAT deficiency-mediated
recombinant human alpha-1 antitrypsin (rAAT) emphysema and bronchiectasis

Recombinant Human Alpha-Fetoprotein


(rhAFP) Treatment of myasthenia gravis

Recombinant human alpha-mannosidase Treatment of alpha-mannosidosis

Recombinant human anti-GDF-8 (growth and Treatment of Duchenne and Becker muscular
differentiation factor-8) antibody dystrophies
Treatment of antithrombin III dependent heparin
Recombinant human antithrombin III resistance requiring anticoagulation.

Recombinant human C1 inhibitor Treatment of capillary leakage syndrome


Prevention and/or treatment of delayed graft function
Recombinant human C1 inhibitor after solid organ transplantation
Treatment of (acute attacks of) angioedema caused
by hereditary or acquired C1-esterase inhibitor
Recombinant human C1-esterase inhibitor deficiency.
Prophylactic treatment of angioedema caused by
hereditary or acquired C1-esterase inhibitor
Recombinant human C1-esterase inhibitor deficiency.

Recombinant human CD4 immunoglobulin G Treatment of AIDS resulting from infection with HIV-1.
Prevention of neonatal bronchopulmonary dysplasia
in premature neonates with respiratory distress
Recombinant human Clara Cell 10kDa protein syndrome.

recombinant human endostatin protein Treatment of neuroendocrine tumors.

recombinant human endostatin protein Treatment of metastatic melanoma

recombinant human fibroblast growth factor-


20 Treatment of radiation induced oral mucositis
Treatment of acute and chronic respiratory symptoms
Recombinant human gelsolin of bronchiectasis.
Treatment of the respiratory symptoms of cystic
Recombinant human gelsolin fibrosis.

Recombinant human granulocyte colony


stimulating factor Prevention of implantation failure
For enzyme replacement therapy in patients with all
Recombinant human highly phosphorylated subtypes of glycogen storage disease type II (GSDII,
acid alpha-glucosidase TBD Pompe Disease)

Recombinant human insulin-like growth factor


1 IGF-1 Treatment
Treatment of
of growth hormone receptor
antibody-mediated growthdeficiency.
hormone
Recombinant human insulin-like growth factor resistance in patients with isolated growth hormone
1 IGF-1 deficiency Ia.
Treatment of short-bowel syndrome as a result of
Recombinant human insulin-like growth resection of the small bowel or as a result of
factor-I PV802 congenital dysfunction of the intestines.

Recombinant human insulin-like growth


factor-I Treatment of post-poliomyelitis syndrome.
Recombinant human insulin-like growth
factor-I/insulin-like growth factor binding
protein-3 Treatment of major burns that require hospitalization.

Recombinant human interleukin-12 Treatment of renal cell carcinoma.

Treatment of stage II (T4), III or IV malignant


Recombinant Human Interleukin-21 (rIL-21) melanoma.

Recombinant human keratinocyte growth Reducing the incidence and severity of radiation-
factor induced xerostomia.

For use in association with recombinant human follicle


stimulating hormone for the treatment of women with
chronic anovulation due to hypogonadotropic
Recombinant human luteinizing hormone Luveris hypogonadism.
Recombinant human lysosomal acid lipase or Treatment of lipase deficiencies, including Wolman
cholesteryl ester hydrolase Cholestrase Disease and cholesteryl ester storage disease

Recombinant human microplasmin Treatment of peripheral arterial occlusion

recombinant human monoclonal antibody to


hsp90 Mycograb Treatment of invasive candidiasis

Recombinant human nerve growth factor Treatment of HIV-associated sensory neuropathy.

recombinant human neutrophil inhibitor (hNE) Treatment of cystic fibrosis

Recombinant human platelet derived growth


factor BB treatment of osteonecrosis of the jaws.

recombinant human porphobilinogen


deaminase Porphozyme Treatment of acute intermittent porphyria attacks

recombinant human porphobilinogen Treatment of acute intermittent porphyria preventing


deaminase, erythropoetic form attacks
Recombinant human relaxin Treatment of progressive systemic sclerosis.
For use in accelerating platelet recovery in patients
Recombinant human thrombopoietin undergoing hematopoietic stem cell transplantation.

Recombinant humanized MAb 5c8 Prevention of rejection of solid organ transplants.

Prevention of rejection of pancreatic islet cell


Recombinant humanized MAb 5c8 transplants.
Prevention and treatment of Factor VIII/Factor IX
Recombinant humanized MAb 5c8 inhibitors in patients with hemophilia A or B.

Recombinant humanized monclonal antibody


5c8 Treatment of immune thrombocytopenic purpura.

Recombinant humanized monoclonal antibody


5c8 Treatment of systemic lupus erythematosus.

recombinant inhibitor of human plasma


kallikrein Treatment of angioedema

Recombinant methionyl brain-derived


neurotrophic factor Treatment of amyotrophic lateral sclerosis.

recombinant ovine interferon tau Tauferon Treatment


Treatment of pediatric
and multiple
prevention sclerosis
of episodic bleeding in
Recombinant Porcine Factor VIII, B-domain patients with inhibitor antibodies to human coagulation
Deleted factor VIII

Prevention of delayed graft function in renal transplant


Recombinant P-Selectin glycoprotein ligand patients
Recombinant P-selectin glycoprotein ligand- Prevention of ischemia reperfusion injury in all solid
immunoglobulin Ig organ transplants
Recombinant retroviral vector - For use as enzyme replacement therapy for patients
glucocerebrosidase with types I, II, or III Gaucher disease.

Recombinant secretory leucocyte protease


inhibitor Treatment of cystic fibrosis.

Recombinant secretory leucocyte protease


inhibitor Treatment of congenital alpha-1 antitrypsin deficiency.

Recombinant soluble human CD4 Receptin Treatment of acquired immunodeficiency syndrome.

Recombinant soluble human CD4 (rCD4) Treatment of AIDS in patients infected with HIV virus.
Treatment of multiple sclerosis patients who are both
HLA-DR2 positive and autoreactive to myelin
Recombinant T-cell receptor ligand oligodendrocyte glycoprotein residues 35-55

Recombinant truncated SPINT2 protease


inhibitor Treatment of cystic fibrosis

Recombinant urate oxidase Prophylaxis of chemotherapy-induced hyperuricemia.


Reduced L-glutathione Cachexon Treatment of AIDS-associated cachexia.

Remacemide Ecovia Treatment of Huntington's disease.

Prevention of delayed graft function in solid organ


Reparixin transplant

repository corticotropin or adrenocorticotropic


hormone H.P. Acthar Gel Treatment of infantile spasms

resiniferatoxin Treatment of intractable pain at end-stage disease


Treatment of respiratory syncytial virus lower
Respiratory Syncytial Virus Immune Globulin respiratory tract infections in hospitalized infants and
(human) Hypermune RSVyoung children.

Prophylaxis of respiratory syncytial virus lower


Respiratory syncytial virus immune globulin respiratory tract infections in infants and young
(Human) Respigam children at high risk of RSV disease.

R-etodolac Treatment of chronic lymphocytic leukemia

Treatment of X linked severe combined immune


retroviral gamma-c cDNA containing vector deficiency disease

Retroviral vector, R-GC and GC gene 1750 Treatment of Gaucher disease.


Treatment of deep vein thrombosis which may lead to
Reviparin sodium Clivarine pulmonary embolism in pediatric patients
Long-term treatment of acute deep vein trombosis
with or without pulmonary embolism in pregnant
Reviparin sodium Clivarine patients

RGG0853, E1A lipid complex Treatment


Treatment of
of ovarian
extremecancer.
insulin resistance syndromes
(type A, Rabson-Mendenhall syndrome,
rhIGF-I/rhIGFBP-3 SomatoKine Leprechaunism, Type B syndrome)

rh-microplasmin Adjunct to surgery in cases of pediatric vitrectomy

Rho (D) immune globulin intravenous (human) WinRho SD Treatment of immune thrombocytopenic purpura.

Ribavirin Virazole Treatment of hemorrhagic fever with renal syndrome.

ribavirin REBETOL Treatment of chronic hepatitis C in pediatric patients


For the ex-vivo purging of leukemic cells from the
Ricin (blocked) conjugated murine mca (anti- bone marrow of non-T cell acute lymphocytic
b4) leukemia patients who are in complete remission.

Ricin (blocked) conjugated murine MCA (anti-


B4) Treatment of B-cell leukemia and B-cell lymphoma.
Ricin (blocked) conjugated murine MCA (anti- Treatment of myeloid leukemia, including AML, and
my9) blast crisis of CML.
For use in the ex-vivo treatment of autologous bone
Ricin (blocked) conjugated murine MCA (anti- marrow and subsequent reinfusion in patients with
my9) acute myelogenous leukemia.

Ricin (blocked) conjugated murine MCA


(n901) Treatment
Treatment of
of small cell lung cancer.
cutaneous T-cell lymphomas, acute T-
Ricin (blocked) conjugated murine monoclonal cell leukemia-lymphoma, and related mature T-cell
antibody (CD6) malignancies.
Prevention of disseminated Mycobacterium avium
complex disease in patients with advanced HIV
Rifabutin Mycobutin infection.

Treatment of disseminated Mycobacterium avium


Rifabutin complex disease.

Rifalazil Treatment of pulmonary tuberculosis.


For antituberculosis treatment where use of the oral
Rifampin Rifadin I.V. form of the drug is not feasible.

Rifampin, isoniazid, pyrazinamide Rifater For the short-course treatment of tuberculosis.


Prophylactic treatment of Mycobacterium avium
complex in patients with AIDS and a CD4+ count less
Rifapentine Priftin than or equal to 75/mm3.

Treatment of Mycobacterium avium complex in


Rifapentine Priftin patients with AIDS.

Rifapentine Priftin Treatment of pulmonary tuberculosis.

Rifaximin Normix Treatment of hepatic encephalopathy

RII retinamide Treatment of myelodysplastic syndromes.

Riluzole Rilutek Treatment of Huntington's disease.

Riluzole Rilutek Treatment of amyotrophic lateral sclerosis.

risedronate sodium Actonel Treatment of patients with osteogenesis imperfecta.


Treatment of patients with anti-neutrophil cytoplasmic
antibody-associated vasculitis (Wegener's
Granulomatosis, Microscopic Polyangiitis, and Churg-
rituximab Rituxan Strauss Syndrome)

rituximab Rituxan Treatment of immune thrombocytopenic purpura

rituximab Rituxan Treatment of non-Hodgkin's B-cell lymphoma.

rituximab Rituxan Treatment of chronic lymphocytic leukemia

rofecoxib VIOXX Treatment of juvenile rheumatoid arthritis


rolespimycin hydrochloride Treatment for gastrointestinal stromal tumor

romidepsin Treatment of non-Hodgkin T-cell lymphomas


To prolong time to relapse in leukemia patients who
have undergone autologous bone marrow
Roquinimex Linomide transplantation.

Rose Bengal Disodium Treatment of metastatic melanoma

rSP-C lung surfactant Venticute Treatment of adult respiratory distress syndrome.


For use in patients with pneumonia or aspiration of
gastric contents leading to intubation, mechanical
rSP-C surfactant Venticute ventilation, and severe oxygen impairment
Treatment of pediatric patients infected with human
immunodeficiency virus and acquired
rubitecan immunodeficiency syndrome

Rufinamide Treatment of Lennox-Gastaut Syndrome.

S(-)-3-[3-amino-phthalimido]-glutaramide Treatment of multiple myeloma

Treatment of congenital sucrase-isomaltase


Sacrosidase Sucraid deficiency.

S-adenosylmethionine Treatment of AIDS-myelopathy.

salirasib Treatment of panreatic cancer.


Treatment of neutropenia associated with bone
marrow transplant, for the treatment of graft failure
and delay of engraftment, and for the promotion of
Sargramostim Leukine early engraftment.

To reduce neutropenia and leukopenia and decrease


the incidence of death due to infection in patients with
Sargramostim Leukine acute myelogenous leukemia.

sarsasapogenin Treatment of amyotrophic lateral sclerosis (ALS)

Satumomab pendetide Oncoscint CR/OVDetection of ovarian carcinoma.

SB-408075 For pancreatic cancer

Treatment of patients with CD55 (sc-1) positive gastric


SC-1 monoclonal antibody tumors

SCH 58500 Treatment of primary ovarian cancer.

SDF-1 (108) Lysine Dlmer Treatment of osteogenic sarcoma


Secalciferol Osteo-D Treatment of familial hypophosphatemic rickets.

Secretory leukocyte protease inhibitor Treatment of bronchopulmonary dysplasia.


As an adjuvant to levodopa and carbidopa treatment
of idiopathic Parkinson's disease (paralysis agitans),
postencephalitic Parkinsonism, and symptomatic
Selegiline HCl Eldepryl Parkinsonism.
Treatment of idiopathic or organic growth hormone
Sermorelin acetate Geref deficiency in children with growth failure.
Adjunct to gonadotropin therapy in the induction of
ovulation in women with anovulatory or oligo-ovulatory
infertility who fail to ovulate in response to adequate
treatment with clomiphene citrate alone and
Sermorelin acetate Geref gonadotropin therapy alone.

Sermorelin acetate Geref Treatment of AIDS-associated catabolism/weight loss.

Serratia marcescens extract (polyribosomes) Imuvert Treatment of primary brain malignancies.

SGN-30 (anti-CD30 antibody) Treatment of CD30 positive T-cell lymphomas

SGN-30 (anti-CD30 mAb) Treatment of Hodgkin's disease

SGN-40 (anti-CD40 antibody) Treatment of multiple myeloma.

Short chain fatty acid enema Colomed Treatment of chronic radiation proctitis.
Treatment of the active phase of ulcerative colitis with
Short chain fatty acid solution Colomed involvement restricted to the left side of the colon.

Silver sulfadiazine and cerium nitrate Flammacerium Prevention of mortality in severely burned patients.

siplizumab Treatment of T-celloflymphomas


For the treatment pulmonary arterial hypertensionin
the absence of chronic obstructive pulmonary disease
Sitaxsentan Sodium or congestive heart failure
For the long term treatment of children who have
growth failure due to a lack of adequate endogenous
SK&F 110679 growth hormone secretion.

Sodium aluminosilicate Treatment of chronic hepatic encephalopathy


Treatment of metastatic or locally advanced
Sodium ascorbate and menadione sodium inoperable transitional cell carcinoma of the
bisulfite Apatone urothelium (stage III and IV bladder cancer)

Treatment of homozygous familial


Sodium dichloroacetate hypercholesterolemia.

Sodium dichloroacetate Treatment of congenital lactic acidosis.

Sodium dichloroacetate Treatment of congenital lactic acidosis.


Treatment of lactic acidosis in patients with severe
Sodium dichloroacetate malaria.
Use as an antidote in the management of systemic
sodium dichloroacetate monochloroacetic acid poisoning

Sodium dichloroacetate Ceresine Treatment of severe head injury.


Sodium Monomercaptoundecahydro-closo- For use in boron neutron capture therapy (BNCT) in
dodecaborate Borocell the treatment of glioblastoma multiforme.
For use in conjunction with a thermal or epithermal
Sodium monomercaptoundecahydro-closo- neutron beam in boron nuclear capture therapy of
dodecaborate glioblastoma multiforme.

Treatment of vaso-occlusive crisis associated with


Sodium nitrite sickle cell disease

Sodium nitrite Treatment of cyanide poisoning

Prevention of vasospasm associated with


Sodium nitrite subarachnoid hemorrhage

Sodium nitrite/sodium thiosulfate Cyanide AntidoteTreatment


Packageof cyanide poisoning

Sodium phenylacetate/sodium benzoate


10%/10% Injection Ammonul Treatment of grade III and VI hepatic encephalopathy

Sodium phenylbutyrate Treatment of spinal muscular atrophy

Sodium phenylbutyrate Buphenyl Treatment of spinal muscular atrophy


For use as an adjuct to surgery, radiation therapy and
chemotherapy for the treatment of patients with
Sodium phenylbutyrate primary or recurrent malignant glioma.

Treatment of urea cycle disorders:


carbamylphosphate synthetase deficiency, ornithine
transcarbamylase deficiency, and arginiosuccinic acid
sodium phenylbutyrate Buphenyl synthetase deficiency.
Treatment for sickling disorders, which include S-S
hemoglobinopathy, S-C hemoglobinopathy, and S-
sodium phenylbutyrate thalassemia hemoglobinopathy.

Sodium pyruvate Treatment of cystic fibrosis

Sodium stibogluconate Treatment of cutaneous leishmaniasis

Prevention of platinum-induced ototoxicity in pediatric


Sodium thiosulfate patients

Sodium thiosulfate and sodium nitrite Treatment of cyanide poisoning

Sodium thiosulfate, sodium nitrite, amyl nitrite Cyanide AntidoteTreatment


Packageof cyanide poisoning
Solasonine and solamargine Coramsine Treatment of renal cell carcinoma

Treaatment of high risk stage II, stage III and stage IV


Solasonine and solamargine Coramsine melanoma
Prevention of post-cardiopulmonary bypass syndrome
Soluble complement receptor type 1 in children undergoing cardiopulmonary bypass.

Soluble recombinant human complement Prevention or reduction of adult respiratory distress


receptor type 1 syndrome.

solvent/detergent treated non-blood group


specific human coagulation active plasma UNIPLAS Treatment of thrombotic thrombocytopenic purpura
Adjunct to the non-operative management of
secreting cutaneous fistulas of the stomach,
duodenum, small intestine (jejunum and ileum), or
Somatostatin Zecnil pancreas.

Somatostatin Treatment of bleeding esophageal varices.

Treatment of short stature associated with Turner's


Somatrem for injection Protropin syndrome.
For long-term treatment of children who have growth
failure due to a lack of adequate endogenous growth
Somatrem for injection Protropin hormone secretion.
Treatment of short stature in pediatric patients with
short stature homeobox-containing gene (SHOX)
Somatropin Humatrope deficiency

Treatment of short stature in patients with Noonan


Somatropin Norditropin syndrome

Treatment of short stature associated with Turner's


Somatropin Norditropin syndrome.

Treatment of short stature associated with Turner


Somatropin Humatrope syndrome.
Adjunct for the induction of ovulation in women with
infertility due to hypogonadotropic hypogonadism or
bilateral tubal occlusion or unexplained infertility, who
are undergoing in vivo or in vitro fertilization
Somatropin Norditropin procedures.

Somatropin Biotropin Treatment of cachexia associated with AIDS.

Somatropin Genotropin Treatment of adults with growth hormone deficiency.


Treatment of patients with HIV-associated adipose
Somatropin Serostim redistribution syndrome
For use in the long-term treatment of children who
have growth failure due to a lack of adequate
Somatropin Nutropin endogenous growth hormone secretion.
For the enhancement of nitrogen retention in
Somatropin (rDNA) Saizen hospitalized patients suffering from severe burns.
Treatment of idiopathic or organic growth hormone
Somatropin (rDNA origin) Saizen deficiency in children with growth failure.
Long-term treatment of children who have growth
failure due to a lack of adequate endogenous growth
Somatropin (rDNA origin) Nutropin Depot hormone secretion.
Treatment of growth failure in children due to
Somatropin (rDNA origin) injection Norditropin inadequate growth hormone secretion.
For use alone or in combination with glutamine in the
Somatropin (r-DNA) Zorbtive treatment of short bowel syndrome.
Treatment of children with AIDS-associated failure-to-
Somatropin (r-DNA) for injection Serostim thrive including AIDS-associated wasting.

Treatment of short stature in patients with Prader-Willi


Somatropin [rDNA] Genotropin syndrome.

Treatment of growth failure in children who were born


somatropin [rDNA] Genotropin small for gestational age.
For the long-term treatment of children who have
growth failure due to inadequate secretion of normal
Somatropin for injection Humatrope endogenous growth hormone.
As replacement therapy for growth hormone
Somatropin for injection Nutropin deficiency in adults after epiphyseal closure.

Treatment of growth retardation associated with


Somatropin for injection Nutropin chronic renal failure.

Somatropin for injection Serostim Treatment of AIDS-associated catabolism/weight loss.

Treatment of short stature associated with Turner's


Somatropin for injection Nutropin syndrome.

Sorafenib Nexavar Treatment of hepatocellular carcinoma

Sorafenib Nexavar Treatment of stage IIB through stage IV melanoma

Sorafenib Nexavar Treatment of renal cell carcinoma.


Treatment of herpes zoster (shingles) in
Sorivudine BRAVAVIR immunocompromised patients.

Prevention of life threatening ventricular


Sotalol HCl Betapace tachyarrhythmias.

Treatment of life-threatening ventricular


Sotalol HCl Betapace tachyarrhythmias.
For symptomatic relief and parasitic cure of chronic
Spiramycin Rovamycine cryptosporidiosis in patients with immunodeficiency.

Treatment of ovarian cancer refractory or resistant to


squalamine lactate standard chemotherapy

SS1(dsFv)-PE38 Treatment of epithelial ovarian cancer

SS1(dsFv)-PE38 Treatment of malignant mesothelioma

Treatment of patients with B-chronic lymphocytic


ST1-RTA immunotoxin (SR 44163) leukemia.
Prevention of acute graft versus host disease in
ST1-RTA immunotoxin (SR 44163) allogenic bone marrow transplantation.
Staphylococcus aureus Immune Globulin Prophylaxis against Staphylococcus aureus infections
(Human) Altastaph in low birth weight neonates
For use as hematopoietic support in patients with
Stem and progenitor cells derived from ex relasped or refractory hematologic malignancies who
vivo expanded allogeneic umbilical cord blood StemEx are receiving high-dose therapy

Sterile talc Steritalc Treatment of malignant pleural effusion.

Sterile talc Steritalc Treatment of pneumothorax.

Sterile talc powder Sclerosol Intrapleural Aerosol


Treatment of malignant pleural effusion.

SU101 Treatment of ovarian cancer.

SU101 Treatment of malignant glioma.

Succimer Chemet Treatment of mercury intoxication.


Prevention of cystine kidney stone formation in
patients with homozygous cystinuria who are prone to
Succimer Chemet stone development.

Succimer Chemet capsulesTreatment of lead poisoning in children.


Treatment of oral mucositis and stomatitis following
Sucralfate radiation therapy for head and neck cancer.
Treatment of oral complications of chemotherapy in
Sucralfate suspension bone marrow transplant patients.
Treatment of oral ulcerations and dysphagia in
Sucralfate suspension patients with epidermolysis bullosa.

For use in combination with pyrimethamine for the


treatment of Toxoplasma gondii
Sulfadiazine encephalitis in patients with and without AIDS.

Sulfapyridine Treatment of dermatitis herpetiformis.


For protection of donor organ tissue from damage or
injury mediated by oxygen-derived free radicals that
are generated during the necessary periods of
ischemia (hypoxia, anoxia), and especially
Superoxide dismutase (human) reperfusion, associated with the operative procedure.

Superoxide dismutase (recombinant human) Oxsodrol Prevention of reperfusion injury to donor organ tissue.

Suramin Metaret Treatment of hormone-refractory prostate cancer.


Surface active extract of saline lavage of Treatment and prevention of respiratory failure due to
bovine lungs Infasurf pulmonary surfactant deficiency in preterm infants.

Prevention and treatment of neonatal respiratory


Surfactant (human) (amniotic fluid derived) Human Surf distress syndrome.
Synsorb Pk Treatment of verocytotoxogenic E. coli infections.
For use in conjunction with diagnostic procedures
(including ERCP) for pancreatic disorders to increase
Synthetic human secretin pancreatic fluid secretion
For use in the diagnosis of gastrinoma associated with
Synthetic human secretin Zollinger-Ellison syndrome.
For use in conjunction with diagnostic procedures for
pancreatic disorders to increase pancreatic fluid
Synthetic human secretin secretion.
For use in obtaining desquamated pancreatic cells for
Synthetic human secretin cytopathologic examination in pancreatic carcinoma.
For use in the evaluation of exocrine pancreas
function.
Synthetic human secretin
For use in obtaining desquamated pancreatic cells for
Synthetic porcine secretin cytopathologic examination in pancreatic carcinoma.

For use in the evaluation of exocrine pancreas


Synthetic porcine secretin function.
For use in conjunction with diagnostic procedures for
pancreatic disorders to increase pancreatic fluid
Synthetic porcine secretin secretion.
For use in the diagnosis of gastrinoma associated with
Synthetic porcine secretin Zollinger-Ellison syndrome.
To prevent cutaneous neoplasms and other skin
T4 endonuclease V, liposome encapsulated abnormalities in xeroderma pigmentosum.

Prophylaxis of organ rejection in patients receiving


Tacrolimus Prograf heart transplants.

Tacrolimus Prograf Prophylaxis of graft-versus-host-disease.

Tadalafil Cialis Treatment of pulmonary arterial hypertension

TAK-603 Treatment of Crohn's disease.

talactoferrin alfa Treatment of non-small cell lung cancer

talactoferrin alfa Treatment of renal cell carcinoma

talactoferrin alfa For the treatment of graft versus host disease

talactoferrin alfa For the prevention of graft-versus-host disease

Talotrexin Treatment of acute lymphoblastic leukemia


T-cell depleted stem cell enriched cellular
product from peripheal b
lood stem cells Treatment of chronic granulomatous disease
TD-K6a.513a.12 ReveKer Treatment of pachyonychia congenita

Technetium Tc 99m pterotetramide For the identification of ovarian carcinomas.


Technetium Tc99m anti-melanoma murine For use in detecting, by imaging, metastases of
monoclonal antibody Oncotrac Melanoma Imaging
malignant Kit
melanoma.
Diagnostic imaging in the evaluation of the extent of
disease in patients with histologically confirmed
diagnosis of non-Hodgkin's B-cell lymphoma, acute B-
Technetium Tc99m murine monoclonal cell lymphoblastic leukemia (in children and adults),
antibody (IgG2a) to B cell LymphoScan and chronic B-cell lymphocytic leukemia.
Technetium Tc99m murine monoclonal Detection of hCG producing tumors such as germ cell
antibody to hCG Immuraid, hCG-Tc-99m
and trophoblastic cell tumors.

Technetium Tc99m murine monoclonal Detection of alpha-fetoprotein producing germ cell


antibody to human AFP AFP-Scan tumors.

Technetium Tc99m murine monoclonal Detection of hepatocellular carcinoma and


antibody to human alpha-fetoprotein Immuraid, AFP-Scan
hepatoblastoma.
Diagnosis or assessment of rejection status in heart,
Technetium Tc99m rh-Annexin V Apomate heart-lung, single lung, or bilateral lung transplants.

Tegafur/gimeracil/oteracil Treatment of gastric cancer

Treatment of pulmonary infections caused by


temocillin sodium Negaban Burkholderia cepacia
Palliative treatment of recurrent, refractory or second
primary squamous cell carcinomas of the head and
neck in patients considered to be incurable with
Temoporfin Foscan surgery or radiotherapy.

temozolomide Temodar Treatment of malignant glioma

Temozolomide Temodal Treatment of newly diagnosed high grade glioma

Temozolomide Temodal Treatment of advanced metastatic melanoma.

Temozolomide Temodar Treatment of recurrent malignant glioma.

Temsirolimus Torisel Treatment of renal cell carcinoma

Treatment of refractory childhood acute lymphocytic


Teniposide Vumon for injection
leukemia.
Diagnostic agent to assist in establishing the
diagnosis in patients presenting with clinical and
laboratory evidence of hypocalcemia due to either
Teriparatide Parathar hypoparathyroidism or pseudohypoparathyroidism.

Teriparatide Parathar Treatment of idiopathic osteoporosis.


Terlipressin Glypressin Treatment of bleeding esophageal varices.

Terlipressin (INN) Treatment of Hepatorenal Syndrome


Treatment of weight loss in AIDS patients with HIV-
Testosterone Androgel associated wasting. testosterone replacement in
For use as physiologic
androgen deficient HIV+ patients with an associated
Testosterone TheraDerm Testosterone Transdermal System
weight loss.

Testosterone propionate ointment 2% Treatment of vulvar dystrophies.

Treatment of constitutional delay of growth and


Testosterone sublingual puberty in boys.

Tetrabenazine Xenazine Treatment of Huntington's disease.

Tetrabenazine Treatment of moderate/severe tardive dyskinesia.

Tetrahydrobiopterin Phenoptin Treatment


Suppressionof of
hyperphenylalaninemia
thyroid stimulating hormone in
patients with well-differentiated cancer of the thyroid
Tetraiodothyroacetic acid gland.

Treatment of adenocarcinoma of the esophagus and


Tezacitabine stomach

TGF(beta)2-specific phosphorothioate
antisense oligodeoxynucleotide Oncomun Treatment of malignant glioma

TGp1PTH1-34 Treatment of solitary (unicameral) bone cysts.

Thalidomide Thalomid Treatment


Treatment of Myelodysplastic
and Syndrome
prevention of recurrent aphthous
ulcers in severely, terminally immunocompromised
Thalidomide patients.

Thalidomide Synovir Treatment of HIV-associated wasting syndrome.

Thalidomide Thalomid Treatment of Crohn's disease.


Prevention of graft versus host disease in patients
Thalidomide receiving bone marrow transplantation.
Treatment of graft versus host disease in patients
Thalidomide receiving bone marrow transplantation.

Treatment and maintenance of reactional


Thalidomide lepromatous leprosy.
Treatment of the clinical manifestations of
mycobacterial infection caused by Mycobacterium
Thalidomide tuberculosis and non-tuberculous mycobacteria.
Thalidomide Prevention of graft versus host disease.

Thalidomide Treatment of graft versus host disease.

Thalidomide Treatment of primary brain malignancies.


Treatment of severe recurrent aphthous stomatitis in
Thalidomide severely, terminally immunocompromised patients.

Thalidomide Thalomid Treatment of erythema nodosum leprosum.

Thalidomide Treatment of Kaposi's sarcoma.

Thalidomide Thalomid Treatment of multiple myeloma


Conditioning treatment prior to hematopoietic stem
Thiotepa Tepadina cell transplantation

Treatment of stage IIb through Stage IV malignant


Thymalfasin Zadaxin melanoma

Thymalfasin Zadaxin Treatment of chronic active hepatitis B.

Thymalfasin Zadaxin Treatment of DiGeorge anomaly with immune defects.

Thymalfasin Zadaxin Treatment of hepatocellular carcinoma.

Thymosin beta 4 Treatment of epidermolysis bullosa


Reversal of phenylephrine-induced mydriasis in
patients who have narrow anterior angles and are at
risk of developing an acute attack of angle-closure
Thymoxamine HCl glaucoma following mydriasis.
Treatment of well-differentiated papillary, follicular or
Thyrotropin alfa Thyrogen combined papillary/follicular carcinomas of the thyroid

Thyrotropin alpha Thyrogen As an adjunct in the diagnosis of thyroid cancer.

Tiapride Treatment of Tourette's syndrome.

Tiazofurin (2-Beta-D-ribofuranosyl-4-
thiazolecarboxamide) Chronic myelogenous leukemia (CML)

Tilarginine acetate Treatment of cardiogenic shock

Prevention of access graft disease in hemodialysis


tin ethyl etiopurpurin patients
tinidazole Tindamax Treatment of giardiasis

Tinidazole Tindamax Treatment of amebiasis


Prevention of cystine nephrolithiasis in patients with
Tiopronin Thiola homozygous cystinuria.

Tipifarnib Zarnestra Treatment of acute myeloid leukemia

tirapazamine Treatment of head and neck cancer


For use in combination with levo-thyroxine to
suppress thyroid stimulating hormone in patients with
well-differentiated thyroid cancer who are intolerant to
Tiratricol Triacana adequate doses of levo-thyroxine alone.
Tissue repair cells obtained from autologous
bone marrow expanded ex vivo with a cell
production system Treatment of osteonecrosis
Tissue repair cells obtained from autologous
bone marrow expanded ex vivo with a cell
production system Treatment of dilated cardiomyopathy

For the secondary prevention (prevention of lesional


induction) of disorders with UV-A and visible light-
induced photosensitivity, specifically Actinic prurigo,
Hydroa vacciniforme, Solar urticara (SU), Chronic
Titanium dioxide and bisoctrizole Actinic Dermatitis (CAD), the cutaneous prop
Treatment of spasticity associated with multiple
Tizanidine HCl Zanaflex sclerosis and spinal cord injury.
Treatment of bronchiectasis patients infected with
Tobramycin Tobi Pseudomonas aeruginosa.

Treatment of bronchopulmonary infections of


Tobramycin for inhalation TOBI Pseudomonas aeruginosa in cystic fibrosis patients.
Treatment of vitamin E deficiency resulting from
malabsorption due to prolonged cholestatic
Tocophersolan oral solution (vitamin E-tpgs) hepatobiliary disease.

Topiramate Topamax Treatment of Lennox-Gastaut syndrome.

toralizumab Treatment of immune thrombocytopenic purpura

Toremifene Treatment of desmoid tumors.

Hormonal therapy of metastatic carcinoma of the


Toremifene Fareston breast.

Tositumomab and iodine I 131 tositumomab Bexxar Treatment of non-Hodgkin's B-cell lymphoma.

trabectedin Yondelis Treatment of soft tissue sarcoma.


trabectedin Yondelis Treatment of patients with epithelial ovarian cancer

Tramadol hydrochloride Management of postherpetic neuralgia

Tramadol hydrochloride Treatment of painful HIV-associated neuropathy


Treatment of patients with congenital coagulopathies
who are undergoing surgical procedures (e.g. dental
Tranexamic acid Cyklokapron extractions).
Treatment of patients undergoing prostatectomy
where there is hemorrhage or risk of hemorrhage as a
Tranexamic acid Cyklokapron result of increased fibrinolysis or fibrinogenolysis.

Tranexamic acid Cyklokapron Treatment of hereditary angioneurotic edema.

Tranilast Rizaben For the treatment of maligant glioma

Transforming growth factor-beta 2 Treatment of full thickness macular holes.


Treatment of emphysema secondary to alpha 1
Transgenic human alpha 1 antitrypsin antitrypsin deficiency.
Treatment of patients with pancreatic cancer that
Trastuzumab Herceptin overexpress p185HER2.

Treosulfan Ovastat Treatment of ovarian cancer.

treprostinil Remodulin Treatment of pulmonary arterial hypertension.

Tretinoin Vesanoid Treatment of acute promyelocytic leukemia.

Tretinoin ATRA-IV Treatment of acute and chronic leukemia.

Tretinoin ATRA-IV Treatment of T-cell non-Hodgkin's lymphoma


Treatment of squamous metaplasia of the ocular
surface epithelia (conjunctiva and/or cornea) with
Tretinoin mucous deficiency and keratinization.

tri-antennary glycotripeptide derivative of 5-


fluorodeoxyuridine monophosphate Treatment for hepatocellular carcinoma
Treatment of patients with Wilson's disease who are
intolerant, or inadequately responsive to
Trientine HCl Syprine penicillamine.

Triheptanoin Triheptanoim-SASOl Special


Treatment Oil acid disorders
of fatty

Trimetrexate Neutrexin Treatment of metastatic osteogenic sarcoma.


Treatment of patients with advanced non-small cell
Trimetrexate glucuronate carcinoma of the lung.
Treatment of Pneumocystis carinii pneumonia in AIDS
Trimetrexate glucuronate Neutrexin patients.

Trimetrexate glucuronate Treatment of pancreatic adenocarcinoma.

Trimetrexate glucuronate Treatment of metastatic colorectal adenocarcinoma.


Treatment of metastatic carcinoma of the head and
Trimetrexate glucuronate neck (i.e. buccal cavity, pharynx, and larynx).
For use in the palliative treatment of advanced
Triptorelin pamoate Decapeptyl Injection
ovarian carcinoma of epithelial origin.
Treatment of moderate to severe clinical forms of
hemolytic disease of the newborn arising from
placental transfer of antibodies against blood group
Trisaccharides A and B Biosynject substances A and B.
Prevention of ABO medical hemolytic reactions arising
Trisaccharides A and B Biosynject from ABO-incompatible bone marrow transplantation.
Treatment of moderate to very severe clinical forms of
transfusion reactions arising from ABO incompatible
transfusions of blood, blood products, and blood
Trisaccharides A and B derivatives.
For use in ABO-incompatible solid organ
transplantation, including kidney, heart, liver and
Trisaccharides A and B Biosynject pancreas.

Trisodium citrate concentration Hemocitrate For use in leukapheresis procedures.


Treatment of patients with known or suspected
Trisodium zinc internal contamination with plutonium, americium, or
Diethylenetriaminepentaacetate curium to increase the rate of elimination.

Troxacitabine Troxatyl Treatment of acute myeloid leukemia


Selectively staining epiretinal membranes during
Trypan blue MembraneBlue ophthalmic surgical
Treatment of victrectomy
symptomatic procedures
patients with AIDS
including all patients with CD4 counts less than 200
Tumor necrosis factor-binding protein 1 cells per mm3.
Treatment of symptomatic patients with the AIDS
including all patients with CD4 T-cell counts less than
Tumor necrosis factor-binding protein II 200 cells per mm3.

Tyloxapol Supervent Treatment of cystic fibrosis.

tyrosine kinase inhibitor Treatment of mastocytosis

Ubiquinol Ubi-Q-Nol, Li-Q-Nol


Treatment of Huntington's Disease

Ubiquinol, coenzyme Q10, ubiquinone UBI-Q-NOL Treatment of pediatric congestive heart failure

Ubiquinone Ubi-Q-Gel Treatment of mitochondrial cytopathies.

Unconjugated Chimeric (human-murine) G250


IgG monoclonal antibody Treatment of renal cell carcinoma.
Urea for intravitreal injection Neurosolve Treatment of retinitis pigmentosa
To facilitate the removal of lung secretions in the
Uridine 5'-triphosphate treatment of patients with primary ciliary dyskinesia.

Uridine 5'-triphosphate Treatment of cystic fibrosis.


For induction of ovulation in patients with polycystic
ovarian disease who have an elevated LH/FSH ratio
and who have failed to respond to adequate
Urofollitropin Metrodin clomiphene citrate therapy.
For the initiation and re-initiation of spermatogenesis
in adult males with reproductive failure due to
hypothalamic or pituitary dysfunction,
Urofollitropin Fertinex hypogonadotropic
For acceleration ofhypogonadism.
corneal epithelial regeneration and
healing of stromal incisions from corneal transplant
Urogastrone surgery.
Management of the clinical signs and symptoms
Ursodiol Actigall associated with primary biliary cirrhosis.

Ursodiol URSO Treatment of patients with primary biliary cirrhosis.

Vaccinia Immune Globulin (Human)


Intravenous CNJ-016 Treatment of complications of vaccinia vaccination

Vaccinia Immune Globulin (Human) Treatment of severe complications from the smallpox
Intravenous vaccine

Valine, isoleucine and leucine VIL Treatment of hyperphenylalaninemia.


Treatment of primary keratoconjunctivitis and
valine-valine-ganciclovir recurrent epithelial keratitis due to HSV1 and HSV2.

Valproic acid, sodium PEAC Treatment of familial adenomatous polyposis

Valrubicin Valstar Treatment of carcinoma in situ of the urinary bladder.


Treatment of patients with follicular thyroid carcinoma,
medullary thyroid carcinoma, anaplastic thyroid
carcinoma, and locally advanced and metastatic
Vandetanib Zactima papillary thyroid carcinoma

Vapreotide Sanvar Treatment of symptomatic carcinoid tumors


Treatment of esophageal variceal hemorrhage
vapreotide Sanvar patients with portal hypertension.
vapreotide Octastatin Treatment of gastrointestinal and pancreatic fistulas.
Prevention of early postoperative complications
vapreotide Octastatin following pancreatic resection.

vapreotide Sanvar For the treatment


Passive of acromegaly
immunization for the treatment of exposed,
susceptible individuals who are at risk of
Varicella Zoster Immune Globulin (Human) VariZIG complications from varicella

Vasoactive intestinal peptide Treatment of Acute Respiratory Distress Syndrome.

Vasoactive Intestinal Peptide Treatment of pulmonary arterial hypertension

Vasoactive intestinal polypeptide Treatment of acute esophageal food impaction.

Debridement of severe, deep dermal burns in


Vibriolysin Vibrilase hospitalized patients

vigabatrin Sabril Treatment of infantile spasms.

Viloxazine HCl Catatrol Treatment of narcolepsy.

Viloxazine HCl Catatrol Treatment of cataplexy.

vincristine sulfate liposome injection Marqibo Treatment of acute lymphoblastic leukemia.

Virulizin Virulizin Treatment of pancreatic cancer.

viscous budesonide Treatment for pediatric eosinophilic esophagitis.

vorinostat Treatment of multiple myeloma

vorinostat Zolinza Treatment of T-cell non-Hodgkin's lymphoma

vorinostat Treatment of mesothelioma

Xenogeneic hepatocytes HepatAssist LiverTreatment


Assist System
of severe liver failure.

Yttrium (90Y) antiferritin polyclonal antibodies Ferritarg P Treatment of Hodgkin's disease.


Yttrium-90 radiolabeled humanized
monoclonal anti-carcinoembroyonic antigen
IgG antibody Cea-Cide Treatment of ovarian carcinoma.
Zalcitabine Hivid Treatment of AIDS.

Zalcitabine Treatment of AIDS.

Zidovudine Retrovir Treatment of AIDS.

Zidovudine Retrovir Treatment of AIDS related complex.

Zinc acetate Galzin Treatment of Wilson's disease.

Zoledronate Zometa, Zabel Treatment of tumor induced hypercalcemia.

Zosuquidar trihydrochloride Treatment of acute myeloid leukemia


total designated products: 1749
Indication Approved for Marketing
Designation Date
Sponsor

2/16/2006 PharmAthene, Inc.

3/31/2003 Intarcia Therapeutics, Inc.

1/10/2005 Tibotec, Inc.

8/10/2004 BioCryst Pharmaceuticals, Inc.

8/13/2004 BioCryst Pharmaceuticals, Inc.

1/29/2004 BioCryst Pharmaceuticals, Inc.

1/10/2005 Fujisawa Healthcare, Inc.

9/1/2004 PTC Therapeutics

1/10/2005 PTC Therapeutics, Inc.

7/5/2007 Global Alliance for TB Drug Development

8/19/2003 Pfizer Global Research and Development

11/29/2002 Novartis Pharmaceuticals Corporation

8/13/2004 Adventrx Pharmaceuticals, Inc.

12/8/2004 Inotek Pharmaceuticals Corporation

7/12/2007 Otsuka Pharmaceutical Company, Ltd

10/3/2001 Phase 2 Discovery, Inc.

7/3/2003 Phase 2 Discovery, Inc.

3/28/2006 Auris Medical, Inc.

11/4/2003 Aeolus Pharmaceuticals, Inc.

7/10/2003 Genzyme Corporation


10/21/2004 Vion Pharmaceuticals, Inc.

5/12/1998 Oxford GlycoSciences

6/10/1999 Louisiana State University Medical Center Foundation

2/10/1999 NeoRx Corporation

1/25/2007 Adeza Biomedical

9/9/2004 Kosan Biosciences, Inc

9/3/2004 Kosan Biosciences, Inc.

2/25/2004 Amicus Therapeutics, Inc.

6/18/2007 Amicus Therapeutics, Inc

5/23/2006 FoldRx Pharmaceuticals, Inc.

12/2/2003 Callisto Pharmaceuticals, Inc.

9/18/2006 Callisto Pharmaceuticals, Inc.

1/13/2003 Repligen Corporation

8/15/2003 Inologic, Inc.

9/17/1993 Kennedy & Hoidal, M.D.'s

12/10/2004 Rexahn Corporation

12/8/2004 Rexahn Corporation

12/8/2004 Rexahn Corporation

12/1/2004 Rexahn Corporation


12/1/2004 Rexahn Corporation

7/21/1987 National Cancer Institute, Dct

2/27/1987 Lemmon Company

8/3/2001 Lawrence Panasci, MD

11/15/2001 Pangene Corporation

9/9/1996 Grant, Steven M.D.

4/11/2005 PR Pharmaceuticals, Inc.

4/4/2005 EntreMed, Inc.

6/16/2006 EntreMed, Inc.

7/10/2001 EntreMed, Inc.

11/18/2005 Prosena B.V.

3/23/2000 Sugen, Inc.

9/11/1998 Sugen, Inc.

12/18/1990 Jacobus Pharmaceutical Company

9/20/2000 Elliot Danforth, Jr., M.D.

11/20/1989 Berlex Laboratories, Inc.

10/11/2006 Dynogen Pharmaceuticals, Inc.

12/12/2005 A. Carlsson Research AB

4/10/2003 Kiadis Pharma Canada, Inc.

12/21/1998 Biomedical Frontiers, Inc.


8/22/2007 Metabasis Therapeutics, Incorporated

12/14/2005 Neurorecovery, Inc.

4/26/2006 Jacobus Pharmaceutical Co., Inc.

12/13/1989 Beeken, Warren M.D.

12/1/2005 Trophos SA

7/20/2006 Johnson & Johnson Pharmaceutical Research & Dev,

12/27/2006 SIGA Technologies, Inc.

12/18/2006 SIGA Technologies, Inc.

6/15/2007 ClinTec International Ltd.

10/11/2006 Reata Pharmaceuticals, Inc.

8/20/2003 Now Pharm AG

5/11/1992 ILEX Oncology, Inc.

6/18/2007 Humanetics, Inc.

9/2/1999 GlaxoSmithKline

12/20/1993 Biogen, Inc.

8/3/1987 SuperGen, Inc.

5/26/2006 Xechem International, Inc.

5/26/2006 Hana Biosciences, Inc.

3/5/2004 InterMune, Inc.

2/6/2006 Cornerstone Pharmaceuticals, Inc.


4/6/1999 MGI Pharma, Inc.

3/24/1997 SciClone Pharmaceuticals, Inc.

6/22/1993 Therakos, Inc.

5/12/1994 Therakos, Inc.

1/29/2004 Immunomedics, Inc.

1/2/1997 Allergan, Inc.

9/16/1996 SuperGen, Inc.

Treatment of pediatric HIV-


infection/AIDS patients 5/15/2001 NovoMed Pharmaceuticals, Inc.

1/15/2003 Celgene Corporation

9/3/2004 Burzynski Research Institute, Inc.

7/28/2000 La Jolla Pharmaceutical Co.

For the use of 11/25/2003 Menarini Ricerche S.p.A.


Acetadote(registered TM)
Injection, administered 8/13/1987 Bristol-Myers Squibb Company
intravenously within 8 to 10
hours after ingestion of a
potentially heptotoxic quantity of
acetaminophen, to prevent or
lessen hepatic injur 10/19/2001 Cumberland Pharmaceuticals, Inc.

8/3/2000 Genzyme Corporation

6/20/1988 Lincoln Diagnostics

10/19/2006 Abbott Laboratories

3/21/2005 Abbott Laboratories

5/21/2007 Amsterdam Molecular Therapeutics BV

6/13/2001 Avigen, Inc.


6/13/2001 Avigen, Inc.

3/20/2007 Applied Genetic Technologies Corporation

5/21/2007 Applied Genetic Technologies Corporation

2/15/1995 Targeted Genetics Corporation

8/1/1989 Medco Research, Inc.

6/17/2005 Advantagene, Inc.

12/15/1999 GenStar Therapeutics Corporation

7/31/2001 Ark Therapeutics Ltd

1/3/1989 Pediatric Pharmaceuticals, Inc.

1/21/2003 Large Scale Biology Corporation

2/6/2006 TolerRX, Inc.

10/8/1992 AutoImmune, Inc.

Treatment of parenchymal
neurocysticercosis due to active
lesions caused by larval forms of
the pork tapeworm, Taenia
Treatment of cystic hydatid
solium. 1/18/1996 SmithKline Beecham Pharmaceuticals
disease of the liver, lung, and
peritoneum, caused by the larval
form of the dog tapeworm,
Echinococcus granulosus. 1/17/1996 SmithKline Beecham Pharmaceuticals

3/12/2002 MotoGen, Inc.

3/22/1989 Chiron Corporation


Treatment of adults (>18 years
old) with metastatic renal cell
carcinoma. 9/14/1988 Chiron Corporation

Treatment of adults with


metastatic melanoma. 9/10/1996 Chiron Corporation

11/24/1998 Chiron Corporation


The treatment of patients with B-
cell chronic lymphocytic
leukemia who have been treated
with alkylating agents and who
have failed fludarabine therapy. 10/20/1997 Genzyme Corporation

3/31/2003 Merck & Co., Inc.

2/13/2001 Richard J. Wenstrup, M.D.

7/8/2005 Cinergen, LLC

8/9/2005 Cinergen, LLC

7/21/1995 Genzyme Corporation

Long-term enzyme replacement


therapy for children, adolescents
and adult patients with a
confirmed diagnosis of Type I
Gaucher disease who
exhibit signs and symptoms that
are severe enough to result in
one or more of the following
conditions:
a) moderate-
Topical treatment of cutaneous
3/11/1985 Genzyme Corporation
lesions in patients with AIDS-
related Kaposi's sarcoma. 3/24/1998 Eisai Medical Research, Inc

4/10/1992 Ligand Pharmaceuticals, Inc.

11/21/2002 Alwyn Company, Inc.

7/18/1997 Bayer Healthcare Pharmaceuticals, Inc.

6/13/1997 Applied Immunotherapeutics, LLC

9/1/2004 Neurotech USA, Inc.

1/28/2005 MolMed S.p.A.

12/4/1985 Burroughs Wellcome Company

Management of patients with


leukemia, lymphoma, and solid 12/4/1985 Burroughs Wellcome Company
tumor malignancies who are
receiving cancer therapy which
causes elevations of serum and
urinary uric acid levels and who
cannot tolerate oral therapy. 10/16/1992 Catalytica Pharmaceuticals, Inc
11/9/1987 Burroughs Wellcome Company

3/5/2004 Bio Products Laboratory

3/17/2004 Bio Products Laboratory

1/1/1984 Chiron Corporation

12/22/2004 Kamada Ltd.

9/1/2004 Kamada Ltd.


For chronic replacement therapy
of individuals having congenital 11/24/1999 Aventis Behring L.L.C.
deficiency of alpha1- proteinase
inhibitor with clinically
demonstrable panacinar
emphysema. 12/7/1984 Bayer Corporation

7/20/1990 Desnick, Robert J. M.D.

6/17/1991 David Calhoun, Ph.D.

6/22/1998 Shire Human Genetic Therapies, Inc.

8/19/1997 National Institute of Diabetes, and Digestive and Kidney Diseases

3/28/2006 Penwest Pharmaceuticals Company

10/20/1993 Schwarz Pharma, Inc.


Single agent palliative treatment
of patients with persistent or 1/27/2003 Daniel F. Hanley, MD
recurrent ovarian cancer
following first-line therapy with a
cisplatin and/or alkylating agent
based combination. 2/9/1984 Medimmune Oncology, Inc.
Treatment of pulmonary arterial
hypertension (WHO group I) in 4/13/2007 Sanofi-Aventis US, Inc.
patients with WHO class II or III
symptoms to improve exercise
capacity and delay clinical
worsening 7/16/2004 Gilead Colorado

3/27/2003 Amgen, Inc.

10/4/1999 Medimmune Oncology, Inc.

5/30/1990 Medimmune Oncology, Inc.


To reduce the cumulative renal
toxicity associated with repeated
administration of cisplatin in
5/30/1990 Medimmune Oncology, Inc.
patients with advanced ovarian
cancer. 5/30/1990 Medimmune Oncology, Inc.
Reduction of the incidence of
moderate to severe xerostomia
in patients undergoing post-
operative radiation treatment for
head and neck cancer, where
the radiation port includes a
substantial portion of the parotid
glands. 5/12/1998 Medimmune Oncology, Inc.

11/24/1998 Medimmune Oncology, Inc.

3/9/2006 Transave, Inc.

7/18/1990 Glaxo Wellcome Research and Development

1/6/1995 Eastern Virginia Medical School

3/20/2007 DUSA Pharmaceuticals, Inc.

4/6/1993 Syncom Pharmaceuticals, Inc.

Treatment of tuberculosis 2/19/1992 Jacobus Pharmaceutical Company

3/29/2005 The Institute for One World Health

9/9/1994 Kanyok, Thomas P. Pharm.D.

5/14/1993 Kanyok, Thomas P. Pharm.D.

11/15/1993 Kanyok, Thomas P. Pharm.D.


For initiation of treatment and
prophylaxis of frequently
recurring ventricular fibrillation 8/17/1993 Academic Pharmaceuticals, Inc.
and hemodynamically unstable
ventricular tachycardia in
patients refractory to other
therapy. 3/16/1994 Wyeth-Ayerst Laboratories

1/31/1994 Pipex Pharmaceuticals, Inc.

12/20/2006 Xanthus Pharmaceuticals, Inc.

12/15/2005 Nektar Therapeutics

8/21/1996 The Liposome Company, Inc.

9/23/1996 The Liposome Company, Inc.


5/6/1996 The Liposome Company, Inc.

5/6/1996 The Liposome Company, Inc.

Treatment of invasive fungal 6/27/1996 The Liposome Company, Inc.


infections in patients who are
refractory to or intolerant of
conventional amphotericin B
therapy. 12/5/1991 Liposome Company, Inc.

12/7/1984 Warner-Lambert Company

12/18/2006 Akorn, Inc.

Treatment of patients with


essential thrombocythemia to 7/14/1986 Roberts Pharmaceutical Corp.
reduce the elevated platelet
count and the risk of thrombosis
and to ameliorate associated
symptoms. 1/27/1988 Roberts Pharmaceutical Corp.

6/11/1985 Roberts Pharmaceutical Corp.

1/21/1992 Genzyme Corporation

8/27/1992 Scios, Inc.

4/10/1992 Scios, Inc.

4/15/2005 Xytis, Inc.

10/20/1989 Knoll Pharmaceutical Company

8/3/2001 Maret Pharmaceutical Corporation

2/16/2000 Maret Pharmaceuticals

1/29/1986 Xoma Corporation

1/29/1986 Xoma Corporation

10/16/2002 AEterna Zentaris, Inc.

2/12/2003 Biogen IDEC, Inc.

10/6/2005 Seattle Genetics, Inc.


9/10/1990 Baxter Healthcare Corporation

5/21/2003 Xenova Biomedix Limited

5/2/1990 Biomedical Research Institute

5/2/1990 Biomedical Research Institute

5/3/1990 Biomedical Research Institute

5/3/1990 Biomedical Research Institute

For surgical and/or invasive 9/18/2006 Pfizer Global Research & Development
procedures in patients with von
Willebrand Disease (VWD) in 3/23/1989 Children's Hospital
whom desmopressin is either
ineffective or contraindicated. It
is not indicated for patients with
severe VWD (Type 3)
undergoing major surgery 1/5/1996 Grifols Biologicals Inc.

2/8/1996 Wyeth Pharmaceuticals, Inc.


Treatment and prophylaxis of
bleeding in patients with
hemophilia
(1) A (not von
In adult patients for treatment
Willebrand's
and preventiondisease)
of bleeding in 9/25/1989 Bayer Corporation
hemophilia A (classic
hemophilia) and (2) in adult and
pediatric patients for treatment
of spontaneous and trauma-
induced bleeding episodes in
severe von Willebrand disease,
and in mild and 10/16/1992 Aventis Behring L.L.C.

11/18/2003 Advanced Biotherapy, Inc.

11/14/1984 Xoma Corporation

11/14/1984 Xoma Corporation

2/21/1985 Upsher-Smith Laboratories, Inc

4/15/2005 Lorus Therapeutics, Inc.

3/12/2003 Lorus Therapeutics, Inc

5/23/2006 Isis Pharmaceuticals, Inc.


3/6/1987 Xoma Corporation

10/4/2005 Bradmer Pharmaceuticals, Inc.

2/8/1985 Pharmacia & Upjohn AB

11/26/1984 Bayer Corporation

7/2/1985 CSL Behring

1/2/1986 American National Red Cross

9/6/2000 Genzyme Corporation

6/2/1993 Applied Medical Research

1/29/2004 Rare Disease Therapeutics, Inc.

Carol Clark-Evans direct line


(615) 963-4510 1/12/1994 Protherics, Inc.

2/12/1991 Ophidian Pharmaceuticals, Inc.

11/24/1999 Ariad Pharmaceuticals, Inc.

3/8/1995 Wyeth-Lederle Vaccines and Pediatrics

10/20/1997 Scherer DDS


For the acute, intermittent
treatment of hypomobility, "off" 7/17/1995 Pentech Pharmaceuticals, Inc.
episodes ("end-of-dose-wearing-
off" and unpredictable :on/off"
episodes) associated with
advanced Parkinson's disease 4/22/1993 Vernalis R & D Ltd

5/23/2006 NeuroHealing Pharmaceuticals, Inc.

11/17/1993 Bayer Corporation

5/10/1996 Immunomedics, Inc.

5/25/1994 Vertex Pharmaceuticals Inc.


4/7/1992 Perrine, Susan P., M.D.

3/29/2005 CytRx Corporation

1/25/2006 Floyd R. Sallee, M.D., Ph.D.

11/2/2001 Cephalon, Inc.

3/4/2005 Cephalon Inc

For induction of remission and


consolidation in patients with
acute promyelocytic leukemia 10/18/2001 Cephalon, Inc.
(APL) who are refractory to, or
have relapsed from, retinoid and
anthracycline chemotherapy,
and whose APL is characterized
by the presence of the t(15;17)
transloc 3/3/1998 Cell Therapeutics, Inc.

4/28/2000 Cephalon, Inc.

6/13/2003 Cephalon, Inc.

5/13/2003 Cephalon, Inc.

7/17/2000 Cephalon, Inc.

8/31/2007 Novartis Pharmaceuticals

3/28/2006 US Army Medical Materiel Development Activity

7/19/1999 World Health Organization

11/9/1987 NPDC-AS101, Inc.

8/31/2007 McGuff Pharmaceuticals Inc.

8/26/2003 ELI LILLY & Company

Prevention of PCP in patients


who are intolerant to
For the acute oral treatment of 8/14/1991
trimethoprim-sulfamethoxazole. Glaxo Wellcome Research and Development
mild to moderate Pneumocystis
carinii pneumonia in patients
who are intolerant to
trimethoprim-sulfamethoxazole. 9/10/1990 Glaxo Wellcome Inc.
3/16/1993 GlaxoSmithKline, Inc.

3/16/1993 GlaxoSmithKline, Inc.

4/27/2007 TVAX Biomedical, LLC

8/28/2001 Genta Inc.

8/28/2001 Genta, Inc.

8/28/2001 Genta, Inc,

4/18/2002 Dendreon Corporation

6/1/2007 Cellular Bioengineering, Inc.

11/29/2002 Northwest Biotherapeutics, Inc.

2/23/1999 Avax Technologies, Inc.

9/3/2004 Proneuron Biotechnologies, Inc.

7/14/2005 TissueTech, Inc.

5/10/2002 Antigenics, Inc.

7/11/2002 Antigenics, Inc.

7/12/1994 Cytogen Corporation

Treatment of patients with the


following myelodysplastic 5/31/2007 Pfizer, Inc.
syndrome subtypes: refractory
anemia or refractory anemia
with ringed sideroblasts (if
accompanied by neutropenia or
thrombocytopenia and requiring
transfusions), refractory anemia
with excess blas 12/3/2001 Pharmion Corporation

9/14/1999 Oral Solutions, Inc.

3/12/2002 Gilead Sciences (formerly Corus Pharma)

8/9/2006 OncoVac Corporation


Management of severe 3/13/1984 A. L. Laboratories, Inc.
spasticity of spinal cord origin in
patients who are unresponsive
to oral baclofen therapy or
experience intolerable CNS side
effects at effective doses. 11/10/1987 Medtronic, Inc.

12/16/1991 Infusaid, Inc.

9/26/1994 Medtronic, Inc.


Treatment of mildly to
moderately active ulcerative
colitis in patients 5 years of age 12/2/2003 Medtronic Neurological
and older. Safety and
Prophylaxis
Effectivenessofofacute organ
Colazal beyond
rejection
8 weeks in in children
patients (ages
receiving
5-17)
renal
and 12 transplantation
weeks in adultswhen used
have not
as part
been of an
established. 8/12/2005 Salix Pharmaceuticals, Inc.
immunosuppressive regimen
that includes cyclosporine and
corticosteroids.
12/12/1997 Novartis Pharmaceuticals Corporation

8/28/2001 Enteron Pharmaceuticals, Inc./DOR BioPharma, Inc.

3/27/1998 Enteron Pharmaceuticals, Inc./DOR BioPharma, Inc.

8/17/2007 Cephalon, Inc.

Adjunctive therapy in the Immunex


treatment of acute
hyperammonemia and 1/21/1986 Immunex
associated encephalopathy in
patients with deficiencies in
enzymes of the urea cycle.

11/22/1993 Medicis Pharmaceutical Corp.

8/13/2001 Fallien Cosmeceuticals Ltd.

5/18/1998 Angelini Pharmaceuticals, Inc.

9/29/1987 AllerQuest LLC

Prevention of RDS (hyaline


membrane disease) in 12/20/1993 Ross Laboratories
premature infants less than
1250 grams birthweight or with
evidence of surfactant
deficiency. 2/5/1986 Ross Laboratories
Treatment of ("rescue") of
premature infants with RDS
confirmed by x-ray and requiring
mechanical ventilation. 2/5/1986 Ross Laboratories

4/29/1999 United Therapeutics Corporation

3/24/1997 Dovetail Technologies, Inc.


3/24/1997 Dovetail Technologies, Inc.
Treatment of homocystinuria to
decrease elevated
homocysteine blood levels. 5/16/1994 Jazz Pharmaceuticals

11/24/1989 Medco Research, Inc.

9/20/1988 Medco Research, Inc.

8/9/2007 Advanced Life Sciences, Inc. (ALS)

5/26/2006 Genentech, Inc.

2/9/2006 Genentech, Inc.

10/20/2004 Genentech, Inc.

Treatment of cutaneous 11/6/2003 Genentech, Inc.


manifestations of cutaneous T-
cell lymphoma in patients who
are refractory to at least one
prior systemic therapy. 6/18/1999 Eisai Medical Research, Inc.

1/16/2003 Alimentary Health Limited

2/3/1998 Angelini Pharmaceuticals, Inc.

Use as a replacement solution in


Continuous Renal Replacement 2/11/2002 Excorp Medical, Inc.
Therapy (CRRT) to replace
water and to correct electrolytes
and acid-base imbalances in
adults and children 8/9/2005 Dialysis Solutions, Inc.

4/27/2006 TissueTech, Inc.

3/2/2000 ICAgen Inc.

2/6/2006 MedImmune Oncology, Inc.

11/2/2005 The Medicines Company

2/9/1999 Genetronics, Inc.


Treatment of malignant pleural
effusion. 9/17/1993 Bristol-Myers Squibb Pharmaceutical Research Institute

10/15/1990 Bristol-Myers Squibb


Treatment of multiple myeloma
patients who have received at
least one prior therapy 1/15/2003 Millennium Pharmaceuticals, Inc.

Treatment of pulmonary arterial


hypertension. 10/6/2000 Actelion Life Sciences Ltd.

10/20/1999 Ipsen Limited

8/12/1998 Ipsen Limited

3/23/1989 Porton International, Inc.

12/6/1991 Allergan, Inc.

Treatment of cervical dystonia in 9/15/1992 Botulinum Toxin Research Associates, Inc.


adults to decrease the severity
of abnormal head position and
neck pain associated with
cervical dystonia. 8/20/1986 Allergan, Inc.

3/22/1984 Allergan, Inc.


Treatment of patients with
cervical dystonia to reduce the 3/22/1984 Allergan, Inc.
severity of abnormal head
position and neck pain
associated with cervical
dystonia. 1/16/1992 Elan Pharmaceuticals, Inc.

10/24/1991 Ipsen Limited

12/5/1991 Ipsen Limited (name changed from Porton International Inc)


Indicated for treatment of infant
botulism caused by type A or
type B Clostridium botulinum.
1/31/1989 California Department of Health Services

11/19/1990 Hastings, Donald DVM

3/1/1994 GalaGen, Inc.

9/30/1993 Biomune Systems, Inc.

12/23/1988 Mount Sinai Medical Center

2/7/2000 Allergan, Inc.


10/5/2005 UCB Pharma, Inc.

5/15/1989 Boehringer Ingelheim Pharmaceuticals, Inc.

9/18/1995 NeoPharm, Inc.


For the intrathecal
administration of methotrexate 12/3/2001 GPC Biotech, Inc.
and cytarabine for the
prevention or treatment of
meningeal leukemia and
lymphocytic lymphoma. 8/24/1994 QOL Medical, LLC

9/3/2004 Digestive Care, Inc.

Treatment of opioid dependence


in patients 16 years of age or
older 6/15/1994 Reckitt Benckiser Pharmaceuticals, Inc.

For use in combination


Treatment with
of opioid dependence
cyclophosphamide
in patients 16 yearsasof aage or
conditioning
older regimen prior to 10/27/1994 Reckitt Benckiser Pharmaceuticals, Inc.
allogeneic hematopoietic
progenitor cell transplantation
for chronic myelogenous
leukemia. 7/28/1994 PDL BioPharma, Inc..

4/21/1994 Sparta Pharmaceuticals, Inc.

3/5/2001 SuperGen, Inc.

11/25/2002 SuperGen, Inc.

7/7/1997 SuperGen, Inc.

10/5/2005 USC-CHLA Institute for Pediatric Clinical Research

10/5/2005 USC-CHLA Institute for Pediatric Clinical Research

9/30/1992 Shire Laboratories Inc.

3/25/1992 Shire Laboratories Inc.

10/23/1987 Burroughs Wellcome Company

7/16/2004 Lev Pharmaceuticals, Inc.

8/21/1996 Alpha Therapeutic Corporation

10/16/1992 Aventis Behring L.L.C.

8/30/1990 Baxter Healthcare Corp.


8/30/1990 Baxter Healthcare Corp.

1/30/2007 Seattle Genetics, Inc.


Short term treatment of apnea of
prematurity in infants between
28 and less than 33 weeks
gestational age. 9/20/1988 O.P.R. Development, L.P.

10/29/1990 Sandoz Pharmaceuticals Corp.

1/20/1987 Novartis Pharmaceutical Corporation

12/22/1988 Braintree Laboratories

6/27/1989 Pharmedic Company

6/6/1990 R & D Laboratories, Inc.

11/20/1997 Calgonate Corp.

5/21/1991 LTR Pharmaceuticals, Inc.

9/10/1990 Paddock Laboratories, Inc.

9/5/2000 Pneuma Partners, LLC

8/3/2005 TheraQuest Biosciences, LLC

9/29/2006 Anesiva, Inc.

10/23/2002 NeurogesX, Inc.

5/2/2003 NeurogesX, Inc.

1/20/1998 Orphan Europe

12/13/1989 Glaxo Wellcome Inc.

7/3/2000 Direct Therapeutics, Inc.

3/21/1989 Intramed Corporation

6/9/2006 Fresenius Biotech North America, Inc.


11/21/1989 SmithKline Beecham

8/27/1987 Xoma Corporation

12/11/1997 Celltech Chiroscience Limited

3/28/2006 Mass General Hospital

7/10/2002 Aastrom Biosciences Incorporated

5/8/2006 ELEOS, Inc.

For use in patients with Fabry


disease to reduce 6/12/2000 Silanes Laboratories S.A. de C.V.
globotriaosylceramide (GL-3)
deposition in capillary
endothelium of the kidney and
certain other cell types 1/19/1988 Genzyme Corporation

2/28/2007 Advanced LIfe Sciences, Inc.

12/22/1988 Baker Cummins Pharmaceuticals, Inc.

For use in combination with


radiation therapy, for the
treatment of locally or regionally 6/15/2007 ImClone Systems Incorporated
advanced squamous cell
carcinoma of the head and neck
(SCCHN) and for use as a
single agent for the treatment of
patients with recurrent or
metastatic SCCHN for whom 7/3/2000 ImClone Systems Incorporated

1/29/2004 Dr. Falk Pharma GmbH

2/12/2007 Sigma Tau

9/21/1984 Solvay

7/24/2000 Wilex Biotechnology GmbH

10/11/2005 Centocor, Inc.

5/26/2006 Centocor, Inc.

10/4/2005 Caprion Pharmaceuticals, Inc.


10/31/2006 Morphotek, Inc.

6/5/1991 Centocor, Inc.

8/3/2000 Biosynexus, Inc.

8/18/1986 Procter & Gamble Company

7/18/2003 Dr. Falk Pharma GmbH

2/10/1994 Bioniche Pharma

7/20/2006 Alan L. Buchman, M.D., M.S.P.H.

12/1/1997 Curis, Inc.

2/9/1995 Bausch & Lomb Pharmaceuticals, Inc.

5/27/2005 EMD Serono, Inc.

1/30/1992 Regeneron Pharmaceuticals Inc

5/8/1992 Syntex-Synergen Neuroscience

4/2/1992 Syntex-Synergen Neuroscience

Treatment of hypercalcemia in
patients with parathyroid
carcinoma 5/12/2003 Amgen, Inc.

11/2/2005 NeoRx Corporation

3/20/2007 Transave, Inc.

9/7/2000 Matrix Pharmaceutical, Inc.

4/3/2000 Matrix Pharmaceutical, Inc.

8/28/1989 United-Guardian, Inc.

12/9/2002 Winston Laboratories, Inc.


7/20/1990 Johnson & Johnson Pharmaceutical Research & Dev., LLC

11/15/1990 R. W. Johnson Pharmaceutical Research Institute

12/31/1990 R. W. Johnson Pharmaceutical Research Institute

4/19/1994 Johnson & Johnson Pharmaceutical R & D, LLC

4/19/1993 Johnson &Johnson Pharmaceutical Research Institute

2/16/2006 Actelion Pharmaceuticals Ltd.

10/28/1988 Pfizer Inc.

10/28/1988 Pharmacia & Upjohn

8/9/2006 Autoimmunity Research Foundation

Treatment of pediatric patients 1 3/14/2002 Genzyme Corp (Ilex Products, Inc.)


to 21 years old with relapsed or
refractory acute lymphoblastic
leukemia after at least two prior
regimens 2/7/2002 Genzyme Corporation

6/11/1984 Novartis Pharmaceutical Corporation

In combination with opiates for 8/4/1994 Hoffmann-La Roche, Inc.


the treatment of severe pain in
cancer patients that is not
adequately relieved by opioid
analgesics alone. 1/24/1989 Roxane Laboratories, Inc.

5/23/1996 Auxilium Pharmaceuticals, Inc.

6/14/2005 Effective Pharmaceuticals, Inc.

3/13/2006 EnVivo Pharmaceuticals, Inc.

4/24/1995 Brugnara, Carlo M.D.

Prevention and control of


bleeding in factor IX deficiency,
2/22/2005 Genta, Inc.
also known as hemophilia B or
Christmas disease. 6/27/1989 Armour Pharmaceutical Company
For the control and prevention of
hemorrhagic episodes in 7/5/1990 Alpha Therapeutic Corporation
patients with hemophilia B
(congenital factor IX deficiency
and Christmas disease),
including control and prevention
Prevention of bleeding in
of bleeding in surgical
surgical interventions orsettings.
invasive
10/3/1994 Genetics Institute, Inc.
procedures in patients with
acquired hemophilia 7/21/2004 Novo Nordisk, Inc.

6/18/2004 Novo Nordisk, Inc.


Prevention of bleeding in
surgical interventions or invasive
procedures
Treatment ofinbleeding
patients episodes
with
congenital F VII deficiency
in surgical interventions or
9/10/2004 Novo Nordisk, Inc.
invasive procedures in patients
Prevention
with acquiredof bleeding in
hemophilia 7/16/2004 Novo Nordisk, Inc.
surgical interventions or invasive
procedures in hemophilia A or B
patients with inhibitors to Factor
VIII or Factor IX 6/18/2004 Novo Nordisk, Inc.

Treatment of bleeding episodes


6/18/2004 Novo Nordisk, Inc.
in patients with Factor VII
Deficiency 9/10/2004 Novo Nordisk, Inc.

Treatment of bleeding episodes


in hemophilia A or B patients
10/3/2006 Novo Nordisk, Inc.
with inhibitors to Factor VIII or
Factor IX. 6/6/1988 Novo Nordisk, Inc.

11/14/2002 Sucampo Pharmaceuticals, Inc.

3/5/2001 Integrative Therapeutics, Inc.

9/25/2007 AR Scientific, Inc.

9/25/2007 AR Scientific, Inc.

12/9/1985 Pharmacontrol Corporation

10/20/1989 Glaxo Wellcome Inc.

10/20/1989 Glaxo Wellcome Inc.

1/11/1993 GlaxoSmithKline

3/12/1996 Auxilium Pharmaceuticals, Inc.

5/8/2006 OXiGENE, Inc.

7/23/2003 OXiGENE, Inc


12/3/2001 Xenova Biomedix Limited

7/18/2003 Jarrow Formulas, Inc.

7/7/2005 Cognetix, Inc.

To differentiate between pituitary


and ectopic production of ACTH
7/5/2007 OncoVista, Inc.
in patients with ACTH-
dependent Cushing's syndrome. 11/24/1989 Ferring Laboratories, Inc.

4/6/1998 Neurobiological Technologies, Inc.

12/22/1994 Drossapharm LTD

12/15/2005 Viralytics Limited

10/11/2005 Avicena Group, Inc.

2/12/2002 Avicena Group, Inc.

3/8/1984 Fisons Corporation

7/24/1985 Fisons Corporation

12/30/1991 ImmuCell Corporation

8/15/2003 Duke University Medical Center

7/18/1997 Cytel Corporation

12/22/1993 Cytel Corporation

3/16/1994 Cytel Corporation

12/20/2006 Lux Biosciences, Inc.

Kristin Miller, CSO, HFD-590. 11/25/2003 APT Pharmaceuticals, Inc.

10/29/2004 Maas BiolAB

11/25/2003 APT Pharmaceuticals, Inc.


8/1/1991 Allergan, Inc.

8/1/1991 Allergan, Inc.

5/4/2007 NOVAGALI Pharma SA

1/8/2007 Lux Biosciences, Inc.

12/6/2000 RTP Pharma Corporation

11/9/1988 University Of Georgia

10/26/1984 Berlex Laboratories, Inc.

5/1/1986 Thoene, Jess G., M.D.

Treatment of nephropathic
cystinosis in adults and children. 1/25/1991 Mylan Laboratories, Inc.

8/19/1997 Sigma-Tau Pharmaceuticals, Inc.

6/30/1992 Genzyme Corporation

3/9/1995 GenVec, Inc.

1/14/1992 Genzyme Corporation

1/8/1993 Genetic Therapy, Inc.

Intrathecal treatment of
lymphomatous meningitis. 6/2/1993 Pacira Pharmaceuticals, Inc.

1/30/2007 Bruce Frankel, MD

9/23/2006 Vical Inc.

#1) Attenuation of primary CMV


disease associated with kidney
transplant recipients who are 6/3/2005 Vical Incorporated
seronegative for CMV and who
receive a kidney from a CMV
seropositve donor; #2)
Prophylaxis of CMV disease
associated transplantation of
kidney (all other), lung, 8/3/1987 Massachussetts Public Health Biologic Laboratories

1/28/1991 Bayer Corporation


Prophylaxis of acute organ
rejection in patients receiving
renal transplants, to be used as
a part of an immunosuppressive
regimen that includes
cyclosporine and corticosteroids. 3/5/1993 Hoffmann-La Roche, Inc.

12/14/1987 Norwich Eaton Pharmaceuticals

11/7/1994 Jacobus Pharmaceutical Company, Inc.

1/8/1992 Jacobus Pharmaceutical Company

Treatment of adults with 12/24/1991 Jacobus Pharmaceutical Company


Philadelphia chromosome-
positive acute lymphoblastic
leukemia with resistance or
intolerance to prior therapy 11/18/2005 Bristol-Myers Squibb Company
Treatment of adults with chronic
myeloid leukemia with
resistance or intolerance to prior
therapy including imatinib
First line cytotoxic therapy for
11/28/2005 Bristol-Myers Squibb Company
advanced, HIV related Kaposi's
sarcoma. 5/14/1993 NeXstar Pharmaceuticals, Inc.

3/1/2004 Helsinn Healthcare SA

8/20/2003 MediWound, Ltd.

8/4/2006 MGI Pharma

9/9/2002 MGI CP, d/b/a MGI Pharma

3/8/1999 MGI CP, Inc. d/b/a MGI Pharma

for treatment of patients with


myelodysplastic syndromes
(MDS) including previously
treated and untreated, de novo
and secondary MDS of all
French-American-British
subtypes
Treatment(refractory
of chronicanemia,
iron
refractory anemia with ringed
overload due to blood
sideroblasts, refractory anemia
transfusions (transfusional
3/8/1999 MGI CP, Inc. d/b/a MGI Pharma
hemosiderosis) in patients 2
years of age or older 11/21/2002 Novartis Pharmaceuticals Corporation

12/12/2001 ApoPharma, Inc. A Division of

1/28/2005 Biomedical Frontiers, Inc.

1/8/2007 Gentium SpA

5/21/2003 Gentium SpA


7/5/1985 Crinos International

7/13/1994 Genelabs Technologies, Inc.

8/19/2003 Paladin Labs, Inc.

1/29/1997 Pharmadigm, Inc.

Treatment of patients with


persistent or recurrent 1/28/1997 Pharmadigm, Inc.
cutaneous T-cell lymphoma
whose malignant cells express
the CD25 component of the IL-2
receptor. 8/21/1996 Eisai Medical Research, Inc.

11/5/1987 Roberts Pharmaceutical Corp.

Treatment of patients with 10/26/2004 Peptimmune, Inc.


hemophilia A or von
Willebrand's disease (type I)
whose factor VIII coagulant
activity level is greater than 5%. 1/22/1991 Aventis Behring L.L.C.

9/11/1998 Allergan

8/11/2004 Pharmos Corporation


Treatment of extravasation
resulting from IV anthracycline
Cardiomyopathy
chemotherapy associated with 3/25/2004 Topo Target A/S
doxorubicin administration in
women with metastatic breast
cancer who have received a
cumulative dose of 300mg/m2. 12/17/1991 Pharmacia & Upjohn

3/21/2003 BCY LifeSciences Inc.

3/5/1990 Holles Laboratories, Inc.

3/8/1991 Biomedical Frontiers, Inc.

10/5/1990 Kennedy & Hoidal, M.D.'s

11/19/1987 Ueno Fine Chemicals Industry, Ltd.

9/25/2001 Luitpold Pharmaceuticals, Inc..

5/1/2003 Luitpold Pharmaceuticals, Inc.

10/10/2002 Luitpold Pharmaceuticals, Inc..


6/11/1992 Baxter Healthcare Corporation

2/25/1992 Valeant Pharmaceuticals

11/10/1983 Warner-Lambert Company

6/22/1988 Bristol-Myers Squibb

4/3/1986 Connaught Laboratories

4/14/2004 CIS-US
Treatment of internal
contamination with plutonium,
americium or curium 4/28/2004 Hameln Pharmaceuticals gmbh

5/25/2004 Genzyme Corporation

6/13/2003 Allertein Therapeutics, LLC

5/27/2005 Bette S. Pollard, LLC

10/18/2001 PrimeCyte, Inc.

11/2/2001 PrimeCyte, Inc.

11/1/1984 Glaxo Wellcome Inc.

3/11/1985 Boehringer Mannheim Corp.

1/8/2007 Sigma-Tau Pharmaceuticals, Inc.

2/5/1996 Besins Internaitonal, US Inc.

11/22/1994 Pharma 21

6/6/1986 Research Industries Corp.

4/6/1998 Cancer Technologies, Inc.

4/15/1997 Cancer Technologies, Inc.


7/28/1988 Forum Products, Inc.

6/13/2003 Lloyd E. King, Jr.

3/1/1990 ImmunoTherapeutics, Inc.

6/16/1993 Discovery Experimental & Development, Inc.

3/5/1990 Anthra Pharmaceuticals, Inc.

7/10/1986 Pharmaquest Corporation

6/4/1996 DuPont Pharmaceuticals Company

4/4/2005 Expression Genetics, Inc.

4/28/2000 Vical Incorporated

9/21/2000 AVAX Technologies, Inc.

3/5/2001 Luitpold Pharmaceuticals, Inc.


In conjunction with standard
therapies in the management of
cystic fibrosis patients to reduce 7/16/2004 Johnson & Johnson Pharmaceutical Research & Dev.
the frequency of respiratory
infections requiring parenteral
antibiotics and to improve
pulmonary function. 1/16/1991 Genentech, Inc.

For use in combination with


bortezomib for the treatment of 10/3/2006 Novartis Pharmaceuticals Corporation
patients with multiple myeloma
who have not previously
received bortezomib and have
at least one prior
therapy. 12/29/2004 Johnson & Johnson Pharmaceutical Research & Dev.

Treatment of metastatic
carcinoma of the ovary in
patients with disease that is 10/7/2005 Supratek Pharma Inc.
refractory to both paclitaxel- and
platinium-based chemotherapy
regimens. Refractory disease is
defined as disease that has
progressed while on treatment,
or within 6 months 11/4/1998 Alza Corporation

3/14/2005 BioAlliance Pharma

Treatment of anorexia
10/23/2002 Demegen, Inc.
associated with weight loss in
patients with AIDS. 1/15/1991 Unimed Pharmaceuticals, Inc.
1/17/2007 Chelsea Therapeutics, Inc.

12/11/1997 MoliChem Medicines Inc.

10/16/1991 Mayo Foundation

2/5/1990 Mayo Foundation

3/5/2001 Alexion Pharmaceuticals, Inc.


Treatment of paroxysmal
nocturnal hemoglobinuria to
reduce hemolysis 8/20/2003 Alexion Pharmaceuticals, Inc.

7/28/2005 Novartis Pharmaceuticals Corp.

7/28/2004 Allos Therapeutics, Inc.

9/29/2006 VBL Pharmaceuticals, Inc.

4/18/1986 Marion Merrell Dow, Inc.

4/23/1986 Hoechst Marion Roussel

9/25/1995 Innapharma, Inc.

1/28/1997 Warner-Lambert Company

7/5/1995 VivoRx

12/15/2005 Adherex Technologies, Inc.

10/20/1989 G.D. Searle & Company

10/20/1989 G.D. Searle & Company

10/24/2006 Univ of Cal. San Diego Medical Center, Hillcrest

9/19/2005 Eli Lilly and Company

10/5/1987 Chiron Vision

Component of adjuvant therapy 3/6/1985 Ethicon, Inc.


in patients with evidence of
axillary node tumor involvement
following resection of primary
breast cancer. 9/14/1999 Pharmacia & Upjohn Company
Treatment of AZT-induced
anemia in HIV infected patients. 7/1/1991 Amgen, Inc.

4/10/1986 Amgen, Inc.

12/20/1993 Johnson & Johnson Pharmaceutical Research & Dev.,

8/27/1987 R. W. Johnson Pharmaceutical Research Institute

7/21/1988 Johnson & Johnson Pharmaceutical R & D, LLC

3/7/1989 R. W. Johnson Pharmaceutical Research Institute


For the long-term intravenous
treatment of pulmonary
hypertension associated with the
scleroderma spectrum of 10/22/1987 Chugai-USA, Inc.
disease in New York Heart
Association (NYHA) Class III
and Class IV patients who do
not respond adequately to
conventional therapy. 3/22/1999 GlaxoSmithKline
Long-term intravenous treatment
of primary pulmonary
hypertension in NYHA Class III
and Class IV patients. 9/25/1985 Glaxo Wellcome Inc.

3/29/1984 Glaxo Wellcome Inc.

10/29/1984 Upjohn Company

7/13/1998 Immunomedics, Inc.

4/6/1999 Neurochem, Inc.

12/27/2006 Center for Cell and Gene Therapy

7/18/2003 Genentech, Inc

7/30/1986 EUSA Pharma (US), Inc.

1/25/1985 Lyphomed, Inc.

11/19/1987 Organon Teknika Corporation

8/19/1987 McDonnell Douglas Corp


Reduction in signs and
symptoms of moderately to
severely active polyarticular-
course juvenile rheumatoid 10/31/2006 Ascend Therapeutics, Inc.
arthritis in patients who have
had an inadequate response to
one or more disease-modifying
anti-rheumatic drugs.
10/27/1998 Immunex Corporation

3/13/2006 Orfagen

3/29/2006 Orfagen

3/22/1984 Block Drug Company, Inc.

6/22/1988 Bio-Technology General Corp.

8/1/1989 U.S. Bioscience

4/6/2000 Laxdale Ltd.

5/2/1991 MGI Pharma, Inc.

5/2/1991 MGI Pharma, Inc.

3/21/1986 MGI Pharma, Inc.

5/7/1996 SuperGen, Inc.

11/3/1995 SuperGen, Inc.

Treatment of advanced breast


cancer in postmenopausal
women whose disease has
12/14/2005 Osiris Therpeutics, Inc.
progressed following tamoxifen
therapy. 9/19/1991 Pharmacia & Upjohn

2/14/1994 OSI Pharmaceuticals, Inc.

5/21/2003 Novo Nordisk Pharmaceuticals, INc.

11/6/2003 Novo Nordisk, Inc.

1/16/1985 CSL Behring L.L.C.

4/22/1993 Zymogenetics, Inc.

6/2/1997 Acorda Therapeutics, Inc.


As adjunctive therapy in the 6/2/1987 Acorda Therapeutics
treatment of partial and
generalized seizures associated
with the Lennox-Gastaut
syndrome in children. 1/24/1989 Wallace Laboratories

11/20/2006 Neuropharm, Ltd.

2/1/2007 Cancer Research UK

10/5/2005 USC-CHLA Institute for Pediatric Clinical Research

6/26/2003 Degussa AG

7/24/1992 Oclassen Pharmaceuticals, Inc.

8/23/1995 Alpha Therapeutic Corporation

9/5/1988 Melville Biologics, Inc.

12/5/1988 Chiron Vision

Treatment of patients with


severe chronic neutropenia. 11/7/1990 Amgen, Inc.

Reduce the duration of


neutropenia and neutropenia 8/30/1990 Amgen, Inc.
sequelae in patients with non-
myeloid malignancies
Reducing
undergoing the time to neutrophil
ablative
recovery and the
chemotherapy duration
followed byof
BMT. 10/1/1990 Amgen, Inc.
fever, following induction or
consolidation chemotherapy
treatment of adults with acute
myeloid leukemia. 11/7/1996 Amgen, Inc.

9/3/1991 Amgen, Inc.


For use in the mobilization of
hematopoietic progenitor cells
into the peripheral blood
collection by leukapheresis. 7/17/1995 Amgen, Inc.

12/22/2004 Franco Muggia, M.D.

4/18/1989 Berlex Laboratories, Inc.

4/18/1989 Berlex Laboratories, Inc.

1/15/1985 Farmacon, Inc.

1/6/1986 Janssen Research Foundation


Treatment of chronic non-
infectious uveitis affecting the
posterior segment of the eye 7/31/2000 Bausch & Lomb Pharmaceuticals, Inc.

2/6/1989 Lederle Laboratories

10/27/1989 Hoffmann-La Roche, Inc.

4/18/1990 Hoffmann-La Roche, Inc.

6/29/2000 Ethypharm SA

4/14/2004 Hollander, Eric MD

4/30/1999 Mt. Sinai School of Medicine


For the induction of
spermatogenesis in men with
primary and secondary
hypogonadotropic
hypogonadism in whom the
cause of infertility is not due to
primary testicular failure. 12/21/1998 Serono Laboratories, Inc.
Use for suspected or confirmed
methanol poisoning, either alone
or in combination with
hemodialysis 12/22/1988 Jazz Pharmaceuticals
As an antidote to ethylene glycol
(antifreeze) poisoning, or for use
in suspected ethylene glycol
ingestion. 12/22/1988 Jazz Pharmaceuticals

For the control of generalized


convulsive status epilepticus. 6/4/1991 Warner-Lambert Company

5/29/1998 Questcor Pharmaceuticals, Inc.

1/11/2006 Apoxis SA

7/18/2002 Receptor BioLogix, Inc.

7/10/2002 Receptor BioLogix, Inc.

7/5/1995 Warner-Lambert Company

12/5/1988 Solopak Pharmaceutical Co.

12/3/1987 Biocraft Laboratories, Inc.

1/22/1985 Sigma Chemical Company

7/27/1994 Zurier, Robert B. M.D.


5/25/1994 Marinus Pharmaceuticals, Inc.

3/22/2007 Sirion Therapeutics, Inc.


Treatment of CMV retinitis in
patients with acquired
immunodeficiency syndrome. 6/7/1995 Bausch & Lomb Surgical, Chiron Vision Products

10/31/1985 Syntex (USA), Inc.

6/7/1985 Burroughs Wellcome Company

11/17/1988 Fidia Pharmaceutical Corp.

Treatment of patients with CD33


positive acute myeloid leukemia 11/20/2000 Amgen
in first relapse who are 60 years
of age or older and who are not
considered candidates for
cytotoxic chemotherapy 11/24/1999 Wyeth-Ayerst Laboratories

10/24/2000 Ark Therapeutics Ltd.

4/29/2002 MediGene, Inc.

6/6/2005 ProcesScience, Inc (PSI)

1/31/1991 Lipha Pharmaceuticals, Inc.

7/10/1990 Liposome Company, Inc.


For reduction of the frequency of
relapses in patients with
relapsing-remitting multiple
sclerosis. 11/9/1987 Teva Pharmaceuticals USA

6/5/2001 TEVA Pharmaceuticals, USA


Treatment of short bowel
syndrome in patients receiving
specialized nutritional support 8/19/2003 Protherics, Inc.
when used in conjunction with a
rercombinant human growth
hormone that is approved for
this indication. 3/6/1995 Nutritional Restart Pharmaceutical, L.P.

2/22/1990 Chugai Pharmaceutical Co., Ltd.

5/24/2005 Ucyclyd Pharma, Inc

2/14/1995 Moser, Hugo W. M.D.

6/9/2006 Sciele Pharma, Inc.


11/2/2004 Centocor, Inc.

4/22/1987 Ferring Laboratories, Inc.

10/22/1990 Reidenberg, Marcus M. M.D.

3/25/1997 Genzyme Corporation

6/6/1989 Schering Corporation

5/4/1990 Schering Corporation

8/7/1989 Schering Corporation

12/12/1989 Schering Corporation

5/3/1990 Schering Corporation

5/8/1990 North American Biologicals, Inc.

8/7/1989 Valeant Pharmaceuticals International

1/6/1986 Novartis Pharmaceuticals Corporation

8/5/1999 Watson Laboratories, Inc.

6/27/1996 Bristol-Myers Squibb Pharmaceutical Research Institute

Treatment of adults who can 9/21/2000 Alexion Pharmaceuticals, Inc.


tolerate oral medication and who
have mild to moderate malaria
caused by Plasmodium
falciparum or Plasmodium vivax. 11/4/1991 SmithKline Beecham Pharmaceuticals

2/7/2000 Collgard Biopharmaceuticals Ltd.

9/3/2004 Cadila Pharmaceuticals Limited, Inc.

11/21/2002 CPL, Inc.

3/10/1988 Orphan Europe

3/1/1994 Orphan Europe


3/16/1984 Abbott Laboratories

12/20/1993 Bonkovsky, Herbert L. M.D.

11/3/2005 Vectura Group, Inc.

6/29/2006 Ockham Biotech Limited

9/18/2006 Trillium Therapeutics, Inc.

3/8/1995 NABI

11/14/2002 NABI

7/15/2003 Cubist Pharmaceuticals

10/16/1992 Genetic Therapy, Inc.

2/1/2000 EpiCept Corporation

12/15/1999 EpiCept Corporation

Treatment of central precocious


puberty 11/18/2005 Indevus Pharmaceuticals (Formerly Valera Pharma.)

5/3/1991 Anderson, Karl E., M.D.

Treatment of central precocious


puberty. 8/10/1988 Roberts Pharmaceutical Corp.

3/24/1992 Hemacare Corporation

9/30/1999 Vical Incorporated

2/8/2002 American BioScience, Inc.

7/17/1985 Rhone-Poulenc Rorer Pharm.

3/19/2001 StressGen Biotechnologies, Inc. is now Nventa

11/28/2001 PDL BioPharma, Inc.

9/10/1996 Pharming/Genzyme LLC


4/4/2005 Falk Center for Molecular Therapeutics

9/27/2004 Medarex, Inc.

8/13/2004 Genmab A/S

5/5/2005 Centocor, Inc.

12/1/2004 Centocor, Inc.

1/11/2002 Genzyme Corporation

7/9/2004 Genzyme Corporation

12/20/2006 Biotest Diagnostics Corporation

9/16/2002 Protein Therapeutics, Inc.

11/14/2003 Protein Therapeutics, Inc.

5/25/2001 PediaMed Pharmaceuticals, Inc.

8/7/1989 Centocor, Inc.

8/7/1989 Centocor, Inc.

3/29/2006 Pharmalink AB

11/21/1989 NABI

3/25/1992 NABI

1/4/1995 NABI

1/10/2006 Medarex, Inc.

6/3/2004 Bristol-Myers Squibb Pharmaceutical Research Insti

7/7/2005 IRX Therapeutics, Inc.

11/2/2004 CuraGen Corporation

9/18/2006 Kenta Biotech Limited


10/24/2006 Centocor, Inc.

4/18/2007 Octapharma USA, Inc.

7/20/2006 Pharmexa A/S

11/20/1989 MicroGeneSys, Inc.

3/13/2006 Centocor, Inc

9/29/2006 MacroGenics, Inc.

3/21/2005 Genzyme Corporation

9/17/1998 Biotransplant, Inc.

3/5/1993 Hoffmann-La Roche, Inc.

2/9/1999 Biogen IdecInc.

9/12/2001 Teijin America, Inc.

6/16/2006 Morphotek, Inc.

3/19/2002 Exhale Therapeutics, Inc.

4/9/2004 Barbeau Pharma, Inc.

Treatment on known or
suspected cyanide poisoning 11/25/2003 Merck Sante, s.a.a.

9/22/2000 Jazz Pharmaceuticals

10/4/1985 Hall, Alan H., M.D.


To reduce the frequency of
painful crises and to reduce the
need for blood transfusions in 4/15/2005 UPM Pharmaceuticals, Inc.
adult patients with sickle cell
anemia with recurrent moderate
to severe painful crises
(generally at least 3 during the
preceding 12 months). 10/1/1990 Bristol-Myers Squibb Pharmaceutical Research Institute
8/3/2000 Nexell Therapeutics

2/7/2000 Nexell Therapeutics, Inc.

2/14/2002 TransMolecular, Inc.

Treatment of patients with


relapsed or refractory low-grade, 6/3/2005 SmithKlineBeecham Corporation
follicular, or transformed B-cell
non-Hodgkin?s lymphoma,
including patients with Rituximab
(Rituxan?) refractory follicular
non-Hodgkin?s lymphoma 9/6/1994 Biogen IDEC Inc.

For closure of a clinically


significant patent ductus
arteriosus in premature infants 10/29/1996 Farmacon-IL, LLC
weighing between 500 and 1500
g, who are no more than 32
weeks gestational age when
usual medical management
(e.g., fluid restriction, diuretics,
respiratory support, et 10/29/1996 Farmacon-IL, LLC

11/25/2003 Jerini AG
For use as a single daily
exchange for the long (8-16
hour) dwell during continuous 5/5/2004 Jerini AG
ambulatory peritoneal dialysis
(CAPD) or automated peritoneal
dialysis (APD) for the
management of chronic renal
failure. 7/18/1997 Baxter Healthcare Corporation

12/2/1992 Pharmacia & Upjohn

12/1/1992 Pharmacia & Upjohn

7/25/1988 Adria Laboratories, Inc.

2/12/1991 Pharmacia & Upjohn

10/31/2006 Santhera Pharmaceuticals Limited

2/16/2007 Santhera Pharaceuticals Limited

3/25/2004 Santhera Pharmaceuticals LLC

4/8/1996 NeoPharm, Inc.


Indicated for patients with
Hunter syndrome
(mucopolysaccharidosis II, MPS
II). Idursulfase has been shown
to improve walking capacity in
In combination
these patients with certain other 11/28/2001 Shire Human Genetic Therapies, Inc.
approved antineoplastic agents,
for third line chemotherapy in
the treatment of germ cell
testicular cancer. 1/20/1987 Bristol-Myers Squibb Pharmaceutical Research Institute

8/7/1985 Bristol-Myers Squibb Pharmaceutical Research Institute

8/7/1985 Bristol-Myers Squibb Pharmaceutical Research Institute

11/2/2001 NeoPharm, Inc.

4/6/2000 Protox Therapeutics, Inc.


Treatment of pulmonary arterial
hypertension (WHO Group I) in
patients with NYHA Class III or
IV symptoms 8/17/2004 CoTherix, Inc.

9/21/1989 Berlex Laboratories, Inc.

Treatment of patients with


chronic myeloid 5/14/1990 Berlex Laboratories, Inc.
leukemia (CML) in blast crisis,
accelerated phase, or in chronic
phase after failure of interferon-
Treatment of adult patients with
alpha therapy 1/31/2001 Novartis Pharmaceuticals Corporation
aggressive mastocytosis (ASM)
without the D816V c-Kit mutation
Treatment
or with c-Kitofmutational
adult patients with
status
myelodysplastic/myeloproliferati
unknown 9/9/2005 Novartis Pharmaceuticals Corporation
ve diseases (MDS/MPD)
associated
Treatment of with PDGFR
adult patients with
(platelet-derived growth
hypereosinophic syndromefactor
receptor)
(HES) genechronic
and/or re-arrangements 10/5/2005 Novartis Pharmaceuticals Corporation
eosinophilic leukemia (CEL) who
have the FIP1L1-PDGFRα
fusion kinase (mutational
analysis or FISH demonstration
of CHIC2 allele deletion) and for
Treatment of HES
patients with adult and/or
patients with
CEL 8/25/2005 Novartis Pharmaceuticals Corporation
relapsed or refractory
Philadelphia chromosome
positive acute lymphoblastic
leukemia (Ph+ALL) 10/11/2005 Novartis Pharmaceuticals Corporation
Treatment of adult patients with
unresectable, recurrent and/or
metastatic dermatofibrosarcoma
Treatment
protuberans of(DFSP)
patients with Kit 12/19/2005 Novartis Pharmaceuticals Corporation
(CD117) positive unresectable
and/or metastatic malignant
gastrointestinal stromal tumors
(GIST) 11/1/2001 Novartis Pharmaceuticals Corp.

1/25/1989 Centocor, Inc.

8/12/2005 AmpliMed Corporation

11/8/1996 AmpliMed Corporation


11/1/2003 AmpliMed Corporation

Enzyme replacement therapy in


8/3/2001 AmpliMed Corporation
patients with type I Gaucher's
disease. 11/5/1991 Genzyme Corporation

7/16/2004 Vital Therapies, Inc.

7/27/2004 Talecris

3/17/2004 OMRIX Biopharmaceuticals, Ltd.

5/4/2004 ZLB Bioplasma AG

7/20/2006 Baxter Healthcare Corporation,

11/22/1993 Immuno Clinical Research Corp.

10/13/1992 Immuno Clinical Research Corp.


For prophylaxis of children with
clinical or immunologic evidence
of human immunodeficiency 12/16/1992 Immuno Clinical Research Corp.
virus to decrease the frequency
of serious and minor bacterial
infections and the frequency of
hospitalization, and to increase
the time free of serious bacterial 2/18/1993 Bayer Corporation

9/22/2004 Aventis Behring, L.L.C.

8/13/2004 Medical Research Laboratories International

5/12/1992 ALK Laboratories, Inc.

1/10/2006 Therion Biologics Corporation

8/7/1989 Centocor, Inc.

2/6/1990 Hybritech, Inc.

6/16/2006 RadioIsotope Therapy of America (RITA) Foundation

10/23/2002 Centocor, Inc.


5/6/2003 Centocor, Inc.
For reducing signs and
symptoms and inducing and
maintaining clinical remission in 11/12/2003 Centocor, Inc.
pediatric patients with
moderately to severely active
Crohn's disease who have had
an inadequate response to
conventional therapy 11/12/2003 Centocor, Inc.

Treatment of moderately to
severely active Crohn's disease
for the reduction of the signs 5/21/2003 Centocor, Inc.
and symptoms, in patients who
have an inadequate response to
conventional therapies; and
treatment of patients with
fistulizing Crohn's disease for
the reduction in 11/14/1995 Centocor, Inc.

1/27/2003 Introgen Therapeutics, Inc.

6/13/2001 Inhibitex, Inc.

10/23/2002 OPi

9/20/1988 Newport Pharmaceuticals

Treatment of chronic
myelogenous leukemia. 6/6/1989 Hoffmann-La Roche, Inc.

4/18/1988 Hoffmann-La Roche, Inc.

5/11/1990 Hoffmann-La Roche, Inc.

5/2/1990 Hoffmann-La Roche, Inc.

12/14/1987 Hoffmann-La Roche, Inc.

5/14/1990 Hoffmann-La Roche, Inc.

10/27/1989 Hoffmann-La Roche, Inc.

Treatment of selected patients


with AIDS-related Kaposi's
sarcoma. 6/24/1987 Schering Corporation

11/17/1988 Schering Corporation

5/13/1988 Schering Corporation

8/10/1988 Schering Corporation


4/18/1988 Schering Corporation

8/3/1987 Schering Corporation

6/22/1987 Schering Corporation

6/22/1987 Schering Corporation

8/17/1988 Schering Corporation

5/4/1990 Schering Corporation

10/16/1987 Glaxo Wellcome Inc.

8/25/1986 Burroughs Wellcome Company

2/12/1991 Biogen, Inc.

5/9/1991 Biogen, Inc.

4/18/1991 Biogen, Inc.

11/15/1988 Berlex Laboratories, Inc.

Treatment of relapsing forms of


multiple sclerosis to slow the 3/11/1996 Serono Laboratories, Inc.
accumulation of physical
disability and decrease the
frequency of clinical
exacerbations. 12/16/1991 Biogen, Inc.

7/24/1992 Biogen, Inc.

4/3/1991 Biogen, Inc.

In ambulatory patients with 12/2/1992 Serono Laboratories, Inc.


relapsing-remitting multiple
sclerosis to reduce the
frequency of clinical
exacerbations. 11/17/1988 Chiron Corp. & Berlex Laboratories

Delaying time to disease


9/30/1988 InterMune, Inc.
progression in patients with
severe, malignant osteopetrosis. 9/30/1996 InterMune , Inc.

12/4/1995 Genentech, Inc.


4/17/2001 Ernest C.Borden

6/17/1991 Immunex Corporation

6/17/1991 Immunex Corporation

9/23/1991 Amgen, Inc.

10/16/1992 Amgen, Inc.

4/4/2005 Regeneron Pharmaceuticals, Inc.

12/20/2004 Regeneron Pharmaceuticals, Inc.

5/11/1990 Hoffmann-La Roche, Inc.

2/6/1990 Hoffmann-La Roche, Inc.

2/5/1990 Hoffmann-La Roche, Inc.

5/3/1990 Hoffmann-La Roche, Inc.

5/20/1991 Immunex Corporation

9/30/1993 Sandoz Pharmaceuticals Corp.

7/31/2001 Digestive Care, Inc.

7/26/2007 GammaCan Ltd.

12/1/2006 GE Healthcare, Inc.

12/1/2006 GE Healthcare, INc.

7/5/2007 DraxImage

1/18/2006 Molecular Insight Pharmaceuticals


Adjunctive diagnostic agent in
the localization of primary or
metastatic pheochromocytomas. 11/14/1984 University of Michigan

10/17/2005 Brogan Pharmaceuticals, LLC

10/21/2005 Brogan Pharmaceuticals, LLC


8/1/1984 David E. Kuhl, M.D.

9/30/1988 Immunomedics, Inc.

9/30/1988 Immunomedics, Inc.

11/7/1988 Immunomedics, Inc.

2/22/2000 IBC Pharmaceuticals, L.L.C.

11/2/1987 Lederle Laboratories Division

9/18/1989 Immunomedics, Inc.

9/30/1988 Immunomedics, Inc.

9/30/1988 Immunomedics, Inc.

11/7/1988 Immunomedics, Inc.

2/12/1999 Peregrine Pharmaceuticals, Inc.

7/27/1999 MGI Pharma, Inc.


Treatment of patients with
known or suspected internal
contamination with radioactive 7/6/1999 MGI Pharma, Inc.
cesium and/or radioactive or
non-radioactive thallium to
increase their rates of
elimination 5/1/2003 Heyl Chemisch-Pharmzeutische Fabrik GMBH & Co, KG

5/25/1994 Alpha Therapeutic Corporation

12/18/1992 Perrine, Susan P., M.D.

1/10/2006 Amicus Therapeutics, Inc.

5/19/1999 Glovax Co., Ltd.

3/27/1991 Pharmedic Company

6/14/1994 Transcend Therapeutics, Inc.


7/30/1996 Transcend Therapeutics, Inc.

1/20/1999 Watson Laboratories, Inc.

6/29/1999 Frontier Pharmaceutical, Inc.

1/15/2002 VSL Pharmaceuticals, Inc.

1/15/2002 VSL Pharmaceuticals, Inc.

9/12/1990 Roxane Laboratories, Inc.

1/18/2006 CepTor Corporation


Adjunctive treatment of Lennox-
Gastaut syndrome in pediatric
Long-term treatment of
and adult patients. 8/23/1995 Glaxo Wellcome Research and Development
acromegalic patients who have
had an inadequate response to
Treatment fortreated
or cannot be patients with
with
Hurler
surgeryand Hurler-Scheie
and/or forms 9/11/2000
radiotherapy IPSEN, Inc.
of Mucopolysaccharidosis I
(MPS I) and for patients with the
Scheie form who have moderate
to severe symptoms 9/24/1997 BioMarin Pharmaceutical, Inc.

6/18/2001 Rare Disease Therapeutics, Inc.

1/30/1992 Pharmascience Inc.

12/17/1991 Pharmascience Inc.

1/6/1998 Pharmascience Inc.

7/13/1990 Fromm, Gerhard M.D.

8/1/1989 Lev, Meir M.D.

Treatment of patients with 5/16/1994 Brigham and Women's Hospital


transfusion dependant anemia
due to low or intermediate-1 risk 10/18/1996 Williams, MD, James W.
myelodysplastic syndromes
associated with a deletion 5 q
cytogenetic abnormality with or
without additional cytogenetic
abnormalities 1/29/2004 Celgene Corporation

For use in combination with 1/17/2007 Celgene Corporation


dexamethasone for the
treatment of multiple myeloma
patients who have received at
least one prior therapy. 9/20/2001 Celgene Corporation
For anticoagulation in patients
with heparin-induced
thrombocytopenia and 1/11/2006 Errant Gene Therapeutics, LLC
associated thromboembolic
disease in order to prevent
further thromboembolic
complications. 2/13/1997 Hoechst Marion Roussel

For use in combination with 5-


fluorouracil to prolong survival in
the palliative treatment of
3/24/2006 Cephalon, Inc.
patients with advanced
colorectal cancer. 12/8/1986 Immunex Corporation

8/17/1988 Immunex Corporation

6/23/1988 Glaxo Wellcome Research and Development

5/4/2007 CEL-SCI Corporation

9/18/1990 Neuromuscular Adjuncts, Inc.

Treatment of children with


central precocious puberty. 7/25/1988 Tap Pharmaceuticals, Inc.

Prevention and treatment of


carnitine deficiency in patients
2/29/1988 Iolab Pharmaceuticals
with end stage renal disease
who are undergoing dialysis. 9/6/1988 Sigma-Tau Pharmaceuticals, Inc.

11/24/1986 Sigma-Tau Pharmaceuticals, Inc.

11/15/1989 Sigma-Tau Pharmaceuticals, Inc.

11/15/1989 Sigma-Tau Pharmaceuticals, Inc.

4/7/1997 Sigma-Tau Pharmaceuticals, Inc.

Treatment of primary systemic


carnitine deficiency. (approved 11/22/1993 Sigma-Tau Pharmaceuticals, Inc.
12/27/85)
Treatment of secondary
carnitine deficiency. (approved
12/16/92) 7/26/1984 Sigma-Tau Pharmaceuticals, Inc.

2/28/1984 Sigma-Tau Pharmaceuticals, Inc.

1/18/2000 Solvay Pharmaceuticals, Inc.

For the management of opiate


dependence. 1/24/1985 Biodevelopment Corporation

8/1/2001 Emmaus Medical, Inc.

10/20/1999 Implicit Bioscience Pty Ltd


6/18/2004 Barrier Therapeutics, Inc

10/24/1995 Teikoku Pharma USA, Inc.

3/20/2007 Seattle Genetics, Inc.

1/30/2007 Seattle Genetics, Inc.

9/9/2002 Protein Design Labs, Inc.

Treatment of myxedema
coma/precoma. 7/30/1990 SmithKline Beecham Pharmaceuticals

4/8/1996 Genzyme Corporation

12/10/1996 Fujisawa USA, Inc.

Treatment of visceral
leishmaniasis. 12/6/1996 Fujisawa USA, Inc.

Treatment of disseminated
cryptococcosis including
meningitis. 12/10/1996 Fujisawa USA, Inc.

6/17/2005 Callisto Pharmaceuticals, Inc.

6/17/2005 Callisto Pharmaceuticals, Inc.

12/27/2006 Aradigm Corporation

4/19/2006 Aradigm Corporation

5/23/2006 Transave, Inc.

4/30/1998 Vernon Knight, M.D.

12/27/2006 GP-Pharm SA

6/10/1998 Endorex Corp.

6/10/1998 Endorex Corp.


6/13/2000 The University of Texas

12/5/2003 Interpath Pharmaceuticals, INc.

4/25/1996 Liposome Company, Inc.

9/1/1999 Antigenics Incorporated

11/25/1991 Biomira, Inc.

6/20/1994 Biomira, Inc.

6/10/1999 Cell Therapeutics, Inc.

12/18/1990 Targent, Inc.

8/1/1991 Targent, Inc.


Treatment of ocular disorders
referred to by the terms vernal
keratoconjunctivitis, vernal
conjunctivitis, vernal keratitis. 10/16/1991 Alcon Laboratories, Inc.

2/24/1992 R. W. Johnson Pharmaceutical Research Institute

7/24/1992 Interneuron Pharmaceuticals, Inc.

2/6/1989 Tyson And Associates

4/26/2005 Nyxis Neurotherapies, Inc.

9/10/2004 CMS Peptides Patent Holding Company Limited

5/23/2006 Discovery Laboratories, Inc

10/21/2005 Discovery Labsoratories, Inc.

7/30/1996 Discovery Laboratories, Inc.

7/17/1995 Discovery Laboratories, Inc.

10/18/1995 Discovery Laboratories, Inc.


8/1/1989 G.D. Searle & Company

7/18/1990 Mylan Laboratories, Inc.

1/21/2003 Baxter Healthcare Corporation

8/12/2005 ARIAD Pharmaceuticals, Inc

2/11/2005 Pharmaxis Ltd.

4/27/2004 Progen Industries Limited

2/1/2007 ViroPharma Inc.

5/25/1999 Multidisciplinary Association for Psychedelic Studies, Inc.

12/5/1991 Glycomed, Inc

3/3/2003 GenStar Therapeutics Corporation

12/8/1986 Collipp, Platon J. M.D.

10/14/1998 Targacept, Inc.


Long-term treatment of growth
failure in children with severe
primary IGF-1 deficiency 8/5/1991 Cephalon, Inc.
(Primary IGFD) or with growth
hormone (GH) gene deletion
who have developed
Treatment
neutralizingofantibodies
growth failure in
to growth
children
hormone.with severe primary 12/12/1995 Tercica, Inc.
IGF-1 deficiency (Primary IGFD)
or with growth hormone (GH)
gene deletion who have
developed neutralizing
antibodies to growth hormone 5/17/2002 Insmed, Inc.

8/12/2004 Yaupon Therapeutics, Inc.

4/14/2004 MedImmune Oncology. Inc

2/22/2001 InKine Pharmaceutical Company, Inc.

7/22/1987 Mepha AG
7/22/1987 Mepha AG

4/13/1988 Hoffmann-La Roche, Inc.

Treatment of anorexia, 4/13/1988 Hoffmann-La Roche, Inc.


cachexia, or an unexplained
significant weight loss in patients
with a diagnosis of acquired
immune deficiency syndrome. 4/13/1988 Bristol-Myers Squibb Pharmaceutical Research Institute

9/6/2006 Hoag Memorial Hospital Presbyterian

10/13/1994 CancerVax Corporation

3/29/2005 Bristol-Myers Squibb Research Inst

12/20/1989 Ribi ImmunoChem Research, Inc.

7/9/2004 Neurim Pharmaceuticals, Ltd.

For relief of the signs and 11/15/1993 Sack, Robert, M.D.


symptoms of pauciarticular or
polyarticular course Juvenile
Rheumatoid Arthritis in patients
2 years of age or older 11/22/2002 Boehringer Ingelheim Pharmaceuticals, Inc.

For the palliative treatment of


patients with multiple myeloma
3/3/1992 Glaxo Wellcome Research and Development
for whom oral melphalan is not
appropriate. 2/24/1992 Glaxo Wellcome Inc.

1/8/2007 Cinergen, LLC

10/18/2006 Cinergen

5/28/2004 GlaxoSmithKline Pharmaceuticals

4/27/2000 AstraZeneca Pharmaceuticals

12/16/1987 Asta Medica , Inc.

11/14/1985 Degussa Corporation

8/21/1996 Genopia USA, Inc.


For the use of high dose
methotrexate with leucovorin
rescue in patients with non- 8/23/1993 Wyeth-Ayerst Laboratories
metastatic osteosarcoma who
have undergone surgical
resection or amputation for the
primary tumor. 10/21/1985 Lederle Laboratories

10/15/1990 Durham Pharmaceuticals LLC


10/14/1998 Therakos, Inc.

8/22/2001 Amylin Pharmaceuticals, Inc.

8/22/2001 Amylin Pharmaceuticals, Inc.

10/24/1991 Galderma Laboratories, Inc.

11/24/1987 Searle

10/22/1987 Galderma Laboratories, Inc.

6/15/2007 Tau Therapeutics, LLC

11/16/1990 Cav-Con, Inc.

1/25/2007 Thrombotargets Corp.

5/8/2006 Schwarz Biosciences, Inc.

Treatment of symptomatic
orthostatic hypotension. 12/5/1996 Schier Ridgewood F.K.A. (Roberts Pharmaceutical Corp.)

6/5/2001 Immuno-Designed Molecules

Treatment of mild to moderate 2/7/2005 HRA Pharma


Type I Gaucher disease in
adults for whom enzyme 7/5/2007 Corcept Therapeutics, Inc.
replacement therapy is not a
therapeutic option (e.g., due to
constraints such as allergy,
hypersensitivity, or poor venous
access). 5/29/1998 Actelion Pharmaceuticals Ltd

10/10/2006 Zentaris GmbH

6/19/1992 Lederle Laboratories Division

3/28/2006 Autoimmunity Research Foundation

1/10/2005 Gynuity Health Projects, LLC

3/18/1994 ILEX Oncology, Inc.

1/23/1989 Biopharmaceutics, Inc.


7/12/1995 Biopharmaceutics, Inc.
In combination with
corticosteroids as initial 8/20/1993 IOP Inc.
chemotherapy for the treatment
of patientsneurologic
Reducing with pain related
disabilityto
advanced
and/or the hormone-refractory
frequency of clinical
prostate
relapses cancer.
in patients with 8/21/1996 Serono
secondary (chronic) progressive,
progressive relapsing, or
worsening relapsing-remitting
multiple sclerosis
Reducing (i.e.,disability
neurologic patients
whose the
and/or neurologic status
frequency is
of clinical
significantly
relapses in patients with 8/13/1999 Serono, Inc.
secondary (chronic) progressive,
progressive relapsing, or
worsening relapsing-remitting
multiple sclerosis (i.e., patients
whose neurologic status is
significantly 8/13/1999 Serono, Inc.

7/13/1987 Lederle Laboratories

9/18/1998 Immunomedics, Inc.

11/24/1998 Immunomedics, Inc.


Improve wakefulness in patients
with excessive daytime
sleepiness associated with
narcolepsy. 3/15/1993 Cephalon, Inc.

1/24/1989 Schering Corporation

9/25/1989 Schering Corporation

11/14/2003 Medica Venture Partners

9/19/1994 IDEC Pharmaceuticals Corporation

5/6/1986 IDEC Pharmaceuticals Corporation

4/4/1988 Centocor, Inc.

1/7/1993 VivoRx Autoimmune, Inc.

11/15/1991 Protein Design Labs, Inc.

9/13/1991 Protein Design Labs, Inc.

6/17/1991 Protein Design Labs, Inc.

11/25/1996 Unither Pharmaceuticals. Inc.


11/4/1985 Pfizer, Inc.

For intrathecal or epidural 4/29/1993 Glaxo Wellcome Inc.


infusion in the treatment of
tractable chronic pain. It was 5/30/1984 Ethitek Pharmaceuticals, Inc.
developed for use in continuous
microinfusion devices and may
require dilution before use as
directed. 7/12/1990 Elkins-Sinn, Inc.

1/27/2003 Pharmacyclics, Inc.

1/3/2001 FeRx Incorporated

1/9/1991 North American Biologicals, Inc.

11/7/1990 North American Biologicals, Inc.

7/27/2004 Novartis Pharmaceuticals Corporation


Prevention of vitamin deficiency
and thrombormbolic 12/12/1989 Astra Pharmaceuticals, L.P.
complications in people
receiving home parenteral
nutrition who also receive
warfarin-type anticoagulant
therapy 3/8/2004 Mayne Pharma (USA) Inc.

11/27/1998 Peregrine Pharmaceuticals, Inc.

3/22/1999 Antisoma plc

8/15/2003 Epeius Biotechnologies Corporation

10/11/1995 Statens Seruminstitut

12/19/2005 Hoffman-La Roche, Inc.

5/26/2006 Hoffman-La Roche, Inc.

6/27/1991 AutoImmune, Inc.

4/7/2005 Ross Products Division

5/21/2003 Inflazyme Pharmaceuticals, Ltd.

4/20/2005 AB Science

1/13/2005 Amgen, Inc.


12/20/2006 Vertex Pharmaceuticals, Inc.

8/8/2007 Pharmion Corporation

10/17/2005 AB Science

9/30/2004 Abbott Laboratories

12/27/2006 Innovive Pharmaceuticals

5/23/2007 Abbott Laboratories

8/13/2004 Coley Pharmaceuticals Group, Inc.

3/24/2006 Coley Pharmaceuticals Group, Inc.

5/13/2002 NeuroSearch A/S

12/27/2000 Galephar Pharmaceutical Research, Inc.

For patients with


mucopolysaccharidosis VI.
Galsulfase has been shown to
9/9/2002 William M. Lee, MD, FACP
improve walking and stair-
climbing capacity. 2/17/1999 BioMarin Pharmaceutical, Inc.

2/6/2006 ExSAR Corporation

3/23/1990 Medco Research, Inc.

12/10/1996 NAPA of the Bahamas

12/9/2003 Abbott Laboratories


Treatment of central precocious
puberty (gonadotropin-
dependent precocious puberty)
in children of both sexes. 7/20/1988 Syntex (USA), Inc.

3/11/1985 DuPont Pharmaceuticals

11/18/2002 Amarillo Biosciences, Inc.

1/18/2000 Amarillo Biosciences, Inc.


8/10/2000 Amarillo Biosciences, Inc.

Treatment of patients with T-cell 11/1/1984 WATSON Laboratories, Inc.


acute lymphoblastic leukemia
and T-cell lymphoblastic 10/1/1986 Centocor, Inc.
lymphoma whose disease has
not responded to or has
relapsed following treatment
with at least two chemotherapy
regimens 8/10/2004 GlaxoSmithKline

9/13/1994 Ericsson, Arthur Dale, M.D.

8/8/1989 Ferring Laboratories, Inc.

6/13/1991 Fleischmann, Jonathan M.D.

2/14/2006 Valley Fever Center for Excellence (1-111 INF)

3/20/2007 Novartis Pharmaeuticals Corporation

4/27/2006 Novartis Pharmaceutical Corporation

11/17/2004 YM Biosciences Inc.

8/15/2003 Xechem International, Inc.

10/23/2001 Romark Laboratories, L.C.


Treatment of diarrhea caused by
Cryptosporidium parvum and
Giardia lamblia 2/14/2002 Romark Laboratories, L.C.
Treatment of diarrhea caused by
Cryptosporidium parvum and
Giardia lamblia 12/12/1996 Romark Laboratories, L.C.

10/19/2001 Swedish Orphan AB


Adjunctive therapy to dietary
restriction of tyrosine and
phenylalanine in the treatment of
hereditary tyrosinemia type 1 5/16/1995 Swedish Orphan AB

2/16/2005 SensorMedics Corporation

9/27/2004 INO Therapeutics


In conjunction with ventilatory
support and other appropriate
agents, in the treatment of term
and near-term (>34 weeks)
neonates with hypoxic
respiratory failure associated
with clinical or
echocardiographic evidence of
pulmonary hypertension, where
it i 6/22/1993 INO Therapeutics, Inc.

7/10/1995 INO Therapeutics, Inc.

2/21/2001 Thomas, MD, Jeffrey Evan

5/4/2007 Pfizer, Inc.

1/26/2001 Nuvelo, Inc. Inc.

8/17/2004 Aptamera, Inc.

Enzyme replacement therapy in


7/28/2005 Antisoma Research Ltd.
patients with all subtypes of
Mucopolysaccharidosis I. 4/11/2001 Novazyme Pharmaceuticals, Inc.

10/8/2004 Gemin X, Inc.

11/6/2006 Gemin X, Inc.

12/1/2006 Gemin X, Inc.

Supression of severe diarrhea


7/31/2000 Genta, Inc.
and flushing associated with
malignant carcinoid syndrome. 8/24/1998 Novartis Pharmaceuticals Corporation
Reduction of growth hormone
and IGF-1 (somatomedin C) in
acromegaly. 8/24/1998 Novartis Pharmaceuticals Corporation

Treatment of profuse watery


diarrhea associated with
VIPoma. 8/24/1998 Novartis Pharmaceuticals Corporation

Treatment of bacterial corneal


ulcers. 4/18/1991 Allergan, Inc.

9/24/2001 Implicit Bioscience Pty Ltd

10/24/1991 Omex International, Inc.

3/10/2006 ChemGenex Pharmaceuticals, Inc.


11/22/1995 Research Triangle Pharmaceuticals

5/4/2000 Pronova Biocare, AS

4/24/1990 Cytogen Corporation

12/17/1996 Genetics Institute, Inc.

1/29/2004 TRF Technologies, Inc.

Treatment of multiple myeloma 12/22/1994 Oxis International, Inc.


patients who have received at
least two prior therapies and
have demonstrated disease
progression on the last therapy 1/15/2003 Millennium Pharmaceuticals, Inc.

10/6/1992 Debio Pharm S.A.

3/29/2006 OxThera, Inc.

7/5/1990 Bio-Technology General Corp.

10/5/1990 Bio-Technology General Corp.

4/22/1997 Savient Pharmaceuticals, Inc.

9/6/1991 Bio-Technology General Corp.

3/18/1994 Bio-Technology General Corp.

Treatment of excessive daytime


sleepiness in patients with
narcolepsy 11/7/1994 Jazz Pharmaceuticals

Treatment of cataplexy
associated with narcolepsy. 11/7/1994 Jazz Pharmaceuticals

3/19/1985 DuPont Merck Pharmaceutical Company

11/9/1998 Cardiome Pharma Corp.

3/7/2001 Inspire Pharmaceuticals, Inc.

10/27/1998 Inspire Pharmaceuticals, Inc.


11/12/2003 Human Genome Sciences, Inc.

For the second line treatment of


AIDS-related Kaposi's sarcoma. 3/25/1997 Bristol-Myers Squibb Pharmaceutical Research Institute

4/15/1997 Baker Norton Pharmaceuticals, Inc.

12/22/2004 Sonus Pharmaceuticals, Inc.

8/31/2007 Immtech Pharmaceuticals, Inc.

5/14/2007 Immtech Pharmaceuticsl, Inc.

11/17/2006 Immtech Pharmaceuticals, Inc.

8/10/2007 Axcan Scandipharm, Inc.

9/26/2007 Novartis Pharmaceuticals Corporation

12/21/1998 Marlyn Nutraceuticals, Inc.

2/6/1992 Pharmedic Company

8/31/2007 NPS Pharmaceuticals, Inc.

5/7/1999 MedImmune, Inc.

2/18/1997 Ear Foundation

10/4/2005 Novartis Pharmaceutical Corporation

Combination chemotherapy for 5/29/1984 Enzon, Inc.


the treatment of patients with
acute lymphoblastic leukemia
who are hypersensitive to native
forms of L-asparaginase. 10/20/1989 Enzon, Inc.

12/9/1992 National Institute of Mental Health, NIH

9/30/1999 Hoffman-La Roche Inc.


Treatment of acromegaly in 7/13/1998 Hoffman-La Roche Inc.
patients who have had an
inadequate response to surgery 2/1/1990 Chiron Corporation
and/or radiation therapy and/or
other medical therapies, or for
whom these therapies are not
appropriate 6/24/1997 Sensus Corporation

4/12/1999 Phoenix Pharmacologics, Inc.

3/26/1999 Phoenix Pharmacologics, Inc.

10/20/1997 Amgen, Inc.

Treatment of patients with


malignant pleural mesothelioma 10/5/1993 BioCryst Pharmaceuticals, Inc.
whose disease is either
unresectable or who are
otherwise not candidates for
curative surgery 8/28/2001 Eli Lilly and Company

1/12/1988 Fujisawa USA, Inc.

2/28/1984 Fujisawa USA, Inc.

10/29/1984 Aventis Behring L.L.C.

10/5/1987 Fisons Corporation

8/28/1985 Du Pont Pharmaceuticals

4/12/2004 Heyl Chemisch-Pharmazeutische Fabrik GMBH & Co. KG

Relief of bladder pain or


discomfort associated with
interstitial cystitis. 8/7/1985 Alza Corporation

1/29/1991 SuperGen, Inc.

11/24/1999 SuperGen, Inc.

3/27/1998 SuperGen, Inc.


Single agent treatment for adult
patients with alpha-interferon-
refractory hairy cell leukemia. 9/10/1987 SuperGen, Inc.

4/27/2006 Digna Biotech, S.L.

4/26/2006 Digna Biotech, S.L.


5/14/2007 Ardana Bioscience Ltd.

4/26/2001 Alliance Pharmaceutical Corp.

12/4/1989 Scios Nova, Inc.

11/20/1997 Sallee, Floyd R. M.D., Ph.D.

3/6/1998 Elan Drug Delivery, Inc.

3/8/1995 Biomarin Pharmaceutical

1/19/2000 Elan Drug Delivery, Inc.

2/14/2002 S.L.A. Pharma

Treatment of symptoms of 9/12/1988 Medea Research Laboratories


xerostomia from salivary gland
hypofunction caused by
radiotherapy for cancer of the
head and neck. 9/24/1990 MGI Pharma, Inc.

Treatment of dry mouth in


patients with Sjogren's
syndrome. 2/28/1992 MGI Pharma, Inc.

10/2/1987 UCB, Inc.

6/13/1988 Burroughs Wellcome Company

3/29/2005 Copernicus Therapeutics, Inc.

5/14/2007 BTG International, Ltd

5/29/2007 BTG International Ltd

6/18/2004 PharmaMar USA, Inc

9/30/2004 PharmaMar USA, Inc.


Expanding the indication to
include patients with malignant
glioma undergoing primary
surgical resection. 12/13/1989 Guilford Pharmaceuticals, Inc.
As an adjunct to surgery to
prolong survival in patients with
recurrent glioblastoma
multiforme for whom surgical
resection is indicated 12/13/1989 Guilford Pharmaceuticals, Inc.

8/5/1997 CytRx Corporation

6/27/1989 SynthRx Corporation

2/22/1990 CytRx Corporation

3/21/1991 CytRx Corporation

5/20/1991 Hemispherx Biopharma, Inc.

12/9/1993 Hemispherx Biopharma, Inc.

12/9/1993 Hemispherx Biopharma, Inc.

7/19/1988 Hemispherx Biopharma, Inc.

2/21/2001 Savient Pharmaceuticals, Inc.

6/6/2005 Phoenix Pharmacologics, Inc.

9/14/1999 Phoenix Pharmacologics, Inc.

12/21/1998 Phoenix Pharmacologics, Inc.

3/17/1997 Oncovir

3/3/2003 Oncovir

8/2/2002 Oncovir

11/19/2002 Oncovir

3/25/1992 Capmed USA

6/9/2006 Jean-Claude Bystryn, M.D.

12/17/1996 Diacrin/Genzyme LLC


12/17/1996 Diacrin/Genzyme LLC

12/10/1996 Diacrin/Genzyme LLC

12/10/1996 Diacrin/Genzyme LLC

For the ablation of high-grade


dysplasia in Barrett's esophagus
6/24/1997 Titan Pharmaceuticals, Inc.
patients who do not undergo
esophagectomy 10/19/2001 Axcan Scandipharm Inc.
Photodynamic therapy with
PHOTOFRIN for the palliation of
patients with completely
obstructing esophageal cancer, 11/18/2004 Axcan Scandipharm Inc.
or of patients with partially
obstructing esophageal cancer
who cannot be satisfactorily
treated with Nd:YAG laser
therapy. 6/6/1989 QLT Phototherapeutics, Inc.

11/15/1989 QLT Phototherapeutics, Inc.

3/13/1997 Boehringer Ingelheim Pharmaceuticals, Inc.

9/19/1995 Boehringer Ingelheim Pharmaceuticals, Inc.

7/16/2004 Schering Corporation

9/12/1985 University of Texas Health Science Center at Dallas

9/16/1985 University of Texas Health Science Center at Dallas

11/1/1984 University of Texas Health Science Center at Dallas

For use as a thyroid blocking


2/14/1986 Willen Drug Company
agent in pediatric patients
exposed to radiactive iodine 11/17/2004 Fleming & Company, Pharmaceuticals

1/8/2007 Framework Therapeutics, LLC

9/3/2004 The Vaccine Company

9/3/2004 The Vaccine Company

9/3/2004 The Vaccine Company

7/5/1990 Pharmos
5/29/1990 Pharmos

5/23/1990 Pharmos

7/20/1990 Pharmos

7/20/2006 Allos Therapeutics, Inc.

11/4/1991 Cambridge Neuroscience, Inc.

4/18/1988 EM Pharmaceuticals, Inc.

6/17/1985 Pharmacia Inc.

7/23/1993 Sanofi Winthrop, Inc.

8/8/2006 Sigma-Tau Pharmaceuticals, Inc.

12/22/1994 Watson Laboratories, Inc.

3/10/1988 Bausch & Lomb

6/12/1998 LTT Baio-Pharma Co., Ltd

9/10/1996 Alpha Therapeutic Corporation

5/21/2003 Biophysica, Inc.


Prevention and treatment of
venous thrombosis and purpura
fulminans 6/23/1992 Baxter Healthcare Corporation

4/22/1993 Immuno Clinical Research Corp.

6/19/1992 Immuno Clinical Research Corp.

8/24/1993 UCB Pharma, Inc.

1/10/1985 Abbott Laboratories

Treatment (rescue) of
12/5/1988 Scios Nova, Inc.
respiratory distress syndrome in
premature infants. 8/2/1993 Dey Laboratories

9/22/1997 Able Laboratories, Inc.

2/9/1995 AutoImmune, Inc.


2/21/2001 Cellular Sciences, Inc

10/17/1984 Lyphomed, Inc.

Treatment of uncomplicated
Plasmodium falciparum malaria 6/3/2004 AR Holding Company, Inc.

10/24/2006 Ascenta Therapeutics, Inc.

2/11/2005 Applied Genetic Technologies Corp.

9/26/2006 Children's Hospital of Pittsburgh

7/14/2005 Eli Lilly and Company

1/25/2007 Alfacell Corporation

3/20/2007 OncoImmune, Inc.


Initial management of plasma
uric acid levels in pediatric
patients with
leukemia,lymphoma, and solid 8/9/2005 ARIAD Pharmaceuticals, Incx.
tumor malignancies who are
receiving anti-cancer therapy
expected to result in tumor lysis
and subsequent elevation of
plasma uric acid. 10/11/2000 Sanofi-Synthelabo Research

1/27/2003 Applied Genetic Technologies Corp.

8/12/2005 Novartis Pharmaceutical Corporation

1/25/2006 Novartis Pharmaceutical Corporation

6/22/1998 Xoma (US) LLC

6/9/2006 Elusys Therapeutics, Inc.

4/26/2006 PharmaOrigin ApS

11/18/2005 BioAxone Therapeutics, Inc.

8/18/2005 Henogen S.A.

1/28/2005 Viventia Biotech, Inc.


For use in patients with Pompe
disease (GAA deficiency). 6/29/2000 NPS Allelix Corp.
Alglucosidase alfa has been
shown to improve ventilator-free
survival in patients with infantile
onset Pompe disease as
compared to an untreated
historical control, whereas use
of Alphaglucosidase 8/19/1997 Genzyme Corporation

4/28/2005 Arriva Pharmaceuticals, Inc.

11/20/2001 Arriva Pharmaceuticals, Inc.

3/6/1998 PPL Therapeutics (Scotland) Limited

8/28/2001 Arriva Pharmaceuticals, Inc.

2/22/2001 Merrimack Pharmaceuticals, Inc.

2/2/2006 Zymenex A/S

2/16/2005 Wyeth Pharmaceuticals, Inc.

4/6/2000 AT III LLC

6/9/2006 Pharming Technologies B.V.

6/9/2006 Pharming Technologies B.V.

2/23/1999 Pharming N.V.

2/23/1999 Pharming N.V.

8/30/1990 Genentech, Inc.

7/13/1998 CC10 Sweden AB

8/13/2001 EntreMed, Inc.

2/21/2002 EntreMed, Inc.

1/29/2004 CuraGen Corporation

3/6/1995 Biogen, Inc.


1/12/1994 Biogen, Inc.

7/24/2006 Nora, LLC

9/20/2000 Novazyme Pharmaceuticals, Inc.

6/7/1995 Pharmacia & Upjohn

6/7/1995 Pharmacia & Upjohn

2/16/2000 GroPep Pty Ltd.

10/13/1995 Cephalon, Inc.

6/15/1999 Insmed, Inc.

10/20/1997 Genetics Institute, Inc.

10/4/2005 Zymo Genetics, Inc


Luveris (lutropin alfa for
injection), concomitantly
administered with Gonal-f
(follitropin alfa for injection), is 12/20/1999 Amgen Inc.
indicated for stimulation of
follicular development in infertile
hypogonadotropic hypogonadal
women with profound LH
deficiency (LH (less t 10/7/1994 Serono Laboratories, Inc.

7/14/2005 Large Scale Biology Corporation

1/23/2006 ThromboGenics Ltd

9/16/2002 Novartis Pharmaceuticals Corp.

4/16/1999 Genentech, Inc.

12/9/2003 Dyax Corporation

2/1/2007 BioMimetic Therapeutics, Inc.

9/9/2002 Zymenex A/S

7/11/2002 ZymmenexA/S
11/3/1995 Connetics Corporation

9/29/1997 Genentech, Inc.

3/22/1999 Biogen, Inc.

3/22/1999 Biogen, Inc.

10/14/1998 Biogen, Inc.

2/3/1998 Biogen, Inc.

2/18/1998 Biogen, Inc.

2/4/2003 Dyax Corp

11/28/1994 Amgen, Inc.

1/25/2005 PEPGEN Corporation

3/16/2004 Ipsen Limited

3/29/2006 Y's Therapeutics, Inc.

7/26/2007 Y's Therapeutics, Inc.

11/15/1993 Genetic Therapy, Inc.

3/29/1991 Amgen, Inc.

3/29/1991 Amgen Inc.

11/20/1989 Biogen, Inc.

3/23/1989 Genentech, Inc.

5/2/2003 Artielle ImmunoTherapeutics, Inc.

6/24/2005 Aerovance, Inc.

10/11/2000 Sanofi-Synthelabo Research


2/14/1994 Telluride Pharmaceutical Corporation

3/6/2000 AstraZeneca LP

1/27/2003 Dompe s.p.a.

5/21/2003 Questcor Pharmaceuticals, Inc.

For the prevention of serious 5/13/2003 Andrew J. Mannes, Md


lower respiratory tract infections
caused by RSV in children less 9/27/1990 MedImmune, Inc.
than 24 months of age with
bronchopulmonary dysplasia or
a history of prematurity (less
than or equal to 35 weeks
gestation). 9/27/1990 MedImmune & Massachussetts Public Health Biologics Labs.

12/9/2002 Cephalon, Inc.

4/29/2002 AVAX technologies, Inc.

5/6/1997 Genzyme Corporation

6/18/2001 Abbott

6/18/2001 Abbott

9/15/1995 Targeted Genetics Corporation

12/9/2003 Insmed Inc.

3/16/2004 ThromboGenics Inc.


Treatment of adults and children
with chronic and acute immune
thrombocytopenic purpura. 11/9/1993 Rh Pharmaceuticals, Inc.

4/12/1991 Valeant Pharmaceuticals International


Treatment of chronic hepatitis C
among previously untreated
pediatric patients at least three
years of age or older. 4/4/2003 Schering Corporation

1/24/1991 ImmunoGen, Inc.

11/17/1988 ImmunoGen, Inc.

8/3/1989 ImmunoGen, Inc.


2/1/1990 ImmunoGen, Inc.

1/25/1991 ImmunoGen, Inc.

Prevention of disseminated
Mycobacterium avium complex
9/6/1994 ImmunoGen, Inc.
disease in patients with
advanced HIV infections. 12/18/1989 Adria Laboratories, Inc.

12/18/1989 Pfizer, Inc.

4/13/1999 PathoGenesis Corporation

12/9/1985 Hoechst Marion Roussel

Short-course treatment of
tuberculosis. 9/12/1985 Hoechst Marion Roussel

3/12/1996 Hoechst Marion Roussel, Inc.

6/9/1995 Hoechst Marion Roussel , Inc.

6/9/1995 Hoechst Marion Roussel

2/10/1998 Salix Pharmaceuticals, Inc.

5/6/1993 Sparta Pharmaceuticals, Inc.

10/15/1996 Rhone-Poulenc Rorer Pharmaceuticals, Inc.


Treatment of patients with
amyotrophic lateral sclerosis.
Riluzole extends survival and/or
time to tracheostomy. 3/16/1993 Rhone-Poulenc Rorer Pharmaceuticals, Inc.

12/18/2006 Proctor and Gamble Pharmaceuticals

2/14/2006 Genentech, Inc.

3/12/2002 Genentech, Inc.

6/13/1994 Genentech, Inc.

1/29/2004 Biogen IDEC, Inc.

3/16/2004 MERCK & Co., Inc.


8/31/2007 Infinity Pharmaceuticals, Inc.

9/30/2004 Gloucester Pharmaceuticals, Inc.

7/1/1993 Pharmacia & Upjohn

12/20/2006 Provectus Pharmaceuticals, Inc.

4/3/2000 Byk Gulden Pharmaceuticals

9/18/2006 Altana Pharma

7/17/2002 SuperGen, Inc.

10/8/2004 Eisai Medical Research, Inc.

Oral replacement therapy of the 3/14/2002 EntreMed Incorporated


genetically determined sucrase
deficiency, which is part of
congenital sucrease-isomaltase
deficiency. 12/10/1993 QOL Medical, LLC

4/30/1998 Genopia USA, Inc.

12/18/2006 Concordia Pharmaceuticals, Inc.


Following induction
chemotherapy in older adult
patients with acute myelogenous 5/3/1990 Immunex Corporation
leukemia to shorten time to
neutrophil recovery and to
reduce the incidence of severe
and life-threatening infections
and infections resulting in death. 3/6/1995 Immunex Corporation

For determining the extent and 6/18/2004 Phytopharm plc


location of extraphepatic
malignant disease in patients
with known colorectal and
ovarian cancer. 9/25/1989 Cytogen Corporation

12/7/2000 SmithKline Beecham Pharmaceuticals

11/12/2003 Debiovision Inc.

4/12/1999 Schering Corporation

7/7/2005 Chemokine Therapeutics Corporation


7/26/1993 Teva Pharmaceuticals USA

6/30/1992 Synergen, Inc.

11/7/1984 Somerset Pharmaceuticals, Inc.

9/14/1988 Serono Laboratories, Inc.

2/13/1990 EMD Serono, Inc.

12/5/1991 EMD Serono, Inc.

9/7/1988 Cell Technology, Inc.

2/18/2004 Seattle Genetics, Inc.

7/18/2003 Seattle Genetics, Inc

8/13/2004 Seattle Genetics, Inc.

8/19/1997 Richard I. Breuer, M.D.

5/29/1990 Richard I. Breuer

11/17/1999 Synthes (USA)

7/15/2003 MedImmune Oncology, Inc.

11/2/2004 Encysive, L.P.

5/23/1990 SmithKline Beecham Pharmaceuticals

3/4/2005 Framework Therapeutics, LLc

7/31/2007 IC-MedTech Corporation

6/11/1990 Stacpoole, Peter W. M.D., Ph.D.

6/11/1990 Stacpoole, Peter W. M.D., Ph.D.

12/31/1997 Questcor Pharmaceuticals, Inc.


11/10/1994 Stacpoole, Peter W. M.D., Ph.D.

7/3/2003 EBD Group

6/14/1999 Questcor Pharmaceuticals, Inc.

4/15/1992 Neutron Technology Corp.& Neutron R&D Partner

12/18/1984 Theragenics Corporation

4/2/2007 Hope Pharmaceuticals, Inc

4/18/2007 Hope Pharmaceuticals

1/17/2007 Hope Pharmaceuticals

3/23/2007 Keystone Pharmaceuticals, Inc.

6/3/2005 Ucyclyd Pharma, Inc.

3/20/2007 Tikvah Therapeutics, Inc.

1/25/2007 Ucyclyd Pharma, Inc.


Adjunctive therapy in the chronic
managment of patients with urea
cycle disorders involving 4/24/1998 Elan Drug Delivery, Inc.
deficiencies of
carbamylphosphate synthetase,
ornithine transcarbamylase, or
argininosuccinic acid
synthetase. 11/22/1993 Medicis Pharmaceutical Corp.

7/2/1992 Medicis Pharmaceutical Corp.

3/31/2003 Cellular Sciences, Inc.

6/16/2006 Surgeon General of the US Army

3/17/2004 Adherex Technologies, Inc.

12/18/2006 Akorn, Inc.

6/16/2006 Keystone Pharmaceuticals, Inc.


11/2/2005 Solbec Pharmaceuticals Limited

2/6/2006 Solbec Pharmaceuticals Limited

3/6/2000 Avant Immunotherapeutics, Inc.

11/21/1994 T Cell Sciences, Inc.

12/12/2005 Octapharma USA, Inc.

6/20/1988 Ferring Laboratories, Inc.

12/22/1994 UCB, Inc.

12/9/1985 Genentech, Inc.

12/9/1985 Genentech, Inc.

12/15/2005 Eli Lilly and Company

Treatment of short stature in


patients with Noonan syndrome 8/9/2006 Novo Nordisk Inc.

11/5/1987 Novo Nordisk Pharmaceuticals


Treatment of short stature
associated with Turner
syndrome in patients whose
epiphyses are not closed. 5/8/1990 Eli Lilly and Company

9/1/1987 Novo Nordisk Pharmaceuticals

2/12/1993 Bio-Technology General Corp.

9/6/1994 Pharmacia & Upjohn

3/16/2004 Serono, Inc.

3/6/1987 Genentech, Inc.

Long term treatment of children


with growth failure due to
5/3/1989 EMD Serono, Inc.
inadequate secretion of
Long-term
endogenous treatment of growth 3/6/1987
growth hormone. Serono Laboratories, Inc.
failure due to a lack of adequate
endogenous growth hormone
secetion for once- or twice-a-
month administration. 10/28/1999 Genentech, Inc.
Long-term treatment of children
who have growth failure due to
inadequate secretion of
endogenous growth hormone.
Treatment of short bowel
7/10/1987 Novo Nordisk Pharmaceuticals
syndrome in patients receiving
specialized nutritional support 3/6/1995 Serono Laboratories, Inc.

3/26/1996 Serono Laboratories, Inc.


Long-term treatment of pediatric
patients who have growth failure
due to Prader-Willi syndrome
For long-term treatment of
(PWS). 7/6/1999 Pharmacia & Upjohn
growth failure in children born
small for gestational age who fail
to manifest catch-up growth by
two years of age. 12/27/2000 Pharmacia and Upjohn Company

6/12/1986 Eli Lilly and Company

11/18/1996 Genentech, Inc.


Treatment of children with
growth failure associated with
chronic renal insufficency. 8/4/1989 Genentech, Inc.

Treatment of AIDS wasting or


cachexia. 11/15/1991 Serono Laboratories, Inc.

Treatment of growth failure


associated with Turner
syndrome. 3/23/1989 Genentech, Inc.

4/20/2006 Bayer Pharmaceuticals Corporation

9/29/2006 Bayer Pharmaceuticals Corp.

Treatment of patients with


advanced renal cell carcinoma 10/8/2004 Bayer Pharmaceutical Corporation

11/9/1995 Bristol-Myers Squibb

9/23/1988 Berlex Laboratories, Inc.

9/23/1988 Berlex Laboratories, Inc.

10/17/1984 Rhone-Poulenc Rorer Pharmaceuticals

Treatment of ovarian cancer 5/11/2001 Genaera Corporation

2/11/2002 Cambridge Antibody Technology, Inc.

2/11/2002 Cambridge Antibody Technology, Inc.

8/12/1987 Sanofi Winthrop, Inc.


8/12/1987 Sanofi Winthrop, Inc.

1/29/2004 Nabi Biopharmaceuticals

3/4/2005 Gamida Cell Ltd

12/8/1997 Novatech SA

12/8/1997 Novatech SA
Prevention of recurrence of
malignant pleural effusions in
symptomatic patients. 9/18/1995 Bryan Corporation

3/12/1996 Sugen, Inc.

5/25/1995 Sugen, Inc.

3/22/1991 Sanofi Winthrop, Inc.

11/5/1990 Sanofi Winthrop, Inc.

5/9/1984 Bock Pharmacal Company

7/15/1993 Fuisz Technologies, Ltd.

3/12/1990 Darby Pharmaceuticals, Inc.

3/4/1991 Darby Pharmaceuticals, Inc.

Toxoplasmosis, as adjunctive
with pyrimethamine 3/14/1994 Eon Labs Manufacturing, Inc.

9/10/1990 Jacobus Pharmaceutical Company

3/6/1985 Pharmacia-Chiron Partnership

5/17/1988 Bio-Technology General Corp.

Treatment and prevention of


respiratory failure due to
5/6/1997 Warner-Lambert Company
pulmonary surfactant deficiency
in preterm infants. 6/7/1985 ONY, Inc.

3/25/1987 Merritt, T. Allen M.D.


7/17/1995 Synsorb Biotech Inc.

9/18/2006 Repligen Corporation

6/16/1999 ChiRhoClin, Inc.

3/7/2000 ChiRhoClin, Inc.

6/16/1999 ChiRhoClin, Inc.

For use in secretin stimulation 6/16/1999 ChiRhoClin, Inc.


testing for: Stimulation of
pancreatic secretions to facilitate 6/18/1999 ChiRhoClin, Inc.
the identification of the ampulla
of Vater and accessory papilla
during endoscopic retrograde
Use in secretin stimulation
cholangio-pancreatography
testing
(ERCP)for stimulation of 6/18/1999 ChiRhoClin, Inc.
pancreatic secretions, including
bicarbonate, to aid in the
diagnosis of pancreatic exocrine
Use in secretin stimulation
dysfunction
testing for stimulation of gastrin
3/7/2000 ChiRhoClin, Inc.
secretion to aid in the diagnosis
of gastrinoma 6/18/1999 ChiRhoClin, Inc.

6/27/1989 AGI Dermatics


Prophylaxis of organ rejection in
patients receiving allogenic
heart transplants. 6/6/2005 Astellas Pharma US, Inc.

4/6/1998 Fujisawa USA, Inc.

12/18/2006 Lilly ICOS LLC

5/13/1998 Tap Holdings Inc.

8/8/2007 Agennix, Inc.

9/29/2006 Agennix, Inc.

8/20/2003 Agennix, Inc.

8/20/2003 Agennix, Inc.

5/8/2006 Hana Biosciences, Inc.

11/1/2001 Nexell Therapeutics Inc.


6/15/2006 TransDerm, Inc.

2/16/2000 Endocyte, Inc.

6/2/1987 NeoRx Corporation

4/7/1992 Immunomedics, Inc.

8/7/1989 Immunomedics, Inc.

8/1/1989 Immunomedics, Inc.

8/1/1989 Immunomedics, Inc.

11/3/2000 Theseus Imaging Corporation

7/20/2006 Taiho Pharma USA, Inc.

4/21/2004 Belpharma N.V.

Treatment of adult patients with 10/28/1999 Biolitec Pharma Ireland Ltd.


newly diagnosed glioblastoma
multiforme concomitatly with
radiotherapy and then as
maintenance treatment 10/5/1998 Schering-Plough Reasearch Institute

10/18/2004 Schering-Plough Research Institute

Treatment of adult patients with


refractory anaplastic 10/14/1998 Schering-Plough Research Institute
astrocytoma, i.e., patients at first
relapse who have experienced
disease progression on a drug
regimen containing a
nitrosourea and procarbazine. 10/5/1998 Schering-Plough Research Institute

Treatment of advanced renal


Induction therapy in patients
cell carcinoma 12/16/2004 Wyeth Pharmaceuticals, Inc.
with refractory childhood acute
lymphoblastic leukemia when
used in combination with other
approved anticancer agents. 11/1/1984 Bristol-Myers Squibb Pharmaceutical Research Institute

1/9/1987 Rhone-Poulenc Rorer Pharmaceuticals, Inc.

10/28/1999 Henri Beaufour Institute USA, Inc.


3/6/1986 Ferring Laboratories, Inc.

10/29/2004 Orphan Therapeutics, LLC

2/5/1996 Unimed Pharmaceuticals, Inc.

9/22/1997 Watson Laboratories

7/31/1991 Star Pharmaceuticals, Inc.

1/16/1991 Bio-Technology General Corp.

12/11/1997 Prestwick Pharmaceuticals, Inc

5/12/1998 Prestwick Pharmaceuticals, Inc.

1/29/2004 Biomarin Pharmaceutical Inc.

5/1/2000 Danforth, Jr., MD, Elliot

1/27/2003 Sanofi-Aventis Pharma

6/5/2002 Antisense Pharma GmbH

2/1/2007 Kuros Biosurgery AG

9/27/2004 Celgene Corporation

5/15/1995 Andrulis Research Corporation

3/11/1996 Celgene Corporation

4/6/1999 Celgene Corporation

9/19/1988 Pediatric Pharmaceuticals, Inc.

9/19/1988 Pediatric Pharmaceuticals, Inc.

11/15/1988 Pediatric Pharmaceuticals, Inc.

1/12/1993 Celgene Corporation


3/5/1990 Andrulis Research Corporation

3/5/1990 Andrulis Research Corporation

Acute treatment of the 2/27/1998 Celgene Corporation


cutaneous manifestations of
moderate to severe erythema 5/1/1995 Celgene Corporation
nodosum leprosum (ENL) and
as maintenance therapy for
prevention and suppression of
the cutaneous manifestations of
ENL recurrences. 7/26/1995 Celgene Corporation

7/29/1998 Celgene Corporation

Treatment of patients with newly


diagnosed multiple myeloma 10/14/1998 Celgene Corporation

4/2/2007 Adienne S.r.l.

3/13/2006 SciClone Pharmaceuticals, Inc.

5/3/1991 SciClone Pharmaceuticals, Inc.

1/8/1998 SciClone Pharmaceuticals, Inc.

3/6/2000 SciClone Pharmaceuticals, Inc.

5/28/2004 RegeneRx Biopharmaceuticals, Inc.

11/16/1987 Iolab Pharmaceuticals


As an adjunctive diagnostic tool
for serum thyroglobulin (Tg) 8/3/2001 Genzyme Corporation
testing with or without
radioiodine imaging in the
follow-up of patients with thyroid
cancer. 2/24/1992 Genzyme Corporation

4/21/1998 Sanofi-Synthelabo, Inc.

12/27/2000 Valeant Research & Development

4/11/2005 Arginox Pharmceuticals, Inc.

11/4/2003 Miravant Medical Technologies


Treatment of giardiasis caused
by G. duodenalis (also termed
Treatment
G. lamblia)ofin intestinal
both adults and
amebiasis and amebic
pediatric patients older liver
than
abcess caused
three years by E. histolytica 4/18/2002
of age Presutti Laboratories, Inc.
in both adults and pediatric
patients older than three years
of age. It is not indicated for the
treatment of asymptomatic cyst
passage. 8/20/2003 Presutti Laboratories, Inc.

1/17/1986 Pak, Charles Y.C. M.D.

7/6/2004 Johnson & Johnson Pharmaceutical Research & Dev.

10/23/2002 Sanofi-Aventis US, Inc.

8/13/1991 Laphal Laboratoires

3/13/2006 Aastrom Biosciences, Inc.

1/25/2007 Aastrom Biosciences, Inc.

For the acute and intermittent


management of increased
5/25/2005 Orfagen
muscle tone associated with
spasticity. 1/31/1994 Athena Neurosciences, Inc.

6/18/1999 Novartis Pharmaceuticals Corp.

Management of cystic fibrosis


patients with P.aeruginosa. 10/13/1994 Novartis Pharmaceuticals Corp

4/15/1988 Sterling Winthrop


As adjunctive therapy in patients
two years and older with
siezures associated with
Lennox-Gastaut syndrome. 11/25/1992 Johnson & Johnson Pharmaceutical R & D, LLC

3/14/2002 Biogen IDEC Inc.

8/17/1993 Orion Corporation


Treatment of metastatic breast
Treatment of patients with CD20
cancer in postmenopausal
positive,
women withfollicular, non-positive or
estrogen
Hodgkin's lymphoma,
receptor unknown with and 9/19/1991
tumors. Orion Corporation
without transformation, whose
disease is refractory to
Rituximab and has relapsed
following chemotherapy 5/16/1994 GlaxoSmithKline

9/30/2004 Johnson & Johnson Pharmaceutical Research & Dev.


3/29/2005 Johnson & Johnson Pharmaceutical Research & Dev.

4/26/2005 TheraQuest Biosciences, LLC

1/28/2005 TheraQuest Biosciences, LLC

10/29/1985 Pharmacia Inc.

7/23/1987 Pharmacia Inc.

9/9/1985 Pharmacia Inc.

12/2/2003 Angiogen Pharmaceuticals, Pty. Ltd.

12/18/1992 Celtrix Pharmaceuticals, Inc.

5/19/1999 PPL Therapeutics (Scotland) Limited

12/14/1999 Genentech, Inc.

5/16/1994 Medac GmbH

Induction
Treatmentofofremission
pulmonaryin arterial
patients with acute
hypertension. 6/4/1997 United Therapeutics Corp.
promyelocytic leukemia who are
refractory to or unable to tolerate
anthracycline based cytotoxic
chemotherapeutic regimens. 10/24/1990 Hoffmann-La Roche, Inc.

1/14/1993 Antigenics, Inc.

4/11/2003 Antigenics, Inc.

4/15/1985 Hannan Ophthalmic Marketing Services, Inc

11/23/2001 Cell Works Inc.

12/24/1984 Merck Sharp & Dohme Research

5/26/2006 Baylor Research Institute

8/10/2000 Medimmune Oncology, Inc.

1/13/1988 Medimmune Oncology, Inc.


Concurrent leucovorin
administration as an alternative
therapy for the treatment of
moderate to severe PCP in
immunocompromised patients
who are intolerant of, or are
refractory to, trimethoprim
sulfamethoxazole. 5/15/1986 Medimmune Oncology, Inc.

7/25/1985 Medimmune Oncology, Inc.

7/25/1985 Medimmune Oncology, Inc.

7/25/1985 Medimmune Oncology, Inc.

8/10/1990 Debio R.A. Inc.

4/12/1987 Chembiomed, Ltd.

4/15/1988 Chembiomed, Ltd.

8/3/1987 Chembiomed, Ltd.

4/20/1987 Chembiomed, Ltd.

6/15/1995 Hemotec Medical Products, Inc.

2/27/2004 CustomCare Pharmacy

4/4/2005 Structural GenomiX, Inc. (SGX)

8/2/2006 Dutch Ophthalmic Research Center Int'l BV

1/6/1993 Serono Laboratories, Inc.

1/6/1993 Serono Laboratories, Inc.

3/8/1995 Kennedy & Hoidal, M.D.'s

9/14/2005 AB Science

4/12/2004 Gel-Tec

4/12/2004 Gel-Tec, Division of TISHCON Corporation

12/14/1999 Gel-Tec, Division of Tishcon Corp.

3/22/2001 Wilex Biotechnology GmbH


12/14/2005 Vitreo Retinal Techologies, Inc

6/26/1996 Inspire Pharmaceuticals, Inc.

12/4/1995 Inspire Pharmaceuticals, Inc.

11/25/1987 Serono Laboratories, Inc.

12/5/1997 Serono Laboratories, Inc.

11/1/1984 Chiron Vision

2/19/1991 Novartis Pharmaceuticals Corporation

6/20/1991 Axcan Pharma Inc.

treatment and/or modification of


the following conditions, which
are complications resulting from
smallpox vaccination: Eczema
vaccinatum Progressive vaccinia
Severe generalized vaccinia
Vaccinia infections in individuals
who have skin conditions such
as 6/18/2004 Cangene Corporation

Treatment and modification of


aberrant infections induced by
vaccinia virus that include its
accidental implantation in eyes
(except in cases of isolated
keratitis), mouth, or other areas
where vaccinia infection would
constitute a special hazard;
eczema 6/18/2004 DynPort Vaccine Company LLC

1/5/1996 Leas Research Products

5/21/2007 Verenta Pharmaceuticals, Inc.


For intravesical therapy of BCG-
refractory carcinoma in situ of
the urinary bladder in patients 6/24/2005 Topo Target Germany AG
for whom immediate cystectomy
would be associated with
unacceptable morbidity or
mortality. 5/23/1994 Anthra Pharmaceuticals, Inc.

10/21/2005 AstraZeneca Pharmaceutical LP

4/6/2004 H3 Pharma, Inc.

1/10/2000 Debiovision, Inc.


1/10/2000 Debiopharm S.A.

3/6/2000 Debiopharm S.A.

11/4/2003 H3 Pharma, Inc.

11/7/2006 Cangene Corporation

3/9/2001 Biogen Idec MA, Inc.

2/22/2005 Biogen Idec MA, Inc.

6/23/1993 Research Triangle Pharmaceuticals

6/16/2006 BioMarin Pharmaceutical Inc.

6/12/2000 Ovation Pharmaceuticals, Inc.

6/11/1984 Stuart Pharmaceuticals

6/11/1984 Stuart Pharmaceuticals

1/8/2007 Hana Biosciences, Inc.

2/1/2001 Lorus Therapeutics Inc.

12/20/2006 University of California San Diego Medical Center


Treatment of cutaneous
manifestations in patients with
cutaneous T-cell lymphoma 6/12/2003 Merck Research Laboratories
(CTCL) who have progressive,
persistant or recurrent disease
on or following two systemic
therapies. 3/16/2004 Merck & Co., Inc.

3/17/2004 Merck & Co., Inc.

11/27/1998 Circe Biomedical, Inc.

9/18/2006 MAT Biopharma

8/3/1999 Immunomedics, Inc.


Combination therapy with
zidovudine is indicated for the
treatment of adult patients with
advanced HIV infection (CD4
count < 300) who have
demonstrated malignant clinical
or immunologic deterioration. 6/28/1988 Hoffmann-La Roche, Inc.

12/9/1986 National Cancer Institute, DCT

7/17/1985 Glaxo Wellcome Inc.

5/12/1987 Glaxo Wellcome Inc.


For maintenance treatment of
patients with Wilson's disease
who have been initially treated
with a chelating agent. 11/6/1985 Lemmon Company

Treatment of hypercalcemia of
malignancy. 8/18/2000 Novartis Pharmaceuticals Corp.

12/15/2005 Kanisa Pharmaceuticals, Inc.


Sponsor Address Text4 Text34 Text56

One Park Place Suite 450 Annapolis MD 21401

2000 Powell Street Suite 1640 Emeryville CA 94608

1020 Stony Hill Road Yardley PA 19067

2190 Parkway Lake Drive Birmingham AL 35244

2190 Parkway Lake Drive Birmingham AL 35244

2190 Parkway Lake Drive Birmingham AL 35244

Three Parkway North Deerfield IL 60015-2548

100 Corporate Court South Plainfield NJ 07080

100 Corporate Court South Plainfield NJ 07080

80 Broad Street New York NY 10004

50 Pequot Avenue New London CT 06320

East Hanover NJ
One Health Plaza Building 105 07936-1080

6725 Mesa Ridge Road Suite 100 San Diego CA 92121

100 Cummings Center Beverly MA 01915

2440 Research Blvd Rockville MD 20850

3130 Highland Avenue, Third Floor Cincinnati OH 45219-2374

3130 Highland Ave. Third Floor Cincinnati OH 45219

211 East Ontario Street Chicago IL 60611

Research Triangle
PO Box 14287; 79 T.W. Alexander Dr. 4401 Research Park NC 27709

500 Kendall Street Cambridge MA 02142


Four Science Park New Haven CT 06511

10, The Quadrant Abington Science Park United Kingdom

New Orleans LA
1600 Canal St. 10th Floor 70112

410 W. Harrison Street Seattle WA 98119-4007

1240 Elko Drive Sunnyvale CA 94089

3832 Bay Center Place Hayward CA 94545

3832 Bay Center Place Hayward CA 94545

6 Cedar Brook Drive Cranbury NJ 08512

6 Cedar Brook Drive Cranbury NJ 08512

300 Technology Square Cambridge MA 02139

2 Executive Drive Suite 450 Somerset NJ 08873

420 Lexington Avenue New York NY 10170

41 Seyon Street Building 1, Suite 100 Waltham MA 02453

101 Elliott Ave., West Seattle WA 98119

University of Utah Health Sciences Salt Lake City UT


Center 50 North Medical Drive, Room 4R240 84132

9620 Medical center Drive Rockville MD 20850

9620 Medical Center Drive Rockville MD 20850

9620 Medical center Drive Rockville MD 20850

9620 Medical Center Drive Rockville MD 20850


9620 Medical Center Drive Rockville MD 20850

NIH, Exec. Plaza N., Room 7-18 Bethesda MD 20892

1510 Delp Drive Kulpsville PA 19443

Montreal, Quebec H3T


Professor of Medicine, McGill University 3755 Cote Ste Catherine 1E2

5500 Stewart Avenue Fremont CA 94538


Richmond VA 23298-
Massey Cancer Center, VCU P.O. Box 980230 0230

1716 Heath Parkway Fort Collins CO 80524

9640 Medical Center Drive Rockville MD 20850

9640 Medical Center Drive Rockville MD 20850

9640 Medical Center Drive Rockville MD 20850

Einsteinweg 55

230 East Grand Ave. South San Francisco CA 94080

230 East Grand Ave. South San Francisco CA 94080-4811

37 Cleveland Avenue P.O. Box 5290 Princeton NJ 08540

University of Vermont 84 Beartown Road Underhill VT 05489

1401 Harbor Bay Parkway Alameda CA 94501

52 Second Avenue Waltham MA 02451

Joakim Tedroff, M.D. S-412 46 Goteborg

2525 Marie-Curie Saint-Laurent (Quebec) H4S 2E1

1095 10th Ave., S.E. Minneapolis MN 55414


11119 North Torrey Pines Road LaJolla CA 92037

Crescent Center Suite 930 Memphis TN 38119

37 Cleveland Lane Princeton NJ 08540

University Of Vermont Given C-317 Burlington VT 05405

Parc scientifique de Lumigny, Case 931 1322 Marseille cedex

920 U S Highway 202 P.O. Box 300 Raritan NJ 08869

4575 SW Research Way Corvallis OR 97333

4575 SW Research Way Corvallis OR 97333

1055 Westlakes Drive Berwyn PA 19312

1950 N. Stemmons Freeway Dallas TX 75207-3199

241, route d'Arlon L-1150

4545 Horizon Hill Blvd. San Antonio TX 78229-2263

10400 Viking Drive Eden Prairie MN 55344

Research Triangle
Five Moore Dr. P.O. Box 13398 Park NC 27709-3398

14 Cambridge Center Cambridge MA 02142

4140 Dublin Blvd. Suite 200 Dublin CA 94568

New Brunswick NJ
New Brunswick Technoloogy Center Building 1, Suite 310 08901-3279

South San Francisco


7000 Shoreline Court Suite 370 CA 94080

3280 Bayshore Blvd Brisbane CA 94005

25 Health Science Drive Stony Brook NY 11790


Bloomington MN
5775 West Old Shakopee Suite 100 55437-3107

901 Mariner's Island Boulevard San Mateo CA 94404-1593

Oaklands Corporate Center 437 Creamery Way Exton PA 19341

Oaklands Corporate Center 437 Creamery Way Exton PA 19341

300 American Road Morris Plains NJ 07950

2525 Dupont Drive P.O. Box 19534 Irvine CA 92623-9534

4140 Dublin Blvd. Suite 200 Dublin CA 94568

P.O. Box 900 Germantown MD 20875-0900

7 Powder Horn Drive Warren NJ 07059

9432 Old Katy Road Houston TX 77055

6455 Nancy Ridge Dr. San Diego CA 92121

Via Tito Speri 10 Pomezia Roma

P.O. Box 4500 Princeton NJ 08543-4500

209 10th Street South Suite 332 Nashville TN 37203 38009

500 Kendall Street Cambridge MA 02142

P.O. Box 1128 Decatur IL 62525

200 Abbott Park Road Abbott Park IL 60064-6188

200 Abbott Park Road Abbott Park IL 60064-6157

P. O. Box 22506

1301 Harbor Bay Parkway Alameda CA 94502


1301 Harbor Bay Parkway Alameda CA 94502

11801 Research Drive Alachua FL 32615

11801 Research Drive Alachua FL 32615

1100 Olive Way, Suite 100 Seattle WA 98101

Los Angeles CA
8455 Beverly Boulevard Suite 308 90048

160 Paulson Road Waban MA 02468

10835 Altman Row Suite 150 San Diego CA 92121

6 Warren Mews London W1T6AR London

718 Bradford Avenue Westfield NJ 07090

3333 Vacaville Parkway Suite 1000 Vacaville CA 95688

300 Technology Square Cambridge MA 02139

128 Spring Street Lexington MA 02173

Philadelphia PA
One Franklin Plaza P.O. Box 7929 19101 35227

Philadelphia PA
One Franklin Plaza P.O. Box 7929 19101 35227

3 Pine View Road Mount Kisco NY 10549

4560 Horton Street Emeryville CA 94608-2916

4560 Horton Street Emeryville CA 94608-2916 33729

4560 Horton Street Emeryville CA 94608-2916 35804

4560 Horton St. Emeryville CA 94608-2916


4545 Horizon Hill Blvd. San Antonio TX 78229-2263 37018

126 East Lincoln Ave. Rahway NJ 07065-0900

Cincinnati OH 45229-
Division of Human Genetics Children's Hospital Research Foundation 3039

146 Medinah Drive Blue Bell PA 19422-3212

146 Medinah Drive Blue Bell PA 19422-3212

One Kendall Square Cambridge MA 02139-1562

One Kendall Square Cambridge MA 02139-1562 33333

55 Challenger Road Ridgefield Park NJ 07660 36193

10275 Science Center Dr. San Diego CA 92121-1117

2301 Highway 60 East Lake Crystal MN 56055

Montville NJ 07045-
Post Office Box 1000 50 Division Street, Suite 503 1000

14132 E. Firestone Boulevard Santa Fe Springs CA 90670

6 Blackstone Valley Place Lincoln RI 02865

Via Olgettina 58 Milan 20132

Research Triangle
3030 Cornwallis Road P.O. Box 12700 Park NC 27709

Research Triangle
3030 Cornwallis Road P.O. Box 12700 Park NC 27709

PO Box 1887 Greenville NC 27835-1887 35202


3030 Cornwallis Road Research Triangle Pk NC 27709

Dagger Lane, Elstree, Hertfordshire WD6 3BX

Dagger Lane Elstree, Hertfordshire

4560 Horton Street Emeryville CA 94608-2916

Kiryat Weizmann

Kiryat Weizmann
King of Prussia PA
1020 First Ave. PO Box 61501 19406-0901

Pharmaceutical Division, Biological


Products 400 Morgan Lane New Haven CT 06516 32113

The Mount Sinai School Of Medicine Fifth Avenue at 100th Street, Box 1203 New York NY 10029

Department of Chemistry Convent Avenue & 138th Street New York NY 10031

700 Main Street Cambridge MA 02139


National Institutes of Health, 31 Center Bethesda MD 20892-
Drive MSC Building 31, Room 9N-222 2560

39 Old Ridgebury Road Suite 11 Danbury CT 06810

P.O. Box 2038 Milwaukee WI 53201

Johns Hopkins University 600 N. Wolfe St., Jefferson 1-109 Baltimore MD 21287

Conshohocken PA
One Tower Bridge 100 Front Street, Suite 400 19428 33233

55 Corporate Drive Bridgewater NJ 08807

Westminister CO
7575 West 103rd Avenue Suite 102 80021-5426 39248

One Amgen Center Drive Thousand Oaks CA 91320-1799

One MedImmune Way Gaithersburg MD 20878

One MedImmune Way Gaithersburg MD 20878

One MedImmune Way Gaithersburg MD 20878


West Conshohocken
One Tower Bridge 100 Front Street, Suite 400 PA 19428 35041
Conshohocken PA
One Tower Bridge 100 Front Street, Suite 400 19428 36335

One MedImmune Way Gaithersburg MD 20878

11 Deer Park Drive Monmouth Junction NJ 08852-1923

Research Triangle
5 Moore Drive PO Box 13398 Park NC 27709

Norfolk VA 23502-
Department of Ophthalomology 880 Kempsville Road, Suite 2500 3990

25 Upton Drive Wilmington MA 01887

66 Hanover Road Florham Park NJ 07932

37 Cleveland Lane P.O. Box 5290 Princeton NJ 08540 34515

580 California Street San Francisco CA 94104

University of Illinois at Chicago College


of Pharm 833 South Wood Street (m/c886) Rm. 176 Chicago IL 60612

University Of Illinois At Chicago College


of Pharm 833 South Wood Street (m/c886) Rm. 176 Chicago IL 60612

University of Illinois at Chicago College


of Pharm 833 South Wood Street (m/c886) Rm. 176 Chicago IL 60612

21 N. Skokie Valley Highway Suite G3 Lake Bluff IL 60044

P.O. Box 8299 Philadelphia PA 19101 34914

3930 Varsity Drive Ann Arbor MI 48108

300 Technology Square Cambridge MA 02139

150 Industrial Road San Carlos CA 94070-6256

One Research Way Princeton NJ 08540

One Research Way Princeton NJ 08540


One Research Way Princeton NJ 08540

One Research Way Princeton NJ 08540

One Research Way Princeton NJ 08540

One Research Way Princeton NJ 08540 35356

Parke-Davis Pharmaceutical Research


Division 2800 Plymouth Road Ann Arbor MI 48106

2500 Millbrook Drive Buffalo Grove IL 60089

Eatontown NJ 07724-
Meridian Center II 4 Industrial Way West 2274

Meridian Center III 6 Industrial Way West Eatontown NJ 07724 35503

Eatontown NJ 07724-
Meridian Center II 4 Industrial Way West 2274

One Kendall Square Cambridge MA 02139

2450 Bayshore Parkway Mountain View CA 94043

2450 Bayshore Parkway Mountain View CA 94043

San Mateo CA 94402-


400 South El Camino Real Suite 1200 1703

3000 Continental Dr., North Mt. Olive NJ 07828

4041 MacArthur Boulevard, Suite 375 Newport Beach CA 92660


Newport Beach CA
4041 MacArthur Blvd. Suite 375 92660

2910 Seventh Street Berkeley CA 94710

2910 Seventh Street Berkeley CA 94710

Quebec G1P 4P5,


Dr. Claude Hariton Chief Medical Officer, VP, Cli Canada

5200 Research Place San Diego CA 92122

21823 30th Drive Southeast Bothell WA 98021


1620 Waukegan Road Mcgaw Park IL 60085

957 Buckingham Avenue Berkshire SL1 4NL

345 North Smith Avenue St. Paul MN 55102

345 North Smith Avenue St. Paul MN 55102

345 North Smith Avenue St. Paul MN 55102

345 North Smith Avenue St. Paul MN 55102

50 Pequot Avenue New London CT 06320

700 Children's Drive Columbus OH 43205

5555 Valley Boulevard Los Angeles CA 90032-3548 39113

P. O. Box 8299 Philadelphia PA 19101-8299

1884 Miles Avenue Elkhart IN 46515 34025

King Of Prussia PA
1020 First Avenue PO Box 61501 19406-0901 36251

Woodland Hills CA
6355 Topanga Canyon Blvd. Suite 510 91367

2910 Seventh Street Berkeley CA 94710

2910 Seventh Street Berkeley CA 94710

4905 23rd Avenue North Minneapolis MN 55447

2 Meridan Road M9W 4Z7

2 Meridan Road M9W427

1896 Rutherford ?Road Carlbad CA 92008


2910 Seventh Street Berkeley CA 94710

9900 Corporate Campus Drive Suite 3000 Louisville KY 40223

Lindhagensgatan 133 SE-112 87 32855


Pharmaceutical Division, Biological
Products 400 Morgan Lane New Haven CT 06516 33602
King of Prussia PA
1020 First Ave. PO Box 61501 19406-0901

9312 Old Georgetown Road Bethesda MD 20814

500 Kendall Street Cambridge MA 02142

1600 Hayes Street Nashville TN 37203

1101 Kermit Drive, Suite 608 Nashville TN 37217

1207 17th Ave. S., Suite 103 Nashville TN 37212 36801

5445 East Cheryl Parkway Madison WI 53711

26 Landsdowne St. Cambridge MA 02139-4234

211 Bailey Rd. West Henrietta NY 14586-9728

Frankland Road Swindon SN5 8RU Wiltshire


Buffalo Grove IL
1110 Lake Cook Rd. Suite 257 60089

Oakdene Court Winnersh, Berkshire RG41 5UA 38097

50 Undine Road Newton MA 02135

West Haven CT
Pharmaceutical Division 400 Morgan Lane 06516 34332

300 American Road Morris Plains NJ 07950

130 Waverly Street Cambridge MA 02139-4242


Boston University Cancer Research Center Boston MA 02118

11726 San Vicente Blvd. Los Angeles CA 90049

University of Cincinnati School of Cincinnati OH 45267-


Medicine/ P. O. Box 670669 231 Albert Sabin Way 0559

41 Moores Road Frazer PA 19355

41 Moores Road Frazer PA 19355

41 Moores Road Frazer PA 19355

201 Elliott Ave. West Suite 400 Seattle WA 98119 36794

41 Moores Road Frazer PA 19355

41 Moores Road Frazer PA 19355

41 Moores Road Frazer PA 19355

41 Moores Road P.O. Box 4011 Frazer PA 19355


East Hanover NJ
Bldg 405/4051 One Health Plaza 07936-1080

Ft. Detrick MD 21702-


Office of the Surgeon General 622 Neiman Street 9240

Special Programme for Research and


Training in Tro Via Appia , Geneva 27

783 Jersey Avenue New Brunswick NJ 08901

2921 W. McArthur Blvd. Santa Ana CA 92704-6929

Lilly Corporate Center Indianapolis IN 46285

Research Triangle
5 Moore Drive PO Box 13398 Park NC 27709 36165

5 Moore Drive Research Triangle Park NC 27709 33933


Research Triangle
5 Moore Drive PO Box 13398 Park NC 27709

Research Triangle
5 Moore Drive PO Box 13398 Park NC 27709-3398

8060 Reeder Street Lenexa KS 66214-1554

Two Connell Drive Berkeley Heights NJ 07922

Two Connell Drive Berkeley Heights NJ 07922

Two Connell Drive Berkeley Heights NJ 07922

3005 First Avenue Seattle WA 98121

1946 Young Street Honolulu HI 96826

22322 20th Avenue SE Suite 150 Bothell WA 98021


Overland Park KS
9200 Indian Creek Parkway Building 9, Suite 200 66210
Los Angeles CA
2029 Century Park East Sixth Floor 90067

7000 SW 97th Avenue Miami FL 33173

3 Forbes Rd. Lexington MA 02421

3 Forbes Rd. l MA 02421

Princeton NJ 08540-
600 College Road East CN 5308 5308

La Jolla Laboratories San Diego CA 92121

2525 28th Street Boulder CO 80301 38126

787 Seventh Ave., 48th Floor New York NY 10019

2025 First Ave. Suite 800 Seattle WA 98121

P. O. Box 970 Pacific Palisades CA 90272


One Executive Drive P.O. Box 1399 Fort Lee NJ 07024

800 53rd Avenue N.E. Minneapolis MN 55432 33780

1400 Providence Highway Norwood MA 02062

Minneapolis MN
800 53rd Avenue N.E. P.O. 1250 55440-9087

710 Medtronic Parkway NE Minneapolis MN 55432-5604

1700 Perimeter Park Drive Morrisville NC 27560 39071

59 Route 10 East Hanover NJ 07936-1080 35927

A Subsidiary of DOR BioPharma, Inc. 850 Bear Tavern Road Ewing NJ 08628

A Subsidiary of DOR BioPharma, Inc. 850 Bear Tavern Road Ewing NJ 08628

41 Moores Road Frazer PA 19355

2525 McGaw Avenue P.O. Box 19791 Irvine CA 92623 32134

8125 N. Hayden Road Scottsdale AZ 85258 38400

677 W. Dekalb Pike King of Prussia PA 19406

70 Grand Avenue River Edge NJ 07661

West Hanford CT
836 Farmington Avenue Suite 207 06119-1551

625 Cleveland Avenue Columbus OH 43215

625 Cleveland Avenue Columbus OH 43215 33420

625 Cleveland Avenue Columbus OH 43215 33420

68 T.W. Alexander Drive, PO Box 14186 Research Triangle Park NC 27709

Bldg. 337, Paint Branch Drive College Park MD 20742


Bldg. 337, Paint Branch Drive College Park MD 20742

3180 Porter Drive Palo Alto CA 94304 35363

Los Angeles CA
8455 Beverly Blvd. Suite 308 90048

Los Angeles CA
8455 Beverly Blvd. Suite 308 90048

1440 Davey Road Woodridge IL 60517

1 DNA Way South San Francisco CA 94080-4990

1 DNA Way South San Francisco CA 94080-4990

1 DNA Way, MS #242 South San Francisco CA 94080-4990

1 DNA Way South San Francisco CA 94080-4990

55 Challenger Road Ridgefield Park NJ 07660 36523

Guardwell, Kinsale County Cork

70 Grand Avenue Suite 109 River Edge NJ 07661

Suite 235 7200 Hudson Blvd. Oakdale MN 55128

14 Emmett Place Whitby, Ontario L1R 2B4 38924

7000 SW 97th Avenue Miami FL 33173

Ion Channel Advances PO Box 14487 Durham NC 27709

One MedImmune Way Gaithersburg MD 20878

8 Campus Drive Parsippany NJ 07054

11199 Sorrento Valley Rd. San Diego CA 92121-1334


P.O. Box 4000 Princeton NJ 08543 35115

5 Research Parkway Wallingford CT 06492

40 Landsdowne Street Canbridge MA 02139 38436

1840 Gateway Dr. 2nd Floor San Mateo CA 94404 37215

1 Bath Rd., Maidenhead Berkshire SL6 4UH

1 Bath Road Maidenhead Berkshire, SL6 4UH

1155 15th Street, N.W., #315 Washington DC 20005

2525 Dupont Drive P.O. Box 19534 Irvine CA 92623-9534

1261 Furnace Brook Parkway Quincy MA 02169

2525 Dupont Drive P.O. Box 19534 Irvine CA 92623-9534 36881

2525 Dupont Drive P.O. Box 19534 Irvine CA 92713 32871

2525 Dupont Drive P.O. Box 19534 Irvine CA 92713 32871

800 Gateway Blvd. South San Francisco CA 94080 36868

27 Maple Street Milford MA 01757-3650

27 Maple Street Milford MA 01757-3650

2151 Berkeley Way Berkeley CA 94704-1011 37917

1030 North Parkview Drive Bismarck ND 58501

4001 Lexington Avenue North Arden Hills MN 55126

540 Arapeen Drive, Suite 202 Salt Lake City UT 84108

One Gustave L. Levy Place New York NY 10029

2525 Dupont Dr. P.O. Box 19534 Irvine CA 92623-9534


1950 Lake Park Drive Smyra GA 30080

900 Ridgebury Road, Box 368 Ridgefield CT 06877-0368

225 East Deerpath, Suite 250 Lake Forest IL 60045

610 Lincoln Street Waltham MA 02451

12419 198th Drive, NE Woodinville WA 98072 35335

1120 Win Drive Bethlehem PA 18017

1901 Huguenot Road Richmond VA 23235 37537

1901 Huguenot Road Richmond VA 23235 37537

34801 Campus Drive Fremont CA 94555 36195

111 Rock Road Horsham PA 19044-2310

4140 Dublin Boulevard Dublin CA 94568

4140 Dublin Blvd Suite 200 Dublin CA 94568

Two Annabel Lane, Suite 220 San Ramon CA 94583


Childrens Hospital of Los Angeles MS
55 Los Angeles CA 90027
Los Angeles CA
Childrens Hospital of Los Angeles 4650 Sunset Blvd, MS 55 90027

1550 East Gude Drive Rockville MD 20850

1550 East Gude Drive Rockville MD 20850

Research Triangle Pk
3030 Cornwallis Road P.O. Box 12700 NC 27709

236 Old Lancaster Road Merion Station PA 19066

5555 Valley Boulevard Los Angeles CA 90032


King of Prussia PA
1020 First Ave. PO Box 61501 19406-0901

One Baxter Way Westlake Village CA 91362


Hyland Division (Baxter Hyland) 550 North Brand Blvd. Glendale CA 91203

21823 30th Drive Southeast Bothell WA 98021

1501 Wakarusa Drive Lawrence KS 66047 36424

59 Route 10 East Hanover NJ 07936

59 Route 10 East Hanover NJ 07936 31716

60 Columbian Street P.O. Box 361 Braintree MA 02184 33217

28101 Ballard Road, Suite F Lake Forest IL 60045

4204 Glencoe Avenue Marina Del Rey CA 90292

190 Commerce Drive Warwick RI 02886

145 Sakonnet Blvd. Narragansett RI 02882

3940 Quebec Avenue North Minneapolis MN 55427

1576 Sweet Home Road Amherst NY 14228

146 Medinah Drive Blue Bell PA 19422-3212

650 Gateway Blvd South San Francisco CA 94080

981F Industrial Road San Carlos CA 94070

San Carols CA
San Carlos Business Park 981F Industrial Road 94070-4117

Immeuble "Le Guillaumet" 60, avenue du General de Gaulle

5 Moore Drive Research Triangle Park NC 27709

460 Seaport Court Suite 220 Redwood CA 94063

102 Tremont Way Augusta GA 30907

99 Hayden Avenue Lexington MA 02420-9192


Route 23 & Woodmont Ave., P.O. Box
1510 King Of Prussia PA 19406

2910 Seventh Street Berkeley CA 94710

216 Bath Road Slough SL1 4EN

Charlestown MA
Merit E. Cudkowicz, MD, MSc Building 149 13th Street, Room 2274 02129

P.O. Box 376 Ann Arbor MI 48106

7824 Jackson Street Omaha NE 68114

Amores #1034 Col Del Valle C.P. 03100 Mexico D.F.

One Kendall Square Cambridge MA 02139-1562 37735

1440 Davey Road Woodridge IL 60517

33 ImClone Drive Branchburg NJ 08876

33 ImClone Drive Branchburg NJ 08876 38777

Leinenweberstrasse 5 9041 Freiburg, GERMANY

800 South Frederik Avenue, Suite 300 Gaithersburg MD 20877

901 Sawyer Road Marietta GA 30062 30525

Grillparzerstrasse 10B 81675 Munich

200 Great Valley Parkway Malvern PA 19355-1307

200 Great Valley Parkway Malvern PA 19355-1307

7150 Alexander-Fleming
210 Welsh Pool Road Exton PA 19341

244 Great Valley Parkway Malvern PA 19355

9298 Gaither Road Rockville MD 20877

Sharon Wood Technical Center 11370 Reed Hartman Highway Cincinnati OH 45241

Leinenweberstrasse 5 Postfach 6529

275, avenue Labrosse Pointe-Claire


Feinberg School of Medicine, Dept. of
Gastroentero 676 N. St. Clair St., Suite 1400 Chicago IL 60611

61 Moulton Street Cambridge MA 02138

8500 Hidden River Pkwy. Tampa FL 33637

One Technology Place Rockland MA 02370

777 Old Saw Mill River Road Tarrytown NY 10591

3200 Walnut Street Boulder CO 80301

3200 Walnut Street Boulder CO 80301

Thousand Oaks CA
One Amgen Center Drive 91320-1799 38054

300 Elliott Avenue West Seattle WA 98119

11 Deer Park Drive Monmouth Junction NJ 08852-1923

34700 Campus Drive Fremont CA 94555-3612

34700 Campus Drive Fremont CA 94555-3612

P.O. Box 2500 Smithtown NY 11787 33148

100 Fairway Drive, Suite 134 Vernon Hills IL 60061


920 US Highway 202 P.O. Box 300 Raritan NJ 08869

Route 202, P.O. Box 300 Raritan NJ 08869 34026

1125 Tenton-Harbourton Road P. O. Box 200 Titusville NJ 08560

Raritan NJ 08869-
920 Route 202 PO Box 300 0602

Route 202 South, P.O. Box 300 Raritan NJ 08869-0602

Gewerbestrasse 16

235 East 42nd Street 150-3-46 New York NY 10017


Kalamazoo MI 49001-
7000 Portage Road Unit 0633-298-113 0199

3423 Hill Canyon Avenue Thousand Oaks CA 91360

4545 Horizon Hill Blvd. San Antonio TX 78229-2263

4545 Horizon Hill Blvd. San Antonio TX 78229-2263 38349

59 Route 10 East Hanover NJ 07936 31761

340 Kingsland Street Nutley NJ 07110

PO Box 16532 Columbus OH 43216-6532 35340

40 Valley Stream Parkway Malvern PA 19335

150 Broadway Suite 1800 New York NY 10038

480 Arsenal Street Watertown MA 02472

The Children's Hospital 300 Longwood Avenue, Bader 760 Boston MA 02115

Two Connell Drive Berkeley Heights NJ 07922

500 Arcola Road, P.O. Box 1200 Collegeville PA 19426 33836


5555 Valley Boulevard Los Angeles CA 90032 33238

87 Cambridge Park Drive Cambridge MA 02140 35472

100 College Road West Princeton NJ 08540 39003

100 College Road West Princeton NJ 08540

100 College Road West Princeton NJ 08540 38544

100 College Road West Princeton NJ 08540 39003

100 College Road West Princeton NJ 08540 38576

100 College Road West Princeton NJ 08540

100 College Road West Princeton NJ 08540 38544

100 College Road West Princeton NJ 08540


Princeton NJ 08540-
100 Overlook Center Suite 200 7810 36244

4520 East-West Highway Third Floor Bethesda MD 20814

825 Challenger Drive Green Bay WI 54311

1100 Orthodox Street Philadelphia PA 19124

1100 Orthodox Street Philadelphia PA 19124

661 Palisade Ave., P.O. Box 931 Englewood Cliffs NJ 07632

5 Moore Drive Research Triangle Park NC 27709 33087

5 Moore Drive Research Triangle Park NC 27709 33087

Research Triangle
5 Moore Drive P.O. Box 13398 Park NC 27709

40 Valley Stream Parkway Malvern PA 19355

230 Third Avenue Waltham MA 02451

321 Arsenal Street Watertown MA 02472


957 Budkingham Avenue Slough

1824 S. Robertson Blvd. Los Angeles CA 90035-4317

421 Wakara Way Salt Lake City UT 84108

14785 Omicron Drive San Antonio TX 78245

400 Rella Boulevard, Suite 201 Suffern NY 10901 35208

1387 Marina Way South Richmond CA 94804

4002 Basel

Level 1, 82 Waterloo Road North Ryde NSW, 2113

228 Hamilton Avenue Palo Alto CA 94301

San Francisco CA
580 California St. Suite 1600 94104

755 Jefferson Rd P.O. Box 1710 Rochester NY 14603 32864

755 Jefferson Rd. P.O. Box 1710 Rochester NY 14603 30958

56 Evergreen Drive Portland ME 04103


Division of Pediatric Allergy &
Immunology Erwin Road Durham NC 27710

3525 John Hopkins Court San Diego CA 92121

3525 John Hopkins Court San Diego CA 92121

3525 John Hopkins Court San Diego CA 92121

Hoarborside Financial Center Plaza 10, 14th Floor Jersey City NJ 07302

950 Tower Lane Suite 790 Foster City CA 94404

Tecnology Ventures Corporation Albuquerque NM


Technopolis 1155 University Blvd., SE 87106

950 Tower Lane Suite 790 Foster City CA 94404


2525 Dupont Drive P.O. Box 19534 Irvine CA 92623-9534

2525 Dupont Drive P.O. Box 19534 Irvine CA 92623-9534

Batiment Genavenir IV F-91058-Evry cedex

Harborside Financial Center Plaza 10, 14th Floor Jersey City NJ 07302

Durham NC 27713-
200 Westpark Corporate Center 4364 South Alston Avenue 2280

College Of Veterinary Medicine Department of Small Animal Medicine Athens GA 30602

300 Fairfield Road Wayne NJ 07470

Ann Arbor MI 48109-


University of Michigan Medical School 300 NIB, 1192 SE 0408

Morgantown WV
781 Chestnut Ridge Road P.O. Box 4310 26504 34561

800 South Frederick Avenue Gaithersburg MD 20877

Framingham MA
One Mountain Rd. P.O. Box 9322 01701-9322

12111 Parklawn Drive Rockville MD 20852


Framingham MA
One Mountain Road P.O. Box 9322 01701-9322

938 Clopper Road Gaithersburg MD 20878

10450 Science Center Drive San Diego CA 92121 36251

Medical University of South Carolina 96 Jonathan Lucas Street, Suite 428 CSB Charleston SC 29425

10390 Pacific Center Court San Diego CA 92121

10390 Pacific Center Court San Diego CA 92121

305 South Street Boston MA 02130-3597 36133


Pharmaceutical Division, Biological
Products 400 Morgan Lane New Haven CT 06516
340 Kingsland Street Nutley NJ 07110 35774

P.O. Box 191 Norwich NY 13815

37 Cleveland Lane P.O. Box 5290 Princeton NJ 08540

37 Cleveland Lane P.O. Box 5290 Princeton NJ 08540

37 Cleveland Lane P.O. Box 5290 Princeton NJ 08540

5 Research Parkway Wallingford CT 06492 38896

5 Research Parkway Wallingford CT 06492 38896

650 Cliffside Drive San Dimas CA 91773 35163

Via Pian Scairolo, 6912 Pazzallo Lugano

3, Azrieli Center Triangular Tower 45th Floor

6611 Tributary Street Baltimore MD 21224-6515

6611 Tributary Street Baltimore MD 21224

6611 Tributary Street Suite 200 Baltimore MD 21224

6611 Tributary Street Suite 200 Baltimore MD 21224 38839

59 Route 10 East Hanover NJ 07936-1080 38658

Apotex Research Inc. Toronto, Canada M9L 1T9

1095 10th Avenue, SE Minneapolis MN 55414

Piazza XX Settembre, 2

Piazza XX Settembre, 2 22079 Villa Guardia (CO)


Via Belvedere 1 Villa Guardia, Italy 22079

505 Penobscot Drive Redwood City CA 94063

6111 Royalmount Avenue, Suite 102 Montreal Quebec H4P 2T4

2401 Foothill Drive Salt Lake City UT 84109-1405

2401 Foothill Drive Salt Lake City UT 84109-1405

55 Challenger Road Ridgefield Park NJ 07660 36196


Eatontown NJ 07724-
Meridian Center II Four Industrial Way West 2274

64 Sidney Street Cambridge MA 02139-4170

King of Prussia PA
1020 First Avenue PO Box 61501 19406-0901 34400

2525 Dupont Drive P. O. Box 19534 Irvine CA 92623-9534

99 Wood Avenue Suite 311 Iselin NJ 08830

Fruebjergvej 3, 2100 Copenhagen 39331

7000 Portage Road Kalamazoo MI 49001-0199 34845

Toronto, Ontario M4P


160 Eglinton Ave. East Suite 600 3B

30 Forest Notch Cohasset MA 02025

1095 10th Avenue S.E. Minneapolis MN 55414

Salt Lake City UT


University Of Utah Medical Center 50 North Medical Drive, Room 4R240 84132

2-31 Koraibashi, Higashi-ku Osaka 541

1000 Madison Ave. Norristown PA 19403

1000 Madison Ave. Norristown PA 19403

1000 Madison Ave. Norristown PA 19403


1620 Waukegan Road McGaw Park IL 60085

3300 Hyland Avenue Costa Mesa CA 92626 35640

2800 Plymouth Rd., P.O. Box 1047 Ann Arbor MI 48106

2400 West Lloyd Expressway Evansville IN 47721

Route 611, P.O. Box 187 Swiftwater PA 18370

10 DeAngelo Drive Bedford MA 01730

Langes Feld 13 Hameln 38210

153 Second Avenue Waltham MA 02451

640 Sasco Hill Road Fairfield CT 06824

11008 Lamplighter Lane Potomac MD 20854

130 Fifth Ave., N. Seattle WA 98109-4933

130 Fifth Ave., N. Seattle WA 98109-4933

5 Moore Drive Research Triangle Park NC 27709 31524

1301 Piccard Drive Rockville MD 20850

800 South Frederick Avenue Gaithersburg MD 20877

610 Herndon Parkway Suite 750 Herndon VA 20170

La Jolla CA 92093-
c/o Univ. of Calif., San Diego 9500 Gilman Dr. 0624

7301 East 22nd Street Suite 10E Tucson AZ 85710

7301 East 22nd Street Suite 10E Tucson AZ 85710


33 Flying Point Road Southampton NY 11968

1900 Patterson Street Suite 104 Nashville TN 37203

3505 Riverview Circle Moorhead MN 56560

29949 S.R. 54 West Wesley Chapel FL 33543

103 Carnegie Center, Suite 102 Princeton NJ 08540

4470 Redwood Highway San Rafael CA 94903

Chestnut Run, Maple Run Centre Rd. Wilmington DE 19805

2215 Mock Road Huntsville AL 35801

San Diego CA 92121-


9373 Towne Center Dr. Suite 100 3088

Overland Park KS
9200 Indian Creek Parkway Building 9, Suite 200 66210

1000 Madison Ave Norristown PA 19403

920 US Highway 202 P. O. Box 300 Raritan NJ 08869

460 Point San Bruno Boulevard South San Francisco CA 94080 34333

One Health Plaza East Hanover NJ 07936-1080

920 US Highway 202, P. O. Box 300 Raritan NJ 08869 39219

215Bouchard Blvd Dorval Quebec H9S 1A9

Mountain View CA
1550 Plymouth St. PO Box 7210 94039-7210 36339

59, Bd Gal Martial Valin - 75015 Paris

100 Technology Drive Suite 440 B Pittsburgh PA 15219

901 Sawyer Rd. Marietta GA 30062 33960


13950 Ballantyne Corporate Place Charlotte NC 28277

207 South Elliott Road PMB#231 Chapel Hill NC 27514

200 First Street Southwest Rochester MN 55905

200 First Street Southwest Rochester MN 55905

352 Knotter Drive Cheshire CT 06410

352 Knotter Drive Cheshire CT 06410 39157


East Hanover NJ
59 Route 10/Bldg 122/N142 One Health Plaza 07936-1080
Westminster CO
11080 CirclePoint Road Suite 200 80020

460 Seaport Court Redwood City CA 94063

P.O. Box 9627 Kansas City MO 64134

P.O. Box 9627 Kansas City MO 64134 33205

10 Mountainview Road Upper Saddle River NJ 07458

Parke-Davis Pharmaceutical Research


Division 2800 Plymouth Road Ann Arbor MI 48105
Santa Monica CA
2825 Santa Monica Blvd. 2nd Floor 90404-2429

4620 Creekstone Drive Research Triangle Park Durham NC 27703

4901 Searle Parkway Skokie IL 60077

4901 Searle Parkway Skokie IL 60077

200 West Arbor Drive San Diego CA 92103-8450

Lilly Corporate Center Indianapolis IN 46285

500 Iolab Drive Claremont CA 91711

P.O. Box 151 Somerville NJ 08876

Kalamazoo MI 49001-
0634-298-113 7000 Portage Rd. 0199 36418
1840 Dehavilland Drive Thousand Oaks CA 91320 33238

1840 Dehavilland Drive Thousand Oaks CA 91320 32660

Raritan NJ 08869-
920 U.S. Highway Route 202, P.O. Box 300 0602

Route 202 South P.O. Box 300 Raritan NJ 08869

Raritan NJ 08869-
920 US Highway 202 P.O. Box 300 0602

Route 202, P.O. Box 300 Raritan NJ 08869

3780 Hawthorn Court Waukegan IL 60087

Research Triangle
Five Moore Dr. PO Box 13398 Park NC 27709-3398 36630

5 Moore Drive Research Triangle Park NC 27709 34962

5 Moore Drive Research Triangle Park NC 27709

301 Henrietta Street Kalamazoo MI 49001

300 American Road Morris Plains NJ 07950

7220 Frederick Banting, Suite 100 Saint-Laurent Quebec H4S 2A1

Houston TX 77030-
Feigin Center Suite 1120 2399

1 DNA Way South San Francisco CA 94080-4990

1980 South Easton Road Suite 250 Doylestown PA 18901

P.O. Box 516, 107/2 MS10 St. Louis MO 63166


607 Herndon Parkway Herndon VA 21070

51 University St. Seattle WA 98101-2936 36307

Parc Technologique du Canal 31521 Ramonville Saint Agne Cedex

Parc Technologique du Canal 31521 Ramonville Saint Agne Cedex

257 Cornelison Avenue Jersey City NJ 07302 32499

70 Wood Avenue, South Iselin NJ 08830

100 Front Street West Conshohocken PA 19428

Kings Park House, Laurelhill Business


Park Polmaise Road, Stirling FK7 9JQ

Bloomington MN
6300 West Old Shakoppe Rd. Suite 110 55438-2318

Bloomington MN
6300 West Old Shakoppe Rd. Suite 110 55438-2318
Bloomington MN
5775 West Old Shakoppe Rd. Suite 100 55437-3107 31888

Two Annabel Lane, Suite 220 San Ramon CA 94583

San Ramon CA
Two Annabel Lane, Suite 220 Suite 10 94583

2001 Aliceanna Street Baltimore MD 21231-3043


Kalamazoo MI 49001-
7000 Portage Road Mail Stop: 0636-298-113 0199 36454

58 South Service Road Suite 110 Melville NY 11747

100 College Road West Princeton NJ 08540

100 College Road West Princeton NJ 08540

King of Prussia PA
1020 First Ave. PO Box 61501 19406-0901

4225 Roosevelt Way Seattle WA 98105

15 Skyline Dr. Hawthorne NY 10532


15 Skyline Dr. Hawthorne NY 10532

301B College Road East Princeton NJ 08540 34179

Fetcham Park House Leatherhead, Surrey KT22 9HD

61 Lincoln's Inn Fields London WC2A 3PX

Los Angeles CA
Childrens Hospital Los Angeles 4650 Sunset Blve, MS 55 90027

Weissfrauenstr.9 D-60287 Frankfurt

100 Pelican Way San Rafael CA 94901

5555 Valley Boulevard Los Angeles CA 90032

310 East 67th Street New York NY 10021

9342 Jeronimo Road Irvine CA 92718

1840 Dehavilland Drive Thousand Oaks CA 91320 34687

1840 Dehavilland Drive Thousand Oaks CA 91320

1840 Dehavilland Drive Thousand Oaks CA 91320 34500

One Amgen Center Dr. Thousand Oaks CA 91320-1799 35887

One Amgen Center Dr. Thousand Oaks CA 91320-1799

1840 Dehavilland Drive Thousand Oaks CA 91320 35061

160 East 34th Street New York NY 10016


15049 San Pablo Avenue, P.O. Box
4099 Richmond CA 94804 33346
Richmond CA 94804-
15049 San Pablo Avenue P.O. Box 4099 0099
Westport CT 06880-
Post House, Suite 213 1720 Post Road East 5643

P.O. Box 200 Titusville NJ 08560


8500 Hidden River Parkway Tampa FL 33637 38450
Division of American Cyanamid
Company 401 N. Middletown Road Pearl River NY 10965

340 Kingsland Street Nutley NJ 07110-1199

340 Kingsland Street Nutley NJ 07110-1199

194 Bureaux de la Colline - Batiment D 92213 Saint-Cloud Cedex

New York NY 10029-


The Mount Sinai School of Medicine One Gustave L. Levy Place 6574

New York NY 10029-


Dept. of Psychiatry Box 1230, One Gustave L. Levy Place 6574

100 Longwater Circle Norwell MA 02061 36670

3180 Porter Drive Palo Alto CA 94304 36868

3180 Porter Drive Palo Alto CA 94304 35768

2800 Plymouth Road Ann Arbor MI 48106 35282

3260 Whipple Road Union City CA 94587-1217

Av de Sevelin, 18-20 Lausanne, Switzerland

South San Francisco


1140 Veterans Blvd. Suite A CA 94080

South San Francisco


1140 Veterans Blvd. Suite A CA 94080

Parke-Davis Pharmaceutical Research


Division 2800 Plymouth Road Ann Arbor MI 48105

1845 Tonne Road Elk Grove Village IL 60007 33255

18-01 River Road Fair Lawn NJ 07410

University of Massachusetts Medical


Center 55 Lake Avenue Worcester MA 01655
21 Business Park Drive Branford CT 06405

3110 Cherry Palm Drive Tampa FL 33619

9342 Jeronimo Road Irvine CA 92718-1903 35128

3401 Hillview Avenue Palo Alto CA 94304 32682


Research Triangle
3030 Cornwallis Road P.O. Box 12700 Park NC 27709

1401 Eye Street, N.W. Suite 900 Washington DC 20005

Thousand Oaks CA
One Amgen Center Drive Mail Stop 17-2-A 91320-1799

PO Box 8299 Philadelphia PA 19101-8299 36663

1 Fitzroy Mews London W1T6DE

10660 Scripps Ranch Blvd. Suite 200 San Diego CA 92131

505 Irving Avenue Syracuse NY 13210


New York NY 10019-
9 West 57th Street Suite 3825 2701

One Research Way Princeton NJ 08540

1510 Delp Drive Kulpsville PA 19443 35419

1090 Horsham Road North Wales PA 19454

5214 Maryland Way, Suite 405 Brentwood TN 37027

4364 South Alston Avenue Durham NC 27713 38148

Subsidiary of Medicis Pharmaceutical


Corporation Scottsdale AZ 85258

Kennedy Krieger Institute, 707 North


Johns Hopkins University Broadway Baltimore MD 21205

Five Concourse Parkway Suite 1800 Atlanta GA 30328


200 Great Valley Parkway Malvern PA 19355-1307

400 Rella Boulevard, Suite 201 Suffern NY 10901 32791

The New York Hospital - Cornell Medical


Center 525 East 68th Street, Box 70 New York NY 10021

500 Kendall Street Cambridge MA 02142

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033

12280 Wilkins Avenue Rockville MD 20852

One Enterprise Way Aliso Viejo CA 92656

59 Route 10 East Hanover NJ 07936-1080

Corona CA 91718-
311 Bonnie Circle PO Box 1900 1900

Wallingford CT
5 Research Parkway P.O. Box 5100 06492-7660

352 Knotter Drive Cheshire CT 06410

Philadelphia PA
One Franklin Plaza P.O. Box 7929 19101 33809

Textile House, 2 Koifman St. Tel-Aviv 68012

Gaithersburg MD
9801 Washingtonian Blvd Suite 220 20878
Chesterfield MO
16020 Swingley Ridge Road Suite 145 63017

Immeuble Le Guillaumet 92046 Paris La Defense

92056 Paris La
Immeuble Le Guillaumet 70 avenue du General de Gaulle, Defense
Diagnostics Division Abbott Park IL 60064 30517

University Of Massachusetts Medical


Center 55 Lake Avenue North Worcester MA 01655

1 Prospect West Wiltshire SN14 6FH

261 Aldwick Road West Sussex PO21 3QU

96 Skyway Avenue M9W 4Y4

12280 Wilkins Avenue Rockville MD 20852

12276 Wilkins Avenue Rockville MD 20852

65 Hayden Avnue Lexington MA 02421

938 Clopper Road Gaithersburg MD 20878

777 Old Saw Mill River Road Tarrytown NY 10591

777 Old Saw Mill River Road Tarrytown NY 10591

33 Hayden Avenue Lexington MA 02421 39205


University of Texas Medical Branch at
Galveston Route J-09, 700 The Strand Galveston TX 77550

Meridian Center III 6 Industrial Way West Eatontown NJ 07724 33596

4954 Van Nuys Boulevard Sherman Oaks CA 91403

9373 Towne Centre Dr., Suite 100 San Diego CA 92121

2730 Wilshire Blvd. #110 Santa Monica CA 90403

500 Arcola Road Collegeville PA 19426

San Diego CA 19426-


Nventa Biopharmaceuticals Corporation 6055 Lusk Boulevard 2655

34801 Campus Drive Fremont CA 94555

Framingham MA
c/o Genzyme Corporation 1 Mountain Rd. 01701-9322
1801 Maple Avenue Suite 4300 Evanston IL 60201

519 Route 173 West Bloomsbury NJ 08804

Tolbodgade 33 DK-1253 Copenhagen K

200 Great Valley Parkway Malvern PA 19355-1307

200 Great Valley Parkway Malvern PA 19355-1307

One Kendall Square Cambridge MA 02139

500 Kendall Street Cambridge MA 02142

66 Ford Road Denville NJ 07834

70 Calle Encanto Tucson AZ 85716

70 Calle Encanto Tucson AZ 85716

7310 Turfway Road Suite 490 Florence KY 41042

244 Great Valley Parkway Malvern PA 19355

244 Great Valley Parkway Malvern PA 19355

P. O. Box 625

5800 Park of Commerce Blvd., NW Boca Raton FL 33487

5800 Park of Commerce Blvd., N.W. Boca Raton FL 33487

5800 Park of Commerce Blvd., NW Boca Raton FL 33487

519 Route 173 West Bloomsbury NJ 08804

5 Research Parkway Signature 91 Bldg/3SIG-3012 Wallingford CT 06492

140 West 57th Street New York City NY 10019

322 East Main Street Branford CT 06405

Rehhagstrsase
200 Great Valley PArkway Malvern PA 19355-1307

5885 Trinity Parkway Suite 350 Centreville VA 20120

Koigle Alle 6

1000 Research Parkway Meriden CT 06450

200 Great Valley Parkway Malvern PA 19355-1307

1500 East Gude Drive Rockville MD 20850

500 Kendall Street Cambridge MA 02142

Charlestown MA
Building 75, 3rd. Ave. Charlestown Navy Yard 02129

340 Kingsland Street Nutley NJ 07110-1199

3030 Callan Rd. San Diego CA 92121

600 Alexander Park Suite 304 Princeton NJ 08540

210 Welsh Pool Road Exton PA 19341

1301 Shoreway Road Suite 320 Belmont CA 94002

790 W. Frontage Road Suite 125 Northfield IL 60093

37 rue Saint Romain 69008 Lyon 39066

3180 Porter Drive Palo Alto CA 94304

Elk Mountain WY
Mile 5.0 Pass Creek Road PO Box 24 82324

6200 Seaforth Street Baltimore MD 21224

P.O. Box 4000 Princeton NJ 08543 35851


2751 Centerville Rd., Suite 210 Wilmington DE 19808

2751 Centerville Rd., Suite 210 Wilmington DE 19808

840 Memorial Drive Second Floor Cambridge MA 02139

Philadelphia PA
d/b/a GlaxoSmithKline P. O. Box 7929 19101

5200 research Place San Diego CA 92122 37306

Westport CT 06880-
1720 Post Road East Suite 213 5643

Westport CT 06880-
1720 Post Road East Suite 213 5643 38820

Invalidenstr. 130 10115 Berlin

Invalidenstr, 130 10115 Berlin

Renal Division 1620 Waukegan Road McGaw Park IL 60085 37610

Kalamazoo MI 49001-
7000 Portage Road Unit 0633-298-113 0199

Kalamazoo MI 49001-
7000 Portage Road Unit 0633-298-113 0199

P.O. Box 16529 Columbus OH 43216 33143

Kalamazoo MI 49001-
7000 Portage Road Unit 0633-298-113 0199

Hammerstrasse 47

Hammerstrasse 47

Hammerstrasse 25 CH-4410 Liestal

225 East Deerpath, Suite 250 Lake Forest IL 60045


700 Main Street Cambridge MA 02139 38922

5 Research Parkway, P.O. Box 5100 Wallingford CT 06492 32507

P.O. Box 4000 Princeton NJ 08543-4000

P.O. Box 4000 Princeton NJ 08543

150 Field Drive Suite 195 Lake Forest IL 60045

1210-885 West Georgia Vancouver, British Columbia San Diego

5000 Shoreline Court South San Francisco CA 94080 38350

300 Fairfield Road Wayne NJ 07470

300 Fairfield Road Wayne NJ 07470

59 Route 10 East Hanover NJ 07936-1080 37021

One Health Plaza East Hanover NJ 07936-1080 39009

One Health Plaza East Hanover NJ 07936-1080 39009

One Health Plaza East Hanover NJ 07936-1080 39009

One Health Plaza East Hanover NJ 07936-1080 39009

One Health Plaza East Hanover NJ 07936-1080 39009

One Health Plaza East Hanover NJ 07936-1080 37288

244 Great Valley Parkway Malvern PA 19355

4380 N. Campbell Ave. Tucson AZ 85718

2321 Camino La Zorrela Tucson AZ 85718


2321 Camino La Zorrela Tucson AZ 85718

2321 Camino La Zorrela Tucson AZ 85718

One Kendall Square Cambridge MA 02139-1562 34477

15222 Avenue of Science Suite C San Diego CA 92128

8368 US 70 West Clayton NC 27520

Plasma Fractionation Institute Ramat Gan 52621

Wankdorfstrasse 10 CH-3000 Bern 22

Baxter Bioscience Westlake Village CA 91362

750 Lexington Avenue New York NY 10022

155 East 56th Street New York NY 10022

750 Lexington Avenue, 19th Floor New York NY 10022

Pharmaceutical Division, Biological


Products 400 Morgan Lane New Haven CT 06516 34330

King of Prussia PA
1020 First Avenue P.O. Box 61501 19406-0901

2 Tesseneer Drive Highland Heights KY 41076

Research Center 27 Village Lane Wallingford CT 06492

76 Rogers Street Cambridge MA 02142

244 Great Valley Parkway Malvern PA 19355

11095 Torreyanna Road San Diego CA 92196

9701 Richmond Avenue Houston TX 77042

Malvern PA 19355-
200 Great Valley Parkway 1307
200 Great Valley Parkway Malvern PA 19355-1307

200 Great Valley Parkway Malvern PA 19355-1307

200 Great Valley Parkway Malvern PA 19355-1307 38856

200 Great Valley Parkway Malvern PA 19355-1307

200 Great Valley Parkway Malvern PA 19355-1307 36031

2250 Holcombe Blvd Houston TX 77030

8995 Westside Parkway Suite 150 Alpharetta GA 30004

3, allee des sequoias* 69760 LIMONEST - France

897 West Sixteenth Street Newport Beach CA 92663

340 Kingsland Street Nutley NJ 07110 34991

340 Kingsland Street Nutley NJ 07110-1199

340 Kingsland Street Nutley NJ 07110

340 Kingsland Street Nutley NJ 07119

340 Kingsland Street Nutley NJ 07110 32468

340 Kingsland Street Nutley NJ 07110-1199

340 Kingsland Street Nutley NJ 07110-1199

2000 Galloping Hill Road Kenilworth NJ 07033 32468

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033


2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033

5 Moore Drive Research Triangle Park NC 27709

3030 Cornwallis Road Research Triangle Pk NC 27709

14 Cambridge Center Cambridge MA 02142

14 Cambridge Center Cambridge MA 02142

14 Cambridge Center Cambridge MA 02142

15049 San Pablo Avenue, P.O. Box


4099 Richmond CA 94804

100 Longwater Circle Norwell MA 02061

14 Cambridge Center Cambridge MA 02142 35202

14 Cambridge Center Cambridge MA 02142

14 Cambridge Center Cambridge MA 02142

100 Longwater Circle Norwell MA 02061

4560 Horton Street Emeryville CA 94608 34173

3280 Bayshore Blvd Brisbane CA 94005 33227


Burlingame CA
1710 Gilbreth Road, Suite 301 94010-1317 36566

1 DNA Way South San Francisco CA 94080-4990


Center for Cancer Drud Discovery and
Development 9500 Euclid Avenue Clevland OH 44195

51 University Street Seattle WA 98101

51 University Street Seattle WA 98101

One Amgen Center Drive Thousand Oaks CA 91320-1799

One Amgen Center Drive Thousand Oaks CA 91320-1799

777 Old Saw Mill River Road Tarrytown NY 10591

777 Old Saw Mill River Road Tarrytown NY 10591

340 Kingsland Street Nutley NJ 07110

340 Kingsland Street Nutley NJ 07110

340 Kingsland Street Nutley NJ 07110

340 Kingsland Street Nutley NJ 07110

51 University Street Seattle WA 98101

59 Route 10 East Hanover NJ 07936

1120 Win Drive Bethlehem PA 18017

39 Jerusalem Street

101 Carnegie Center Princeton NJ 08540

101 Carnegie Center Princeton NJ 08540

Div. of Draxis Specialty


Pharmaceuticals, Inc. Kirkland, Quebec H9H 4J4

160 Second street Cambridge MA 02142

Ann Arbor MI 48109-


UH B1 H410/0028 1500 E. Medical Center Drive 0028 32953

312 Lacebark Street Schererville IN 46375

312 Lacebark Street Schererville IN 46375


University of Michigan Medical Ann Arbor MI 48109-
Center/1500 E. Med. B1G412 /0028 University Hospital 0028

300 American Road Morris Plains NJ 07950

300 American Road Morris Plains NJ 07950

300 American Road Morris Plains NJ 07950

300 American Rd. Morris Plains NJ 07950

American Cyanamide Company 401 N. Middletown Road Pearl River NY 10965

300 American Road Morris Plains NJ 07950

300 American Road Morris Plains NJ 07950

300 American Road Morris Plains NJ 07950

300 American Road Morris Plains NJ 07950

14282 Franklin Ave. Tustin CA 92780-7017

Bloomington MN
5775 West Old Shakoppe Rd. Suite 100 55437-3107

Bloomington MN
5775 West Old Shakoppe Rd. Suite 100 55437-3107

D-14167 Berlin, Federal Republic of


Goerzallee 253 Germany 37896

5555 Valley Boulevard Los Angeles CA 90032

Boston University Cancer Research Center Boston MA 02118

6 Cedar Brook Drive Cranbury NJ 08512

Room 307, Koryo Academytel, 437-3 Ahyun-Dong, Mapo-Gu, Seoul 121-010

28101 Ballard Road Lake Forest IL 60045

640 Memorial Drive, 3rd Floor West Cambridge MA 02139


640 Memorial Drive, 3rd Floor West Cambridge MA 02139

Corona CA 91718-
311 Bonnie Circle P.O. Box 1900 1900
Farmingdale NY
SUNY Farmingdale Conklin Hall 11735

800 S. Frederick Avenue Gaithersburg MD 20877

800 S. Frederick Ave. Gaithersburg MD 20877

P.O. Box 16532 Columbus OH 43216-6532

200 International Circle Hunt Valley MD 21030

Research Triangle
5 Moore Drive P.O. Box 13398 Park NC 27709 36031

27 Maple Street Milford MA 01757 39324

371 Bel Marin Keys Boulevard, Suite


210 Novato CA 94949-5608 37741

1101 Kermit Drive, Suite 608 Nashville TN 37217

6111 Royalmount, Suite 100 Montreal, Quebec H4P 2T4

6111 Royalmount, Suite 100 Montreal, Quebec H4P 2T4

6111 Royalmount, #100 Montreal, Quebec H4P 2T4

University Of Pittsburgh School of


Medicine Pittsburgh PA 15261

The City College, City University Of NY


Medical Sc Convent Avenue at 138 Street New York NY 10031

Channing Laboratory Dept. of Medicine Boston MA 02115


Rush-Presbyterian-St. Luke's Medical Chicago IL 60612-
Ctr., Dept. o 1653 West Congress Parkway 3833

86 Morris Avenue Summit NJ 07901 38713

86 Morris Avenue Summit NJ 07901

86 Morris Avenue Summit NJ 07901 38897


200 West Jackson Blvd. Chicago IL 60606

Frankfurt am Main P.O. Box 1140 Marburg 35860

41 Moores Road Frazer PA 19355

51 University Street Seattle WA 98101 33584

51 University Street Seattle WA 98101 32386


Research Triangle
5 Moore Drive PO Box 13398 Park NC 27709

8229 Boone Blvd. Suite 802 Vienna VA 22182

Stony Brook NY
S.U.N.Y. at Stony Brook H.S.C. T18-020 11794-8181

2355 Waukegan Road Deerfield IL 60015 34075

500 Iolab Drive Claremont CA 94608

800 South Frederick Avenue, Suite 300 Gaithersburg MD 20877 36509

800 South Frederick Avenue Gaithersburg MD 20877

800 South Frederick Avenue Gaithersburg MD 20877

800 South Frederick Avenue Gaithersburg MD 20877

800 S. Frederick Avenue, Suite 300 Gaithersburg MD 20877

800 South Frederick Avenue Gaithersburg MD 20877

800 South Frederick Avenue Gaithersburg MD 20877 33954

800 South Frederick Avenue Gaithersburg MD 20877 31512

901 Sawyer Road Marietta GA 30062

8180 Greensboro Drive, Suite 1000 McLean VA 22102 34159

Torrance CA 90503-
3870 Del Amo Blvd Unit 507 7701

P. O. Box 2072. Toowong Business Center


600 College Road East Princeton NJ 08540

745-D Camden Ave. Campbell CA 95008-4146 36238

21823 30th Drive Southeast Bothell WA 98021

21823 30th Drive Southeast Bothell WA 98021

34801 Campus Drive Fremont CA 94555

Philadelphia PA
One Franklin Plaza P.O. Box 7929 19101 33603

Framingham MA
Metrowest Place 15 Pleasant Street Connector 01701-9322

3 Parkway North Center Deerfield IL 60015

3 Parkway North Center Deerfield IL 60015 35653

3 Parkway North Center Deerfield IL 60015 35653

420 Lexington Avenue New York NY 10170

420 Lexington Avenue New York NY 10170

3929 Point Eden Way Hayward CA 94545

3929 Point Eden Way Hayward CA 94545

11 Deer Park Drive Monmouth Junction NJ 08852-1923

Baylor College of Medicine, Dept. of


Molecular Phy One Baylor Plaza Houston TX 77030

Pol. Ind. Els Vinyets els Fogars n 2, Quinti de Mediona Barcelona

900 North Shore Drive Lake Bluff IL 60044

900 North Shore Drive Lake Bluff IL 60044


M.D. Anderson Cancer Center Unit 038 Houston TX 77030

20651 Prince Creek Dr. Katy TX 77450

One Research Way Princeton NJ 08540

3 Forbes Road Lexington MA 02421

2011 - 94th Street Edmonston, AB

2011 - 94th Street T6N 1H1

201 Elliot Avenue West201 Suite 400 Seattle WA 98119

181 Cherry Valley Road Princeton NJ 08540

181 Cherry Valley Road Princeton NJ 08540

6201 South Freeway Fort Worth TX 76134 34235

Route 202, P.O. Box 300 Raritan NJ 08869

99 Hayden Ave., Suite 200 Lexington MA 02421-7966

12832 Chadron Avenue Hawthorne CA 90250

1801 Maple Avenue Suite 4300 Evanston IL 60201

Subsidiary of China Medical System


Holdings Limite Room 1404, 14th Floor North Point

2600 Kelly Road Warrington PA 18976

2600 Kelly Road Warrington PA 18976

2600 Kelly Road Warrington PA 18976

2600 Kelly Road Warrington PA 18976

2600 Kelly Road Warrington PA 18976


4901 Searle Parkway Skokie IL 60077

Morgantown WV
781 Chestnut Ridge Road P.O. Box 4310 26504-4310 35951

Route 120 & Wilson Road Round Lake IL 60073-0490

26 Landsdowne Street Cambridge MA 02139-4234

10 Rodborough Rd. NSW 2086

P. O. Box 28 Richlands 4077

397 Eagleview Blvd. Exton PA 19341

3 Francis St. Belmont MA 02478

860 Atlantic Avenue Alameda CA 94501

San Diego CA 92121-


10865 Altman Row Suite 200 1113

176 Memorial Drive Jesup GA 31545

Winston-Salem NC
200 East First St. Suite 300 27101-4165

41 Moores Road P. O. Box 4011 Frazer PA 19355

2000 Sierra Point Parkway Suite 400 Brisbane CA 94005 38594

8720 Stony Point Parkway Suite 200 Richmond VA 23235 38698

259 Radnor Chester Road Radnor PA 19087

One MedImmune Way Gaithersburg MD 20878

1787 Sentry Parkway West Building 18, Suite 440 Blue Bell PA 19422

4143 Dornach POSTFASH 137


4143 Dornach POSTFASH 137

340 Kingsland Street Nutley NJ 07110 32630

340 Kingsland Street Nutley NJ 07110 32630

2400 West Lloyd Expressway Evansville IN 47721 34222

Hoag Cancer Center Cell Biology Newport Beach CA


Laboratory Building 41 92658

2110 Rutherford Road Carlsbad CA 92008

5 Research Parkway P. O. Box 5100 Wallingford CT 06492

533 Old Corvallis Road Hamilton MT 59840

8 Hanechoshet St. Tel-Aviv

Oregon Health Sciences University 3181 S.W. Sam Jackson Park Road Portland OR 97201

Ridgefield CT 06877-
900 Ridgebury Road P. O. Box 368 0368 38575
Research Triangle
5 Moore Drive PO Box 13398 Park NC 27709

5 Moore Drive Research Triangle Park NC 27709 33926

146 Medinah Drive Blue Bell PA 19422-3212

146 Medinah Drive Blue Bell PA 19422-3212

P.O. Box 7929 Philadelphia PA 19101


Wilmington DE
1800 Concord Pike PO Box 15437 19850-5437

890 East St. Tewksbury MA 01876-1496

65 Challenger Road Ridgefield Park NJ 07660 32507

90 Gold Street, 6N New York NY 10038

P.O. Box 8299 Philadelphia PA 19101-8299

Division of American Cyanamid


Company 401 N. Middletown Road Pearl River NY 10965 32240

Durham NC 27713-
200 Westpark Corporate Center 4364 South Alston Avenue 2280
437 Creamery Way Exton PA 19431

9360 Towne Centre Drive San Diego CA 92121

9360 Towne Center Drive San Diego CA 92121

P.O. Box 331329 Fort Worth TX 76163

4901 Searle Parkway Skokie IL 60077

P.O. Box 331329 Fort Worth TX 76163 32469

2988 Cove Trace Charlottesville VA 22911

55 Knollwood Road Farmington CT 06032

2530 Meridian Parkway Suite 3023 Durham NC 27713

8010 Arco Corporate Drive Raleigh NC 27617

Meridian Center III 6 Industrial Way West Eatontown NJ 07724 35314

9 Parker Irvine CA 92618-1605

19, rue Frederick Lmaitre 75020 Paris

149 Commonwealth Drive Menlo Park CA 94025

Gewerbestrasse 16 CH - 4123 Allschwi 37833

Weismullerstrasse 50

Division of American Cyanamid


Company 401 N. Middletown Road Pearl River NY 10965

Autoimmunity Research, Inc. Thousand Oaks CA 91360

15 East 26th Street New York NY 10010

4545 Horizon Hill Blvd. San Antonio TX 78229-2263

990 Station Road Bellport NY 11713


990 Station Road Bellport NY 11713

3100 Airway Avenue, Suite 106 Costa Mesa CA 92626

One Technology Place Rockland MA 02370 35382

One Technoloogy Place Rockland MA 02370 36812

One Technology Place Rockland MA 02370 36812


Division of American Cyanamid
Company 401 N. Middletown Road Pearl River NY 10965 32134

300 American Rd. Morris Plains NJ 07950

300 American Road Morris Plains NJ 07950

145 Brandywine Parkway West Chester PA 19380 36153

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Road Kenilworth NJ 07033

Ackerstein Towers, Bldg B, 10th Floor ISRAEL

3030 Callan Road San Diego CA 92121

11011 Torreyana Road San Diego CA 92121

244 Great Valley Parkway Malvern PA 19355

2825 Santa Monica Blvd., Suite 200 Santa Monica CA 90404

2375 Garcia Avenue Mountain View CA 94043

2375 Garcia Avenue Mountain View CA 94043

34801 Campus Dr. Fremont CA 94555

Wellesley Hills MA
15 Walnut Street Suite 300 02481
235 East 42nd Street New York NY 10017

Research Triangle
5 Moore Drive PO Box 13398 Park NC 27709

7855 Gross Point Road, Unit L Skokie IL 60077 31351

2 Esterbrook Lane Cherry Hill NJ 08003 33438

999 East Arques Avenue Sunnyvale CA 94085-4521

4330 La Jolla Village Drive Suite #250 San Diego CA 92122

12280 Wilkins Avenue Rockville MD 20852

12280 Wilkins Avenue Rockville MD 20852

One Health Plaza East Hanover NJ 07936-1080

725 Chesterbrook Blvd. Wayne PA 19087-5677

Mack-Cali Centre II Second Floor Paramus NJ 07652 38239

14272 Franklin Ave. Suite 100 Tustin CA 92780

West Africa House Hanger Lane Ealing London W5 3QR

345 Pioneer Drive, 1803W Glendale CA 91203

5 Artillerivej DK-2300 Copenhagen S

340 Kingsland Street Nutley NJ 07110

340 Kingsland Street Nutley NJ 07110

128 Spring Street Lexington MA 02173


Columbus OH 43215-
Abbott Laboratories 625 Cleveland Ave. 1724

5600 Parkwood Way Suite 425

3, avenue George V

One Amgen Center Drive Thousand Oaks CA 91320-1799


130 Waverly St. Cambridge MA 02139-4242

2525 - 28th Street Boulder CO 80301

3, avenue George V

Abbott Park IL 60064-


Pharmaceuticals Products Division D-491, AP30-1E 6157

555 Madison Avenue New York NY 10022

Global Pharmaceuticals Research &


Development Abbott Park IL 60064

93 Worcester Street Suite 101 Wellesley MA 02481

93 Worcester Street Suite 101 Wellesley MA 02481

93 Pederstrupvej DK-2750 Ballerup

Juncos UN 00777-
Road 198, No. 100 km. 14.7 Juncos Industrial Park 3873

University of Texas Southwestern Dallas TX 75390-


Medical Center at 5323 Harry Hines Blvd 9151

105 Digital Drive Novato CA 94949-5608 38503

11 Deer Park Drive Monmouth Junction NJ 08852

Los Angeles CA
8455 Beverly Blvd. Suite 308 90048

3560 Pennsylvania Avenue, Suite 7 Dubuque IA 52002

Pharmaceutical Products Division 200 Abbott Park Road Abbott Park IL 60064

3401 Hillview Avenue Palo Alto CA 94303 33660

E.I. Du Pont De Nemours & Co. Wilmington DE 19880 31016

4134 Business Park Drive Amarillo TX 79110

4134 Business Park Drive Amarillo TX 79110


4134 Business Park Drive Amarillo TX 79110

Copiaque NY 11726-
33 Ralph Avenue P.O. Box 30 0030

200 Great Valley Parkway Malvern PA 19355

One Franklin Plaza Phildelphia PA 19101 38653

6560 Fannin, Scurlock Tower, Suite 720 Houston TX 77303

400 Rella Boulevard, Suite 201 Suffern NY 10901

MetroHealth Medical Center 3395 Scranton Road Cleveland OH 44109

University of Arizona Tucson AZ 85723

One Health Plaza East Hanover NJ 07936-1080

One Health Plaza East Hanover NJ 07936-1080

5045 Orbitor Drive Mississauga, Ontario L4W 4Y4

New Brunswick NJ
New Brunswick Technology Center 100 Jersey Avenue, Building B, Suite 310 08901

6200 Courtney Campbell Causeway Suite 880 Tampa FL 33607

6200 Courtney Campbell Causeway Suite 880 Tampa FL 33607 37582

6200 Courtney Campbell Causeway Suite 880 Tampa FL 33607 37582

Kungsgatan 37, 7th Floor SE-111 56

Drottninggatan 98 SE-111 60 Stockholm 37274

22705 Savi Ranch Parkway Yorba Linda CA 92887-4645

6 Route 173 Clinton NJ 08809


54 Old Highway 22 Clinton NJ 08809 36517

54 Old Highway 22 Clinton NJ 08809


Thomas Jefferson University and Wills Philadelphia PA
Neurosensory 834 Walnut Street, Suite 650 19107-5102

La Jolla Laboratories 10646 Science Center Drive San Diego CA 92121

675 Almanor Avenue Sunnyvale CA 94085-1

640 S. Fourth Street Louisville KY 40202

West Africa House London W5 3QR


Oklahoma City OK
800 Research Parkway Suite 200 73104

5 Great Valley Parkway Malvern PA 19355

5 Great Valley Parkway Malvern PA 19355

5 Great Valley Parkway Malvern PA 19355

Two Connell Drive Berkeley Heights NJ 07922

59 Route 10 East Hanover NJ 07936-1080 36124

59 Route 10 East Hanover NJ 07936-1080 36124

59 Route 10 East Hanover NJ 07936-1080 36124

2525 Dupont Drive P.O. Box 19534 Irvine CA 92713 35207

P. O. Box 2072 Toowong Business Center

6001 Savoy, Suite 110 Houston TX 77036

3715 Haven Avenue Menlo Park CA 94025


4364 South Alston Avenue Durham NC 27713

PO Box 420 1327 Lysaker

600 College Road East Princeton NJ 08540

87 Cambridge Park Drive Cambridge MA 02140 35759

863 Mitten Road, Suite 101 Burlingame CA 94010

6040 N. Cutter Circle, Suite 317 Portland OR 97217-3935

40 Landsdowne Street Cambridge MA 02139 37754

Rue des Terreaux 17 CH-1000

13709 Progress Blvd. #17 Alachua FL 32615

70 Wood Avenue, South Iselin NJ 08830

70 Wood Avenue, South Iselin NJ 08830

One Tower Center Boulevard, 12th floor East Brunswick NJ 08816

One Tower Center Boulevard, 12 th floor East Brunswick NJ 08816

70 Wood Avenue South Iselin NJ 08830

3180 Porter Drive Palo Alto CA 94304 38674

3180 Porter Drive Palo Alto CA 94304 37454

P.O. Box 80027 Wilmington DE 19880

3650 Westbrook Mall Vancouver, B.C.

4222 Emperor Blvd. Suite 470 Durham NC 27703

4222 Emperor Blvd., Suite 470 Durham NC 27703


9410 Key West Avenue Rockville MD 20850

Wallingford CT
5 Research Parkway P.O. Box 5100 06492-7660 35646

4400 Biscayne Boulevard Miami FL 33137

22026 20th Avenue SE Bothell WA 98021

150 Fairway Drive Vernon Hills IL 60061

150 Fairway Drive Vernon Hills IL 60061

150 Fairway Drive Suite 150 Vernon Hills IL 60061

22 Inverness Parkway Birmingham AL 35242

One Health Plaza East Hanover NJ 07936-1080

14851 N. Scottsdale Rd. Scottsdale AZ 85254

417 Harvester Court Wheeling IL 60090

300 Interpace Parkway Parsippany NJ 07054

35 West Watkins Mill Rd. Gaithersburg MD 20878

2420 Castillo Street, Suite 100 Santa Barbara CA 93105

One Health Plaza East Hanover NJ 07936-1080

20 Kingsbridge Road Piscataway NJ 08854 32953

20 Kingsbridge Road Piscataway NJ 08854 34366


Bethesda MD 20892-
49 Convent Dr. MSC4405 Bldg. 49, Room B1EE16 4405

340 Kingsland St. Nutley NJ 07110-1199


340 Kingsland St. Nutley NJ 07110-1199

4560 Horton Street Emeryville CA 94608

Suite 430, 98 San Jacinto Boulevard Austin TX 78701 37705

115 John Robert Thomas Dr. Exton PA 19341

115 John Robert Thomas Dr. Exton PA 19341

One Amgen Center Dr. Thousand Oaks CA 91320-1789

2190 Parkway Lake Drive Birmingham AL 35244

Lilly Corporate Center Indianapolis IN 46285 38021

3 Parkway North Center Deerfield IL 60015 32674

3 Parkway North Center Deerfield IL 60015 30971

King of Prussia PA
1020 First Avenue PO Box 61501 19406-0901

755 Jefferson Rd., P.O. Box 1710 Rochester NY 14603

E.I. Du Pont De Nemours & Co. Wilmington DE 19898 31916

Goerzallee 253 Fedderal of Republic of Germany

Palo Alto CA 94303-


950 Page Mill Rd. PO Box 10950 0802 35334

4140 Dublin Blvd. Suite 200 Dublin CA 94568

4140 Dublin Blvd. Suite 200 Dublin CA 94568

4140 Dublin Blvd. Suite 200 Dublin CA 94568

4140 Dublin Blvd. Suite 200 Dublin CA 94568 33522

Avenida Carlos III el Noble Pamplona (Navarra)

Avenida Carlos III el Noble, 36, 1 Dcha.


31003
38 Melville Street Scotland

3040 Science Park Road San Diego CA 92191

2450 Bayshore Parkway Mountain View CA 94043

Cincinnati Children's Hospital Medical Cincinnati OH 45229-


Center 3333 Burnet Ave. 3039

1300 Gould Dr. Gainesville GA 30504

371 Bel Marin Keys Blvd. Suite 210 Novato CA 94949

1300 Gould Dr. Gainesville GA 30504

Unit 3, Hill Farm Industrial Estate Leavesden, Watford

Port Jefferson NY
Port Jefferson Business Center 200 Wilson Street, Building D-6 11776

Bloomington MN
5775 West Old Shakopee Rd. Suite 100 55437-3107 34415

Bloomington MN
5775 West Old Shakopee Rd. Suite 100 55437-3107 35837

1950 Lake Park Drive Smyrna GA 30080


Research Triangle
3030 Cornwallis Road P.O. Box 12700 Park NC 27709

11000 Cedar Avenue Cleveland OH 44106

10 Fleet Place London EC4M 7SB

10 Fleet Place London EC4M 7SB

Cambridge MA
University Park at M.I.T. The Richards Building 64 02139-4170

Cambridge MA
University Park at M.I.T. The Richards Building 64 02139-4170

6611 Tributary Street Baltimore MD 21224 37677


6611 Tributary Street Baltimore MD 21224 35331

154 Technology Parkway Norcross GA 30092

4606 Willow Bellaire TX 77401

154 Technology Parkway Norcross GA 30092

154 Technology Parkway Norcross GA 30092

Philadelphia PA
One Penn Center 1617 JFK Boulevard 19103

Philadelphia PA
One Penn Center 1617 JFK Boulevard 19103

Philadelphia PA
One Penn Center 1617 JFK Boulevard 19103

Philadelphia PA
One Penn Center 1617 JFK Boulevard 19103

One Tower Center Boulevard, 14th floor East Brunswick NJ 08816

115 John Robert Thomas Dr. Exton PA 19341

115 John Robert Thomas Dr. Exton PA 19341

115 John Robert Thomas Dr. Exton PA 19341

3202 Cleveland Avenue N.W. Washington DC 20008

3203 Cleveland Ave., NW Washington DC 20008-3450

3203 Cleveland Ave., NW Washington DC 20008-3450

3203 Cleveland Ave., NW Washington DC 20008-3450

P.O. Box 14 Bryn Mawr PA 19010

211 Central Park West New York NY 10024

One Kendall Square Cambridge MA 02139-1562


One Kendall Square Cambridge MA 02139-1562

One Kendall Square Cambridge MA 02129-1562

One Kendall Square Cambridge MA 02139-1562

Post Office Plaza 50 Division Street, Suite 503 Somerville NJ 08876

22 Inverness Parkway Suite 310 Birmingham AL 35242 37834

22 Inverness Parkway Birmingham AL 35242

Lederle Laboratories 401 North Middletown Road Pearl River NY 10965 35060

Lederle Laboratories 401 North Middletown Road Pearl River NY 10965

900 Ridgebury Road PO Box 368 Ridgefield CT 06877

900 Ridgebury Road PO Box 368 Ridgefield CT 06877

2000 Galloping Hill Road Kenilwortoh NJ 07033

5323 Harry Hines Blvd Dallas TX 75235 31289

5323 Harry Hines Blvd Dallas TX 75235 31289

5323 Harry Hines Boulevard Dallas TX 75235 31289

1733 Gilsinn Lane Fenton MO 63026 2958101

1564 33rd Street, NW Washington DC 20007

P. O. Box 93921 Carmel CA 93921

P. O. Box 93921 Carmel CA 93921

P. O. Box 93921 Carmel CA 93921

2 Innovation Drive Alachua FL 32615


2 Innovation Drive Alachua FL 32615

2 Innovation Drive Alachua FL 32615

2 Innovation Drive Alachua FL 32615

11080 CirclePoint Road Westminster CO 80020

1 Kendall Square, Bldg. 700 Cambridge MA 02139

P.O. Box 16529 Columbus OH 43216-6529

90 Park Avenue New York NY 10016

800 South Frederick Avenue Gaithersburg MD 20877

311 Bonnie Circle Corona CA 91720

Pharmaceuticals Division 8500 Hidden River Parkway Tampa FL 33637

Research & Development Division 2-5-1 Atago, Minato-ku, Tokyo

5555 Valley Boulevard Los Angeles CA 90032

2159 Avenida de la Playa Suite B La Jolla CA 92037

One Baxter Way West Lake Village CA 91362 39171

750 Lexington Avenue, 19th Floor New York NY 10022

750 Lexington Avenue, 19th Floor New York NY 10022

1950 Lake Park Drive Smyrna GA 30080

200 Abbott Park Road Abbott Park IL

2450 Bayshore Parkway Mountain View CA 94043

2751 Napa Valley Corporate Drive Napa CA 94558 2958101

200 Highland Avenue Suite 30 Needham MA 02494

128 Spring Street Lexington MA 02421


84 park Avenue P.O. Box 968 Flemington NJ 08822

1100 Orthodox Street Philadelphia PA 19124 38576

11455 El Camino Real San Diego CA 92130

11801 Research Drive Suite D Alachua FL 32615

University of Pittsburgh Pittsburgh PA 15213

Lilly Corporate Center Drop Code 1853 Indianapolis IN 46285

225 Belleville Ave. Bloomfield NJ 07003

1275 Kinnear Road Columbus OH 43212

26 Landsdowne Street Cambridge MA 02139-4234

9 Great Valley Parkway Malvern PA 19355 37449

12085 Research Drive Suite 110 Alachua FL 32615

East Hanover NJ
Oncology Business Unit One Health Plaza 07986

East Hanover NJ
Oncology Business Unit One Health Plaza 07936

2910 Seventh Street Berkeley CA 94710

25 Riverside Drive P.O. Box 102 Pine Brook NJ 07058

Kongevejen 153 2830 Virum

3575 av. du Parc Montreal, Quebec H2X 3P9


Rue des Professeurs Jenner et Brachet,
12 B-6041-Gosselies

10 Four seasons Place Toronto ON M9B 6H7


6850 Goreway Dr. Mississauga

One Kendall Square Cambridge MA 02139 38835

1010 Atlantic Avenue Alameda CA 94501

2020 Challenger Drive Alameda CA 94501

Roslin, Edinburgh EH259PP Scotland

1010 Atlantic Avenue Alameda CA 94501

101 Binney Street Cambridge MA 02142

Roskildevej 12 C

P. O. Box 8299 Philadelphia PA 19101-8299


Framingham MA
c/o Genzyme Corporation 15 Pleasant St. Connector, P.O. Box 9322 01701

Archimedesweg 4

Archimedesweg 4

Cipalstreet 3 B-2440 Geel

Cipalstreet 3 B-2440 Geel

460 Point San Bruno Boulevard South San Francisco CA 94080

Kornhamnstorg 53 Box 2077

9640 Medical Center Drive Rockville MD 20850

9640 Medical Center Drive Rockville MD 20850

322 East Main Street Branford CT 06405

14 Cambridge Center Cambridge MA 02142


14 Cambridge Center Cambridge MA 02124

2400 Boston Street Baltimore MD 21224


Oklahoma City OK
800 Research Parkway Suite 200 73104

7000 Portage Road Kalamazoo MI 49001-0199

7000 Portage Road Kalamazoo MI 49001-0199

Gate 11, Victoria Dr. Adelaide SA 5000

41 Morres Road P. O. Box 4011 Frazer PA 19355

P.O. Box 2400 Glen Allen VA 23058-2400

87 CambridgePark Drive Cambridge MA 02140

1201 Eastlake Avenue East Seattle WA 98102

One Amgen Center Dr. Thousand Oaks CA 91320-1799

One Technology Place Rockland MA 02370 38268

3333 Vaca Valley Parkway Vacaville CA 95688

Unit 14, Bridgecourt Office Park Dublin

One Health Plaza East Hanover NJ 07936-1080

1 DNA Way South San Francisco CA 94080

300 Technology Square Cambridge MA 02139

389-A Nichol Hill Road Franklin TN 37067

Roskildevej 12C 3400 Hillerod

Roskildevej 12C 3400 Hillerod


3400 West Bayshore Road Palo Alto CA 94303

1 DNA Way South San Francisco CA 94080-4990

14 Cambridge Center Cambridge MA 02142

14 Cambridge Center Cambridge MA 02142

14 Cambridge Center Cambridge MA 02142

14 Cambridge Center Cambridge MA 02142

14 Cambridge Center Cambridge MA 02142

300 Technology Square Cambridge MA 02139

One Amgen Center Dr. Thousand Oaks CA 91320-1799

1301 Harbor Bay Parkway Alameda CA 94502

190 Bath Road Berkshire S11 3XE

866 Malcolm Road Burlingame CA 94010

866 Malcolm Road Burlingame CA 94010

938 Clopper Road Gaithersburg MD 20878

3200 Walnut Street Boulder CO 80301

3200 Walnut Street Boulder CO 80301

14 Cambridge Center Cambridge MA 02142

460 Point San Bruno Boulevard South San Francisco CA 94080

Tigard, OR 97223-
9020 SW Washington Square Road Suite 380 4332

2929 Seventh Street Berkeley CA 94710

9 Great Valley Parkway Malvern PA 19355


146 Flanders Drive Hillsborough NJ 08876

725 Chesterbrook Blvd. Wayne PA 19087-5677

Via Campo di Pile 67100 - L'Aquila

3260 Whipple Road Union City CA 94587-1217

Bldg 10/Rm 2N236 -


DASS/PPCS/NIDCR/NIH 10 Convent Drive Bethesda MD 20892

35 West Watkins Mill Road Gaithersburg MD 20878

35 West Watkins Mill Road Gaithersburg MD 20878 35082

41 Moores Road Frazer PA 19355

Overland Park KS
9200 Indian Creek Parkway Building 9, Suite 200 66210

Framingham MA
One Mountain Road P.O. Box 9322 01701-9322
Abbott Laboratories, Dept. 389, Bldg. J- Abbott Park IL 60064-
45 200 Abbott Park Rd. 6135
Abbott Laboratories, Dept. 389, Bldg. J- Abbott Park IL 60064-
45 200 Abbott Park Rd. 6133

1100 Olive Way, Suite 100 Seattle WA 98101

4851 Lake Brooke Drive Glen Allen VA 23060

Unit 14 Walkinstown Avenue Dublin 12

104 Chancellor Matheson Road Winnipeg, Manitoba 34782

3300 Hyland Avenue Costa Mesa CA 92626

2000 Galloping Hill Road Kenilworth NJ 07033 37831

148 Sidney Street Cambridge MA 02139

148 Sidney Street Cambridge MA 02139

148 Sidney Street Cambridge MA 02139


148 Sidney Street Cambridge MA 02139

148 Sidney Street Cambridge MA 02139

148 Sidney Street Cambridge MA 02139

P.O. Box 16529 Columbus OH 43216 33961

235 East 42nd Street New York NY 10017

201 Elliott Avenue West Suite 150 Seattle WA 98119

P.O. Box 9627 Kansas City MO 64134 32653

P.O. Box 9627 Kansas City MO 64134 34485


Kansas City MO
P.O. Box 9627 Mail Station: H3-M2516 64134-0627

Kansas City MO
P.O. Box 9627 Mail Station: H3-M2516 64134-0627

Kansas City MO
P.O. Box 9627 Mail Station: H3-M2516 64134-0627 35968

1700 Perimeter Park Drive Morrisville NC 27560

111 Rock Road Horsham PA 19044-2310

Collegeville PA
500 Arcola Road PO Box 5096 19426-0800

500 Arcola Road, P.O. Box 1200 Collegeville PA 19426 35045

8700 Mason-Montgomery Road Mason OH 08807

1 DNA Way South San Francisco CA 94080-4990

1 DNA Way South San Francisco CA 94080-4990

1 DNA Way, MS 242 South San Francisco CA 94080-4990 35760

5200 Research Place San Diego CA 92122

126 East Lincoln Ave. Rahway NJ 07065


780 Memorial Drive Cambridge MA 02139

One Broadway Cambridge MA 02142

7000 Portage Road Kalamazoo MI 49001-0199

7327 Oak Ridge Highway Knoxville TN 37931

Byk-Gulden StraBe 2 78467 Konstanz

220 Park avenue Florham Park NJ 07932

4140 Dublin Blvd. Suite 200 Dublin CA 94568

55 Challenger Road Ridgefield NJ 07660

9640 Medical Center Dr. Rockville MD 20850

12419 198th Drive, NE Woodinville WA 98072 35894

90 Gold Street, 6N New York NY 10038

1550 Sawgrass Corporate Parkway Sunrise FL 33323

51 University Street Seattle WA 98101 33302

51 University Street Seattle WA 98101 34957

Godmanchester, Cambridgeshire PE29


Corpus Christi House 2HY

600 College Road East Princeton NJ 08540 33967

1250 S. Collegeville Road Collegeville PA 19426-0989

666 Sherbrooke Street West, Suite 1400 Montreal, Quebec

2000 Galloping Hill Rd. Kenilworth NJ 07033

Vancouver, BC V6T
190 Agronomy Road (UBC) Suite 405 1Z3
650 Cathill Rd. Sellersville PA 18960

1885 33rd Street Boulder CO 80301

777 South Harbor Island Boulevard Tampa FL 33602 32664

100 Longwater Circle Norwell MA 02061 35699

One Technology Place Rockland MA 02370

One Technology Place Rockland MA 02370

1668 Valtec Lane Boulder CO 80306

21823 30th Drive Southeast Bothell WA 98021

21823 30th Drive, Southeast Bothell WA 98021

21823 30th Drive Southeast Bothell WA 98021

1000 Central Street, Suite 615 Evanston IL 60201

1000 Central Street, Suite 615 Evanston IL 60201

1690 Russell Road PO Box 1766 Paoli PA 19301

One MedImmune Way Gaithersburg 20878

6700 West Loop South Suite 400 Bellaire TX 77401

One Franklin Plaza Philadelphia PA 19101

1564 33rd Street, NW Washington DC 20007

9902 Indian Creek Lane El Cajon CA 92021

University of Florida P.O. Box 100277 Gainesville FL 32610

University of Florida P.O. Box 100277 Gainesville FL 32610

3260 Whipple Rd. Union City CA 94587-1217


University Of Florida P.O. Box 100277 Gainesville FL 32610

2032 Corte del Nogal Suite 120 Carlsbad CA 92011

3260 Whipple Rd. Union City CA 94587-0700

877 Main Street, Suite 402 Boise ID 83702

8260 E. Gelding Drive #104 Scottsdale AZ 85260

8260 East Gelding Drive Scottsdale AZ 85260

8260 E. Gelding Drive Scottsdale AZ 85260

26072 Merit Circle Laguna Hills CA 92653

8125 North Hayden Road Scottsdaale AZ 85258

75 5th Street, NW. Atlanta GA 30308

8125 N. Hayden Road Scottsdale AZ 85258

1300 Gould Dr. Gainesville GA 30504

8125 N. Hayden Road Scottsdale AZ 85258 35185

8125 N. Hayden Road Scottsdale AZ 85258

84 Park Avenue P. O. Box 968 Flemington NJ 08822

Commander, Us Army Medical Materiel


Dev. Activity Ft. Detrick MD 21702

4620 Creekstone Drive Suite 200 Durham NC 27703

2500 Millbrook Drive Buffalo Grove IL 60089

26072 Merit Circle Laguna Hills CA 92653


P. O. Box 2142 WA 6018

P. O. Box 2142 Osbourne Park, Western Australia 6017

119 Fourth Ave. Needham MA 02494-2725

119 Fourth Avenue Needham Heights MA 02194

5885 Trinity Parkway Suite 350 Centreville VA 20120

400 Rella Boulevard, Suite 201 Suffern NY 10901

1950 Lake Park Drive Smyrna GA 30080

460 Point San Bruno Boulevard South San Francisco CA 94080

460 Point San Bruno Boulevard South San Francisco CA 94080 31337

Lilly Corporate Center Indianapolis IN 46285

100 College Road West Princeton NJ 08540 39233

100 Overlook Center Suite 200 Princeton NJ 08540

Lilly Corporate Center Indianapolis IN 46285 35429

100 Overlook Center Suite 200 Princeton NJ 08540

70 Wood Avenue, South Iselin NJ 08830

7000 Portage Road Kalamazoo MI 49001-0199 35734

One Technology Place Rockland MA 02370

460 Point San Bruno Boulevard South San Francisco CA 94080 31337

One Technology Place Rockland MA 02370

100 Longwater Circle Norwell MA 02061 2958101

1 DNA Way South San Francisco CA 94080-4990 2958101


100 Overlook Center Suite 200 Princeton NJ 08540 2958101

One Technology Place Roackland MA 02370 37956

One Technology Place Rockland MA 02370

Kalamazoo MI 49001-
7000 Portage Rd. 0633-298-113 0199 36697

7000 Portage Road Kalamazoo MI 49001 37097

Lilly Corporate Center Indianapolis IN 46285 31844

460 Point San Bruno Boulevard South San Francisco CA 94080 35779

460 Point San Bruno Boulevard South San Francisco CA 94080 34290

100 Longwater Circle Norwell MA 02061 35300

460 Point San Bruno Boulevard South San Francisco CA 94080 35429

400 Morgan Lane West Haven CT 06516

400 Morgan Lane New Haven CT 06516

400 Morgan Lane West Haven CT 06516 38706

5 Research Parkway P.O. Box 5100 Wallingford CT 06492

300 Fairfield Road Wayne NJ 07470

300 Fairfield Road Wayne NJ 07470 33907

500 Arcola Road Collegeville PA 19426

5110 Campus Drive Plymouth Meeting PA 19462

3260 Hillview Avenue Palo Alto CA 94394

3260 Hillview Avenue Palo Alto CA 94304

9 Great Valley Parkway Malvern PA 19355


9 Great Valley Parkway Malvern PA 19355

12276 Wilkins Avenue Rockville MD 20852

5, Nahum Hafzadi St. Jerusalem 95484

Avenue du Vent des Dames - Z.l. les


Paluds 13685 Aubagne

Avenue du Vent des Dames - Z.l. les


Paluds 13685 Aubagne

4 Plympton Street Woburn MA 01801 35788

230 East Grand Ave. South San Francisco CA 94080-4811

230 East Grand Ave. South San Francisco CA 94080-4811

90 Park Avenue New York NY 10016-1389

90 Park Avenue New York NY 10016-1389

P.O. Box 419056 Saint Louis MO 63141-9056 32499

14555 Avion at Lakeside Chantilly VA 20151

100 Banks Avenue Rockville Centre NY 11570

100 Banks Avenue Rockville Centre NY 11570

227-15 North Conduit Avenue Laurelton NY 11413 34544

37 Cleveland Lane P.O. Box 5290 Princeton NJ 08540

4560 Horton Street Emeryville CA 94608

70 Wood Avenue, South Iselin NJ 08830

Parke-Davis Pharmaceutical Research Ann Arbor MI 48105-


Division 2800 Plymouth Road 2430

1576 Sweet Home Road Amherst NY 14228 2958101

2516 Stockton Boulevard Sacramento CA 95817


201, 1204 Kensington Road, N.W. Calgary, Alberta

41 Seyon Street Waltham MA 02453

15500 Gallaudet Ave. Silver Spring MD 20905-4176

15500 Gallaudet Ave. Silver Spring MD 20905-4176

15500 Gallaudet Ave. Silver Spring MD 20905-4176

1550 Gallaudet Ave. Silver Spring MD 20905-4176

15500 Gallaudet Ave. Silver Spring MD 20905-4176

15500 Gallaudet Ave. Silver Spring MD 20905-4176 37561

15500 Gallaudet Ave. Silver Spring MD 20905-4176 37350

15500 Gallaudet Ave. Silver Spring MD 20905-4176 37350

205 Buffalo Avenue Freeport NY 11520

Three Parkway North Deerfield IL 60015-2548 38805

3 Parkway North Center Deerfield IL 60015

Lilly Corporate Center Indianapolis IN 46285

2355 Waukegan Road Deerfield IL 60015

8 Greenway Plaza Houston TX 77046

8 Greenway Plaza Suite 910 Houston TX 77046

Greenway Plaza Suite 910 Houston TX 77046

8 Greenway Plaza Suite 910 Houston TX 77046

South San Francisco


7000 Shoreline Court Suite 370 CA 94080

9 Parker Irvine CA 92618-1605


2161 Delaware Aenue Santa Cruz CA 95060

1205 Kent Ave. West Lafayette IN 47906

410 West Harrison Seattle WA 98119-4007

300 American Road Morris Plains NJ 07950

300 American Road Morris Plains NJ 07950

300 American Road Morris Plains NJ 07950

300 American Road Morris Plains NJ 07950

124 Mount Auburn Street Suite 200 North Cambridge MA 02138

210 Carnegie Center Princeton NJ 08540

67 Winston Churchill Avenue Brussels

United Drug House Dublin

2000 Galloping Hill Rd. Kenilworth NJ 07033 38426

2000 Galloping Hill Road Kenilworth NJ 07033

2000 Galloping Hill Rd. Kenilworth NJ 07033

2000 Galloping Hill Rd. Kenilworth NJ 07033 36383

P. O. Box 8299 Phildelphia PA 19101-8299 39232

5 Research Parkway P.O. Box 5100 Wallingford CT 06492 33799

500 Arcola Road Collegeville PA 19426 32134

27 Maple St. Milford MA 01757


400 Rella Boulevard, Suite 201 Suffern NY 10901

3 Werner Way Round Valley Executive Center Lebanon NJ 08833

901 Sawyer Rd. Marietta GA 30062


Salt Lake City UT
Research Park 417 Wakara Way 84108

1990 N.W. 44th Street Pompano Beach FL 33064

70 Wood Avenue South Iselin NJ 08830

Washington DC
1825 K Street NW Suite 1475 20006

Washington DC
1825 K Street, NW Suite 1475 20006

371 Bel Marin Blvd. Novato CA 94949

University of Vermont 84 Beartown Rd. Underhill VT 05489

9 Great valley Parkway Malvern PA 19355-1304

Josef-Engert-Str. 9 93053 Regensberg

Technoiparkstrasse 1 Zurich

86 Morris Avenue Summit NJ 07901

11800 Baltimore Avenue, Suite 113 Beltsville MD 20705

P.O. Box 4914 7 Powder Horn Drive Warren NJ 07059

7 Powder Horn Dr. Warren NJ 07059

718 Bradford Avenue Westfield NJ 07090

718 Bradford Avenue Westfield NJ 07090

718 Bradford Avenue Westfield NJ 07090

P.O. Box 4914 7 Powder Horn Drive Warren NJ 07059


11800 Baltimore Avenue, Suite 113 Beltsville MD 20705

11800 Baltimore Avenue, Suite 113 Beltsville MD 20705

7 Powder Horn Dr. Warren NJ 07059

P.O. Box 4914 7 Powder Horn Srive Warren NJ 07059

86 Morris Avenue Summit NJ 07901 35992

7 Powder Horn Dr. Warren NJ 07059

7 Powder Horn Dr. Warren NJ 07059 38862

24128 Bergamo, 64/B Broseta Street Bergamo

901 Mariner's Island Blvd San Mateo CA 94404

901 Mariner's Island Blvd. San Mateo CA 94404-1593

901 Mariner's Island Blvd. San Mateo CA 94404-1593

901 Mariner's Blvd., Suite 205 San Mateo CA 94404-1593

3 Bethesda Metro Center Suite 700 Bethesda MD 20814

500 Iolab Drive Claremont CA 91711

One Kendall Square Cambridge MA 02139-1562

One Kendall Square Cambridge MA 02139 36129

9 Great Valley Parkway PO Box 3026 Malvern PA 19355

3300 Hyland Avenue Costa Mesa CA 92626

120 Constitution Drive Menlo Park CA 94025

336 Bollay Drive Goleta CA 93117


1607 N. Douglas Ave. Arlington Heights IL 60004 38124

1607 N. Douglas Avenue Arlington Heights IL 60004 38124


The University of Texas Health Scienc
Center at Da 5323 Harry Hines Boulevard Dallas TX 75235 32366

920 U.S. Highway 202 Raritan NJ 08869

11 Great Valley Parkway P. O. Box 3026 Malvern PA 19355

48 Bis, Rue des Belles-Feuilles 75116 Paris

Domino's Farms 24 Frank Lloyd Wright Drive Ann Arbor MI 48105

Domino's Farms, Lobby L Ann Arbor MI 48105

Parc Technologique Du Canal-4 31521 Ramonville Saint Agne

800 Gateway Boulevard South San Francisco CA 94080


East Hanover NJ
Drug Regulatory Affairs One Health Plaza 07936-1080

East Hanover NJ
Drug Regulatory Affairs One Health Plaza 07936-1080 35786

9 Great Valley Parkway Malvern PA 19355

Route 202, P.O. Box 300 Raritan NJ 08869-0602 37131

3030 Callan Road San Diego CA 92121

P.O. Box 65 02101 Espoo

P.O. Box 65 02101 ESPOO 35579

King of Prussia PA
2301 Renaissance Blv. P.O. Box 61540 19406-2772 37799

920 US Highway 202 Raritan NJ 08869


920 U S Highway 202 Raritan NJ 08869

146 Medinah Drive Blue Bell PA 19422-3212

146 Medinah Drive Blue Bell PA 19422-3212

P.O. Box 16529 Columbus OH 43216 31776

P.O. Box 16529 Columbus OH 43216

P.O. Box 16529 Columbus OH 43216

Level 31, ABN AMRO Tower 88 Phillip Street Sydney, N.S.W. 2000

3055 Patrick Henry Drive Santa Clara CA 95054

Roslin, Edinburgh EH259PP Scotland

1 DNA Way South San Francisco CA 94080-4990

Fehlandtstrasse 3 D-20354 Hamburg

Research Triangle
68 T.W. Alexander Dr. P.O. Box 14186 Park NC 27709 37397

340 Kingsland Street Nutley NJ 07110 35025

3 Forbes Road Lexington MA 02421

3 Forbes Road Lexington MA 02421

34 Sherrill Rd. Marshfield MA 02050

6200 Seaforth Street Baltimore MD 21224-6506

Division Of Merck And Company West Point PA 19486 31359

Institute of Metabolic Disease 3812 Elm Street Dallas TX 75226

One MedImmune Way Gaithersburg MD 20878

One MedImmune Way Gaithersburg MD 20878


West Conshohocken
One Tower Bridge 100 Front Street, Suite 400 PA 19428 34320

One MedImmune Way Gaithersburg MD 20878

One MedImmune Way Gaithersburg MD 20878

One MedImmune Way Gaithersburg MD 20878

7929 Westpark Drive, Suite 400 Mclean VA 22102

P.O. Box 8050, Station F Edmonton, Alberta

P.O. Box 8050 Edmonton, Alberta

P.O. Box 8050 Edmonton, Alberta

P.O. Box 8050 Edmonton, Alberta

Box 19255 Johnston RI 02919

5710 Hoover Blvd Tampa FL 33634

10505 Roselle Street San Diego CA 92121

Scheijdelveweg 2 P.O. Box 43 3214ZG Zuidland

100 Longwater Circle Norwell MA 02061

100 Longwater Circle Norwell MA 02061

University of Utah Health Sciences Salt Lake City UT


Center 50 North Medical Drive, Room 4R240 84132-0001

3, avenue GeorgeV 75008 Paris

Division of Tishcon Corp P. O. Box 331 Westbury NY 11590

30 New York Avenue P.O. Box 331 Westbury NY 11590

30 New York Ave. PO Box 331 Westbury NY 11590

Grillparzerstrasse 10B 81675 Munich


2 Venture Plaza Irvine CA 92618

4222 Emperor Boulevard, Suite 470 Durham NC 27703

4222 Emperor Boulevard, Suite 470 Durham NC 27703

100 Longwater Circle Norwell MA 02061 31673

One Technology Place Rockland MA 02370

500 Iolab Drive Claremont CA 91711

59 Route 10 East Hanover NJ 07936-1080

597 Laurier Blvd Mount St. Hilaire Quebec H7L 4S3 35774

104 Chancellor Matheson Road Winnipeg, ManitobaR3T 5Y3 2958101

64 Thomas Johnson Drive Frederick MD 21702 38401

78 Fallon Drive North Haven CT 06473

10901 Granada Lane Suite 101 Leawood KS 66211

Paul-Ehrlich Str. 42-44 D-60596 Frankfurt am Main

103 Carnegie Center, Suite 102 Princeton NJ 08540 36063

1800 Concord Pike Wilmington DE 19830-8355

666 Sherbrooke Street West Suite


1400 Montreal, Quebec,
Montreal, Quebec H3A
666 Sherbrooke Street West Suite 1400 1E7
17 rue des Terreaux CH-1000 Lausanne 9

17 rue des Terreaux CH-1000 Lausanne 9

666 Sherbrooke Street West, Suite 1400 Montreal, Quebec

155 Innovation Drive R3T 5Y3

14 Cambridge Center Cambridge MA 02142

14 Cambridge Center Cambridge MA 02142

Durham NC 27713-
200 Westpark Corporate Center 4364 South Alston Avenue 2280

105 Digital Drive Novato CA 94949

Four Parkway North Deerfield IL 60015

Division of ICI Americas Wilmington DE 19897

Division of ICI Americas Wilmington DE 19897

7000 Shoreline Court South San Francisco CA 94080

7100 Woodbine Avenue, Suite 215 Markham, ON L3R 5J2

Hillcrest San Diego CA 92103-8450

Rahway NJ 07065-
Merck & Co., Inc. P. O. Box 2000, RY 32-605 0900

P. O. Box 2000, RY 32-605 Rahway NJ 07065-0900 38996

P. O. Box 2000, RY 32-605 Rahway NJ 07065-0900

99 Hayden Ave. Lexington MA 02421-7995

4 rue Pierre Fontaine

300 American Rd. Morris Plains NJ 07950


340 Kingsland Street Nutley NJ 07110 33774

NIH, Executive Plaza North, Room 7-18 Bethesda MD 20892

5 Moore Drive Research Triangle Park NC 27709 31855

5 Moore Drive Research Triangle Park NC 27709 31855

1510 Delp Drive Kulpsville PA 19443 35458

59 Route 10 East Hanover NJ 07936-1080 37123

12264 El Camino Real San Diego CA 02130


Text72
UNITED KINGDOM
CANADA

NETHERLANDS

SWEDEN

CANADA
FRANCE

LUXEMBOURG
ITALY

NETHERLANDS
UNITED KINGDOM
ITALY
UNITED KINGDOM

UNITED KINGDOM

ISRAEL

ISRAEL
CANADA
UNITED KINGDOM

CANADA

CANADA
SWEDEN

UNITED KINGDOM

UNITED KINGDOM
IRELAND

CANADA
UNITED KINGDOM

UNITED KINGDOM
FRANCE
UNITED KINGDOM

MEXICO

GERMANY

GERMANY

CANADA
GERMANY

CANADA
SWITZERLAND
UNITED KINGDOM

SWITZERLAND

AUSTRALIA
FRANCE
SWITZERLAND

ISRAEL

CANADA

ITALY

ITALY
CANADA

DENMARK

CANADA

JAPAN
GERMANY
CANADA

FRANCE
CANADA
FRANCE

FRANCE

UNITED KINGDOM
UNITED KINGDOM

UNITED KINGDOM

GERMANY
UNITED KINGDOM
ISRAEL

FRANCE

FRANCE
UNITED KINGDOM

UNITED KINGDOM

CANADA
DENMARK

SWEDEN

SWITZERLAND
DENMARK

FRANCE
GERMANY

GERMANY

SWITZERLAND

SWITZERLAND

SWITZERLAND
CANADA
ISRAEL

SWITZERLAND
FRANCE
ISRAEL

CANADA
CANADA

CANADA

CANADA
GERMANY

AUSTRALIA
SPAIN
CANADA

CANADA

HONG KONG
AUSTRALIA

AUSTRALIA

SWITZERLAND
SWITZERLAND

ISRAEL
FRANCE

SWITZERLAND

GERMANY
ISRAEL
UNITED KINGDOM

SWEDEN

CANADA

FRANCE
FRANCE

DENMARK

PUERTO RICO
CANADA

SWEDEN

SWEDEN
UNITED KINGDOM

AUSTRALIA
NORWAY

SWITZERLAND

CANADA
GERMANY

SPAIN

SPAIN
UNITED KINGDOM

UNITED KINGDOM

UNITED KINGDOM

UNITED KINGDOM
JAPAN
DENMARK

CANADA

CANADA
CANADA

UNITED KINGDOM

DENMARK

NETHERLANDS

NETHERLANDS

BELGIUM

BELGIUM

SWEDEN
AUSTRALIA

IRELAND

UNITED KINGDOM

DENMARK

DENMARK
UNITED KINGDOM
ITALY

IRELAND

CANADA
GERMANY

UNITED KINGDOM

CANADA
AUSTRALIA

AUSTRALIA
ISRAEL

FRANCE

FRANCE
CANADA
BELGIUM

IRELAND
GERMANY

SWITZERLAND
ITALY
FRANCE

FRANCE

FINLAND

FINLAND
AUSTRALIA

UNITED KINGDOM

GERMANY
CANADA

CANADA

CANADA

CANADA

NETHERLANDS

FRANCE

GERMANY
CANADA

GERMANY

CANADA

CANADA
SWITZERLAND

SWITZERLAND

CANADA

SWITZERLAND

CANADA

FRANCE